<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003189.pub3" GROUP_ID="HAEMATOL" ID="594900071714310264" MERGED_FROM="" MODIFIED="2008-08-12 13:20:17 +0200" MODIFIED_BY="Nicole Skoetz" REVIEW_NO="" REVMAN_SUB_VERSION="5.0.15" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="13.2">
<COVER_SHEET MODIFIED="2008-08-12 13:20:17 +0200" MODIFIED_BY="Nicole Skoetz">
<TITLE>Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma</TITLE>
<CONTACT MODIFIED="2008-08-12 13:20:17 +0200" MODIFIED_BY="Nicole Skoetz"><PERSON ID="19365" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Julia</FIRST_NAME><LAST_NAME>Bohlius</LAST_NAME><SUFFIX>MPH</SUFFIX><EMAIL_1>julia.bohlius@uk-koeln.de</EMAIL_1><EMAIL_2>jbohlius@ispm.unibe.ch</EMAIL_2><URL>www.chmg.de</URL><ADDRESS><DEPARTMENT>Cochrane Haematological Malignancies Group - Department of Internal Medicine 1</DEPARTMENT><ORGANISATION>University Hospital of Cologne</ORGANISATION><ADDRESS_1>Kerpener Str. 62</ADDRESS_1><CITY>Cologne</CITY><ZIP>50924</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 221 710770 25</PHONE_1><PHONE_2>+49 221 478 0</PHONE_2><FAX_1>+49 221 710770 24</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-08-12 13:20:17 +0200" MODIFIED_BY="Nicole Skoetz"><PERSON ID="19365" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Julia</FIRST_NAME><LAST_NAME>Bohlius</LAST_NAME><SUFFIX>MPH</SUFFIX><EMAIL_1>julia.bohlius@uk-koeln.de</EMAIL_1><EMAIL_2>jbohlius@ispm.unibe.ch</EMAIL_2><URL>www.chmg.de</URL><ADDRESS><DEPARTMENT>Cochrane Haematological Malignancies Group - Department of Internal Medicine 1</DEPARTMENT><ORGANISATION>University Hospital of Cologne</ORGANISATION><ADDRESS_1>Kerpener Str. 62</ADDRESS_1><CITY>Cologne</CITY><ZIP>50924</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 221 710770 25</PHONE_1><PHONE_2>+49 221 478 0</PHONE_2><FAX_1>+49 221 710770 24</FAX_1></ADDRESS></PERSON><PERSON ID="29E9683C82E26AA20129AA212C25DD8A" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Christine</FIRST_NAME><LAST_NAME>Herbst</LAST_NAME><EMAIL_1>christine.herbst@uk-koeln.de</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane Haematological Malignancies Group - Department of Internal Medicine 1</DEPARTMENT><ORGANISATION>University Hospital of Cologne</ORGANISATION><ADDRESS_1>Kerpener Str. 62</ADDRESS_1><CITY>Cologne</CITY><ZIP>50924</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 221 710770 19</PHONE_1><FAX_1>Fax: +49 221 710770 24</FAX_1></ADDRESS></PERSON><PERSON ID="13778" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Marcel</FIRST_NAME><LAST_NAME>Reiser</LAST_NAME><POSITION>Senior Registrar</POSITION><EMAIL_1>Marcel.Reiser@uni-koeln.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of Internal Medicine 1</DEPARTMENT><ORGANISATION>University Hospital of Cologne</ORGANISATION><ADDRESS_1>Kerpener Str. 62</ADDRESS_1><CITY>Cologne</CITY><ZIP>50924</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49-221-478 ext: 3540</PHONE_1></ADDRESS></PERSON><PERSON ID="5936" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Guido</FIRST_NAME><LAST_NAME>Schwarzer</LAST_NAME><POSITION>Statistician</POSITION><EMAIL_1>sc@imbi.uni-freiburg.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of Medical Biometry and Statistics</DEPARTMENT><ORGANISATION>German Cochrane Center</ORGANISATION><ADDRESS_1>University Medical Center</ADDRESS_1><ADDRESS_2>Stefan-Meier-Str. 26</ADDRESS_2><CITY>Freiburg</CITY><ZIP>D-79104</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 761 203 6668</PHONE_1><FAX_1>+49 761 203 6680</FAX_1></ADDRESS></PERSON><PERSON ID="8933" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Andreas</FIRST_NAME><LAST_NAME>Engert</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Senior Consultant</POSITION><EMAIL_1>a.engert@uni-koeln.de</EMAIL_1><EMAIL_2>baerbel.baecker@uk-koeln.de</EMAIL_2><URL>www.chmg.de</URL><ADDRESS><DEPARTMENT>Cochrane Haematological Malignancies Group - Department of Internal Medicine 1</DEPARTMENT><ORGANISATION>University Hospital of Cologne</ORGANISATION><ADDRESS_1>Kerpener Str. 62</ADDRESS_1><CITY>Cologne</CITY><ZIP>50924</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 221 478 5933</PHONE_1><PHONE_2>+49 221  478 5966</PHONE_2><FAX_1>+49 221  478 3778</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-08-12 12:52:28 +0200" MODIFIED_BY="Nicole Skoetz">
<UP_TO_DATE>
<DATE DAY="23" MONTH="4" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="13" MONTH="4" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="6" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2001"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2002"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2004"/>
</DATES>
<WHATS_NEW MODIFIED="2008-08-12 13:13:56 +0200" MODIFIED_BY="Nicole Skoetz">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-08-11 15:38:18 +0200" MODIFIED_BY="Nicole Skoetz">
<DATE DAY="8" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Review updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2008-08-12 13:13:56 +0200" MODIFIED_BY="Nicole Skoetz">
<DATE DAY="7" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>A new search was done in April 2008, with one additional study identified. A total of 13 randomized controlled trials were included in this review update. <BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-08-12 13:16:52 +0200" MODIFIED_BY="Nicole Skoetz">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2008-08-12 13:16:52 +0200" MODIFIED_BY="Nicole Skoetz">
<DATE DAY="22" MONTH="4" YEAR="2004"/>
<DESCRIPTION>
<P>Substantive amendment.</P>
<P>We identified one full text publication (Ösby 2003) to a study which was previously included on the basis of an abstract publication (Björkholm 1999). Additionally we identified one study which has been recently published (Doorduijn 2003). Of these publications we included only reported data. Updating the review we include now 12 trials with 1.823 patients. Compared to the old version with 11 studies and 1.434 patients none of the results changed significantly. We now include results on Quality of Life.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-08-12 12:57:48 +0200" MODIFIED_BY="Nicole Skoetz">
<INTERNAL_SOURCES MODIFIED="2008-08-12 12:54:40 +0200" MODIFIED_BY="Nicole Skoetz">
<SOURCE>
<NAME>Department I of Internal Medicine, University of Cologne</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2008-08-12 12:54:40 +0200" MODIFIED_BY="Nicole Skoetz">
<NAME>Köln Fortune</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION>
<P>Funding programme &#8220;Köln Fortune&#8221;, Medical Faculty University of Cologne</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2008-08-12 12:57:48 +0200" MODIFIED_BY="Nicole Skoetz">
<SOURCE MODIFIED="2008-08-12 12:55:19 +0200" MODIFIED_BY="Nicole Skoetz">
<NAME>BMBF</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION>
<P>The Editorial Base is funded by Federal Ministry of Education and Research (BMBF) No : 01GH0501</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2008-08-12 12:57:48 +0200" MODIFIED_BY="Nicole Skoetz">
<NAME>Cochrane Incentive Scheme</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>Department of Health, England</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-08-11 15:40:25 +0200" MODIFIED_BY="Nicole Skoetz">
<SUMMARY>
<TITLE>Granulopoiesis-stimulating factors in the prevention of adverse effects during the therapeutic treatment of malignant lymphoma.</TITLE>
<SUMMARY_BODY>
<P>Lymphoma is a cancer that begins in the lymph nodes. It can be treated with chemotherapy (anti-cancer drugs), but this disrupts the immune system and lowers white cell counts. This can increase a person's risk of infection and limit the amount of chemotherapy that can be given. Granulopoiesis-stimulating factors (GSF) can increase the body's production of white cells. The review found that treatment with GSF increases white cell counts and reduces the risk of infection in people receiving chemotherapy for lymphoma. However, GSF treatment did not improve survival. More research is needed to improve GSF treatments.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Granulopoiesis-stimulating factors, such as granulocyte-colony-stimulating factor (G-CSF) and granulocyte-macrophage-colony-stimulating factor (GM-CSF), are being used to prevent febrile neutropenia and infection in patients undergoing treatment for malignant lymphoma. The question of whether G-CSF and GM-CSF improve dose intensity, tumour response, and overall survival in this patient population has not been answered yet. Since the results from single studies are inconclusive, a systematic review was undertaken.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To determine the effectiveness of G-CSF and GM-CSF in patients with malignant lymphoma with respect to preventing neutropenia, febrile neutropenia and infection; improving quality of life, adherence to treatment protocol, tumour response, freedom from treatment failure (FFTF) and overall survival (OS); and adverse effects.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-04-23 15:41:27 +0200" MODIFIED_BY="[Empty name]">
<P>We searched The Cochrane Library, MEDLINE, EMBASE, CancerLit, and other relevant literature databases; Internet databases of ongoing trials; and conference proceedings of the American Society of Clinical Oncology and the American Society of Hematology (1980 - 2007). We included full-text and abstract publications as well as unpublished data.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised controlled trials comparing prophylaxis with G-CSF or GM-CSF versus placebo/no prophylaxis in adult patients with malignant lymphoma undergoing chemotherapy were included for review. Both study arms had to receive identical chemotherapy and supportive care. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>Trial eligibility and quality assessment, data extraction and analysis were done by two reviewers independently. Authors were contacted to obtain missing data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>We included 13 eligible randomised controlled trials with 2607 randomised patients. Compared with no prophylaxis, both G-CSF and GM-CSF did not improve overall survival (hazard ratio 0.97; 95% CI 0.87 to 1.09) or FFTF (hazard ratio 1.11; 95% CI 0.91 to 1.35). Prophylaxis significantly reduced the relative risk (RR) for severe neutropenia (RR 0.67; 95% confidence interval (CI) 0.60 to 0.73), febrile neutropenia (RR 0.74; 95% CI 0.62 to 0.89) and infection (RR 0.74; 95% CI 0.64 to 0.85). There was no evidence that either G-CSF or GM-CSF reduced the number of patients requiring intravenous antibiotics (RR 0.82; 95%CI 0.57 to 1.18); lowered infection related mortality (RR 0.93; 95% CI 0.51 to 1.71); or improved complete tumour response (RR 1.03; 95% CI 0.95 to 1.10).One study evaluated quality of life parameters and found no differences between the treatment groups.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>G-CSF and GM-CSF, when used as a prophylaxis in patients with malignant lymphoma undergoing conventional chemotherapy, reduce the risk of neutropenia, febrile neutropenia and infection. However, based on the randomised trials currently available, there is no evidence that either G-CSF or GM-CSF provide a significant advantage in terms of complete tumour response, FFTF or OS. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-08-11 15:39:40 +0200" MODIFIED_BY="Nicole Skoetz">
<BACKGROUND MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2008-06-09 10:26:31 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Malignant lymphomas are a heterogeneous group of neoplastic disorders that develop in lymphatic cells (<LINK REF="REF-Freedman-1999" TYPE="REFERENCE">Freedman 1999</LINK>). These tumours usually originate in lymph nodes and spread along the lymphatic system, involving lymphatic tissues such as lymph nodes and the spleen. Malignant cells can also infiltrate non-lymphatic tissues such as bone, liver, lung and, less frequently, skin and brain, either by haematogenesis or by invasion of adjacent tumour masses. Based on their distinct histology, malignant lymphomas are classified as Hodgkin's disease (HD) or non-Hodgkin's lymphoma (NHL). The incidence of HD is steady, affecting 3 people out of every 100,000 per year in Europe and Northern America, whereas the incidence of NHL has increased in recent years. Nowadays 14 people in 100,000 are affected by NHL every year (<LINK REF="REF-Engert-1994" TYPE="REFERENCE">Engert 1994</LINK>). The aetiology of malignant lymphoma remains unclear. An association with viral infections, such as Epstein-Barr virus, and genetic predisposition are being discussed (<LINK REF="REF-Engert-1994" TYPE="REFERENCE">Engert 1994</LINK>; <LINK REF="REF-Herrmann-1998" TYPE="REFERENCE">Herrmann 1998</LINK>). Depending on their histological classification, stage and prognostic factors, malignant lymphomas are treated with chemotherapy, radiotherapy or both.<BR/>One limiting factor in the treatment of malignant lymphoma is the myelosuppressive side effect of cytotoxic drugs. Myelosuppression is characterised by leucopenia, anaemia and thrombocytopenia. Neutropenia, neutropenic fever and neutropenia-related infections are dose-limiting events during chemotherapy. The risk of febrile neutropenia and subsequent infection is directly related to the degree and duration of neutropenia (<LINK REF="REF-Bodey-1966" TYPE="REFERENCE">Bodey 1966</LINK>; <LINK REF="REF-Bodey-1986" TYPE="REFERENCE">Bodey 1986</LINK>). Febrile neutropenia and neutropenia-related infections can result in longer hospital stays and higher mortality. Consequently, reducing the dose of cytostatic drugs or increasing the interval between treatment courses is often required (<LINK REF="REF-Talcott-1992" TYPE="REFERENCE">Talcott 1992</LINK>; <LINK REF="REF-Klastersky-2000" TYPE="REFERENCE">Klastersky 2000</LINK>). The Goldie-Coldman hypothesis suggests that the application of the intended dose on time may improve tumour response and overall survival (<LINK REF="REF-Goldie-1983" TYPE="REFERENCE">Goldie 1983</LINK>). Therefore, reducing the intended dose intensity is clinically undesirable (<LINK REF="REF-Hryniuk-1984" TYPE="REFERENCE">Hryniuk 1984</LINK>; <LINK REF="REF-Hryniuk-1986" TYPE="REFERENCE">Hryniuk 1986</LINK>; <LINK REF="REF-Hryniuk-1987" TYPE="REFERENCE">Hryniuk 1987</LINK>). In this context, malignant lymphomas are of particular interest since they have been shown to be chemosensitive, both in experimental models (<LINK REF="REF-Skipper-1990" TYPE="REFERENCE">Skipper 1990</LINK>) and in retrospective clinical analyses (<LINK REF="REF-DeVita-1987" TYPE="REFERENCE">DeVita 1987</LINK>; <LINK REF="REF-Armitage-1993" TYPE="REFERENCE">Armitage 1993</LINK>; <LINK REF="REF-Lepage-1993" TYPE="REFERENCE">Lepage 1993</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-06-09 10:31:12 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Haematopoietic growth factors, such as granulocyte-colony-stimulating factor (G-CSF) and granulocyte-macrophage-colony-stimulating factor (GM-CSF), stimulate haematopoietic progenitors, thereby increasing the number of functional neutrophils (<LINK REF="REF-Lopez-1986" TYPE="REFERENCE">Lopez 1986</LINK>; <LINK REF="REF-Bronchud-1988" TYPE="REFERENCE">Bronchud 1988</LINK>; <LINK REF="REF-Crawford-1991" TYPE="REFERENCE">Crawford 1991</LINK>). These drugs were introduced in an attempt to prevent and treat neutropenia, neutropenic fever and neutropenia-related infections. G-CSF predominantly augments the proliferation, maturation and release of neutrophils (<LINK REF="REF-Roskos-1998" TYPE="REFERENCE">Roskos 1998</LINK>; <LINK REF="REF-Dempke-2000" TYPE="REFERENCE">Dempke 2000</LINK>), whereas GM-CSF enhances the proliferation and differentiation of macrophages as well (<LINK REF="REF-Dempke-2000" TYPE="REFERENCE">Dempke 2000</LINK>). The most common side effect of G-CSF is bone pain; other less common side effects are myalgia and elevation of lactate dehydrogenase, uric acid and serum and leucocyte alkaline phosphatase levels. Less frequently, patients may also suffer from exacerbation of pre-existing inflammatory conditions such as psoriasis, vasculitis or eczema. GM-CSF has similar side effects, although injection site reactions are seen more often. Patients also complain of bone pain, myalgia, fever, nausea, fatigue, headache and chills (<LINK REF="REF-ASCO-Guidelines-1994" TYPE="REFERENCE">ASCO Guidelines 1994</LINK>). Clinical trials indicate that both G-CSF and GM-CSF decrease fever incidence and the incidence and duration of neutropenia after standard chemotherapy (<LINK REF="REF-Morstyn-1988" TYPE="REFERENCE">Morstyn 1988</LINK>; <LINK REF="REF-Yoshida-1990" TYPE="REFERENCE">Yoshida 1990</LINK>; <LINK REF="STD-Hovgaard-1992" TYPE="STUDY">Hovgaard 1992</LINK>). However, the scant results from prospective, randomised studies directly comparing G-CSF and GM-CSF are inconclusive, and it is unknown which of these agents is superior (<LINK REF="REF-Lydaki-1995" TYPE="REFERENCE">Lydaki 1995</LINK>; <LINK REF="REF-Magrath-1997" TYPE="REFERENCE">Magrath 1997</LINK>; <LINK REF="REF-Beveridge-1998" TYPE="REFERENCE">Beveridge 1998</LINK>; <LINK REF="REF-Deb-1998" TYPE="REFERENCE">Deb 1998</LINK>; <LINK REF="REF-Alvarado-Ibarra-1999" TYPE="REFERENCE">Alvarado Ibarra 1999</LINK>; <LINK REF="REF-Bennett-2000a" TYPE="REFERENCE">Bennett 2000a</LINK>). In a meta-analysis of patients with solid cancers or lymphoma, pegfilgrastim reduced the incidence of febrile neutropenia. However, only 15% of patients had malignant lymphoma (<LINK REF="REF-Pinto-2007" TYPE="REFERENCE">Pinto 2007</LINK>).</P>
<P>Although G-CSF and GM-CSF are cost intensive drugs, economic evaluations have demonstrated an overall cost reduction from reduced antibiotic use and shorter hospital stays (<LINK REF="REF-Bow-1998" TYPE="REFERENCE">Bow 1998</LINK>). However, this economic benefit is achieved only in specific clinical settings, and the controversy over defining economic thresholds continues (<LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>; <LINK REF="STD-Zagonel-1994" TYPE="STUDY">Zagonel 1994</LINK>; <LINK REF="REF-Bobey-1998" TYPE="REFERENCE">Bobey 1998</LINK>; <LINK REF="REF-Lyman-1998" TYPE="REFERENCE">Lyman 1998</LINK>; <LINK REF="REF-ASCO-Guidelines-2000" TYPE="REFERENCE">ASCO Guidelines 2000</LINK>; <LINK REF="REF-Bennett-2000b" TYPE="REFERENCE">Bennett 2000b</LINK>; <LINK REF="REF-Lyman-2000" TYPE="REFERENCE">Lyman 2000</LINK>; <LINK REF="REF-EORTC-Guidelines-2006" TYPE="REFERENCE">EORTC Guidelines 2006</LINK>; <LINK REF="REF-ASCO-Guidelines-2006" TYPE="REFERENCE">ASCO Guidelines 2006</LINK>).</P>
</INTERVENTION>
<IMPORTANCE MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>The considerable uncertainty surrounding the clinical use of these agents led the American Society of Clinical Oncology (ASCO) to set up guidelines in 1994 for the use of G-CSF and GM-CSF in the treatment of both solid and haematological malignancies (updated in 1996, 2000 and 2006) in order to avoid infectious complications and maintain dose intensities. The current ASCO guidelines recommend the primary administration of G-CSF and GM-CSF in clinical settings where the expected risk of suffering febrile neutropenia is at least 20%. This threshold was reduced from 40% in 2005, following the publication of two trials in patients with solid tumours and a risk of febrile neutropenia in the control arm between 19% in one study (<LINK REF="REF-Vogel-2005" TYPE="REFERENCE">Vogel 2005</LINK>) and 32% with concomitant antibiotic prophylaxis int the other study (<LINK REF="REF-Timmer_x002d_Bonte-2005" TYPE="REFERENCE">Timmer-Bonte 2005</LINK>). Granulopoiesis-stimulating factors are also recommended for patients who have developed febrile neutropenia in a previous chemotherapy cycle or when the alternative of reducing the chemotherapy dose is not appropriate (secondary prophylaxis). G-CSF and GM-CSF were not recommended as a supportive measure to increase chemotherapy dosages beyond standard regimens outside of a clinical trial (ASCO Guidelines 2006). Systematic reviews on the effectiveness of G-CSF in the chemotherapeutic treatment of solid and haematological malignancies provided evidence that G-CSF reduced the incidence of febrile neutropenia (<LINK REF="REF-Rusthoven-1998" TYPE="REFERENCE">Rusthoven 1998</LINK>; <LINK REF="REF-Kuderer-2007" TYPE="REFERENCE">Kuderer 2007</LINK>). However, the relevance of the results with respect to malignant lymphoma are questionable since both reviews only included a limited number of lymphoma trials. For example, the review by <LINK REF="REF-Kuderer-2007" TYPE="REFERENCE">Kuderer 2007</LINK> only included 5 trials with lymphoma patients (<LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003;</LINK> <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>), compared to 12 trials published during their search period. Another systematic review assessing the effectiveness of G-CSF and GM-CSF in the treatment of haematological tumours has not been published in full and cannot be assessed in detail (<LINK REF="REF-Hackshaw-2004" TYPE="REFERENCE">Hackshaw 2004</LINK>). Therefore, the critical question of whether G-CSF and GM-CSF improve dose intensity, tumour response and overall survival in the treatment of malignant lymphoma remains unanswered.</P>
<P>Since current evidence based information on the use of G-CSF and GM-CSF is inconclusive in a number of key questions and includes only parts of the existing literature, we conducted a comprehensive systematic review. In the first publication of this review we included 11 prospectively randomised studies with a total of 1431 patients, the first update included 12 trials with 1820 patients. We now present the second update, which includes 13 trials with 2604 randomised patients. All patients had either HD or NHL and received standard chemotherapy with or without G-CSF or GM-CSF prophylaxis. The outcome measures examined included overall survival (OS), freedom from treatment failure (FFTF), risk and duration of neutropenia and febrile neutropenia, infection, mortality, received dose intensity, tumour response, adverse events and quality of life.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-06-09 12:00:35 +0200" MODIFIED_BY="Nicole Skoetz">
<P>We conducted a systematic review of randomised controlled trials of patients with malignant lymphoma to determine the effectiveness of G-CSF and GM-CSF in:</P>
<OL>
<LI>improving OS and FFTF (primary outcome measures);</LI>
<LI>decreasing the risk and duration of neutropenia and febrile neutropenia, infection and mortality during chemotherapy; improving received dose intensity, tumour response and quality of life (secondary outcome measures). Adverse effects were also assessed.</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-06-09 12:03:29 +0200" MODIFIED_BY="Nicole Skoetz">
<CRIT_STUDIES MODIFIED="2008-06-09 10:18:03 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Only randomised controlled trials comparing G-CSF or GM-CSF prophylaxis with placebo/no prophylaxis were included. Studies on long lasting G-CSF preparations such as filgrastim are eligible as well (this inclusion criterion was added in 2008). Crossover studies, quasi-randomised, e.g. treatment allocation alternate or by date of birth, and non-randomised comparative studies were excluded. Studies with less than ten lymphoma patients per study arm were disqualified. Abstracts and unpublished data were included if sufficient information on study design, patient characteristics, interventions and outcomes was available. Otherwise they were excluded or included with reservations.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-06-09 12:00:56 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Eligible patients were older than 16 years and had NHL or HD confirmed by biopsy. The following histological classifications were admitted: Working Formulation, Kiel-, REAL- and WHO-classification. Acute and chronic leukaemias, including chronic lymphatic leukaemia, multiple myeloma and human immunodeficiency virus (HIV) associated lymphoma were excluded because they include disease specific immunodeficiencies that may confound the results.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>G-CSF or GM-CSF had to be given at doses of at least 1 µg/kg/day, intravenously or subcutaneously, as primary prophylaxis during a standard non-myeloablative chemotherapy prior to the onset of neutropenia in the first- or second-line treatment of malignant lymphoma. G-CSF or GM-CSF had to be given within 72 hours of administering cytotoxic substances and in each cycle of chemotherapy. The control group had to receive an identical chemotherapy regimen and, apart from G-CSF or GM-CSF, the same supportive care, e.g. antibiotic prophylaxis, in addition to a placebo or no prophylaxis. Trials investigating the sequential administration of G-CSF or GM-CSF, or their secondary prophylactic administration and therapeutic use in established neutropenia and febrile neutropenia, were excluded, as were trials on myeloablative chemotherapy regimens with consecutive stem cell support. </P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-06-09 12:03:29 +0200" MODIFIED_BY="Nicole Skoetz">
<P>
<BR/>
</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-06-09 12:03:29 +0200" MODIFIED_BY="Nicole Skoetz">
<UL>
<LI>overall survival; </LI>
<LI>freedom from treatment failure.</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-06-09 12:03:21 +0200" MODIFIED_BY="Nicole Skoetz">
<UL>
<LI>quality of life;</LI>
<LI>risk and duration of neutropenia;</LI>
<LI>risk and duration of febrile neutropenia;</LI>
<LI>infection;</LI>
<LI>mortality during chemotherapy;</LI>
<LI>received dose intensity of chemotherapy;</LI>
<LI>tumour response (complete response);</LI>
<LI>adverse effects of G-CSF and GM-CSF;</LI>
<LI>risk and duration of parenteral antibiotic treatment;</LI>
<LI>hospitalisation;</LI>
<LI>risk and duration of thrombocytopenia and anaemia.</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-06-09 12:07:05 +0200" MODIFIED_BY="Nicole Skoetz">
<ELECTRONIC_SEARCHES MODIFIED="2008-06-09 12:07:05 +0200" MODIFIED_BY="Nicole Skoetz">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CancerLit, Medikat, Russmed Articles, SOMED, Toxline, BIOSIS Previews and LILACS. The search covered the time period from January 1980 to April 21 2008. No language restriction was applied. In databases other than CENTRAL, we used the highly sensitive search strategy for identifying reports of randomised controlled trials developed by <LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>. See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for the MEDLINE search strategy. This search strategy was adapted for use in the other databases. </P>
<P>We also searched internet databases of grey literature (SIGLE) and ongoing trials as follows. These websites were last checked for relevant trials in April 2008.</P>
<OL>
<LI>www.controlled-trials.com</LI>
<LI>http://clinicaltrials.nci.nih.gov</LI>
<LI>http://clinicaltrials.gov/ct/gui</LI>
<LI>www.eortc.be/</LI>
<LI>www.ctc.usyd.edu.au/</LI>
<LI>www.trialscentral.org/index.html</LI>
</OL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-06-09 12:04:56 +0200" MODIFIED_BY="Nicole Skoetz">
<P>We handsearched the conference proceedings of the American Society of Clinical Oncology (1980 to August 2007) and the American Society of Hematology (1980 to 2007) and two medical journals: American Journal of Hematology and Annals of Hematology. Citations of all trials identified in the search were checked for additional references. We also contacted experts in the field and pharmaceutical companies (Amgen, Chugai, Novartis Pharma, Janssen-Cilag, Sandoz, Schering-Plough) for additional unpublished or ongoing trials.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2008-06-09 12:08:31 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Titles and abstracts of studies identified from the above sources were screened independently by two reviewers (JB, MR, CH) according to the eligibility criteria. If this could not be done satisfactorily from the title and abstract, the full-text was obtained. Studies that met the inclusion criteria were assessed with an eligibility form, which contained the following questions.</P>
<OL>
<LI>Is the study described as randomised?</LI>
<LI>Did the participants in the study have malignant lymphoma?</LI>
<LI>Were the participants at risk of febrile neutropenia?</LI>
<LI>Were the participants adults ( &gt; 16 years of age)?</LI>
<LI>Was one group (treatment group) given G-CSF or GM-CSF subcutaneously or intravenously (not per os) after the course of chemotherapy in a dose of at least 1 µg/kg/day?</LI>
<LI>Were the groups treated identically (identical chemotherapy and supportive care such as antibiotic prophylaxis) other than for the named intervention?</LI>
<LI>Did the study document dose intensity and tumour response or febrile neutropenia?</LI>
</OL>
<P>Studies had to meet all of the above criteria to be eligible. If there was insufficient information to judge eligibility, the first author of the study or report was contacted for clarification. Any disagreements between the reviewers were resolved by discussion. Any duplicate reports were identified. Full-text versions of all eligible studies were obtained for quality assessment and data extraction.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-06-09 12:55:02 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Data on study design, patient characteristics, interventions and outcome were extracted independently by two reviewers (MR, JB and CH) using a previously designed data extraction form that included the following items.</P>
<OL>
<LI>General information: title, authors, source, contact address, country, language and year of publication, duplicate publications, sponsors and trial setting.</LI>
<LI>Trial characteristics such as inclusion and exclusion criteria, sample size, diagnostic criteria, assessment of compliance;, method of randomisation, concealment of allocation and blinding of patients, care givers and outcome assessors, withdrawals, losses to follow up and intention-to-treat analysis were extracted separately with a validity form.</LI>
<LI>Interventions: placebo, intervention and co-medication including dose, route and timing.</LI>
<LI>Patients: sample size, disease and baseline characteristics.</LI>
<LI>Outcomes: outcomes as specified above.</LI>
</OL>
<P>Disagreements arising at any stage were resolved by discussion and consensus. All authors were contacted to obtain missing data on study design, characteristics of patients, interventions and primary and selected secondary outcome measures (rate and duration of neutropenia and febrile neutropenia, mortality during and after chemotherapy, complete response, FFTF and OS).</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-06-09 12:11:42 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Study quality was assessed independently by two unblinded reviewers (JB, MR, CH). Any disagreements were discussed within the group until consensus was reached. Quality was assessed using an in-house assessment form that has not been validated (sources used: <LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>; <LINK REF="REF-Verhagen-1998" TYPE="REFERENCE">Verhagen 1998</LINK>). The following criteria were considered.</P>
<OL>
<LI>Was the randomisation method satisfactory?</LI>
<LI>Was treatment allocation concealed?</LI>
<LI>Were the groups similar at baseline regarding the most important prognostic factors?</LI>
<LI>Was treatment allocation masked from the participants?</LI>
<LI>Was treatment allocation masked from the clinicians?</LI>
<LI>Was treatment allocation masked from the outcome assessors?</LI>
<LI>Was the number of withdrawals, dropouts and losses to follow-up in each group stated?</LI>
<LI>Was an intention-to-treat analysis included in the data analysis?</LI>
</OL>
<P>We defined important prognostic factors as age, gender, performance status, stage of disease, presence of B-symptoms, above normal lactate dehydrogenase concentration, bone marrow involvement and untreated, resistant or relapsed disease. We explored the influence of individual quality criteria in a sensitivity analysis.</P>
</QUALITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>For statistical analysis, we used RevMan 5, R and STATA. To estimate OS and FFTF, hazard ratios (HR) were calculated. If individual patient data were not available we extracted and analysed data from the published survival curves using methods described by <LINK REF="REF-Parmar-1998" TYPE="REFERENCE">Parmar 1998</LINK>. For binary data, relative risks (RR) and 95% confidence intervals (CI)were calculated for each trial and the Mantel-Haenszel method was used <BR/>for pooling. The results were pooled using a fixed effect model. Number needed to treat and number needed to harm, with corresponding confidence intervals, were calculated for ease of interpretation. Continuous data were calculated as weighted mean differences with 95% CI and summarised, if appropriate. Heterogeneity of treatment effect between trials was tested using a chi squared statistic with significance set at P &lt; 0.05. The robustness of the overall results and causes of heterogeneity were assessed by sensitivity and subgroup analyses as described below. In meta-analyses of at least four trials, a funnel plot was generated and a linear regression test (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>) was performed to examine the presence of bias. A probability value of less than 0.1 was considered significant for the linear regression test. All data included were based on 'intention-to-treat' or 'full set analysis' as defined by <LINK REF="REF-ICH-1999" TYPE="REFERENCE">ICH 1999</LINK>. Data based on 'per protocol analysis' were not included.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2008-06-09 12:10:05 +0200" MODIFIED_BY="Nicole Skoetz">
<P>The clinical and methodological diversity of the included studies, as well as the statistical heterogeneity of selected results were analysed according to the following criteria.</P>
<OL>
<LI>Type of drug (G-CSF compared to GM-CSF);</LI>
<LI>HD versus NHL;</LI>
<LI>Age (trials restricted to age &gt; 60 years versus trials including all ages);</LI>
<LI>Administration of prophylactic antibiotic drugs during chemotherapy;</LI>
<LI>Different toxicity of chemotherapy regimens: chemotherapies applied in the different studies may differ in their specific haematological toxicity. The haemato-toxicity of different chemotherapy regimens was categorised indirectly by means of the incidence of neutropenia in the control group.</LI>
</OL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2008-06-09 12:08:52 +0200" MODIFIED_BY="Nicole Skoetz">
<OL>
<LI>Placebo controlled studies versus open label studies;</LI>
<LI>Concealment of allocation;</LI>
<LI>Size of studies (including less than 100 patients versus at least 100 patients);</LI>
<LI>Published versus unpublished, unreported or abstract based data;</LI>
<LI>Duration of follow-up</LI>
</OL>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>The electronic update search from August 2003 to April 2008 retrieved 306 abstracts. Of these 3 were retrieved for an evaluation of the full text and one was included in the updated version of the review.</P>
<P>Please note: previously unreported data and unpublished studies are marked with an asterix (*).</P>
<P>
<BR/>
<B>Eligible studies </B>
<BR/>We identified 16 randomised controlled trials that met our inclusion criteria. Of these trials, three additional follow-up reports (<LINK REF="STD-Engelhard-1994" TYPE="STUDY">Engelhard 1994</LINK>; <LINK REF="STD-Gerhartz-1994a" TYPE="STUDY">Gerhartz 1994a</LINK>; <LINK REF="STD-Zinzani-1999" TYPE="STUDY">Zinzani 1999</LINK>) and an economic analysis of identical patient data (<LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>) were identified. Two of the 16 studies were excluded. One study of 100 patients has not been published (<LINK REF="STD-Unpublished-trial" TYPE="STUDY">Unpublished trial</LINK>), while the other study was published only as an interim analysis and did not report any useable data (as part of a multicenter trial, N = 14) (<LINK REF="STD-Liberati-1991" TYPE="STUDY">Liberati 1991</LINK>). We were unable to obtain data from the original investigators for either of these studies. In addition, we initially identified three studies that were ongoing (<LINK REF="STD-Blay" TYPE="STUDY">Blay</LINK>; <LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>). Two of these (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>; Doorduijn 2000) were published in the meantime and are included in the present updated review (<LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>).<BR/>
</P>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>Thirteen randomised studies with a total of 2607 randomised patients were analysed (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>) (see 'Characteristics of included studies' table). All trials were reported in English. All first authors were contacted to obtain unreported data. We obtained additional information on study design, patient characteristics and selected outcome data for nine trials (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Bj_x00f6_rkholm-1999" TYPE="STUDY">Björkholm 1999</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>).</P>
<P>Eleven studies evaluated G-CSF (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>) and two studies evaluated GM-CSF versus placebo or no treatment (<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>). Two studies were restricted to patients with HD (<LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>); one study analysed both NHL and HD (<LINK REF="STD-Cunningham_x002a_" TYPE="STUDY">Cunningham*</LINK>) and ten studies included NHL patients only (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>). Twelve studies included newly diagnosed patients only, while one study was conducted in patients with relapsed lymphoma (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*). Nine of the thirteen studies had a sample population aged between 15 and 77 years, whereas four studies were restricted to patients older than sixty years (<LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>, <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>).</P>
<P>Growths factors were given before the onset of neutropenia and less than 48 hours after cytotoxic drug administration at doses of 5 µg/kg/day, or in equivalent doses of 230 µg/m² (G-CSF) (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>), 300 µg/day (G-CSF) (<LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>), 263 µg/day (G-CSF) (Burton 2006) or 400 µg/day (GM-CSF) (<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>), subcutaneously during each course of chemotherapy. In one study, GM-CSF was given between chemotherapy cycles to investigate whether GM-CSF given before chemotherapy is myeloprotective (<LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>). All chemotherapy regimens applied were CHOP or MOPP-like and were moderately myelosuppressive. Antibiotic prophylaxis was given in three studies (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>). Withdrawals and dropouts were stated in nine reports (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>). In one abstract publication, the specific number of patients in each study arm was not reported but results were reported in percentages (<LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>). Assuming equal group sizes, we distributed the total number of patients (N = 119) at random to the four different study arms. One study was never published but the data were kindly provided by the principal investigator (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*). One study (<LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>) presented an economic analysis of patient data that were presented as clinical outcome data elsewhere (<LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>). In five of the studies, two different chemotherapy regimens with or without G-CSF were analysed in four separate study arms (<LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>), and we analysed the data, where possible, accordingly (<LINK REF="STD-Bastion-ACVBP-1993" TYPE="STUDY">Bastion ACVBP 1993</LINK>; <LINK REF="STD-Bastion-VIMMM-1993" TYPE="STUDY">Bastion VIMMM 1993</LINK>; <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>; <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>; <LINK REF="STD-_x00d6_sby-CHOP-2003" TYPE="STUDY">Ösby CHOP 2003</LINK>; <LINK REF="STD-_x00d6_sby-CNOP-2003" TYPE="STUDY">Ösby CNOP 2003</LINK>). Only three studies (<LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>) were not sponsored by the pharmaceutical industry.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2008-06-09 12:18:28 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Thirty-seven studies did not meet the inclusion criteria. One study in children and adults (<LINK REF="STD-Magrath-1996" TYPE="STUDY">Magrath 1996</LINK>; <LINK REF="STD-Adde-1998" TYPE="STUDY">Adde 1998</LINK>) and three studies of various tumour entities (<LINK REF="STD-Yau-1996" TYPE="STUDY">Yau 1996</LINK>; <LINK REF="STD-Gregory-1998" TYPE="STUDY">Gregory 1998</LINK>; <LINK REF="STD-Rao-2005" TYPE="STUDY">Rao 2005</LINK>) were excluded because there were fewer than ten eligible adult lymphoma patients per study arm. We also excluded ten non-randomised studies (<LINK REF="STD-Gianni-1990" TYPE="STUDY">Gianni 1990</LINK>; <LINK REF="STD-Ho-1990" TYPE="STUDY">Ho 1990</LINK>; <LINK REF="STD-Riccardi-1993" TYPE="STUDY">Riccardi 1993</LINK>; <LINK REF="STD-Zagonel-1994" TYPE="STUDY">Zagonel 1994</LINK>; <LINK REF="STD-Mangiagalli-1995" TYPE="STUDY">Mangiagalli 1995</LINK>; <LINK REF="STD-Niitsu-1995" TYPE="STUDY">Niitsu 1995</LINK>; <LINK REF="STD-Bertini-1996" TYPE="STUDY">Bertini 1996</LINK>; <LINK REF="STD-Gustavsson-1997" TYPE="STUDY">Gustavsson 1997</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>; <LINK REF="STD-Gordon-1999" TYPE="STUDY">Gordon 1999</LINK>) and three crossover studies (<LINK REF="STD-Motoyoshi-1986" TYPE="STUDY">Motoyoshi 1986</LINK>; <LINK REF="STD-Shi-1994" TYPE="STUDY">Shi 1994</LINK>; <LINK REF="STD-Shi-1996" TYPE="STUDY">Shi 1996</LINK>). Two trials dealing with the secondary prevention of febrile neutropenia (<LINK REF="STD-Kaku-1993" TYPE="STUDY">Kaku 1993</LINK>; <LINK REF="STD-Maiche-1993" TYPE="STUDY">Maiche 1993</LINK>), two studies on the treatment of chemotherapy induced neutropenia (<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Hartmann-1997" TYPE="STUDY">Hartmann 1997</LINK>) and seven trials on the treatment of established febrile neutropenia (<LINK REF="STD-Bodey-1994" TYPE="STUDY">Bodey 1994</LINK>; <LINK REF="STD-Maher-1994" TYPE="STUDY">Maher 1994</LINK>; <LINK REF="STD-Mayordomo-1995" TYPE="STUDY">Mayordomo 1995</LINK>; <LINK REF="STD-Anaissie-1996" TYPE="STUDY">Anaissie 1996</LINK>; <LINK REF="STD-Vellenga-1996" TYPE="STUDY">Vellenga 1996</LINK>; <LINK REF="STD-Yoshida-1999" TYPE="STUDY">Yoshida 1999</LINK>; <LINK REF="STD-Lopez_x002d_Hernandez-2000" TYPE="STUDY">Lopez-Hernandez 2000</LINK>) were also excluded. Additionally, we discarded one trial on HIV-associated lymphoma (<LINK REF="STD-Kaplan-1991" TYPE="STUDY">Kaplan 1991</LINK>) and two trials investigating patients with multiple myeloma exclusively (<LINK REF="STD-Moreau-1997" TYPE="STUDY">Moreau 1997</LINK>; <LINK REF="STD-Togawa-2000" TYPE="STUDY">Togawa 2000</LINK>). Two further studies were excluded because patients received GM-CSF or placebo only in the first two cycles of chemotherapy (<LINK REF="STD-Bergmann-1995" TYPE="STUDY">Bergmann 1995</LINK>) or received G-CSF only prior to the first cycle of chemotherapy (<LINK REF="STD-Hansen-1995" TYPE="STUDY">Hansen 1995</LINK>). We excluded one study where G-CSF administration did not start before the completion of the second cycle of chemotherapy (<LINK REF="STD-Ogawa-1990" TYPE="STUDY">Ogawa 1990</LINK>; <LINK REF="STD-Kaneko-1991" TYPE="STUDY">Kaneko 1991</LINK>) and one trial on the topical administration of G-CSF for the prevention of mucositis (<LINK REF="STD-Karthaus-1998" TYPE="STUDY">Karthaus 1998</LINK>). Two dose finding studies were also excluded (<LINK REF="STD-Hovgaard-1992" TYPE="STUDY">Hovgaard 1992</LINK>; <LINK REF="STD-Seymour-1995" TYPE="STUDY">Seymour 1995</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-06-09 12:19:15 +0200" MODIFIED_BY="Nicole Skoetz">
<P>All trials were described as randomised. In ten of thirteen trials, adequate measures were taken to conceal treatment allocation (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>). In three studies, the concealment of allocation could not be clarified (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>). At baseline, the distribution of prognostic factors, such as age and stage of disease, was well balanced in the study groups. Five trials were placebo-controlled (<LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>). Nine studies included intention-to-treat calculations in the analysis of primary outcomes (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>). Withdrawals and losses to follow up were stated in nine out of eleven published trials (full text) (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>). In two reports, the number of withdrawals was stated but the reasons were not given (<LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>). For details of the quality assessment see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>As described above, trials that examined two chemotherapy regimens with or without G-CSF were analysed according to the chemotherapy regimen. For this reason the true number of included studies may be lower than the number of studies calculated by RevMan automatically in the table of outcomes. </P>
<P>
<B>Primary outcome measures </B>
<BR/>
<B>Overall survival<BR/>
</B>Ten<B> </B>studies including 2221 patients were analysed (<LINK REF="STD-Cunningham_x002a_" TYPE="STUDY">Cunningham*</LINK>; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Engelhard-1994" TYPE="STUDY">Engelhard 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Bj_x00f6_rkholm-1999" TYPE="STUDY">Björkholm 1999</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>). <LINK REF="STD-Dunlop-1998" TYPE="STUDY">
Dunlop 1998
</LINK> was analysed according to the chemotherapy regimen (<LINK REF="STD-Dunlop-MOPP-1998_x002a_" TYPE="STUDY">
Dunlop MOPP 1998*
</LINK>; <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TYPE="STUDY">
Dunlop MOPP/EVAP 98*
</LINK>). <LINK REF="STD-Aglietta-2000" TYPE="STUDY">
Aglietta 2000
</LINK> only provided data for 29 of 56 patients with complete patient records (see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). The pooled HR was 0.97 (95% CI 0.87 to 1.09). There was no significant statistical heterogeneity among the trials (chi squared = 4.59, df = 10, P = 0.92). The average observation time of the studies was 4.3 years, range 1.3 to 7.9. Sensitivity analyses (see comparison 2) did not show any significant differences with respect to type of growth factor, tumour entity, age of patients, antibiotic prophylaxis, quality and size of study or length of follow-up. Based on the data available, there is no evidence that either G-CSF or GM-CSF improve OS (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>; <LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>).</P>
<P>
<B>Freedom from treatment failure<BR/>
</B>FFTF was defined as freedom from progression, relapse of disease or death of any cause. Five studies with 718 patients were included for analysis (<LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>). Again, <LINK REF="STD-Dunlop-1998" TYPE="STUDY">
Dunlop 1998
</LINK> was analysed by chemotherapy regimen. <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK> only provided data for 29 of the 56 patients initially evaluated. When compared to placebo or no treatment, there was no evidence that G-CSF or GM-CSF had a significant effect on FFTF (HR 1.11; 95% CI 0.91 to 1.35) (<LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>). There was no significant statistical heterogeneity among the trials (chi squared = 0.55, df = 5, P = 0.99). A sensitivity analysis was not performed. Thus, there is no evidence that either G-CSF or GM-CSF improve FFTF rates.</P>
<P>
<B>Secondary outcome measures<BR/>Quality of Life<BR/>
</B>One study assessed quality of life (QoL) (<LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>) with the following questionnaires: the EuroQol questionnaire, the EORTC Quality of Life Questionnaire and the Multidimensional Fatigue Inventory. Of the 389 patients initially included in the trial, 162 patients were asked to participate in the QoL study; 19% refused. Of the participating patients, 96% returned their questionnaires during the study period and 88% in the follow-up period. Overall, no differences in QoL between the G-CSF and the control group were detected.</P>
<P>
<B>Neutropenia</B>
</P>
<P>Seven studies with 1013 patients were included in this analysis (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>*; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>*; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>). <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">
Ösby 2003
</LINK> was analysed by chemotherapy regimen (<LINK REF="STD-_x00d6_sby-CHOP-2003" TYPE="STUDY">
Ösby CHOP 2003
</LINK>, <LINK REF="STD-_x00d6_sby-CNOP-2003" TYPE="STUDY">
Ösby CNOP 2003
</LINK>). The risk of suffering from neutropenia, defined as absolute neutrophil count (ANC) below 0.5 x 10<SUP>9</SUP>/litre, was reduced by 33% for patients treated with G-CSF or GM-CSF (RR 0.67; 95% CI 0.60 to 0.73) (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>). There was significant statistical heterogeneity among the trials (chi squared = 14.98, df = 7, P = 0.04), indicating that the variation in the effect of G-CSF and GM-CSF was larger than would be expected to result from chance alone. Sensitivity analyses (see comparison 3) revealed significant between group heterogeneity for prophylactic administration of antibiotic treatment during chemotherapy (P = 0.0022). A stronger treatment effect was observed in trials with antibiotic prophylaxis (RR 0.43; 95% CI 0.31 to 0.60, 2 trials with N = 229) compared to trials without antibiotic prophylaxis (RR 0.72; 95% CI 0.65 to 0.79, 5 trials with N =784), P value for difference between subgroups: 0.0042); see <LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>. Other sensitivity analyses showed no significant differences with respect to G-CSF versus GM-CSF, HD versus NHL, age, haemato-toxicity, blinded versus open label, concealment of allocation, quality and size of study and publication type (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>; <LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>; <LINK REF="FIG-15" TYPE="FIGURE">Figure 15</LINK>; <LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>; <LINK REF="FIG-17" TYPE="FIGURE">Figure 17</LINK>; <LINK REF="FIG-18" TYPE="FIGURE">Figure 18</LINK>; <LINK REF="FIG-19" TYPE="FIGURE">Figure 19</LINK>; <LINK REF="FIG-20" TYPE="FIGURE">Figure 20</LINK>; <LINK REF="FIG-21" TYPE="FIGURE">Figure 21</LINK>). There was no indication of bias in the meta-analysis.</P>
<P>
<B>Febrile neutropenia, ANC &lt; 1.0 x 10<SUP>9</SUP>/litre and febrile temperatures</B>
</P>
<P>Four studies including 360 patients were analysed (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>). <LINK REF="STD-Dunlop-1998" TYPE="STUDY">
Dunlop 1998
</LINK> was analysed by chemotherapy regimen (<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">
Dunlop MOPP 1998
</LINK>; <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">
Dunlop MOPP/EVAP 98
</LINK>). The risk of febrile neutropenia, defined as ANC below 1.0 x 10<SUP>9</SUP>/litre and febrile temperatures, was reduced by 26% (RR 0.74; 95% CI 0.62 to 0.89); see <LINK REF="FIG-22" TYPE="FIGURE">Figure 22</LINK>. There was no obvious statistical heterogeneity among the trials (chi squared = 4.31, df = 4, P = 0.37). All included studies evaluated G-CSF and had an underlying risk to develop febrile neutropenia of at least 36% in the control group. Data for GM-CSF were not available. Sensitivity analyses (tumour entity, antibiotic prophylaxis, quality and size of study; comparison 4) did not show significant differences (<LINK REF="FIG-24" TYPE="FIGURE">Figure 24</LINK>; <LINK REF="FIG-25" TYPE="FIGURE">Figure 25</LINK>; <LINK REF="FIG-26" TYPE="FIGURE">Figure 26</LINK>; <LINK REF="FIG-27" TYPE="FIGURE">Figure 27</LINK>; <LINK REF="FIG-28" TYPE="FIGURE">Figure 28</LINK>; <LINK REF="FIG-29" TYPE="FIGURE">Figure 29</LINK>). These data suggest that G-CSF significantly reduces the risk for febrile neutropenia.</P>
<P>
<B>Febrile neutropenia, ANC &lt; 0.5 x 10<SUP>9</SUP>/litre and febrile temperatures<BR/>
</B>Two studies, one with two chemotherapy regimens, including 604 patients were analysed. Febrile neutropenia was defined as ANC below 0.5 x 10<SUP>9</SUP>/litre and febrile temperatures (<LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>*; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>). The risk for febrile neutropenia was reduced by 41% (RR 0.59; 95% CI 0.48 to 0.72); see <LINK REF="FIG-23" TYPE="FIGURE">Figure 23</LINK>. There was no statistical heterogeneity among the trials (chi squared = 2.94, df = 2, P = 0.23). All included studies evaluated G-CSF and had an underlying risk to develop febrile neutropenia of at least 50% in the control group. Data for GM-CSF were not available. A sensitivity analysis was not done. These data suggest that G-CSF significantly reduces the risk for febrile neutropenia.</P>
<P>
<B>Infection</B>
<BR/>Nine studies, two with two different chemotherapy regimens, with 1292 patients reporting microbiologically or clinically documented infection were included in the analysis (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Bj_x00f6_rkholm-1999" TYPE="STUDY">Björkholm 1999</LINK>; <LINK REF="STD-Aglietta-2000_x002a_" TYPE="STUDY">Aglietta 2000*</LINK>). When infections were documented by both microbiological and clinical methods, only the microbiologically documented infections were included as these are less prone to bias (<LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>). The risk of developing an infection was reduced by 26% (RR 0.74; 95% CI 0.64 to 0.85); see <LINK REF="FIG-30" TYPE="FIGURE">Figure 30</LINK>. Inclusion of either microbiological or clinical data did change the result (data not shown). There was no significant statistical heterogeneity among the trials (chi squared = 12.02, df = 10, P = 0.28). Sensitivity analyses (tumour entity, antibiotic prophylaxis, quality and size of study; comparison 5) did not show significant differences (<LINK REF="FIG-31" TYPE="FIGURE">Figure 31</LINK>; <LINK REF="FIG-32" TYPE="FIGURE">Figure 32</LINK>; <LINK REF="FIG-33" TYPE="FIGURE">Figure 33</LINK>; <LINK REF="FIG-34" TYPE="FIGURE">Figure 34</LINK>; <LINK REF="FIG-35" TYPE="FIGURE">Figure 35</LINK>; <LINK REF="FIG-36" TYPE="FIGURE">Figure 36</LINK>; <LINK REF="FIG-37" TYPE="FIGURE">Figure 37</LINK>; <LINK REF="FIG-38" TYPE="FIGURE">Figure 38</LINK>; <LINK REF="FIG-39" TYPE="FIGURE">Figure 39</LINK>). These data suggest that G-CSF and GM-CSF significantly reduce the risk of infection.</P>
<P>
<B>Parenteral antibiotic treatment<BR/>
</B>Data from four studies including 359 patients were pooled in this analysis (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>*). The risk of requiring parenteral antibiotic treatment was reduced by 18% in the G-CSF and GM-CSF treated groups (RR 0.82; 95 % CI 0.57 to 1.18), but this was not statistically significant; see <LINK REF="FIG-40" TYPE="FIGURE">Figure 40</LINK>. There was no significant statistical heterogeneity among the trials (chi squared = 9.12, df = 4, P = 0.058). A test for publication bias (P = 0.026) indicated that both the RR and its 95% CI may be overestimated.</P>
<P>
<B>Mortality during chemotherapy<BR/>
</B>Ten studies (one with two chemotherapy regimens) with 1170 patients were included in the analysis. Overall, 36 out of 592 patients treated with G-CSF or GM-CSF and 38 out of 975 patients in the control group died during chemotherapy (RR 0.93; 95% CI 0.60 to 1.43) (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>*; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>*; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>*; <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">
Dunlop MOPP 1998
</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>). There was no significant statistical heterogeneity among the trials (chi squared = 5.92, df = 8 , P = 0.66); see <LINK REF="FIG-41" TYPE="FIGURE">Figure 41</LINK>.</P>
<P>
<BR/>
<B>Infection related mortality during chemotherapy</B>
<BR/>Ten studies (one with two chemotherapy regimens) with 1835 patients were included in the analysis of infection related mortality during chemotherapy. Nineteen out of 920 patients treated with G-CSF or GM-CSF and twenty out of 915patients in the control group died of infection during treatment (RR 0.93; 95% CI 0.51 to 1.71) (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>*; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>*; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>*; <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>*; <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>*; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>*; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>), but this was not statistically significant. There was no significant statistical heterogeneity among the trials (chi squared = 6.67, df = 7, P = 0.46); see <LINK REF="FIG-42" TYPE="FIGURE">Figure 42</LINK>. Overall, there is no evidence that G-CSF or GM-CSF affect overall mortality and infection related mortality during chemotherapy.</P>
<P>
<B>Complete response<BR/>
</B>Analysis of complete tumour response was based on 11 trials including 2368 patients (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Engelhard-1994" TYPE="STUDY">Engelhard 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>*; <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>*; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003;</LINK> <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>). Two trials, <LINK REF="STD-Dunlop-1998" TYPE="STUDY">
Dunlop 1998
</LINK> and <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">
Ösby 2003
</LINK>, were analysed by chemotherapy regimen. The overall risk of achieving complete response for patients treated with G-CSF or GM-CSF was increased by 3% (RR 1.03; 95% CI 0.95 to 1.10), but this was not statistically significant; see <LINK REF="FIG-43" TYPE="FIGURE">Figure 43</LINK>. There was no significant heterogeneity among the trials (chi squared = 9.84, df = 12, P = 0.63). The test for small study bias was significant (P = 0.02624), indicating that the effect of G-CSF or GM-CSF may be overestimated (see <LINK REF="FIG-45" TYPE="FIGURE">Figure 45</LINK>) . A subgroup analysis of study size showed a bigger treatment effect in small studies (RR 1.31; 95% CI 1.08 to 1.60) compared to large studies (RR 0.99; 95% CI 0.92 to 1.07), P value for difference between subgroups: 0.0154; see <LINK REF="FIG-44" TYPE="FIGURE">Figure 44</LINK>, comparison 6.7. Other sensitivity analyses (type of drug, tumour entity, patient age, antibiotic prophylaxis, quality of study and publication type; comparison 6) did not show any significant differences (<LINK REF="FIG-46" TYPE="FIGURE">Figure 46</LINK>; <LINK REF="FIG-47" TYPE="FIGURE">Figure 47</LINK>; <LINK REF="FIG-48" TYPE="FIGURE">Figure 48</LINK>; <LINK REF="FIG-49" TYPE="FIGURE">Figure 49</LINK>; <LINK REF="FIG-50" TYPE="FIGURE">Figure 50</LINK>; <LINK REF="FIG-51" TYPE="FIGURE">Figure 51</LINK>).</P>
<P>
<B>Adverse effects </B>
<BR/>
<B>Bone pain<BR/>
</B>Based on eight studies with 1204 patients, the risk of bone pain for patients treated with G-CSF or GM-CSF was more than doubled, compared to the control group (RR 3.57; 95% CI 2.09 to 6.12) (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>). However, no patient withdrew from the study because of bone pain. There was no significant statistical heterogeneity among the trials (chi squared = 5.73, df = 8, P = 0.68); see <LINK REF="FIG-52" TYPE="FIGURE">Figure 52</LINK>. Subgroup analysis (comparison 7) demonstrated a significantly (P = 0.026) smaller risk of bone pain for patients treated with GM-CSF (RR 1.37; 95% CI 0.54 to 3.47, 2 studies of N = 232), compared to patients receiving G-CSF (RR 5.33; 95% CI 2.66 to 10.68, 6 studies of N = 972); see <LINK REF="FIG-53" TYPE="FIGURE">Figure 53</LINK>. However, this observation is based on indirect comparison. Sensitivity analysis for placebo-controlled or open studies, tumour entity, age of patients, quality and size of study did not show significant differences (<LINK REF="FIG-54" TYPE="FIGURE">Figure 54</LINK>; <LINK REF="FIG-55" TYPE="FIGURE">Figure 55</LINK>; <LINK REF="FIG-56" TYPE="FIGURE">Figure 56</LINK>; <LINK REF="FIG-57" TYPE="FIGURE">Figure 57</LINK>; <LINK REF="FIG-58" TYPE="FIGURE">Figure 58</LINK>).</P>
<P>
<B>Thromboembolic complications<BR/>
</B>Based on 425 patients in 5 trials, a total of 17 thromboembolic complications were observed (RR 1.29; 95% CI 0.56 to 3.01) (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>*; <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>); see <LINK REF="FIG-59" TYPE="FIGURE">Figure 59</LINK>. There was no significant statistical heterogeneity among the trials (chi squared = 2.12, df = 4, P = 0.71). Thus, there is no evidence that G-CSF or GM-CSF increase the risk of thrombosis or related haemodynamic vascular complications such as transient ischaemic attacks, stroke or myocardial infarction.</P>
<P>
<B>Skin rash and injection site reaction<BR/>
</B>Two trials including 232 patients reported 33 cases of skin rash in the GM-CSF group and four in the control group (RR 7.69; 95% CI 2.84 to 20.82) (<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>); see <LINK REF="FIG-60" TYPE="FIGURE">Figure 60</LINK>. There was no significant statistical heterogeneity among the trials (chi squared = 0.90, df = 1, P = 0.34). Data for G-CSF were not reported. Injection site reactions were reported in two trials with 337 patients. Based on 43 observed events in the treatment group and six in the control group, the risk of an injection site reaction was increased more than fivefold (RR 6.55; 95% CI 3.01 to 14.25) (<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>); see <LINK REF="FIG-61" TYPE="FIGURE">Figure 61</LINK>. There was no significant statistical heterogeneity among the trials (chi squared = 0.00, df = 1, P = 0.97). However, the wide confidence intervals indicate that these results should be interpreted with caution.</P>
<P>
<B>Myalgia</B>
<BR/>Two studies including 232 patients failed to detect a significant effect (RR 0.95; 95% CI 0.60 to 1.45) (<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>); see <LINK REF="FIG-62" TYPE="FIGURE">Figure 62</LINK>. There was no significant statistical heterogeneity among the trials (chi squared = 0.92, df = 1, P = 0.34). No other studies could be analysed for this outcome, so the data must be interpreted cautiously.</P>
<P>
<B>Mucositis</B>
<BR/>Three studies (one examining two chemotherapy regimens) including 696 patients did not show a significant effect (RR 0.95; 95% CI 0.64 to 1.41) (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>); see <LINK REF="FIG-63" TYPE="FIGURE">Figure 63</LINK>. There was no significant heterogeneity among the trials (chi squared = 0.65, df = 3 P = 0.89).</P>
<P>
<B>Headache</B>
</P>
<P>Two studies reported the incidence of headache (<LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>); see <LINK REF="FIG-64" TYPE="FIGURE">Figure 64</LINK>.</P>
<P>
<B>Withdrawal from treatment<BR/>
</B>Eight studies reported rates of withdrawal from treatment (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>). Overall, 113 of 531 patients in the G-/GM-CSF group and 122 of 518 patients in the control group withdrew from treatment. In the GM-CSF treated groups, 28 of 117 patients and 5 of 111 patients in the control group left the study due to adverse events attributable to the study medication; see <LINK REF="FIG-65" TYPE="FIGURE">Figure 65</LINK>. None of the withdrawals in the G-CSF group were related to the study drug.</P>
<P>The likelihood of experiencing chemotherapy-related adverse events such as nausea, vomiting, peripheral polyneuropathy and alopecia was similar between the G-CSF and GM-CSF treatment groups (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>).</P>
<P>
<B>Continuous outcome data<BR/>
</B>Insufficient reporting of continuous data precluded analysis of the duration of neutropenia and febrile neutropenia, received dose intensity, duration of antibiotic therapy and length of hospital stay.</P>
<P>
<B>Duration of neutropenia<BR/>
</B>Two studies (<LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>) reported a shortened duration of severe neutropenia (ANC &lt; 500), which was statistically significant in one trial (<LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>). Other trials reported the duration of neutropenia (ANC &lt;1000) with inconclusive results. Thus, there is no conclusive evidence that G-CSF or GM-CSF shorten the duration of neutropenia. Refer to <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> for an overview of how trials reported the duration of neutropenia and of reported results. </P>
<P>
<B>Duration of febrile neutropenia<BR/>
</B>Two studies reported equal lengths of febrile neutropenia for the two treatment groups (<LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>), while two other studies observed a longer duration of febrile neutropenia in the control group (<LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>). Due to the very limited data available there is no conclusive evidence that G-CSF or GM-CSF reduce the duration of febrile neutropenia (see <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>).</P>
<P>
<B>Hospital stay<BR/>
</B>Six studies reported data on the duration of hospitalisation. Only one study reported the overall number of days in hospital (<LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>). There was no significant difference between the study groups (5 days in the G-CSF group, 6 days in the control group, P = 0.4). Most studies reported effectiveness and efficacy parameters on related measurements, e.g. chemotherapy-related and chemotherapy-unrelated services (<LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>), hospitalised days per cycle (<LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>), total number of hospitalised days (<LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>), hospitalised days because of febrile neutropenia (<LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>) or number of patients hospitalised for more than 3 days for infection (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>). The data reported were too divergent to draw meaningful conclusions (see <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>).</P>
<P>
<B>Duration of parenteral antibiotic treatment<BR/>
</B>In three studies (<LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>) the duration of parenteral antibiotic treatment was shorter in the G-/GM-CSF treated group, but this was not statistically significant. A met-analysis was not performed since the data did not appear to be normally distributed (see <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>).</P>
<P>
<B>Relative Dose Intensity<BR/>
</B>Relative dose intensity was reported in 9 out of 13 studies. In all but one study (<LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>), the G-CSF or GM-CSF treated group received a higher dose intensity than the control group. In three studies, the overall differences were statistically significant (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>). Other studies found differences for single substances, but the data were not analysed as the required standard deviation was reported in only two studies (<LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>) (see <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
<P>
<B>Other outcomes<BR/>Thrombocytopenia</B>
<BR/>The rate or the degree of thrombocytopenia was reported in 6 out of 13 trials (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>). As the available data were measured in different, non-convertible units, it was not possible to conduct a meta-analysis. Overall, <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK> showed a significant difference in the mean platelet nadir for thrombocytopenia in favour of the control group. Some studies showed inconsistent and statistically non-significant results in favour of the G-/GM-CSF group (<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>). Others favoured the control group (<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>) or reported similar results for both treatment groups (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>). Overall, there is no conclusive evidence that G-CSF or GM-CSF influence the rate or the degree of thrombocytopenia (see <LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>).</P>
<P>
<B>Anaemia</B>
<BR/>The rate or the degree of anaemia was reported in 4 out of 13 trials (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>). As the available data were measured in different, non-convertible units it was not possible to conduct a meta-analysis. <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK> showed a statistically significant difference in the haemoglobin level in favour of the control group. The other studies found no significant difference in effect between the two treatment groups. There is no conclusive evidence that G-CSF or GM-CSF influence the incidence or degree of anaemia (see <LINK REF="TBL-08" TYPE="TABLE">Table 8</LINK>).</P>
<P>
<B>Potential biases<BR/>
</B>To assess potential biases, previously specified sensitivity and subgroup analysis were performed. <BR/>
<B>
<BR/>Selection bias<BR/>
</B>Information on the method of allocation concealment was not available in three studies (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>), but concealment of allocation was adequate in all the other studies. However, inclusion or exclusion of these three studies did not significantly affect any of the outcomes analysed (neutropenia, febrile neutropenia, infection, overall survival, bone pain).</P>
<P>
<B>Performance bias<BR/>
</B>Five of the included studies were placebo-controlled (<LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>; <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>). However, sensitivity analysis for placebo-controlled and open label studies did not show significant differences for objective outcome measures, such as neutropenia, febrile neutropenia, infection, tumour response and overall survival, or for subjective outcome measures such as bone pain.</P>
<P>
<B>Attrition bias<BR/>
</B>Seven studies (<LINK REF="STD-Cunningham" TYPE="STUDY">Cunningham</LINK>*; <LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>; <LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>) and one substudy (<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>) were based on an intention-to-treat analysis and included all patients who were initially assigned to treatment in the final analysis. The other studies were based on full set analysis and excluded patients who did not meet the eligibility criteria, had major protocol violation or did not receive any study medication. To assess the influence of the excluded data we performed a worst case-best case scenario analysis. None of the results analysed differed markedly from the pooled data reported. One study reported an additional per protocol analysis of patients who received at least 70% of the study medication (<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>). Inclusion of these data resulted in a significantly reduced risk of parenteral antibiotic treatment in the fixed effect model (RR 0.72; 95% CI 0.54 to 0.97). However, this result was not robust in the random effects model, where more weight is given to smaller studies (RR 0.72; 95% CI 0.42 to 1.22). We excluded these data from the final analysis as we consider per protocol analysis to be less reliable than intention-to-treat.</P>
<P>
<B>Publication bias<BR/>
</B>The funnel plot analysis of the data for complete response and parenteral antibiotic treatment showed an imbalance of positive and negative results, indicating that studies with negative findings might be under-represented. Taking this into consideration, the estimated benefit of G-CSF and GM-CSF in improving complete response and reducing the need for antibiotic treatment may be overestimated.</P>
<P>
<B>Reporting bias<BR/>
</B>Overall, none of the outcomes showed a significant difference between published and unpublished or unreported data.</P>
<P>In addition, subgroup analyses were performed to investigate the influence of clinical diversity of the included trials. Use of antibiotic prophylaxis showed a difference between the analysed subsets only for neutropenia, as mentioned before. Other results such as OS, complete response, febrile neutropenia, infection and bone pain were not influenced. Use of G-CSF or GM-CSF resulted in a significant difference only for the rate of bone pain. Different disease entities (HD and NHL) did not show significant differences in any of the results analysed.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>The results of this meta-analysis are as follows.</P>
<OL>
<LI>There is no evidence that G-CSF and GM-CSF improve overall survival or freedom from treatment failure when used as an adjunct in conventional chemotherapy regimens.</LI>
<LI>Granulopoiesis-stimulating factors (G-CSF and GM-CSF) reduce the risk of neutropenia, febrile neutropenia and infection in patients undergoing conventional chemotherapy for malignant lymphoma.</LI>
</OL>
<P>Our review is the first comprehensive meta-analysis evaluating the effects of G-CSF or GM-CSF in patients with malignant lymphoma undergoing conventional chemotherapy. Other analyses included either studies with smaller numbers of patients or have heterogeneous populations which include solid tumours and haematological malignancies (<LINK REF="REF-ASCO-Guidelines-1994" TYPE="REFERENCE">ASCO Guidelines 1994</LINK>; <LINK REF="REF-ASCO-Guidelines-1996" TYPE="REFERENCE">ASCO Guidelines 1996</LINK>; <LINK REF="REF-Rusthoven-1998" TYPE="REFERENCE">Rusthoven 1998</LINK>; <LINK REF="REF-ASCO-Guidelines-2000" TYPE="REFERENCE">ASCO Guidelines 2000</LINK>; <LINK REF="REF-Lyman-2002" TYPE="REFERENCE">Lyman 2002</LINK>; <LINK REF="REF-ASCO-Guidelines-2006" TYPE="REFERENCE">ASCO Guidelines 2006</LINK>; <LINK REF="REF-Kuderer-2007" TYPE="REFERENCE">Kuderer 2007</LINK>; <LINK REF="REF-Sung-2007" TYPE="REFERENCE">Sung 2007</LINK>). The current, updated review includes thirteen prospectively randomised studies with 2607 patients. In addition, we included previously unreported data on outcome, patient characteristics and study design provided on request by the authors of the original publications. One previously unpublished study was also included. The robustness of all results was tested by sensitivity and subgroup analysis based on prospectively defined parameters.</P>
<P>The most convincing effects of G-CSF and GM-CSF were on neutropenia. G-CSF and GM-CSF reduced the risk of lymphoma patients having neutrophil counts below 0.5 x 10<SUP>9</SUP>/litre by 33%. G-CSF reduced the risk of febrile neutropenia (ANC below 1.0 x 10<SUP>9</SUP>/litre) by 26% and by 41% when ANC was defined as &lt; 0.5 x 10<SUP>9</SUP>/litre. The risk of acquiring infection when given G-CSF or GM-CSF was also reduced by 26%. However, there is no evidence that G-CSF and GM-CSF decrease overall or infection related mortality during chemotherapy.</P>
<P>Data presented in this analysis suggest smaller effects than previously reported (<LINK REF="REF-ASCO-Guidelines-1994" TYPE="REFERENCE">ASCO Guidelines 1994</LINK>; <LINK REF="REF-ASCO-Guidelines-1996" TYPE="REFERENCE">ASCO Guidelines 1996</LINK>; <LINK REF="REF-Rusthoven-1998" TYPE="REFERENCE">Rusthoven 1998</LINK>; <LINK REF="REF-ASCO-Guidelines-2000" TYPE="REFERENCE">ASCO Guidelines 2000</LINK>; <LINK REF="REF-Hackshaw-2004" TYPE="REFERENCE">Hackshaw 2004</LINK>; <LINK REF="REF-ASCO-Guidelines-2006" TYPE="REFERENCE">ASCO Guidelines 2006</LINK>; <LINK REF="REF-Kuderer-2007" TYPE="REFERENCE">Kuderer 2007</LINK>). Our results are comparable to the most comprehensive meta-analysis in all cancer patients by <LINK REF="REF-Sung-2007" TYPE="REFERENCE">Sung 2007</LINK>, where the subgroup of patients with solid tumours or lymphoma has a relative risk reduction for febrile neutropenia of 36% (RR 0.64; 95% CI 0.53 to 0.76).</P>
<P>Publication bias due to under-reporting of unexpected or negative data is one of the major obstacles in conducting meta-analyses. Comprehensive literature searching and detection of unreported data can minimise this bias. The funnel plot analysis of the data for complete response showed an imbalance of positive and negative results, indicating that studies with negative findings might be under-represented. We identified two studies on GM-CSF that were never published and were not included in this review (<LINK REF="STD-Liberati-1991" TYPE="STUDY">Liberati 1991</LINK>; <LINK REF="STD-Unpublished-trial" TYPE="STUDY">Unpublished trial</LINK>). Taking this into consideration, the true effect of G-CSF and GM-CSF on complete response may be even less than indicated by our analysis.</P>
<P>According to <LINK REF="REF-Deeks-2001" TYPE="REFERENCE">Deeks 2001</LINK>, meta-analysis of continuous outcome data, e.g. duration of neutropenia and number of days in hospital, requires a normal distribution as well as the mean response and the standard deviation. However, most of the included studies did not report these parameters, rendering a meta-analysis impossible. Single studies in malignant lymphoma (<LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>) and solid tumours (<LINK REF="REF-Crawford-1991" TYPE="REFERENCE">Crawford 1991</LINK>; <LINK REF="REF-Bui-1995" TYPE="REFERENCE">Bui 1995</LINK>; <LINK REF="REF-Chevallier-1995" TYPE="REFERENCE">Chevallier 1995</LINK>; <LINK REF="STD-Mayordomo-1995" TYPE="STUDY">Mayordomo 1995</LINK>) documented a significantly shorter time to neutrophil recovery in patients treated with G-CSF. In contrast, there is no convincing evidence that G-CSF and GM-CSF decrease the length of febrile neutropenia in patients with both malignant lymphoma (<LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Dunlop-1998" TYPE="STUDY">Dunlop 1998</LINK>) and solid tumours (<LINK REF="REF-Crawford-1991" TYPE="REFERENCE">Crawford 1991</LINK>; <LINK REF="REF-Bui-1995" TYPE="REFERENCE">Bui 1995</LINK>; <LINK REF="REF-Chevallier-1995" TYPE="REFERENCE">Chevallier 1995</LINK>) who are undergoing moderately myelosuppressive chemotherapy.</P>
<P>Apart from reducing infections and related complications, G-CSF and GM-CSF are used in clinical practice to maintain dose intensities. Retrospective analysis indicated that a higher relative dose intensity may translate into better tumour control (<LINK REF="REF-DeVita-1987" TYPE="REFERENCE">DeVita 1987</LINK>; <LINK REF="REF-Lepage-1993" TYPE="REFERENCE">Lepage 1993</LINK>). A significantly higher received dose intensity in patients receiving G-/GM-CSF was demonstrated in patients with small cell lung cancer (<LINK REF="REF-Trillet_x002d_Lenoir-1993" TYPE="REFERENCE">Trillet-Lenoir 1993</LINK>; <LINK REF="REF-Woll-1995" TYPE="REFERENCE">Woll 1995</LINK>; <LINK REF="REF-Fukuoka-1997" TYPE="REFERENCE">Fukuoka 1997</LINK>), breast cancer (<LINK REF="REF-de-Graaf-1996" TYPE="REFERENCE">de Graaf 1996</LINK>) and malignant lymphoma (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>). However, we were unable to quantify the received dose intensity described in the included studies. Most of the G-/GM-CSF treated groups received more chemotherapy compared with the corresponding control groups; four studies demonstrated a statistically significant difference for the main components (<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>; <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>; <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>; <LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>).</P>
<P>There was no evidence that the addition of G-CSF or GM-CSF to standard chemotherapy improves tumour response, FFTF or OS in lymphoma patients. The most likely explanation for the very similar complete response rates in patients receiving or not receiving G-/GM-CSF is that the studies focused on the prevention of neutropenia and neutropenia-related events. Studies comparing dose escalated or time intensified chemotherapy regimens with a standard chemotherapy regimen were explicitly excluded from the present analysis.</P>
<P>Adverse effects attributable to G-CSF and GM-CSF, such as bone pain and skin reactions, were more frequently reported in patients treated with G-CSF and GM-CSF than the control group. There was no evidence that thrombosis or related complications occur more frequently in the G-CSF and GM-CSF treated groups than in the control group (odds ratio 1.31; 95% CI 0.54 to 3.19). These findings are consistent with a previous meta-analysis of thrombosis in patients with various malignancies treated with haematopoietic growth factors (odds ratio 1.67; 95% CI 0.92 to 3.04, N = 838) (<LINK REF="REF-Barbui-1996" TYPE="REFERENCE">Barbui 1996</LINK>). Overall, more patients receiving GM-CSF (24/117) discontinued the study due to adverse effects compared with patients receiving G-CSF. Based on these data, G-CSF seems to be superior to GM-CSF in terms of tolerability. However, it should be taken into consideration that this result is based on an indirect comparison, and that data for G-CSF may simply not have been reported. Similarly, subgroup analysis suggests that patients receiving G-CSF are more likely to develop bone pain than patients receiving GM-CSF. However, results from single studies, comparing directly G-CSF and GM-CSF, do not support this hypothesis (<LINK REF="REF-Beveridge-1998" TYPE="REFERENCE">Beveridge 1998</LINK>; <LINK REF="REF-Alvarado-Ibarra-1999" TYPE="REFERENCE">Alvarado Ibarra 1999</LINK>).</P>
<P>Although G-CSF and GM-CSF are cost intensive drugs, economic evaluations have demonstrated an overall cost reduction of treatment due to fewer and shorter hospital admissions (<LINK REF="REF-Lyman-1995" TYPE="REFERENCE">Lyman 1995</LINK>; <LINK REF="REF-Lyman-1998" TYPE="REFERENCE">Lyman 1998</LINK>). These calculations were based on the assumption that G-CSF would reduce the risk of febrile neutropenia by 50%. However, this figure relates to a randomised controlled study including 211 patients with small cell lung cancer (<LINK REF="REF-Crawford-1991" TYPE="REFERENCE">Crawford 1991</LINK>). In our updated analysis, the relative risk reduction for febrile neutropenia with ANC below 1.0 x 109 per litre was 26% and for ANC below 0.5 x 109 per litre 41% in lymphoma patients. A threshold risk for febrile neutropenia in a given cancer population of 40% was estimated at which the added costs of G-CSF would be counterbalanced by the reduced direct hospital costs for febrile neutropenia (<LINK REF="REF-Lyman-1995" TYPE="REFERENCE">Lyman 1995</LINK>). An updated analysis added the indirect institutional costs of care for patients with febrile neutropenia to the direct costs, reducing the potential break-even point to a febrile neutropenia risk of 20% (<LINK REF="REF-Lyman-1998" TYPE="REFERENCE">Lyman 1998</LINK>). In addition, this threshold was swon to be effective in breast cancer patients receiving chemotherapy (<LINK REF="REF-Vogel-2005" TYPE="REFERENCE">Vogel 2005</LINK>) and it now recommended in current guidelines (<LINK REF="REF-EORTC-Guidelines-2006" TYPE="REFERENCE">EORTC Guidelines 2006</LINK>; <LINK REF="REF-ASCO-Guidelines-2006" TYPE="REFERENCE">ASCO Guidelines 2006</LINK>).</P>
<P>In addition to the prevention of neutropenia and related effects, growth factors are currently used in high dose chemotherapy settings to help generate haematopoietic stem cells and to support recovery after myeloablative treatment (<LINK REF="REF-de-Witte-1992" TYPE="REFERENCE">de Witte 1992</LINK>; <LINK REF="REF-Pettengell-1993" TYPE="REFERENCE">Pettengell 1993</LINK>). More recently, growth factors have been used to not only facilitate not only the administration of the planned chemotherapy in dose and time but also to assist haematopoietic recovery in time- or dose-intensified regimen. There are strong arguments for this notion stemming from three large prospectively randomised trials in patients with HD (<LINK REF="REF-Diehl-2003" TYPE="REFERENCE">Diehl 2003</LINK>) and NHL <LINK REF="REF-Preundschuh-2004a" TYPE="REFERENCE">Preundschuh 2004a</LINK>; <LINK REF="REF-Preundschuh-2004b" TYPE="REFERENCE">Preundschuh 2004b</LINK>). Thus, a further meta-analysis to prove the assumed role of haematopoietic growth factors in dose escalation is warranted.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<P>There is no evidence that G-CSF or GM-CSF improve OS or FFTF. We demonstrated that G-CSF and GM-CSF significantly reduce the risk for neutropenia, febrile neutropenia and infections in patients undergoing conventional chemotherapy for malignant lymphoma. .</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Clinical studies and meta-analyses to prove the effectiveness of growth factors in assisting haematopoietic recovery in time- or dose-intensified regimen are warranted. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-07-17 17:06:17 +0200" MODIFIED_BY="[Empty name]">
<P>We thank all authors and coworkers of primary studies who provided us with additional study data: M. Aglietta, Luis Agustin Aviles, Lorraine Bishop, Magnus Björkholm, D. Cunningham, Jeanette K. Doorduijn, D.J. Dunlop, Michael A. Fridrik, Christian Gisselbrecht, Filippo Montemurro, Jim Paul and Pier Luigi Zinzani. Special thanks to the CHMG editors, affiliated consumers and members of the CHMG editorial base for critical advice and strong support: Lia Alewijnse-Poelman, Benjamin Djulbegovic, Céline Fournier, Alexander Greb, Gail Higgins, Sabine Kluge, Thilo Kober, Lena Specht, Ralph Meyer, Sue Richards, Keith Wheatley. We also would like to thank Douglas Altman, Christine Clar, Otávio Clark, Jeremy Franklin, Guido Grass, Atsuko Hasegawa-Rahnenführer, Dirk Hasenclever, Allison Hirst, Carol Lefebvre, Mark Lodge, Bernd Richter, Beate Pfistner, Stefan Sauerland, Nicole Skoetz, Sven Trelle and Chugai Pharma (see Potential conflict of interest).</P>
<P>The editorial base of the Cochrane Haematological Malignancies Group is funded, as part of the Competence Network Malignant Lymphomas, by the German Ministry of Education and Research (BMBF).</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>Chugai Pharma (Chugai Pharma Marketing Ltd., Subsidiary Germany, Frankfurt/Main) provided the translation of a Japanese publication (<LINK REF="STD-Togawa-2000" TYPE="STUDY">Togawa 2000</LINK>) for the Cochrane Haematological Malignancies Group. Andreas Engert received research funding and honoraria from Amgen Ltd. for other projects.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-08-11 15:40:25 +0200" MODIFIED_BY="Nicole Skoetz">
<P>JULIA BOHLIUS: Protocol development, searching for trials, eligibility and quality assessment, data extraction and analysis, drafting of final review, updating review</P>
<P>ANDREAS ENGERT: Clinical and scientific advice, assessment of eligibility and quality, data analysis, content input</P>
<P>CHRISTINE HERBST: Update: abstract screening, eligibility and quality assessment, data extraction and analysis, drafting of the updated review</P>
<P>MARCEL REISER: Searching for trials, assessment of eligibility and quality, data extraction and analysis, content input</P>
<P>GUIDO SCHWARZER: Statisticaladvice and data analysis</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-06-09 10:18:04 +0200" MODIFIED_BY="Nicole Skoetz">
<P>None</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-07-17 16:59:53 +0200" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Aglietta-2000" NAME="Aglietta 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aglietta M, Montemurro F, Fagioli F, Volta C, Botto B, Cantonetti M et al</AU>
<TI>Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease</TI>
<SO>Cancer</SO>
<YR>2000</YR>
<VL>88</VL>
<PG>454-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Aglietta-2000_x002a_" NAME="Aglietta 2000*" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Personal communication in addition to Aglietta 2000</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Avil_x00e9_s-1994" NAME="Avilés 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Avilés A, Díaz-Maqueo JC, Talavera A, Nambo MJ, García EL</AU>
<TI>Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy</TI>
<SO>Leukemia and Lymphoma</SO>
<YR>1994</YR>
<VL>15</VL>
<PG>153-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Avil_x00e9_s-1994_x002a_" NAME="Avilés 1994*" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Personal communication in addition to Avilès 1994</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bastion-1993" NAME="Bastion 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bastion Y, Bosly A, Gisselbrecht C, Reyes F, Tilly H, Herbrecht R et al</AU>
<TI>A randomized double-blind phase III study of Filgrastim (recombinant human G-CSF) vs placebo during intensive induction chemotherapy in 55 to 59 year old patients (pts) with poor prognosis aggressive Non-Hodgkin's Lymphoma</TI>
<SO>Blood</SO>
<YR>1993</YR>
<VL>82 Suppl (1):143a</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bastion-ACVBP-1993" NAME="Bastion ACVBP 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Data on patients from the Bastion 1993 study, who received ACVBP chemotherapy</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bastion-VIMMM-1993" NAME="Bastion VIMMM 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Data on patients from the Bastion 1993 study, who received VIMMM chemotherapy</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bj_x00f6_rkholm-1999" NAME="Björkholm 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Björkholm M, Osby E, Hagberg H, Kvaloy S, Teerenhovi L, Myhre J et al</AU>
<TI>Randomized trial of r-metHu granulocyte colony-stimulating factor (G-CSF) as adjunct to CHOP or CNOP treatment of elderly patients with aggressive non-Hodgkin's lymphoma</TI>
<SO>Blood</SO>
<YR>1999</YR>
<VL>94, 10 Suppl (1):599a</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bj_x00f6_rkholm-CHOP-1999" NAME="Björkholm CHOP 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Data on patients from the Björkholm 1999 study, who received CHOP chemotherapy</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bj_x00f6_rkholm-CNOP-1999" NAME="Björkholm CNOP 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Data on patients from the Björkholm 1999 study, who received CNOP chemotherapy</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burton-2006" MODIFIED="2008-04-23 15:21:26 +0200" MODIFIED_BY="[Empty name]" NAME="Burton 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-04-23 15:21:26 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burton C, Linch D, Hoskin P, Milligan D, Dyer MJS et al</AU>
<TI>A phase III trial comparing CHOP to PMitCEBO with or without G-CSf in patients aged 60 plus with aggressive non-Hodgkin´s lymphoma</TI>
<SO>Br J Cancer</SO>
<YR>2006</YR>
<VL>94</VL>
<PG>806-813</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-04-22 14:47:52 +0200" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burton-CHOP-2006" MODIFIED="2008-04-23 15:19:29 +0200" MODIFIED_BY="[Empty name]" NAME="Burton CHOP 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-04-23 15:19:29 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Data on patients from the Burton 2006 study who received CHOP</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burton-PMitCEBO-2006" MODIFIED="2008-04-23 15:19:21 +0200" MODIFIED_BY="[Empty name]" NAME="Burton PMitCEBO 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-04-23 15:19:21 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Data from patients in the Burton 2006 study who received PMitCEBO</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Cunningham_x002a_" NAME="Cunningham*" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Cunningham D</AU>
<TI>Randomised trial of platinum based chemotherapy +/-G-CSF in relapsed Non-Hodgkins and Hodgkins Lymphoma</TI>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Doorduijn-2003" NAME="Doorduijn 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Doorduijn JK, an der Holt B, van Imhoff GW, van der Hem KG, Kramer MHH, van Oers MHJ et al</AU>
<TI>CHOP compared to CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive Non-Hodgkin's Lymphoma</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2003</YR>
<VL>21</VL>
<NO>16</NO>
<PG>3041-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunlop-1998" NAME="Dunlop 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunlop DJ, Eatock MM, Paul J, Anderson S, Reed NS, Soukop M et al</AU>
<TI>Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group</TI>
<SO>Clinical Oncology (Royal College of Radiologists)</SO>
<YR>1998</YR>
<VL>10</VL>
<PG>107-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunlop-MOPP-1998" NAME="Dunlop MOPP 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Data on patients from the Dunlop 1998 study, who received MOPP chemotherapy</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Dunlop-MOPP-1998_x002a_" NAME="Dunlop MOPP 1998*" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Personal communication in addition to Dunlop MOPP 1994</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunlop-MOPP_x002f_EVAP-98" NAME="Dunlop MOPP/EVAP 98" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Data on patients from the Dunlop 1998 study, who received MOPP/EVAP chemotherapy</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" NAME="Dunlop MOPP/EVAP 98*" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Personal communication in addition to Dunlop MOPP/EVAP 1998</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Engelhard-1994" NAME="Engelhard 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Engelhard M, Gerhartz H, Brittinger G, Engert A, Fuchs R, Geiseler B et al</AU>
<TI>Cytokine efficiency in the treatment of high-grade malignant non- Hodgkin's lymphomas: Results of a randomized double-blind placebo- controlled study with intensified COP-BLAM plus-or-minus sign rhGM- CSF.</TI>
<SO>Annals of Oncology</SO>
<YR>1994</YR>
<VL>5</VL>
<PG>123-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fridrik-1997" NAME="Fridrik 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fridrik MA, Greil R, Hausmaninger H, Krieger O, Oppitz P, Stoger M et al</AU>
<TI>Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Therapy</TI>
<SO>Annals of Hematology</SO>
<YR>1997</YR>
<VL>75</VL>
<PG>135-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Fridrik-1997_x002a_" NAME="Fridrik 1997*" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Personal communication in addition to Fridrik 1997</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerhartz-1993" NAME="Gerhartz 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerhartz HH, Engelhard M, Meusers P, Brittinger G, Wilmanns W, Schlimock G et al</AU>
<TI>Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant Non-Hodgkin's Lymphoma</TI>
<SO>Blood</SO>
<YR>1993</YR>
<VL>82</VL>
<NO>8</NO>
<PG>2329-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerhartz-1994a" NAME="Gerhartz 1994a" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerhartz HH, Engelhard M, Brittinger G, Schlimok G, Thiel E, Huber C et al</AU>
<TI>Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas</TI>
<SO>Seminars in Oncology</SO>
<YR>1994</YR>
<VL>21, 6 Suppl (16): 25-8</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gisselbrecht-1997" NAME="Gisselbrecht 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gisselbrecht C, Haioun C, Lepage E, Bastion Y, Tilly H, Bosly A et al</AU>
<TI>Placebo-controlled phase III study of Lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte</TI>
<SO>Leukemia and Lymphoma</SO>
<YR>1997</YR>
<VL>25</VL>
<PG>289-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Gisselbrecht-1997_x002a_" NAME="Gisselbrecht 1997*" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Personal communication in addition to Gisselbrecht 1997</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pettengell-1992" NAME="Pettengell 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pettengell R, Gurney H, Radford JA, Deakin DP, James R, Wilkinson PM et al</AU>
<TI>Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial</TI>
<SO>Blood</SO>
<YR>1992</YR>
<VL>80</VL>
<NO>6</NO>
<PG>1430-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sou_x00ea_tre-1994" NAME="Souêtre 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Souêtre E, Qing W</AU>
<TI>Economic analysis of Lenograstim in the correction of neutropenia following chemotherapy for non-Hodgkin's lymphoma</TI>
<SO>PharmacoEconomics</SO>
<YR>1994</YR>
<VL>6, Suppl (2):36-43</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zinzani-1997" NAME="Zinzani 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zinzani PL, Pavone E, Storti S, Moretti L, Fattori PP, Guardigni L et al</AU>
<TI>Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma</TI>
<SO>Blood</SO>
<YR>1997</YR>
<VL>89</VL>
<NO>11</NO>
<PG>3974-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Zinzani-1997_x002a_" NAME="Zinzani 1997*" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Personal communication in addition to Zinzani 1997</AU>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zinzani-1999" NAME="Zinzani 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zinzani PL, Storti S, Zaccaria A, Moretti L, Magagnoli M, Pavone E et al</AU>
<TI>Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients</TI>
<SO>Blood</SO>
<YR>1999</YR>
<VL>94</VL>
<NO>1</NO>
<PG>33-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x00d6_sby-2003" NAME="Ösby 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ösby K, Hagberg H, Kvaloy S, Teerenhovi L, Anderson H, Cavallin-Stahl E et al</AU>
<TI>CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial</TI>
<SO>Blood</SO>
<YR>2003</YR>
<VL>101</VL>
<NO>10</NO>
<PG>3840-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x00d6_sby-CHOP-2003" NAME="Ösby CHOP 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x00d6_sby-CNOP-2003" NAME="Ösby CNOP 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-05-01 16:18:12 +0200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Adde-1998" NAME="Adde 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Adde M, Shad A, Venzon D, Arndt C, Gootenberg J, Neely J et al</AU>
<TI>Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphoma</TI>
<SO>Seminars in Oncology</SO>
<YR>1998</YR>
<VL>25, 2 suppl (4):33-9</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anaissie-1996" NAME="Anaissie 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anaissie EJ, Vartivarian S, Bodey GP, Legrand C, Kantarjian H, Abi-Said D et al</AU>
<TI>Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia</TI>
<SO>The American Journal of Medicine</SO>
<YR>1996</YR>
<VL>100</VL>
<PG>17-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bergmann-1995" NAME="Bergmann 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Patients (n=35) were randomized to receive either rhGM-CSF or placebo during the first two chemotherapy cycles and rhGM-CSF for all following cycles&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bergmann L, Karakas T, Knuth A, Lautenschlager G, Mitrou PS, Hoelzer D</AU>
<TI>Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma - a randomised pilot study</TI>
<SO>European Journal of Cancer</SO>
<YR>1995</YR>
<VL>31A</VL>
<PG>2164-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bertini-1996" NAME="Bertini 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Non randomized trial with 67 patients. G-CSF was given according to the drug availability at the specific hospital: &amp;quot;As this factor was not generally available in Italy at that time, only some of the participating centers included it in the treatment program. However, all patients in a single center received the same treatment either with or without G-CSF.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bertini M, Freilone R, Vitolo U, Botto B, Ciotti R, Cinieri S et al</AU>
<TI>The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.</TI>
<SO>Leukemia and Lymphoma</SO>
<YR>1996</YR>
<VL>22</VL>
<PG>483-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bodey-1994" NAME="Bodey 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bodey GP, Anaissie E, Gutterman J, Vadhan-Raj S</AU>
<TI>Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection</TI>
<SO>European journal of clinical microbiology &amp; infectious diseases</SO>
<YR>1994</YR>
<VL>13 Suppl (2):18-22</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerhartz-1993ex" NAME="Gerhartz 1993ex" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Treatment study, 60 patients with established neutropenia were included in this study to receive GM-CSF or placebo at random&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerhartz HH, Stern AC, Wolf-Hornung B, Kazempour M, Schmetzer H, Gugerli U et al</AU>
<TI>Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy</TI>
<SO>Leukemia Research</SO>
<YR>1993</YR>
<VL>17</VL>
<NO>2</NO>
<PG>175-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gianni-1990" NAME="Gianni 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;non randomised study (n=36), NHL and breast cancer patients included, less than 10 NHL patients per study arm&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gianni AM, Bregni M, Siena S, Orazi A, Stern AC, Gandola L et al</AU>
<TI>Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma</TI>
<SO>Jounral of Clinical Oncology</SO>
<YR>1990</YR>
<VL>8</VL>
<NO>5</NO>
<PG>768-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gordon-1999" NAME="Gordon 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Phase II study without control group.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gordon LI, Young M, Weller E, Habermann TM, Winter JN, Glick J et al</AU>
<TI>A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: Analysis of response, toxicity, and dose intensity</TI>
<SO>Blood</SO>
<YR>1999</YR>
<VL>94</VL>
<NO>10</NO>
<PG>3307-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gregory-1998" NAME="Gregory 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Less than 10 lymphoma patients per study arm.&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gregory S, Goh YT, Fuerst T, O'Brien T, Giles FJ</AU>
<TI>Fludarabine, cyclophosphamide and GM-CSF is effective in chronic lymphocytic leukemia and low grade non Hodgkins lymphoma</TI>
<SO>Blood</SO>
<YR>1998</YR>
<VL>92 Suppl (10):276b</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gustavsson-1997" NAME="Gustavsson 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Non randomised study with historical control group.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gustavsson A</AU>
<TI>G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease</TI>
<SO>Acta Oncologica</SO>
<YR>1997</YR>
<VL>36</VL>
<NO>5</NO>
<PG>483-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hansen-1995" NAME="Hansen 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;14 patients with NHL were randomized to receive G-CSF or no treatment prior to chemotherapy.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hansen PB, Johnsen HE, Ralfkiaer E, Jensen L, Gaarsdal E, Hansen NE</AU>
<TI>Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas</TI>
<SO>Leukemia and Lymphoma</SO>
<YR>1995</YR>
<VL>19</VL>
<PG>453-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hartmann-1997" NAME="Hartmann 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Randomized intervention study in patients (n=71) with established neutropenia.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hartmann LC, Tschetter LK, Habermann TM, Ebbert LP, Johnson PS, Mailliard JA et al</AU>
<TI>Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia</TI>
<SO>New England Journal of Medicine</SO>
<YR>1997</YR>
<VL>336</VL>
<NO>25</NO>
<PG>1776-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ho-1990" NAME="Ho 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Non randomised study..&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ho AD, Del VF, Haas R, Engelhard M, Hiddemann W, Ruckle H et al</AU>
<TI>Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma</TI>
<SO>Seminars in Oncology</SO>
<YR>1990</YR>
<VL>17</VL>
<PG>14-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hovgaard-1992" NAME="Hovgaard 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Dose finding study.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hovgaard DJ, Nissen NI</AU>
<TI>Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: A Phase I/II Study</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1992</YR>
<VL>10</VL>
<NO>3</NO>
<PG>390-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaku-1993" NAME="Kaku 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Secondary prophylaxis, only pts (n=62) with granulocytopenia (&amp;lt;1x10&amp;#179;/microliters) after the first cycle of chemotherapy were enrolled.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaku K, Takahashi M, Moriyama Y, Nakahata T, Masaoka T, Yoshida Y et al</AU>
<TI>Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial</TI>
<SO>Leukemia and Lymphoma</SO>
<YR>1993</YR>
<VL>11</VL>
<NO>3-4</NO>
<PG>229-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaneko-1991" NAME="Kaneko 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;G-CSF or placebo was started subcutaneously 72 hours after completion of the second cycle of chemotherapy and continued for 14 days. See also Ogawa 1990.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaneko T, Takaku F, Ogawa M</AU>
<TI>Outline of clinical studies on recombinant human granulocyte colony stimulating factor (KRN 8601) in Japan</TI>
<SO>Tokai Journal of Experimental &amp; Clinical Medicine</SO>
<YR>1991</YR>
<VL>16</VL>
<NO>1</NO>
<PG>51-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaplan-1991" NAME="Kaplan 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Effect of GM-CSF in patients (n=21) receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma, randomised study.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaplan LD, Kahn JO, Crowe S, Northfelt D, Neville P, Grossberg H et al</AU>
<TI>Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1991</YR>
<VL>9</VL>
<NO>6</NO>
<PG>929-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karthaus-1998" NAME="Karthaus 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Randomised controlled trial on topical oral G-CSF to prevent mucositis in patients (n=8) with high-grade lymphoma.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karthaus M, Rosenthal C, Huebner G, Paul H, Elser C, Hertenstein B et al</AU>
<TI>Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial</TI>
<SO>Bone Marrow Transplantation</SO>
<YR>1998</YR>
<VL>22</VL>
<NO>8</NO>
<PG>781-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liberati-1991" NAME="Liberati 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Part of a multicenter study. This pulication reports on 14 pts with non-Hogkin lymhoma receiving GM-CSF or placebo during chemotherapy. This report was written before the randomized code was made known. The author was contacted. However, we were not able to additional data or information.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liberati AM, Cinieri S, Schippa M, Di Clemente F, Filippo S, Grignani F</AU>
<TI>GM-CSF: clinical trials in non-Hodgkin's lymphoma patients with chemotherapy induced leucopenia</TI>
<SO>Leukemia</SO>
<YR>1991</YR>
<VL>5 Suppl (1): 119-22</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lopez_x002d_Hernandez-2000" NAME="Lopez-Hernandez 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lopez-Hernandez MA, Jimenez-Alvarado R, Borbolla-Escoboza R, Flores-Chapa JD, Alvarado-Ibarra M, Gonzalez-Avante M et al</AU>
<TI>Factor estimulante de colonias de granulocitos en el tratamiento de neutropenia febril</TI>
<SO>Gaceta medica de Mexico</SO>
<YR>2000</YR>
<VL>136</VL>
<NO>2</NO>
<PG>99-105</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Magrath-1996" NAME="Magrath 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Ths trial analysed a mixed population of children (n=33) and adults (n=39). 16 adult lymphoma patients were randomized to receive or not eceive GM-CSF.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J et al</AU>
<TI>Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1996</YR>
<VL>14</VL>
<NO>3</NO>
<PG>925-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maher-1994" NAME="Maher 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M et al</AU>
<TI>Filgrastim in patients with chemotherapy-induced febrile neutropenia</TI>
<SO>American College of Physicians</SO>
<YR>1994</YR>
<VL>121</VL>
<PG>492-501</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maiche-1993" NAME="Maiche 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Secondary prophylaxis: 59 pts who had earlier developed an infection following antineoplastic chemotherapy were randomised to receive either granulocyte colony-stimulating factor (G-CSF) alone or G-CSF + quinolone as prophylaxis during subsequent identical chemotherapy courses.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maiche AG, Muhonen T</AU>
<TI>Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients</TI>
<SO>European Journal of Cancer</SO>
<YR>1993</YR>
<VL>29A</VL>
<NO>10</NO>
<PG>1403-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mangiagalli-1995" NAME="Mangiagalli 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Non randomised study with historical control group. 15 NHL pts received G-CSF, 5 NHL pts served as historical control.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mangiagalli M, Miccolis I, Maffe P, Pogliani EM, Corneo G</AU>
<TI>Role of granulocyte colony-stimulating factor in relapsed/resistant intermediate and high-grade non-Hodgkin's lymphoma patients treated with the E-SHAP regimen</TI>
<SO>Tumori</SO>
<YR>1995</YR>
<VL>81</VL>
<PG>91-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mayordomo-1995" NAME="Mayordomo 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Treatment study.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mayordomo JI, Rivera F, Díaz-Puente MT, Lianes P, Colomer R, López-Brea M et al</AU>
<TI>Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1995</YR>
<VL>87</VL>
<NO>11</NO>
<PG>803-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moreau-1997" NAME="Moreau 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;This trial randomizd controlled trial was conducted in pts (n=102) with multiple myeloma.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moreau P, Fiere D, Bezwoda WR, Facon T, Attal M, Laporte JP et al</AU>
<TI>Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1997</YR>
<VL>15</VL>
<NO>2</NO>
<PG>660-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Motoyoshi-1986" NAME="Motoyoshi 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Randomized crossover study comparing the hemopoietic efect of partially purified human urinary colony-stimulating factor in 24 pts with malignant lymphoma, solid tumours, or multiple myeloma.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Motoyoshi K, Takaku F, Maekawa T, Miura Y, Kimura K, Furusawa S et al</AU>
<TI>Protective effect of partially purified human urinary colony-stimulating factor on granulocytopenia after antitumor chemotherapy</TI>
<SO>Experimental Hematology</SO>
<YR>1986</YR>
<VL>14</VL>
<PG>1069-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niitsu-1995" NAME="Niitsu 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Non randomised study (n=64).&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Niitsu N, Umeda M</AU>
<TI>Usefulness of COP-BLAM Therapy with concomitant G-CSF in elderly patients with non-Hodgkin's lymphoma in comparison with patients not given G-CSF</TI>
<SO>Japanese Journal of Geriatrics</SO>
<YR>1995</YR>
<VL>32</VL>
<NO>6</NO>
<PG>410-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ogawa-1990" NAME="Ogawa 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Japanese publication. Pts with malignant lymphoma were ranomized to receive G-CSF or placebo starting 72 hours after the termination of the second cylce of chemotherapy and continued for 14 days. This report seems to be a detailed version of  the phase III study that was reported in english by Kaneko 1991.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ogawa M, Masaoka T, Mizoguchi H, Takaku F, Nakashima M</AU>
<TI>[A phase III study of KRN 8601 (rhG-CSF) on neutropenia induced by chemotherapy for malignant lymphoma--a multi-institutional placebo controlled double-blind comparative study]</TI>
<SO>Gan-To-Kagaku-Ryoho. Cancer &amp; chemotherapy</SO>
<YR>1990</YR>
<VL>17</VL>
<NO>3</NO>
<PG>365-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rao-2005" MODIFIED="2008-05-01 16:18:12 +0200" MODIFIED_BY="[Empty name]" NAME="Rao 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Riccardi-1993" NAME="Riccardi 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Non randomised trial: 17 consecutive pts with HD received chemotherapy with (n=9) or without (n=8) GM-CSF.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riccardi A, Gobbi P, Danova M, Giordano M, Pieresca C, Bertoloni D et al</AU>
<TI>MOPP/ABVD/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease</TI>
<SO>Haematologica</SO>
<YR>1993</YR>
<VL>78</VL>
<NO>1</NO>
<PG>44-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seymour-1995" NAME="Seymour 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Randomized controlled dose finding study in pts with solid tumours (n=55) and malignant lymphoma (n=11).&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seymour AM, de Campos E, Thatcher N, De Greve J, Cunningham D, Howell A et al</AU>
<TI>A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma</TI>
<SO>European Journal of Cancer</SO>
<YR>1995</YR>
<VL>31A</VL>
<PG>2157-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shi-1994" NAME="Shi 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Chinese publication, randomized corss over study in 21 pts receiving chemotherapy. Unclear whether lymphoma pts were enrolled. This might be the same study as Shi 1996, however could not be clarified due to lack of language skills.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shi YK, Sun Y, Su M</AU>
<TI>Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia</TI>
<SO>Chung Hua Chung Liu Tsa Chih</SO>
<YR>1994</YR>
<VL>16</VL>
<NO>5</NO>
<PG>356-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shi-1996" NAME="Shi 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Randomized cross-over clinical trial in pts with NHL (n=10) and solid tumours. Language: Chinese.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shi YK, Feng FY, Liu H-B</AU>
<TI>Clinical study of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy with CHOP and CAF regimen in cancer patients</TI>
<SO>Chinese Journal of Clinical Oncology</SO>
<YR>1996</YR>
<VL>23</VL>
<NO>4</NO>
<PG>252-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Togawa-2000" NAME="Togawa 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;Randomised cotrolled trial of pts (n=98) with multiple myeloma treated with G-CSF for chemotherapy induced neutropenia. Chugai Ltd. kindly provided us with a tranlation of the japanese report.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Togawa A, Mizoguchi H, Toyama K, Urabe A, Ohasi Y, Takaku F</AU>
<TI>Clinical evalutaion of rhG-CSF in patients with neutropenia induced by chemotherapy for multiple myeloma</TI>
<SO>Rinsho Ketsueki. The Japanese Journal of Clinical Hematology</SO>
<YR>2000</YR>
<VL>41</VL>
<NO>2</NO>
<PG>115-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Unpublished-trial" NAME="Unpublished trial" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<TI>Phase III randomized double-blind study of intensive chemotherapy with ARA-C/CACP/VP-16 plus GM-CSF vs placebo in patients with relapsing or refractory intermediate- and high-grade non-Hodgkin's lymphoma (summary last modified 11/90)</TI>
<SO>http://cancernet.nci.nih.gov/cgi-bin/</SO>
<YR>28.12.2000</YR>
<VL>Protocol IDs: AECM-8903071, NCI-V89-0161, UW-C89-049-05, NCI-V89-0252, MAOP-3189, NCI-V90-0118, MSKCC-90085, NCI-V90-0148</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vellenga-1996" NAME="Vellenga 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vellenga E, Uyl-de-Groot CA, de Wit R, Keizer HJ. Löwenberg B, ten Haaft MA et al</AU>
<TI>Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1996</YR>
<VL>14</VL>
<NO>2</NO>
<PG>619-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-1998" NAME="Wilson 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Non randomised study:  first 16 pts recevied no G-CSF and the subsequent 29 pts received G-CSF on all cycles.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson WH, Little R, Pearson D, Jaffe ES, Steinberg SM, Cheson BD et al</AU>
<TI>Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1998</YR>
<VL>16</VL>
<NO>7</NO>
<PG>2345-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yau-1996" NAME="Yau 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Randomised controlled study in pts with breast cancer (n=46) and malignant lymphoma (n=10).&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yau JC, Neidhart JA, Triozzi P, Verma S, Nemunaitis J, Quick DP et al</AU>
<TI>Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin</TI>
<SO>American Journal of Hematology</SO>
<YR>1996</YR>
<VL>51</VL>
<PG>289-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoshida-1999" NAME="Yoshida 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yoshida M, Karasawa M, Naruse T, Fukuda M, Hirashima K, Oh H et al</AU>
<TI>Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.</TI>
<SO>International Journal of Hematology</SO>
<YR>1999</YR>
<VL>69</VL>
<PG>81-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zagonel-1994" NAME="Zagonel 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Non randomised study: 12 consecutive pts received G-CSF during chemotherapy compared to 11 consecutive pts who received the same chemotherapy regimen without growth factor support.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zagonel V, Babare R, Merola MC, Talamini R, Lazzarini R, Tirelle U et al</AU>
<TI>Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy</TI>
<SO>Annals of Oncology</SO>
<YR>1994</YR>
<VL>5 Suppl (2):S127-32</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Blay" NAME="Blay" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Blay JY</AU>
<TI>Elypse 2</TI>
<SO>personal communication</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Cunningham" NAME="Cunningham" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Cunningham D</AU>
<TI>A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma</TI>
<SO>MREC/98/2/52</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-07-17 16:59:53 +0200" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-07-17 16:59:53 +0200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alvarado-Ibarra-1999" NAME="Alvarado Ibarra 1999" NOTES="&lt;p&gt;The name of the author is &amp;quot;Avil&amp;#233;s&amp;quot; and not &amp;quot;Alvil&amp;#233;s&amp;quot;. Because of a spelling mistake in the original paper we will quote this paper identically as &amp;quot;Alvil&amp;#233;s&amp;quot;.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Alvarado Ibarra ML, Borbolla Escoboza JR, López-Hernández MA, González-Avante CM, Flores Chapa JDD, Trueba Christy E et al</AU>
<TI>Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF</TI>
<SO>La Revista de Investigación Clínica</SO>
<YR>1999</YR>
<VL>51</VL>
<PG>77-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Armitage-1993" NAME="Armitage 1993" TYPE="JOURNAL_ARTICLE">
<AU>Armitage JO</AU>
<TI>The treatment of non-Hodgkin's lymphoma</TI>
<SO>New England Journal of Medicine</SO>
<YR>1993</YR>
<VL>328</VL>
<NO>14</NO>
<PG>1023-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ASCO-Guidelines-1994" NAME="ASCO Guidelines 1994" TYPE="JOURNAL_ARTICLE">
<AU>No authors listet</AU>
<TI>American Society of Clinical Oncology Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1994</YR>
<VL>12</VL>
<NO>11</NO>
<PG>2471-508</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ASCO-Guidelines-1996" NAME="ASCO Guidelines 1996" TYPE="JOURNAL_ARTICLE">
<AU>No authors listet</AU>
<TI>Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based Clinical Practice Guidelines</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1996</YR>
<VL>14</VL>
<NO>6</NO>
<PG>1957-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ASCO-Guidelines-2000" NAME="ASCO Guidelines 2000" TYPE="JOURNAL_ARTICLE">
<AU>Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA et al</AU>
<TI>2000 Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2000</YR>
<VL>18</VL>
<NO>20</NO>
<PG>3558-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ASCO-Guidelines-2006" MODIFIED="2008-05-01 20:51:42 +0200" MODIFIED_BY="[Empty name]" NAME="ASCO Guidelines 2006" TYPE="JOURNAL_ARTICLE">
<AU>Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L et al</AU>
<TI>2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline</TI>
<SO>J Clin Oncol</SO>
<YR>2006</YR>
<VL>24</VL>
<NO>19</NO>
<PG>3187-205</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Barbui-1996" NAME="Barbui 1996" TYPE="JOURNAL_ARTICLE">
<AU>Barbui T, Finazzi G, Grassi A, Marchioli R</AU>
<TI>Thrombosis in cancer patients treated with hematopoietic growth factors - a meta-analysis. On behalf of the Subcommittee on Haemaostasis and Malignancy of the Scientific and Standardization Committee of the ISTH</TI>
<SO>Thrombosis and Haemostasis</SO>
<YR>1996</YR>
<VL>75</VL>
<NO>2</NO>
<PG>368-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bennett-2000a" NAME="Bennett 2000a" TYPE="CONFERENCE_PROC">
<AU>Bennett CL, Stinson TJ, Bhoopalam N, Marriott M, Panganiban J, Kozloff MF</AU>
<TI>A double-Blind, randomized trial of toxicity, resource use and costs for filgrastim and sargramostim</TI>
<SO>Conference Proceedings of the American Society of Hematology</SO>
<YR>2000</YR>
<PG>abstract no 1712</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bennett-2000b" NAME="Bennett 2000b" TYPE="JOURNAL_ARTICLE">
<AU>Bennett CL, Stinson TJ, Laver JH, Bishop MR, Godwin JE, Tallman MS</AU>
<TI>Cost analysis of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making</TI>
<SO>Leukemia and Lymphoma</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>1-2</NO>
<PG>65-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beveridge-1998" NAME="Beveridge 1998" TYPE="JOURNAL_ARTICLE">
<AU>Beveridge RA, Miller JA, Kales AN, Binder RA, Robert NJ, Harvey JH et al</AU>
<TI>A comparison of efficacy of sargramostim (yeast-derived rhuGM-CSF) and filgrastim (bacteria-derived rhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression</TI>
<SO>Cancer Investigation</SO>
<YR>1998</YR>
<VL>16</VL>
<NO>6</NO>
<PG>366-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bobey-1998" NAME="Bobey 1998" TYPE="JOURNAL_ARTICLE">
<AU>Bobey N, Woodman RC</AU>
<TI>Neutropenic complications in advanced-stage non-Hodgkin lymphoma: implications for the use of prophylactic recombinant human granulocyte-colony stimulating factor (G-CSF)</TI>
<SO>Clinical and Investigative Medicine - Medicine Clinique et Experimentale</SO>
<YR>1998</YR>
<VL>21</VL>
<NO>2</NO>
<PG>63-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bodey-1966" NAME="Bodey 1966" TYPE="JOURNAL_ARTICLE">
<AU>Bodey GP, Buckley M, Sathe YS, Freireich EJ</AU>
<TI>Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1966</YR>
<VL>64</VL>
<NO>2</NO>
<PG>328-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bodey-1986" NAME="Bodey 1986" TYPE="JOURNAL_ARTICLE">
<AU>Bodey GP</AU>
<TI>Infection in cancer patients</TI>
<SO>The American Journal of Medicine</SO>
<YR>1986</YR>
<VL>81 Suppl (1A): 11-26</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bow-1998" NAME="Bow 1998" TYPE="JOURNAL_ARTICLE">
<AU>Bow EJ</AU>
<TI>Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1998</YR>
<VL>41 Suppl (D):1-5</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bronchud-1988" NAME="Bronchud 1988" TYPE="JOURNAL_ARTICLE">
<AU>Bronchud MH, Potter MR, Morgenstern G, Blasco MJ, Scarffe JH, Thatcher N et al</AU>
<TI>In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients</TI>
<SO>British Journal of Cancer</SO>
<YR>1988</YR>
<VL>58</VL>
<NO>1</NO>
<PG>64-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bui-1995" NAME="Bui 1995" TYPE="JOURNAL_ARTICLE">
<AU>Bui BN, Chevallier B, Chevreau C, Krakowski I, Peny AM ,Thyss A et al</AU>
<TI>Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>10</NO>
<PG>2629-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chevallier-1995" NAME="Chevallier 1995" TYPE="JOURNAL_ARTICLE">
<AU>Chevallier B, Chollet P, Merrouche Y, Roche H, Fumoleau P, Kerbat P et al</AU>
<TI>Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>7</NO>
<PG>1564-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Crawford-1991" NAME="Crawford 1991" TYPE="JOURNAL_ARTICLE">
<AU>Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I et al</AU>
<TI>Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung-cancer</TI>
<SO>New England Journal of Medicine</SO>
<YR>1991</YR>
<VL>325</VL>
<NO>3</NO>
<PG>164-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-de-Graaf-1996" NAME="de Graaf 1996" TYPE="JOURNAL_ARTICLE">
<AU>de Graaf H, Willemse PH, Bong SB, Piersma H, Tjabbes T, van Veelen H et al</AU>
<TI>Dose intensity of standard adjuvant CMF with granulocyte colony-stimulating factor for premenopausal patients with node-positive breast cancer</TI>
<SO>Oncology</SO>
<YR>1996</YR>
<VL>53</VL>
<NO>4</NO>
<PG>289-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-de-Witte-1992" NAME="de Witte 1992" TYPE="JOURNAL_ARTICLE">
<AU>de Witte T, Gratwohl A, van Der LN, Bacigalupo A, Stern AC, Speck B et al</AU>
<TI>Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation</TI>
<SO>Blood</SO>
<YR>1992</YR>
<VL>79</VL>
<NO>5</NO>
<PG>1359-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deb-1998" NAME="Deb 1998" TYPE="JOURNAL_ARTICLE">
<AU>Deb G, Donfrancesco A, Slo LD, Cozza R, Castellano A, Paole F et al</AU>
<TI>Shortened time to recovery from chemotherapy induced neutropenia in pediatric patients with high dose combined cytokines</TI>
<SO>Anticancer Research</SO>
<YR>1998</YR>
<VL>18</VL>
<NO>1B</NO>
<PG>489-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2001" MODIFIED="2008-07-17 16:59:53 +0200" MODIFIED_BY="[Empty name]" NAME="Deeks 2001" TYPE="BOOK_SECTION">
<AU>Deeks JJ, Altman DG, Bradburn M</AU>
<TI>Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis</TI>
<SO>Systematic Reviews in Health Care. Meta-analysis in context</SO>
<YR>2001</YR>
<PG>285-312</PG>
<EN>2nd</EN>
<PB>BMJ Books</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dempke-2000" NAME="Dempke 2000" TYPE="JOURNAL_ARTICLE">
<AU>Dempke W, Poblozki A, Grothey A, Schmoll HJ</AU>
<TI>Human hematopoietic growth factors: Old lessons and new perspectives</TI>
<SO>Anticancer Research</SO>
<YR>2000</YR>
<VL>20</VL>
<PG>5155-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DeVita-1987" NAME="DeVita 1987" TYPE="JOURNAL_ARTICLE">
<AU>DeVita VT, Hubbard SM, Longo DL</AU>
<TI>The chemotherapy of lymphomas: looking back, moving forward. The Richard and Hinda Rosenthal Foundation Award Lecture</TI>
<SO>Cancer Research</SO>
<YR>1987</YR>
<VL>47</VL>
<NO>22</NO>
<PG>5810-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickersin-1994" NAME="Dickersin 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dickersin K, Scherer R, Lefebvre C</AU>
<TI>Identifying relevant studies for systematic reviews</TI>
<SO>British Medical Journal</SO>
<YR>1994</YR>
<VL>309</VL>
<PG>1286-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Diehl-2003" NAME="Diehl 2003" TYPE="JOURNAL_ARTICLE">
<AU>Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D et al</AU>
<TI>Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease</TI>
<SO>New England Journal of Medicine</SO>
<YR>2003</YR>
<VL>348</VL>
<NO>24</NO>
<PG>2386-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>British Medical Journal</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Engert-1994" NAME="Engert 1994" TYPE="BOOK_SECTION">
<AU>Engert A, Schaadt M, Diehl V</AU>
<TI>Malignant Lymphoma</TI>
<TO>Maligne Lymphome</TO>
<SO>Innere Medizin</SO>
<YR>1994</YR>
<VL>1</VL>
<PG>180-203</PG>
<EN>3rd</EN>
<ED>Classen M, Diehl V, Kochsiek K</ED>
<PB>Urban &amp; Schwarzenberg</PB>
<CY>München - Wien - Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EORTC-Guidelines-2006" MODIFIED="2008-05-01 20:52:38 +0200" MODIFIED_BY="[Empty name]" NAME="EORTC Guidelines 2006" TYPE="JOURNAL_ARTICLE">
<AU>Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M et al</AU>
<TI>EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours</TI>
<SO>European Journal of Cancer</SO>
<YR>2006</YR>
<VL>42</VL>
<NO>15</NO>
<PG>2433-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freedman-1999" NAME="Freedman 1999" TYPE="BOOK_SECTION">
<AU>Freedman A, Nadler L</AU>
<TI>Maligne Diseases of lymphatic cells</TI>
<TO>Maligne Erkrankungen lymphatischer Zellen</TO>
<SO>Harrisons Innere Medizin</SO>
<YR>1999</YR>
<VL>1</VL>
<PG>833-862</PG>
<ED>Fauci A, Braunwald E, Isselbacher K et al</ED>
<PB>McGraw-Hill International</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fukuoka-1997" NAME="Fukuoka 1997" TYPE="JOURNAL_ARTICLE">
<AU>Fukuoka M, Masuda N, Negoro S, Matsui K, Yana T, Kudoh S et al</AU>
<TI>CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer</TI>
<SO>British Journal of Cancer</SO>
<YR>1997</YR>
<VL>75</VL>
<NO>2</NO>
<PG>306-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goldie-1983" NAME="Goldie 1983" TYPE="JOURNAL_ARTICLE">
<AU>Goldie JH, Coldman AJ</AU>
<TI>Quantitative model for multiple levels of drug resistance in clinical tumours</TI>
<SO>Cancer Treatment Reports</SO>
<YR>1983</YR>
<VL>67</VL>
<NO>10</NO>
<PG>923-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hackshaw-2004" MODIFIED="2008-06-08 16:15:13 +0200" MODIFIED_BY="[Empty name]" NAME="Hackshaw 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hackshaw A, Sweetenham JW, Knight A</AU>
<TI>Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?</TI>
<SO>British Journal of Cancer</SO>
<YR>2004</YR>
<VL>90</VL>
<NO>7</NO>
<PG>1302-1305</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Herrmann-1998" NAME="Herrmann 1998" TYPE="BOOK_SECTION">
<AU>Herrmann R, Drings P</AU>
<TI>Lymphoproliferative diseases</TI>
<TO>Lymphoproliferative Erkrankungen</TO>
<SO>Innere Medizin</SO>
<YR>1998</YR>
<VL>1</VL>
<PG>1009-28</PG>
<EN>9th</EN>
<ED>Schettler G, Greten H</ED>
<PB>Thieme</PB>
<CY>Stuttgart - New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hryniuk-1984" NAME="Hryniuk 1984" TYPE="JOURNAL_ARTICLE">
<AU>Hryniuk W, Bush H</AU>
<TI>The importance of dose intensity in chemotherapy of metastatic breast cancer</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1984</YR>
<VL>2</VL>
<NO>11</NO>
<PG>1281-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hryniuk-1986" NAME="Hryniuk 1986" TYPE="JOURNAL_ARTICLE">
<AU>Hryniuk W, Levine MN</AU>
<TI>Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1986</YR>
<VL>4</VL>
<NO>8</NO>
<PG>1162-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hryniuk-1987" NAME="Hryniuk 1987" TYPE="JOURNAL_ARTICLE">
<AU>Hryniuk WM</AU>
<TI>Average relative dose intensity and the impact on design of clinical trials</TI>
<SO>Seminars in Oncology</SO>
<YR>1987</YR>
<VL>14</VL>
<NO>1</NO>
<PG>65-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ICH-1999" NAME="ICH 1999" TYPE="JOURNAL_ARTICLE">
<AU>ICH Harmonised Tripartite Guideline</AU>
<TI>Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group</TI>
<SO>Statistics in Medicine</SO>
<YR>1999</YR>
<VL>18</VL>
<PG>1905-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ et al</AU>
<TI>Assessing the quality of reports of randomized clinical trials: Is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Klastersky-2000" NAME="Klastersky 2000" TYPE="JOURNAL_ARTICLE">
<AU>Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R et al</AU>
<TI>The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2000</YR>
<VL>18</VL>
<NO>16</NO>
<PG>3038-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kuderer-2007" MODIFIED="2008-05-01 19:15:49 +0200" MODIFIED_BY="[Empty name]" NAME="Kuderer 2007" TYPE="JOURNAL_ARTICLE">
<AU>Kuderer NM, Dale DC, Crawford J, Lyman GH</AU>
<TI>Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. [Review] [81 refs]</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>21</NO>
<PG>3158-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lepage-1993" NAME="Lepage 1993" TYPE="JOURNAL_ARTICLE">
<AU>Lepage E, Gisselbrecht C, Haioun C, Sebban C, Tilly H, Bosley A et al</AU>
<TI>Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol</TI>
<SO>Annals of Oncology</SO>
<YR>1993</YR>
<VL>4</VL>
<NO>8</NO>
<PG>651-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lopez-1986" NAME="Lopez 1986" TYPE="JOURNAL_ARTICLE">
<AU>Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan JM, Klebanoff SJ et al</AU>
<TI>Recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surfae receptor expression, and survival</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1986</YR>
<VL>78</VL>
<NO>5</NO>
<PG>1220-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lydaki-1995" NAME="Lydaki 1995" TYPE="JOURNAL_ARTICLE">
<AU>Lydaki E, Bolonaki E, Stiakaki E, Dimitriou H, Kalmantis T, Kalmanti M</AU>
<TI>Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granuloyte-macrophage colony-stimulating factor in neutropenic children with malignancies</TI>
<SO>Pediatric Hematology and Oncology</SO>
<YR>1995</YR>
<VL>12</VL>
<NO>6</NO>
<PG>551-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lyman-1995" NAME="Lyman 1995" TYPE="JOURNAL_ARTICLE">
<AU>Lyman GH, Balducci L</AU>
<TI>A cost analysis of hematopoietic colony-stimulating factors</TI>
<SO>Oncology (Huntingt)</SO>
<YR>1995</YR>
<VL>9 Suppl (11):85-91</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lyman-1998" NAME="Lyman 1998" TYPE="JOURNAL_ARTICLE">
<AU>Lyman GH, Kuderer NM, Balducci L</AU>
<TI>Economic impact of granulopoiesis stimulating agents on the management of febrile neutropenia</TI>
<SO>Current Opinion in Oncology</SO>
<YR>1998</YR>
<VL>10</VL>
<PG>291-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lyman-2000" NAME="Lyman 2000" TYPE="JOURNAL_ARTICLE">
<AU>Lyman GH</AU>
<TI>A predictive model for neutropenia associated with cancer chemotherapy</TI>
<SO>Pharmacotherapy</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>7 Pt 2</NO>
<PG>104-11S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lyman-2002" NAME="Lyman 2002" TYPE="JOURNAL_ARTICLE">
<AU>Lyman GH, Kuderer N, Djulbegovic B</AU>
<TI>Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: A meta-analysis</TI>
<SO>The American Journal of Medicine</SO>
<YR>2002</YR>
<VL>112</VL>
<PG>406-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Magrath-1997" NAME="Magrath 1997" TYPE="CONFERENCE_PROC">
<AU>Magrath I, Adde M, Shad A, Venzon D, Seibel N, Neeley J et al</AU>
<TI>Relative efficacy of G-and GM-CSF in ameliorating toxicity in an intensive treatment protocol for advanced, diffuse B cell NHLs, predominantly small noncleaved cell lymphomas</TI>
<SO>Abstracts of the American Society of Hematology</SO>
<YR>1997</YR>
<PG>abstract no 847</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morstyn-1988" NAME="Morstyn 1988" TYPE="JOURNAL_ARTICLE">
<AU>Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M et al</AU>
<TI>Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy</TI>
<SO>Lancet</SO>
<YR>1988</YR>
<VL>26</VL>
<NO>1</NO>
<PG>667-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parmar-1998" NAME="Parmar 1998" TYPE="JOURNAL_ARTICLE">
<AU>Parma MKB, Torri V, Stewart L</AU>
<TI>Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints</TI>
<SO>Statistics in Medicine</SO>
<YR>1998</YR>
<VL>17</VL>
<PG>2815-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pettengell-1993" NAME="Pettengell 1993" TYPE="JOURNAL_ARTICLE">
<AU>Pettengell R; Testa NG; Swindell R; Crowther D; Dexter TM</AU>
<TI>Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma [see comments].</TI>
<SO>Blood</SO>
<YR>1993</YR>
<VL>82</VL>
<PG>2239-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pinto-2007" MODIFIED="2008-05-01 19:15:53 +0200" MODIFIED_BY="[Empty name]" NAME="Pinto 2007" TYPE="JOURNAL_ARTICLE">
<AU>Pinto L, Liu Z, Doan Q, Bernal M, Dubois R, Lyman G</AU>
<TI>Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials</TI>
<SO>Current Medical Research &amp; Opinion</SO>
<YR>2007</YR>
<VL>23</VL>
<NO>9</NO>
<PG>2283-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Preundschuh-2004a" MODIFIED="2008-06-08 15:55:15 +0200" MODIFIED_BY="[Empty name]" NAME="Preundschuh 2004a" TYPE="JOURNAL_ARTICLE">
<AU>Pfreundschuh M, Truemper L, Kloess M, Schmits R, Feller AC, Ruebe C, Rudolph C, Reiser M, Hossfeld DK, Eimermacher H, Hasenclever D, Schmitz N, Loeffler M; German High-Grade Non-Hodgkin´s Lymphoma Study Group</AU>
<TI>Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL</TI>
<SO>Blood</SO>
<YR>2004</YR>
<VL>104</VL>
<NO>3</NO>
<PG>634-641</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Preundschuh-2004b" MODIFIED="2008-06-08 15:57:54 +0200" MODIFIED_BY="[Empty name]" NAME="Preundschuh 2004b" TYPE="JOURNAL_ARTICLE">
<AU>Pfreundschuh M, Truemper L, Kloess M, Schmits R, Feller AC, Rudolph C, Reiser M, Hossfeld DK, Metzner B, Hasenclever D, Schmitz N, Glass B, Ruebe C, Loeffler M; German High-Grade Non-Hodgkin´s Lymphoma Study Group</AU>
<TI>Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL</TI>
<SO>Blood</SO>
<YR>2004</YR>
<VL>104</VL>
<NO>3</NO>
<PG>626-633</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rao-2005" MODIFIED="2008-05-01 19:15:57 +0200" MODIFIED_BY="[Empty name]" NAME="Rao 2005" TYPE="JOURNAL_ARTICLE">
<AU>Rao R, Shammo JM, Enschede SH, Porter C, Adler SS, Venugopal P et al</AU>
<TI>The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma</TI>
<SO>Clinical Lymphoma</SO>
<YR>2005</YR>
<VL>6</VL>
<NO>1</NO>
<PG>26-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Roskos-1998" NAME="Roskos 1998" TYPE="BOOK_SECTION">
<AU>Roskos LK, Cheung EN, Vincent M, Foote MA</AU>
<TI>Pharmacology of filgrastim (r-metHuG-CSF)</TI>
<SO>Filgastim (r-metHuG-CSF) in Clinical Practice</SO>
<YR>1998</YR>
<PG>51-71</PG>
<EN>2</EN>
<ED>Morstyn G, Dexter TM, Foote M</ED>
<PB>Marcel Dekker</PB>
<CY>New York, Basel, Hong Kong</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rusthoven-1998" NAME="Rusthoven 1998" TYPE="JOURNAL_ARTICLE">
<AU>Rusthoven J, Bramwell V, Stephenson B</AU>
<TI>Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer</TI>
<SO>Cancer Prevention and Control</SO>
<YR>1998</YR>
<VL>2</VL>
<NO>4</NO>
<PG>179-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Skipper-1990" NAME="Skipper 1990" TYPE="JOURNAL_ARTICLE">
<AU>Skipper HE</AU>
<TI>Dose intensity versus total dose of chemotherapy: an experimental basis</TI>
<SO>Important Advances in Oncology</SO>
<YR>1990</YR>
<VL>1</VL>
<NO>1</NO>
<PG>43-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sung-2007" MODIFIED="2008-05-01 19:16:04 +0200" MODIFIED_BY="[Empty name]" NAME="Sung 2007" TYPE="JOURNAL_ARTICLE">
<AU>Sung L, Nathan PC, Alibhai SM, Tomlinson GA, Beyene J</AU>
<TI>Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection</TI>
<SO>Ann Intern Med</SO>
<YR>2007</YR>
<VL>147</VL>
<NO>6</NO>
<PG>400-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Talcott-1992" NAME="Talcott 1992" TYPE="JOURNAL_ARTICLE">
<AU>Talcott JA, Siegel RD, Finberg R, Goldman L</AU>
<TI>Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1992</YR>
<VL>10</VL>
<NO>2</NO>
<PG>316-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Timmer_x002d_Bonte-2005" MODIFIED="2008-05-01 19:21:02 +0200" MODIFIED_BY="[Empty name]" NAME="Timmer-Bonte 2005" TYPE="JOURNAL_ARTICLE">
<AU>Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA et al</AU>
<TI>Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study</TI>
<SO>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>31</NO>
<PG>7974-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trillet_x002d_Lenoir-1993" NAME="Trillet-Lenoir 1993" TYPE="JOURNAL_ARTICLE">
<AU>Trillet-Lenoir V, Green J, Manegold C, von Pawel J, Gatzemeier U, Lebeau B et al</AU>
<TI>Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy</TI>
<SO>European Journal of Cancer</SO>
<YR>1993</YR>
<VL>29A</VL>
<NO>3</NO>
<PG>319-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verhagen-1998" NAME="Verhagen 1998" TYPE="JOURNAL_ARTICLE">
<AU>Verhagen AP, DeVet HCW, DeBie RA, Kessels AGH, Boers M, Bouter LM et al</AU>
<TI>The delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by delphi consensus</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1998</YR>
<VL>51</VL>
<NO>12</NO>
<PG>1235-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vogel-2005" MODIFIED="2008-05-01 19:21:02 +0200" MODIFIED_BY="[Empty name]" NAME="Vogel 2005" TYPE="JOURNAL_ARTICLE">
<AU>Vogel C, Rader M, Tyulandin S, Wiens B, Neumann T, Carroll R</AU>
<TI>Pegfilgrastim nearly abrogates occurrence of neutropenic events early in the course of chemotherapy: Results of a phase III, randomized, double-blind, placebo-controlled study of patients with breast cancer receiving docetaxel</TI>
<SO>The Journal of Supportive Oncology</SO>
<YR>2005</YR>
<VL>3</VL>
<NO>2 SUPPL. 1</NO>
<PG>58-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woll-1995" NAME="Woll 1995" TYPE="JOURNAL_ARTICLE">
<AU>Woll PJ, Hodgetts J, Lomax L, Bildet F, Cour-Chabernaud V, Thatcher N</AU>
<TI>Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>3</NO>
<PG>652-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yoshida-1990" NAME="Yoshida 1990" TYPE="JOURNAL_ARTICLE">
<AU>Yoshida T, Nakamura S, Ohtake S, Okafuji K, Kobayashi K, Kondo K et al</AU>
<TI>Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma</TI>
<SO>Cancer</SO>
<YR>1990</YR>
<VL>66</VL>
<NO>9</NO>
<PG>1904-9</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-Bohlius-2003" NAME="Bohlius 2003" TYPE="JOURNAL_ARTICLE">
<AU>Bohlius J, Reiser M, Schwarzer G, Engert A</AU>
<TI>Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review</TI>
<SO>British Journal of Haematology</SO>
<YR>2003</YR>
<VL>122</VL>
<PG>413-23</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2008-05-01 19:16:04 +0200" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-06-09 12:51:36 +0200" MODIFIED_BY="Nicole Skoetz">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-06-09 12:46:52 +0200" MODIFIED_BY="Nicole Skoetz" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-06-09 12:33:10 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Aglietta-2000">
<CHAR_METHODS>
<P>RCT, <BR/>1991-94, allocation concealed*</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:28:56 +0200" MODIFIED_BY="Nicole Skoetz">
<P>56 patients randomised,<BR/>age 18-77,<BR/>gender m/f: 33/23, country: Italy<BR/>Hodgkin's disease, biopsy proven*, untreated,<BR/>stage II-IV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:33:10 +0200" MODIFIED_BY="Nicole Skoetz">
<P>1. CT</P>
<P>Mechlorethamine 6 mg/m², iv, d1</P>
<P>Vincristine 1.4 mg/m², max 2.0 mg/m², iv, d1</P>
<P>Procarbazine 100 mg/m², po, d1-7</P>
<P>Prednisone 40 mg/m², po, d1-7</P>
<P>Doxorubicin 25 mg/m², iv, d15</P>
<P>Bleomycin 10 mg/m², iv, d15</P>
<P>Vinblastine 6 mg/m², iv, d15</P>
<P>Dacarbazine 375 mg/m², iv, d15</P>
<P>this regimen was repeated every 28 days times 6</P>
<P>2. GM-CSF (5 µg /kg/day s.c. prior to each chemotherapy cycle),</P>
<P>used d7-4 before first cycle, d8-11 and d22-25 each subsequent cycle</P>
<P>3. no placebo given</P>
<P>4. no AB prophylaxis given*</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:29:54 +0200" MODIFIED_BY="Nicole Skoetz">
<P>primary endpoints: adherence to the planned delivery rate of planned CT<BR/>secondary endpoints: nadir neutrophil counts, total duration of neutropenia, total number of days of antibiotic or antifungal treatment, additional outcomes: adverse effects, tumour response</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Italian Association for Cancer Research and Novartis Farma, S.p.A., Italy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:32:27 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Aglietta-2000_x002a_">
<CHAR_METHODS>
<P>Additional information obtained by personal communication with the study author.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:32:00 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:32:05 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:32:09 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:32:14 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:33:29 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Avil_x00e9_s-1994">
<CHAR_METHODS>
<P>RCT, 3/1992-9/1992*, computer generated numbers, allocation concealed</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:29:04 +0200" MODIFIED_BY="Nicole Skoetz">
<P>42 patients randomised<BR/>age: 34-63*, mean age 51<BR/>gender: m/f: 18/24<BR/>country: Mexico<BR/>NHL<BR/>diffuse large cell lymphoma, intermediate and high grade,<BR/>untreated;<BR/>stage: IV*</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:33:29 +0200" MODIFIED_BY="Nicole Skoetz">
<P>1. alternating ESAP, m-BECOD, MVPP-Bleo by 9 cycles<BR/>details of CT:<BR/>Etoposide 40 mg/m², iv, d1-4<BR/>Methylprednisolone 350 mg/m², iv, d1-5<BR/>Ara-C 2 g/m², iv, d5<BR/>Cis-Platin 25 mg/m², iv, d1-4<BR/>Bleomycin 10 mg/m², iv, d1<BR/>Epirubicin 70 mg/m², iv, d1<BR/>Cyclophosphamide 600 mg/m², iv, d1<BR/>Vincristine 1.4 mg/m², iv, d1<BR/>Dexamethasone 20 mg/m², po, d1-5<BR/>Methotrexate 120 mg/m², iv, d14<BR/>Mitoxantrone 10 mg/m², iv, d1<BR/>Vincristine 1.4 mg/m², iv, d1<BR/>Prednisone 50 mg/m², iv, d1-14<BR/>Procarbazine 100 mg/m², po, d1-14<BR/>2. G-CSF (5 µg/kg/day, sc, d6-15)<BR/>3. placebo given*<BR/>4. no AB prophylaxis<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:29:14 +0200" MODIFIED_BY="Nicole Skoetz">
<P>duration of leucopenia and granulocytopenia, frequency and severity of infections, hospitalisation, deaths, tumour response, dose intensity, treatment delay, antibiotic use</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Roche Mexcio*</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:30:28 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Avil_x00e9_s-1994_x002a_">
<CHAR_METHODS>
<P>additional information obtained by personal communication with the study author</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:30:22 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:30:28 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-02 17:19:02 +0200" MODIFIED_BY="[Empty name]">
<P>see <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-05-02 17:19:02 +0200" MODIFIED_BY="[Empty name]">
<P>see <LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:33:41 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Bastion-1993">
<CHAR_METHODS>
<P>RCT,<BR/>1990-1992,<BR/>allocation unclear</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>119 patients<BR/>no details available</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:33:41 +0200" MODIFIED_BY="Nicole Skoetz">
<P>1. CT<BR/>A: 3-4 courses ACVBP, 21 days<BR/>B: 2 ACVBP alternat. 2x VIMMM, 21 days<BR/>ACVBP:<BR/>Adriamycin 75 mg/m², d1<BR/>Cyclophsophamide 1200 mg/m², d1<BR/>Vindesine 2 mg/m², d1 and 5<BR/>Bleomycin 10 mg, d1 and 5<BR/>Prednisolone 60 mg/m², d1-5<BR/>Methotrexate 12 mg intrathecal 1-2 /week<BR/>VIMMM:<BR/>VP 16 100 mg/m², d1 and 5<BR/>Ifosfamide 1000 mg/m², d1-5<BR/>Mitoxantrone 10 mg/m², d1<BR/>Methyl GAG 300 mg/m², d1 and 5<BR/>Methotrexate 1500 mg/m², d15<BR/>Methylprednison 60 mg/m², d1-5<BR/>2. G-CSF: 5 µg/kg/day, sc, d6-max d19)<BR/>3. placebo given<BR/>4. no AB prophylaxis</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>risk of febrile neutropenia and documented infection, duration of neutropenia, mortality during induction, dose-intensity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Amgen</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:30:58 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Bastion-ACVBP-1993">
<CHAR_METHODS MODIFIED="2008-06-09 12:30:40 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm A</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:30:44 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm A</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:30:49 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm A</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:30:54 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm A</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:30:58 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm A</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:31:25 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Bastion-VIMMM-1993">
<CHAR_METHODS MODIFIED="2008-06-09 12:31:06 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm B</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:31:10 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm B</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:31:15 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm B</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:31:20 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm B</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:31:25 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bastion-1993" TYPE="STUDY">Bastion 1993</LINK>, arm B</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:31:41 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Bj_x00f6_rkholm-1999">
<CHAR_METHODS MODIFIED="2008-06-09 12:31:41 +0200" MODIFIED_BY="Nicole Skoetz">
<P>This is the abstract publication to Ösby 2003. Apart from G-CSF randomisation this study included 2 different treatment arms. See <LINK REF="STD-Bj_x00f6_rkholm-CHOP-1999" TYPE="STUDY">Björkholm CHOP 1999</LINK> and <LINK REF="STD-Bj_x00f6_rkholm-CNOP-1999" TYPE="STUDY">Björkholm CNOP 1999</LINK>.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:33:51 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Bj_x00f6_rkholm-CHOP-1999">
<CHAR_METHODS>
<P>RCT, 1992-97, concealed allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:32:27 +0200" MODIFIED_BY="Nicole Skoetz">
<P>205 patients randomised, age &gt;60<BR/>stage II-IV high-grade NHL, untreated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:33:51 +0200" MODIFIED_BY="Nicole Skoetz">
<P>CHOP with G-CSF versus CHOP without G-CSF<BR/>1. CT:<BR/>Cyclophosphamide 750 mg/m², iv, d1<BR/>Vincristine 1.4 mg/m², iv, d1<BR/>Doxorubicin 50 mg/m², iv, d1<BR/>Prednisone 100 mg/m², po, d1-5<BR/>2. G-CSF (5 µg/kg/day, sc, d2-d10/14)<BR/>3. no placebo given*<BR/>4. no AB prophylaxis given*</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:32:28 +0200" MODIFIED_BY="Nicole Skoetz">
<P>toxicity (severe neutropenia, infections), tumour response, survival</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Roche, Amgen, Wyeth Lederle and the Swedish Cancer Society</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:33:59 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Bj_x00f6_rkholm-CNOP-1999">
<CHAR_METHODS>
<P>RCT, 1992-97, concealed allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:32:33 +0200" MODIFIED_BY="Nicole Skoetz">
<P>250 patients randomised, age &gt;60<BR/>stage II-IV high-grade NHL, untreated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:33:59 +0200" MODIFIED_BY="Nicole Skoetz">
<P>CNOP with G-CSF versus CNOP without G-CSF<BR/>1. CT:<BR/>Cyclophosphamide 750 mg/m², iv, d1<BR/>Mitoxantrone 10 mg/m², iv, d1<BR/>Vincristine 1.4 mg/m², iv, d1<BR/>Prednisone 100 mg/m², po, d1-5<BR/>2. G-CSF (5 µg/kg/day, sc, d2-d10/14)<BR/>3. no placebo given*<BR/>4. no AB prophylaxis given*</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-23 14:28:45 +0200" MODIFIED_BY="[Empty name]">
<P>toxicity (severe neutropenia, infections), tumour response, survival</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Roche, Amgen, Wyeth Lederle and the Swedish Cancer Society</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:32:38 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Burton-2006">
<CHAR_METHODS MODIFIED="2008-06-09 12:32:38 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Apart from the G-CSF randomisation, the trial also randomised to CHOp or PMitCEBO see Burton CHOP and Burton PMitCEBO. Overall survival reported only for the full group.</P>
<P>RCT, 1997-2003, allocation concealment unclear</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-23 14:30:42 +0200" MODIFIED_BY="[Empty name]">
<P>784 patients randomised, previously untreated, age &gt;= 60 years</P>
<P>Stage Ia bulky or Ib to IV aggressive NHL (diffuse mixed cell, diffuse large cell, diffuse immunoblastic and after 2000 diffuse large B-cell lymphoma)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-04-23 14:30:51 +0200" MODIFIED_BY="[Empty name]">
<P>CHOP or PMitCEBO</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-23 14:32:51 +0200" MODIFIED_BY="[Empty name]">
<P>Overall survival, on treatment mortality, infection related mortality, overall response rate, toxicity (but not for G-CSF vs. control except for the incidence of neutropenia)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-04-23 14:27:15 +0200" MODIFIED_BY="[Empty name]">
<P>public funding acknowledged </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:34:46 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Burton-CHOP-2006">
<CHAR_METHODS MODIFIED="2008-04-23 14:43:06 +0200" MODIFIED_BY="[Empty name]">
<P>RCT, 1997-2003, allocation concealment not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-23 14:37:14 +0200" MODIFIED_BY="[Empty name]">
<P>784 patients randomised, previously untreated, age &gt;= 60 years</P>
<P>397 randomised to PMitCEBO</P>
<P>Stage Ia bulky or Ib to IV aggressive NHL (diffuse mixed cell, diffuse large cell, diffuse immunoblastic and after 2000 diffuse large B-cell lymphoma)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:34:33 +0200" MODIFIED_BY="Nicole Skoetz">
<P>1. CT:</P>
<P>Cyclophosphamide 300mg/m<SUP>2</SUP> d1</P>
<P>Mitoxantrone 7mg/m<SUP>2</SUP> d1</P>
<P>Etopside 150mg/m<SUP>2</SUP> d1</P>
<P>Prednisolone 50mg daily week 1-4, 50mg alternating days weeks 5 to treatment end</P>
<P>Vincristine 1.4 mg/m<SUP>2</SUP> d8</P>
<P>Bleomycin 10mg/m<SUP>2</SUP> d8</P>
<P>2. G-CSF: 263µg/day lenograstim d 6-12</P>
<P>3. no placebo given</P>
<P>4. cotrimoxazole given week one to treatment end plus two weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-23 14:42:41 +0200" MODIFIED_BY="[Empty name]">
<P>On treatment mortality, infection related mortality, overall response rate, toxicity (but not for G-CSF vs. control except for the incidence of neutropenia)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:34:46 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Subgroup of <LINK REF="STD-Burton-2006" TYPE="STUDY">Burton 2006</LINK>, with patients randomised to treatment with PMitCEBO</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:35:08 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Burton-PMitCEBO-2006">
<CHAR_METHODS MODIFIED="2008-04-23 14:43:02 +0200" MODIFIED_BY="[Empty name]">
<P>RCT, 1997-2003, allocation concealment not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-23 14:42:51 +0200" MODIFIED_BY="[Empty name]">
<P>784 patients randomised, previously untreated, age &gt;= 60 years</P>
<P>397 randomised to PMitCEBO</P>
<P>Stage Ia bulky or Ib to IV aggressive NHL (diffuse mixed cell, diffuse large cell, diffuse immunoblastic and after 2000 diffuse large B-cell lymphoma)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:35:08 +0200" MODIFIED_BY="Nicole Skoetz">
<P>1. CT:</P>
<P>Cyclophosphamide 750mg/m<SUP>2</SUP> d1</P>
<P>Doxorubicin 50mg/m<SUP>2</SUP> d1</P>
<P>Vincristine 1.4 mg/m<SUP>2</SUP> d8</P>
<P>Prednisolone 100mg d1-5</P>
<P>2. G-CSF: 263µg/day lenograstim d 8-14</P>
<P>3. no placebo given</P>
<P>4. cotrimoxazole given week one to treatment end plus two weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-23 14:43:19 +0200" MODIFIED_BY="[Empty name]">
<P>On treatment mortality, infection related mortality, overall response rate, toxicity (but not for G-CSF vs. control except for the incidence of neutropenia)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-04-23 14:43:58 +0200" MODIFIED_BY="[Empty name]">
<P>Subgroup of Burton 2006 with patients randomised to CHOP</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:35:29 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Cunningham_x002a_">
<CHAR_METHODS>
<P>RCT, 1993-1995*, concealed allocation*</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:35:23 +0200" MODIFIED_BY="Nicole Skoetz">
<P>39 patients randomised,<BR/>age 23-68,<BR/>gender m/f: 22/17<BR/>country: UK<BR/>relapsed NHL (N = 38)<BR/>relapsed HD (N = 1)<BR/>stage I-IV, biopsy proven<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:35:29 +0200" MODIFIED_BY="Nicole Skoetz">
<P>ECP +/- G-CSF<BR/>1. CT<BR/>Etoposide 50 mg/m², po, d1-10<BR/>Cisplatin 60 mg/m², iv, d1<BR/>Prednisolone 100 mg, po, d1-5<BR/>2. G-CSF 5 µg/kg/day, sc, d11-17<BR/>3. no placebo given*<BR/>4. AB prophylaxis given</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>toxicity, response rate, duration of response, survival</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: ??<BR/>This study was never published. All data presented in this review were kindly provided by Dr. Cunningham.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:35:39 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Doorduijn-2003">
<CHAR_METHODS>
<P>RCT, 1994-2000, concealed allocation*</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>389 patients randomised, age 65-90, median 72, gender m/f: 216/173<BR/>country: Netherlands, Belgium<BR/>stage II-IV high-grade NHL, untreated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:35:39 +0200" MODIFIED_BY="Nicole Skoetz">
<P>CHOP with G-CSF versus CHOP without G-CSF<BR/>1. CT:<BR/>Cyclophosphamide 750 mg/m², iv, d1<BR/>Doxorubicin 50 mg/m², iv, d1<BR/>Vincristine 1.4 mg/m², iv, d1<BR/>Prednisone 50 mg/m², po, d1-5<BR/>2. G-CSF 300 µg/day sc, d2-d11<BR/>3. no placebo given<BR/>4. no AB prophylaxis given</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-23 14:32:03 +0200" MODIFIED_BY="[Empty name]">
<P>received dose intensity, severe neutropenia and infections, tumour response, survival, QoL, costs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>supported by the Dutch National Health Council</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:36:37 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Dunlop-1998">
<CHAR_METHODS MODIFIED="2008-06-09 12:36:37 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Apart from G-CSF randomisation this study included 2 different treatment arms. See <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK> and <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:36:49 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Dunlop-MOPP-1998">
<CHAR_METHODS>
<P>RCT, 1/1991-6/1993*, allocation by phoning central AMGEN Data Centre</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:36:44 +0200" MODIFIED_BY="Nicole Skoetz">
<P>25 patients randomised and evaluated, age 19-41, gender m/f: 15/10, country: UK<BR/>Hodgkin's disease, biopsy proven*, untreated, stage IB-IV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. CT<BR/>Mustine 6 mg/m², iv, d1and 8<BR/>Vincristine 1.4 mg/m², iv, d1 and 8<BR/>Procarbazine 100 mg/m², po, d1-14<BR/>Prednisolone 25 mg/m², po, d1-14<BR/>2. G-CSF (rmetHuG-CSF [Amgen] 5 microgram/kg/d sc d15-d28 of each cycle)<BR/>3. no placebo used <BR/>4. no prophylactic antibiosis allowed.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:36:49 +0200" MODIFIED_BY="Nicole Skoetz">
<P>dose intensity, toxicity (duration and nadir leucopenia, febrile neutropenia, incidence, grade and duration of infections), hospitalisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Amgen, Thousand Oaks, CA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:37:14 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_">
<CHAR_METHODS>
<P>Additional information obtained by personal communication with the study author.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:37:00 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:37:04 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:37:10 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:37:14 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:37:26 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98">
<CHAR_METHODS>
<P>RCT, 1/1991-6/1993*, allocation by phoning central AMGEN Data Centre</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:37:18 +0200" MODIFIED_BY="Nicole Skoetz">
<P>28 patients randomised, 22 evaluated, age 19-41, gender m/f: 15/7, country: UK, Hodgkin's disease,biopsy proven*, untreated, stage IB-IV Hodgkin's disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. CT<BR/>Mustine 6 mg/m², iv, d1and 8<BR/>Vincristine 1.4 mg/m², iv, d1<BR/>Procarbazine 100 mg/m², po, d1-7<BR/>Prednisolone 25 mg/m², po, d1-14<BR/>Etoposide 75 mg/m², iv, d8-10<BR/>Adriamycin 25 mg/m², iv, d8<BR/>Vinblastine 6mg/m², iv, d8<BR/>2. G-CSF (5 microgram/kg/d sc d11-d28 of each cycle rmetHuG-CSF by Amgen)<BR/>3. no placebo used <BR/>4. no prophylactic antibiosis allowed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:37:26 +0200" MODIFIED_BY="Nicole Skoetz">
<P>dose intensity, toxicity (duration and nadir leucopenia, febrile neutropenia, incidence, grade and duration of infections), hospitalisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Amgen, Thousand Oaks, CA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:37:58 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_">
<CHAR_METHODS>
<P>Additional information obtained by personal communication with the study author.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:37:34 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:37:43 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:37:50 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:37:58 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:38:42 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Engelhard-1994">
<CHAR_METHODS MODIFIED="2008-06-09 12:38:33 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>c</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:38:27 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>c</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:38:38 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>c</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>probability of survival, duration of CR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:38:42 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:38:52 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Fridrik-1997">
<CHAR_METHODS>
<P>RCT, 1991-95, central allocation*</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:38:44 +0200" MODIFIED_BY="Nicole Skoetz">
<P>85 patients randomised, 74 pts evaluated, age: 19-72*, median age 52, gender m/f: 43/31, country: Austria, high grade NHL, untreated, stage I-IV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. CT<BR/>Cyclophosphamide 750 mg/m², iv, d1<BR/>Epirubicin 70 mg/m², iv, d1<BR/>Vincristine 1.4 mg/m², iv, d1 and 8<BR/>Prednisolone 100 mg po, d1-5<BR/>Ifosfamide 2000 mg/m2, iv, d15-17<BR/>Uromitexane 400 mg/m², iv, d15-17<BR/>VP16 100 mg/m², iv, d15-17<BR/>Dexamethasone 40 mg/m², po, d15-19<BR/>Methotrexate 800 mg/m², iv, d22<BR/>Ca-folinate 15 mg/m², po, d23-25<BR/>2. G-CSF (E.coli derived, Amgen) was given in a dose of 5 µg/kg on d2-7, d9-14, d18-21 and d23-27. After 10 G-CSF receiving patients entered the study, the dose was modulated, and instead of d9-14 G-CSF was given 2 days less, thus d9-12<BR/>3. no placebo used<BR/>4. no AB prophylaxis given*</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:38:52 +0200" MODIFIED_BY="Nicole Skoetz">
<P>incidence of febrile neutropenia, febrile episodes, number of documented infections, use of iv antibiotics, number of days in hospital due to febrile neutropenia, dose intensity, tumour response, time to first febrile neutropenia, time to relapse, time to treatment failure, survival, adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Roche Austria, later AMGEN*</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:39:26 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Fridrik-1997_x002a_">
<CHAR_METHODS>
<P>Additional information obtained by personal communication with the study author.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:38:58 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:39:15 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:39:22 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:39:26 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:39:47 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Gerhartz-1993">
<CHAR_METHODS>
<P>RCT, 1989-91, allocation with central and independent centre, dispatched with numbered study drugs and sealed envelopes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:39:38 +0200" MODIFIED_BY="Nicole Skoetz">
<P>182 patients randomised, 125 pts analysed for efficacy, 176 pts evaluated for safety analysis, age 15-73, gender m/f: 90/61<BR/>country: D<BR/>high-grade NHL, untreated, stage II-IV, biopsy proven<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. CT:<BR/>Cyclophosphamide 700 mg/m², iv, d1<BR/>Doxorubicin 60mg/ m² , iv, d1<BR/>Bleomycin 15 mg absolute dose, iv, d15<BR/>Vincristine 1mg/m² , iv, d1 and 15<BR/>Procarbazine 100 mg/m², po, d1-7<BR/>Prednisolone 50 mg/m² po, d1-7<BR/>Mesna 400 mg, iv after cyclophosphamide<BR/>2. GM-CSF (unglykosylated GM-CSF produced by Sandoz) 400 µg per patient sc<BR/>3. placebo given<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:39:47 +0200" MODIFIED_BY="Nicole Skoetz">
<P>leucocyte counts, frequency and severity of infections, tumour response, hospitalisation, freedom from treatment failure, adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Sandoz Pharma Ltd</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:40:01 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Gerhartz-1994a">
<CHAR_METHODS MODIFIED="2008-06-09 12:40:01 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Follow-up report of <LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK> and <LINK REF="STD-Engelhard-1994" TYPE="STUDY">Engelhard 1994</LINK>.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:40:17 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Gisselbrecht-1997">
<CHAR_METHODS>
<P>RCT, 1990-92, concealed allocation*</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:40:09 +0200" MODIFIED_BY="Nicole Skoetz">
<P>162 patients randomised and analysed, age15-55, gender m/f: 15-55, country: F, B<BR/>intermediate and high grade NHL, histological subtypes: diffuse large cell lymphoma (48%, diffuse mixed lymphoma 17%), stage I-IV, untreated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. CT <BR/>Cyclophosphamide 1200 mg/m², iv, d1<BR/>Vindesine 2 mg/m², iv, d1 and d5<BR/>Bleomycin 10 mg, iv, d1 and d5<BR/>Prednisone 60 mg/m², po, d1-5<BR/>Methotrexate 15 mg intrathecal, d1<BR/>Adriamycin 75 mg/m², iv, d1<BR/>or <BR/>Mitoxantrone 12 mg/m², iv, d1<BR/>2. G-CSF (glycosylated recombinant human granulocyte colony-stimulating factor, Chugai) 5 µg/kg/d sc, d6-d13, outpatients<BR/>3. placebo<BR/>4. no AB prophylaxis given</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:40:17 +0200" MODIFIED_BY="Nicole Skoetz">
<P>incidence of fever, infection, neutropenia, adverse effects, dose intensity, tumour response, survival</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: Chugai*</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:40:39 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Gisselbrecht-1997_x002a_">
<CHAR_METHODS>
<P>Additional information obtained by personal communication with the study author.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:40:25 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:40:30 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:40:35 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:40:39 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:40:46 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Pettengell-1992">
<CHAR_METHODS>
<P>RCT, 1989-91, method of allocation not specified</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>80 patients randomised, age 16-71, gender m/f: 53/27, c: UK, high grade de novo NHL, stage I-IV, histology: diffuse large and mixed cell lymphoma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. CT<BR/>Adriamycin 35 mg/m², iv, d1, 15, 29, 43, 57, 71<BR/>Cyclophosphamide 350 mg/m², iv, d1, 29, 57<BR/>Vincristine 1.4 mg/m², iv, d8, 22, 36, 50, 64<BR/>Bleomycin 10 mg/m², iv, d8, 36, 64<BR/>Etoposide 100 mg/m², po, d15-19, d43-47, d71-75<BR/>Prednisolone 50 mg po, daily for 5 weeks than reduced.<BR/>2. G-CSF: rmetHuG-CSF 230 µg/m²/d, sc, for 13 weeks except days preceeding and during doxorubicin, cyclophosphamide, etoposide<BR/>3. no placebo given<BR/>4. Antibiotic prophylaxis:<BR/>cotrimoxazole 960 mg po twice daily and Ketoconazole 200 mg po twice daily both drugs given for 12 weeks with start of CT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:40:46 +0200" MODIFIED_BY="Nicole Skoetz">
<P>tumour response, dose intensity, CT delays, incidence of neutropenia, febrile neutropenia, infections, antibiotic use, hospitalisation, adverse events, overall survival, disease free survival</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>funding: supported by Amgen-Roche, the Cancer Research Campaign, Leukaemia Research Fund</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:41:02 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Sou_x00ea_tre-1994">
<CHAR_METHODS MODIFIED="2008-05-02 17:19:20 +0200" MODIFIED_BY="[Empty name]">
<P>Economic evaluation of the clinical study published by <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:40:53 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:40:57 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>economic evaluation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:41:02 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:46:02 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Zinzani-1997">
<CHAR_METHODS>
<P>RCT, 1993-95, allocation concealed*</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:41:06 +0200" MODIFIED_BY="Nicole Skoetz">
<P>158 patients randomised, 149 patients evaluated, age 60-82, gender m/f: 69: 80, country: Italy<BR/>high-grade de novo NHL, stage II-IV, histology: diffuse large-cell centroblastic and immunoblastic lymphoma. anaplastic large cell and peripheral T-cell lymphoma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. CT: <BR/>Cyclophosphamide 300 mg/m², iv, d1,15, 29, 43<BR/>Mitoxantrone 10 mg/m², iv, d1,15,29,43<BR/>Vincristine 2 mg, iv, d8, 22, 36, 50<BR/>Etoposide 150 mg/m², iv, d8 and d36<BR/>Bleomycin 10 mg/m², iv, d22 and d50<BR/>Prednisone 40 mg im, daily, dose tapered over the last 2 weeks<BR/>2. G-CSF<BR/>3. no placebo<BR/>4. AB prophylaxis given</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:45:58 +0200" MODIFIED_BY="Nicole Skoetz">
<P>incidence of neutropenia, anaemia, thrombocytopenia and infections; adverse effects, dose intensity, tumour response, relapse free and progression free survival, overall survival</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:46:02 +0200" MODIFIED_BY="Nicole Skoetz">
<P>funding: not pharmaceutically sponsored*</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:46:20 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Zinzani-1997_x002a_">
<CHAR_METHODS>
<P>Additional information obtained by personal communication with the study author.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:46:08 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-09 12:46:13 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-09 12:46:16 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 12:46:20 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:46:28 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Zinzani-1999">
<CHAR_METHODS MODIFIED="2008-06-09 12:46:28 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Follow-up report to <LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:46:41 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-_x00d6_sby-2003">
<CHAR_METHODS MODIFIED="2008-06-09 12:46:41 +0200" MODIFIED_BY="Nicole Skoetz">
<P>this is the full text publication to <LINK REF="STD-Bj_x00f6_rkholm-1999" TYPE="STUDY">Björkholm 1999</LINK>. For details see <LINK REF="STD-Bj_x00f6_rkholm-1999" TYPE="STUDY">Björkholm 1999</LINK>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-06-09 12:46:52 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-_x00d6_sby-CHOP-2003">
<CHAR_METHODS MODIFIED="2008-06-09 12:46:52 +0200" MODIFIED_BY="Nicole Skoetz">
<P>see <LINK REF="STD-Bj_x00f6_rkholm-CHOP-1999" TYPE="STUDY">Björkholm CHOP 1999</LINK>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-02 17:20:21 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-_x00d6_sby-CNOP-2003">
<CHAR_METHODS MODIFIED="2008-05-02 17:20:21 +0200" MODIFIED_BY="[Empty name]">
<P>see <LINK REF="STD-Bj_x00f6_rkholm-CNOP-1999" TYPE="STUDY">Björkholm CNOP 1999</LINK>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>* data obtained by personal communication with the study author</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-06-09 12:51:02 +0200" MODIFIED_BY="Nicole Skoetz" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:47:02 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Adde-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:47:02 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Follow up report of <LINK REF="STD-Magrath-1996" TYPE="STUDY">Magrath 1996</LINK>.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Anaissie-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT in the treatment of febrile neutropenia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:47:07 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Bergmann-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:47:07 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Patients (N = 35) were randomised to receive either rhGM-CSF or placebo during the first two chemotherapy cycles and rhGM-CSF for all following cycles.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:47:10 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Bertini-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:47:10 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Non randomised trial with 67 patients. G-CSF was given according to the drug availability at the specific hospital: "As this factor was not generally available in Italy at that time, only some of the participating centers included it in the treatment program. However, all patients in a single center received the same treatment either with or without G-CSF."</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bodey-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT in the treatment of febrile neutropenia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gerhartz-1993ex">
<CHAR_REASON_FOR_EXCLUSION>
<P>Treatment study, 60 pts with established neutropenia were included in this study to receive GM-CSF or placebo at random.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:47:21 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Gianni-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:47:21 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Non randomised study (N = 36), NHL and breast cancer patients included, less than 10 NHL pts per study arm.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gordon-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Phase II study without control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gregory-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Less than 10 lymphoma pts per study arm.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gustavsson-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomised study with historical control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:47:26 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Hansen-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:47:26 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Fourteen pts with NHL were randomised to receive G-CSF or no treatment prior to chemotherapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:49:36 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Hartmann-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:49:36 +0200" MODIFIED_BY="Nicole Skoetz">
<P>randomised intervention study in pts (N = 71) with established neutropenia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ho-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hovgaard-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Dose finding study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:47:45 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Kaku-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:47:45 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Secondary prophylaxis, only pts (N = 62) with granulocytopenia (&lt;1x10³/µl) after the first cycle of chemotherapy were enrolled.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:49:50 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Kaneko-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:49:50 +0200" MODIFIED_BY="Nicole Skoetz">
<P>G-CSF or placebo was started subcutaneously 72 hours after completion of the second cycle of chemotherapy and continued for 14 days. See also <LINK REF="STD-Ogawa-1990" TYPE="STUDY">Ogawa 1990</LINK>.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:47:50 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Kaplan-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:47:50 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Effect of GM-CSF in patients (N = 21) receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma, randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:47:54 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Karthaus-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:47:54 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Randomised controlled trial on topical oral G-CSF to prevent mucositis in pts (N = 8) with high-grade lymphoma.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:48:01 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Liberati-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:48:01 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Part of a multicenter study. This publication reports on 14 pts with non-Hogkin lymphoma receiving GM-CSF or placebo during chemotherapy. This report was written before the randomised code was made known. The author was contacted. However, we were not able to obtain additional data or information.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lopez_x002d_Hernandez-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT in the treatment of febrile neutropenia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:48:17 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Magrath-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:48:17 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Ths trial analysed a mixed population of children (N = 33) and adults (N = 39). 16 adult lymphoma pts were randomised to receive or not receive GM-CSF. See also <LINK REF="STD-Adde-1998" TYPE="STUDY">Adde 1998</LINK>.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maher-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT in the treatment of febrile neutropenia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maiche-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Secondary prophylaxis: 59 pts who had earlier developed an infection following antineoplastic chemotherapy were randomised to receive either granulocyte colony-stimulating factor (G-CSF) alone or G-CSF + quinolone as prophylaxis during subsequent identical chemotherapy courses.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mangiagalli-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomised study with historical control group. 15 NHL pts received G-CSF, 5 NHL pts served as historical control.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mayordomo-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Treatment study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:49:24 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Moreau-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:49:24 +0200" MODIFIED_BY="Nicole Skoetz">
<P>This trial randomised controlled trial was conducted in pts (N =102) with multiple myeloma.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:48:46 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Motoyoshi-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:48:46 +0200" MODIFIED_BY="Nicole Skoetz">
<P>randomised crossover study comparing the hematopoietic effect of partially purified human urinary colony-stimulating factor in 24 pts with malignant lymphoma, solid tumours, or multiple myeloma.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:50:48 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Niitsu-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:50:48 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Non randomised study (N = 64).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:50:45 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Ogawa-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:50:45 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Japanese publication. Pts with malignant lymphoma were randomised to receive G-CSF or placebo starting 72 hours after the termination of the second cycle of chemotherapy and continued for 14 days. This report seems to be a detailed version of the phase III study that was reported in English by Kaneko 1991.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:50:39 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Rao-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:50:39 +0200" MODIFIED_BY="Nicole Skoetz">
<P>randomised controlled trial: 34 patients with CLL (N = 16) or low grade NHL (N = 18), i.e. less than 10 lymphoma patients per arm.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:49:24 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Riccardi-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:49:24 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Non randomised trial: 17 consecutive pts with HD received chemotherapy with (N =9) or without (N =8) GM-CSF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:50:25 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Seymour-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:50:25 +0200" MODIFIED_BY="Nicole Skoetz">
<P>randomised controlled dose finding study in pts with solid tumours (N = 55) and malignant lymphoma (N =11).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:48:46 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Shi-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:48:46 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Chinese publication, randomised cross over study in 21 pts receiving chemotherapy. Unclear whether lymphoma pts were enrolled. This might be the same study as Shi 1996, however could not be clarified due to lack of language skills.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:50:19 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Shi-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:50:19 +0200" MODIFIED_BY="Nicole Skoetz">
<P>randomised cross-over clinical trial in pts with NHL (N = 10) and solid tumours. Language: Chinese. Might be the same study as Shi 1994.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:50:20 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Togawa-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:50:20 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Randomised controlled trial of pts (N = 98) with multiple myeloma treated with G-CSF for chemotherapy induced neutropenia. Chugai Ltd. kindly provided us with a translation of the Japanese report.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Unpublished-trial">
<CHAR_REASON_FOR_EXCLUSION>
<P>This trial was identified via internet databases. In this multicenter study 100 patients were randomised to receive GM-CSF or placebo during chemotherapy. None of the participating physicians contacted had data of this trial. The pharmaceutical company supposed to be in charge of did not provide information about this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vellenga-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT in the treatment of febrile neutropenia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wilson-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomised study: the first 16 pts received no G-CSF and the subsequent 29 pts received G-CSF on all cycles.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-09 12:51:02 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Yau-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-09 12:51:02 +0200" MODIFIED_BY="Nicole Skoetz">
<P>Randomised controlled study in pts with breast cancer (N = 46) and malignant lymphoma (N =10).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yoshida-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT in the treatment of febrile neutropenia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zagonel-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomised study: 12 consecutive pts received G-CSF during chemotherapy compared to 11 consecutive pts who received the same chemotherapy regimen without growth factor support.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2008-06-09 12:51:36 +0200" MODIFIED_BY="Nicole Skoetz" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2008-06-09 12:51:30 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Blay">
<CHAR_STUDY_NAME>
<P>Elypse 2</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:51:30 +0200" MODIFIED_BY="Nicole Skoetz">
<P>patients with malignant lymphoma, all sub-entities included less acute leukemias<BR/>adult patients (&gt;16 years)<BR/>undergoing chemotherapy without stem cell transplantation. It is planned to enrol 144 patients.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>G-CSF or GM-CSF</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES/>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES>
<P>study is still ongoing</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2008-06-09 12:51:36 +0200" MODIFIED_BY="Nicole Skoetz" STUDY_ID="STD-Cunningham">
<CHAR_STUDY_NAME>
<P>A Phase III Trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive NHL</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS MODIFIED="2008-06-09 12:51:36 +0200" MODIFIED_BY="Nicole Skoetz">
<P>elderly patients with aggressive non-Hodgkin's lymphoma, target: N = 410</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Two different types of chemotherapy with or without G-CSF</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary endpoint: comparison of failure-free survival between the groups randomised to PMitCEBO and CHOP<BR/>Secondary endpoints: OS, disease specific survival, relapse free survival, death due to toxicity, in-patient days, in-patients days due to sepsis, dose intensity, response rate, toxicity</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>11 March 1997</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES>
<P>study is still ongoing</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Aglietta-2000">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Aglietta-2000_x002a_">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Avil_x00e9_s-1994">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Avil_x00e9_s-1994_x002a_">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bastion-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bastion-ACVBP-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bastion-VIMMM-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Bj_x00f6_rkholm-1999">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Bj_x00f6_rkholm-CHOP-1999">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Bj_x00f6_rkholm-CNOP-1999">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-23 14:32:18 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-2006">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Burton-CHOP-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Burton-PMitCEBO-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Cunningham_x002a_">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Doorduijn-2003">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Dunlop-1998">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Dunlop-MOPP-1998">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Engelhard-1994">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Fridrik-1997">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Fridrik-1997_x002a_">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Gerhartz-1993">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Gerhartz-1994a">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Gisselbrecht-1997">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Gisselbrecht-1997_x002a_">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pettengell-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Sou_x00ea_tre-1994">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Zinzani-1997">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Zinzani-1997_x002a_">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Zinzani-1999">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-_x00d6_sby-2003">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-_x00d6_sby-CHOP-2003">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-_x00d6_sby-CNOP-2003">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-06-09 12:51:58 +0200" MODIFIED_BY="Nicole Skoetz" NO="1">
<TITLE>Quality Assessment</TITLE>
<TABLE COLS="9" ROWS="16">
<TR>
<TH>
<P>Author</P>
</TH>
<TH>
<P>Properly randomised</P>
</TH>
<TH>
<P>Concealment of allocation</P>
</TH>
<TH>
<P>Studies comparable a</P>
</TH>
<TH>
<P>Patients blinded</P>
</TH>
<TH>
<P>Physicians blinded</P>
</TH>
<TH>
<P>Outcome assessors blinded</P>
</TH>
<TH>
<P>ITT</P>
</TH>
<TH>
<P>Withdrawals stated</P>
</TH>
</TR>
<TR>
<TD>
<P>Aglietta 2000</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>Aviles 1994</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>Balducci 2007</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>Bastion 1993</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Burton 2006</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>Yes (survival)</P>
<P>No (neutropenia)</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Ösby 2003/ Björkholm 1999</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>Cunningham</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>No*</P>
</TD>
<TD>
<P>No*</P>
</TD>
<TD>
<P>No*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
</TR>
<TR>
<TD>
<P>Dunlop MOPP 1998</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>Dunlop MOPP/EVAP 1998</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>Fridrik 1997</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes, but</P>
</TD>
</TR>
<TR>
<TD>
<P>Gerhartz 1993</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>Gisselbrecht 1997</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes, but</P>
</TD>
</TR>
<TR>
<TD>
<P>Pettengell 1992</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
<TR>
<TD>
<P>Zinzani 1997</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>Doorduijn 2003</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes*</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2008-07-16 13:02:02 +0200" MODIFIED_BY="[Empty name]" NO="2">
<TITLE>Duration of neutropenia</TITLE>
<TABLE COLS="6" ROWS="10">
<TR>
<TH>
<P>Author</P>
</TH>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>G-/GM-CSF</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
<TH>
<P>Comments</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>
</P>
</TD>
<TD>
<P>mean duraction of neutropenia in days, ANC &lt; 500</P>
</TD>
<TD>
<P>9.77, SD = 14.87, N = 30</P>
</TD>
<TD>
<P>11.85, SD = 12.79, N = 26</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>
</P>
</TD>
<TD>
<P>mean duration of neutropenia in days (ANC &lt; 1000)</P>
</TD>
<TD>
<P>2.1, number of neutropenic episodes:7</P>
</TD>
<TD>
<P>15.4, number of neutropenic episodes: 41</P>
</TD>
<TD>
<P>?</P>
</TD>
<TD>
<P>P value not stated</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>median duration of neutropenia in days (ANC &lt; 1000)</P>
</TD>
<TD>
<P>2.1, SD = 0.5, number of neutropenic episodes:7</P>
</TD>
<TD>
<P>8.3, SD = 1.6, number of neutropenic episodes: 41</P>
</TD>
<TD>
<P>?</P>
</TD>
<TD>
<P>P value not stated</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</TD>
<TD>
<P>1. cycle, median duration of neutropenia in days (ANC &lt;500)</P>
</TD>
<TD>
<P>1 (range 0-8), N = 80</P>
</TD>
<TD>
<P>4 (range 0-3), N = 80</P>
</TD>
<TD>
<P>P &lt; 0.001</P>
</TD>
<TD>
<P>similar dataset available for ANC &lt; 1000</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>2. cycle, median duration of neutropenia in days (ANC &lt;500)</P>
</TD>
<TD>
<P>1 (range 0-6), N = 79</P>
</TD>
<TD>
<P>4 (range 0-15), N = 73</P>
</TD>
<TD>
<P>P &lt; 0.001</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>3. cycle, median duration of neutropenia in days (ANC &lt;500)</P>
</TD>
<TD>
<P>0 (range 0-5), N = 76</P>
</TD>
<TD>
<P>3 (range 0-14), N = 67</P>
</TD>
<TD>
<P>P &lt; 0.001</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>4. cycle, median duration of neutropenia in days (ANC &lt;500)</P>
</TD>
<TD>
<P>1 (range 0-9), N = 74</P>
</TD>
<TD>
<P>2 (range 0-10), N = 63</P>
</TD>
<TD>
<P>P &lt; 0.001</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</TD>
<TD>
<P>median duration of leucopenia (days/cycle with WBC &lt;1x109/L</P>
</TD>
<TD>
<P>0.0 (range 0.0-4.3)</P>
</TD>
<TD>
<P>2.9 (range 0.0-8.6)</P>
</TD>
<TD>
<P>P = 0.007</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</TD>
<TD>
<P>median duration of leucopenia (days/cycle with WBC &lt;1x109/L</P>
</TD>
<TD>
<P>1.5 (range 0.0-6.2)</P>
</TD>
<TD>
<P>0.8 (range 0.0-9.1)</P>
</TD>
<TD>
<P>P = 0.26</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]" NO="3">
<TITLE>Duration of febrile neutropenia</TITLE>
<TABLE COLS="6" ROWS="6">
<TR>
<TH>
<P>Author</P>
</TH>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>G-/GM-CSF</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
<TH>
<P>Comments</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>
</P>
</TD>
<TD>
<P>median duration of febrile episodes in days, ANC &lt; 500, T: 38.5°C</P>
</TD>
<TD>
<P>2.1, SD = 0.5, N =7</P>
</TD>
<TD>
<P>8.3, SD = 1.6, N = 41 (number of febrile episodes)</P>
</TD>
<TD>
<P>?</P>
</TD>
<TD>
<P>P value not stated</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</TD>
<TD>
<P>median duration in days, ANC &lt; 1000, T: &gt; 38.2°C</P>
</TD>
<TD>
<P>1 patient had FN of unknown duration</P>
</TD>
<TD>
<P>4 pts had FN, duration 1,2 , 3, 7 days</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</TD>
<TD>
<P>median duration in days, ANC &lt; 1000, T: &gt; 38.2°C</P>
</TD>
<TD>
<P>6 patients had FN, duration: 1, 1, 2, 2, 5, 9 days</P>
</TD>
<TD>
<P>5 pts had FN, duration 1, 1, 2, 3.5, 20 days</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>
</P>
</TD>
<TD>
<P>median duration in days, ANC &lt; 1000, T: &gt; 37.5°C twice or &gt; 38°C once</P>
</TD>
<TD>
<P>0, range 0-14, N = 36</P>
</TD>
<TD>
<P>1, range 0-14, N = 36</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>
</P>
</TD>
<TD>
<P>median duration in days</P>
</TD>
<TD>
<P>2, range 1-14, N = 197</P>
</TD>
<TD>
<P>3, range 1-32, N = 192</P>
</TD>
<TD>
<P>0.04</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2008-06-09 13:01:20 +0200" MODIFIED_BY="Nicole Skoetz" NO="4">
<TITLE>Stay in hospital</TITLE>
<TABLE COLS="6" ROWS="9">
<TR>
<TH>
<P>Author</P>
</TH>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>G-CSF/GM-CSF</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
<TH>
<P>Comments</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>
</P>
</TD>
<TD>
<P>number of hospitalised days</P>
</TD>
<TD>
<P>67 days (N = 20)</P>
</TD>
<TD>
<P>389 days (N = 22)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>range or standard deviation not stated, P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</TD>
<TD>
<P>median number of days of inpatient hospitalisation per cycle of chemotherapy</P>
</TD>
<TD>
<P>0.2 days (range 0.0-14.6, N = 13)</P>
</TD>
<TD>
<P>2.21 days (range 0.0-14.6, N = 12)</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</TD>
<TD>
<P>median number of days of inpatient hospitalisation per cycle of chemotherapy</P>
</TD>
<TD>
<P>2.7 days (range 0.2-8.3, N = 12)</P>
</TD>
<TD>
<P>1.2 days (range 0.08-8.4, N = 10)</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>
</P>
</TD>
<TD>
<P>mean number of days in hospital for infection</P>
</TD>
<TD>
<P>3.5 days (N = 59)</P>
</TD>
<TD>
<P>8.0 days (N = 66)</P>
</TD>
<TD>
<P>P = 0.01</P>
</TD>
<TD>
<P>range or standard deviation has not been stated</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>
</P>
</TD>
<TD>
<P>number of patients hospitalised for more than 3 days for infection</P>
</TD>
<TD>
<P>20/41</P>
</TD>
<TD>
<P>20/39</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>
</P>
</TD>
<TD>
<P>mean number of days, chemotherapy-related services</P>
</TD>
<TD>
<P>11.9 days (SD: 7.1, N = 82)</P>
</TD>
<TD>
<P>11.4 days (SD:6.8, N = 80)</P>
</TD>
<TD>
<P>0.61</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>mean number of days, chemotherapy-unrelated services</P>
</TD>
<TD>
<P>14.4 days (SD:10.5, N = 82)</P>
</TD>
<TD>
<P>18.5 days (SD:12.6, N = 80)</P>
</TD>
<TD>
<P>0.04</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>
</P>
</TD>
<TD>
<P>median overall number of days in hospital</P>
</TD>
<TD>
<P>5 days (range: 0-157, N =197)</P>
</TD>
<TD>
<P>6 days (range 0-111, N =192)</P>
</TD>
<TD>
<P>0.40</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2008-06-09 13:02:33 +0200" MODIFIED_BY="Nicole Skoetz" NO="5">
<TITLE>Duration of antibiotic use</TITLE>
<TABLE COLS="6" ROWS="4">
<TR>
<TH>
<P>Author</P>
</TH>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>G-/GM-CSF</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
<TH>
<P>Comments</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>
</P>
</TD>
<TD>
<P>mean duration of antibiotic treatment</P>
</TD>
<TD>
<P>14.9, SD = 61.50, N = 30</P>
</TD>
<TD>
<P>18.4, SD = 47.70, N = 26</P>
</TD>
<TD>
<P>P = 0.8</P>
</TD>
<TD>
<P>antibiotic use is not differentiated for iv and po medication</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Sou_x00ea_tre-1994" TYPE="STUDY">Souêtre 1994</LINK>
</P>
</TD>
<TD>
<P>mean duration of iv antibiotic treatment</P>
</TD>
<TD>
<P>5.30, SD = 7.80, N = 82</P>
</TD>
<TD>
<P>8.90, SD = 8.80, N = 80</P>
</TD>
<TD>
<P>P = 0.006</P>
</TD>
<TD>
<P>same patient population as <LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>
</P>
</TD>
<TD>
<P>median duration of antibiotic treatment</P>
</TD>
<TD>
<P>0 days (range 0-126, N = 197)</P>
</TD>
<TD>
<P>6 days (range 0-180, N = 192)</P>
</TD>
<TD>
<P>P = 0.006</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2008-07-16 13:01:46 +0200" MODIFIED_BY="[Empty name]" NO="6">
<TITLE>Relative Dose Intensity</TITLE>
<TABLE COLS="7" ROWS="20">
<TR>
<TH>
<P>Author</P>
</TH>
<TH>
<P>Dose Intensity</P>
</TH>
<TH>
<P>Substance</P>
</TH>
<TH>
<P>G-/GM-CSF</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
<TH>
<P>comments</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Avil_x00e9_s-1994" TYPE="STUDY">Avilés 1994</LINK>
</P>
</TD>
<TD>
<P>defined as by Hryniuk</P>
</TD>
<TD>
<P>Cyclophosphamide</P>
</TD>
<TD>
<P>73%, N =20</P>
</TD>
<TD>
<P>61%, N =22</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>P values were not specified. Overall more chemotherapeutic substances were used, but RDI not calculated by the study author. Not stated whether mean or median values.</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Epirubicin</P>
</TD>
<TD>
<P>82%</P>
</TD>
<TD>
<P>51%</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Etoposide</P>
</TD>
<TD>
<P>83%</P>
</TD>
<TD>
<P>67%</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Cytosine arabinoside</P>
</TD>
<TD>
<P>79%</P>
</TD>
<TD>
<P>53%</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Mitoxantrone</P>
</TD>
<TD>
<P>87%</P>
</TD>
<TD>
<P>49%</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Procarbazine</P>
</TD>
<TD>
<P>89%</P>
</TD>
<TD>
<P>60%</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-_x00d6_sby-2003" TYPE="STUDY">Ösby 2003</LINK>
</P>
</TD>
<TD>
<P>mean cumulative received dose intensity in cycle 8</P>
</TD>
<TD>
<P>Doxorubicin, Mitoxantrone, Cyclophosphamide</P>
</TD>
<TD>
<P>CHOP: 92.6, SD = 9.4, CNOP: 92.3, SD = 8.68</P>
</TD>
<TD>
<P>CHOP: 88.8, SD = 10.09, CNOP: 89.8, SD = 10.17</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</TD>
<TD>
<P>median received dose intensity</P>
</TD>
<TD>
<P>MOPP</P>
</TD>
<TD>
<P>84%, range 59-103%, N =1 3</P>
</TD>
<TD>
<P>82%, range 57-99%, N = 12</P>
</TD>
<TD>
<P>P = 0.57</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</TD>
<TD>
<P>median received dose intensity</P>
</TD>
<TD>
<P>MOPP/EVAP</P>
</TD>
<TD>
<P>96%, range 67-105%, N = 12</P>
</TD>
<TD>
<P>97%, range 71-104%, N = 10</P>
</TD>
<TD>
<P>P = 0.53</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>
</P>
</TD>
<TD>
<P>defined as by Hryniuk</P>
</TD>
<TD>
<P>CEOP-IMVP-Dexa</P>
</TD>
<TD>
<P>82.3%, N = 38</P>
</TD>
<TD>
<P>76.2%, N = 36</P>
</TD>
<TD>
<P>P = 0.041</P>
</TD>
<TD>
<P>not stated whether mean or median</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>
</P>
</TD>
<TD>
<P>defined as by Hryniuk; median received dose intensity</P>
</TD>
<TD>
<P>COP-BLAM</P>
</TD>
<TD>
<P>median =85%, mean = 85%</P>
</TD>
<TD>
<P>median = 84%, mean = 81%</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>efficiency analysis: based only on patients, that received more than 70% of the study drug, 137 of 172 pts evaluated</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gisselbrecht-1997" TYPE="STUDY">Gisselbrecht 1997</LINK>
</P>
</TD>
<TD>
<P>defined as by Hryniuk, mean received dose intensity</P>
</TD>
<TD>
<P>adriamycin and cyclophosphamide</P>
</TD>
<TD>
<P>93.3%, SD = 13.5, N = 73</P>
</TD>
<TD>
<P>80.1%, SD = 13, N = 63</P>
</TD>
<TD>
<P>P = 0.0001</P>
</TD>
<TD>
<P>evaluable for this analysis, more different substances were administered, but not calculated for RDI, only 136 of 162 pts evaluated</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>
</P>
</TD>
<TD>
<P>defined as by Hryniuk, median received dose intensity</P>
</TD>
<TD>
<P>Adriamycin</P>
</TD>
<TD>
<P>96%, N = 39</P>
</TD>
<TD>
<P>85%, N = 41</P>
</TD>
<TD>
<P>P = 0.0004</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Cyclophosphamide</P>
</TD>
<TD>
<P>96%</P>
</TD>
<TD>
<P>83%</P>
</TD>
<TD>
<P>P = 0.0001</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Etoposide</P>
</TD>
<TD>
<P>94%</P>
</TD>
<TD>
<P>82%</P>
</TD>
<TD>
<P>P = 0.02</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>
</P>
</TD>
<TD>
<P>defined as by Hryniuk</P>
</TD>
<TD>
<P>VNCOP-B</P>
</TD>
<TD>
<P>95%, N = 77</P>
</TD>
<TD>
<P>85%, N = 72</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>not stated whether mean or median</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Doorduijn-2003" TYPE="STUDY">Doorduijn 2003</LINK>
</P>
</TD>
<TD>
<P>median received dose intensity</P>
</TD>
<TD>
<P>Cyclophosphamide</P>
</TD>
<TD>
<P>96.3%</P>
</TD>
<TD>
<P>93.9%</P>
</TD>
<TD>
<P>P = 0.01</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Doxorubicin</P>
</TD>
<TD>
<P>95.4%</P>
</TD>
<TD>
<P>93.3%</P>
</TD>
<TD>
<P>P = 0.04</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>overall CHOP</P>
</TD>
<TD>
<P>95.1%</P>
</TD>
<TD>
<P>93.4%</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-07" MODIFIED="2008-06-09 13:07:27 +0200" MODIFIED_BY="Nicole Skoetz" NO="7">
<TITLE>Thrombocytopenia</TITLE>
<TABLE COLS="6" ROWS="8">
<TR>
<TH>
<P>Author</P>
</TH>
<TH>
<P>outcome</P>
</TH>
<TH>
<P>G-CSF/GM-CSF</P>
</TH>
<TH>
<P>control</P>
</TH>
<TH>
<P>P value</P>
</TH>
<TH>
<P>comments</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</TD>
<TD>
<P>median platelets nadir [ /µl]</P>
</TD>
<TD>
<P>41, range 6-193, N =13</P>
</TD>
<TD>
<P>30, range 7-253, N = 12</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</TD>
<TD>
<P>median platelets nadir [ /µl]</P>
</TD>
<TD>
<P>14, range1-76, N = 12</P>
</TD>
<TD>
<P>65, range 6-168, N = 10</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>
</P>
</TD>
<TD>
<P>mean platelet nadir [ /µl]</P>
</TD>
<TD>
<P>95, N = 38</P>
</TD>
<TD>
<P>152, N = 36</P>
</TD>
<TD>
<P>P = 0.000004</P>
</TD>
<TD>
<P>range or standard deviation not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gerhartz-1993" TYPE="STUDY">Gerhartz 1993</LINK>
</P>
</TD>
<TD>
<P>incidence of thrombocytopenia &lt; 25/µl</P>
</TD>
<TD>
<P>8/89</P>
</TD>
<TD>
<P>4/87</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Aglietta-2000" TYPE="STUDY">Aglietta 2000</LINK>
</P>
</TD>
<TD>
<P>incidence of thrombocytopenia &lt; 50 /µl</P>
</TD>
<TD>
<P>0/30</P>
</TD>
<TD>
<P>2/26</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>
</P>
</TD>
<TD>
<P>incidence of thrombocytopenia and platelets transfusion requirements</P>
</TD>
<TD>
<P>similar in both groups</P>
</TD>
<TD>
<P>similar in both groups</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>no numerical data specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>
</P>
</TD>
<TD>
<P>incidence of thrombocytopenia</P>
</TD>
<TD>
<P>similar in both groups</P>
</TD>
<TD>
<P>similar in both groups</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>no numerical data specified</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-08" MODIFIED="2008-06-09 13:08:12 +0200" MODIFIED_BY="Nicole Skoetz" NO="8">
<TITLE>Anaemia</TITLE>
<TABLE COLS="6" ROWS="6">
<TR>
<TH>
<P>Author</P>
</TH>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>G-CSF/GM-CSF</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
<TH>
<P>comments</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP-1998" TYPE="STUDY">Dunlop MOPP 1998</LINK>
</P>
</TD>
<TD>
<P>median haemoglobin nadir [g/dl]</P>
</TD>
<TD>
<P>8.1, range 6.3-10.1, N = 13</P>
</TD>
<TD>
<P>7.4, range 4.9-11.3, N = 12</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dunlop-MOPP_x002f_EVAP-98" TYPE="STUDY">Dunlop MOPP/EVAP 98</LINK>
</P>
</TD>
<TD>
<P>median haemoglobin nadir [g/dl]</P>
</TD>
<TD>
<P>7.2, range 4.6-8.5, N = 12</P>
</TD>
<TD>
<P>8.6, range 7.3-9.7, N = 10</P>
</TD>
<TD>
<P>not significant</P>
</TD>
<TD>
<P>P values not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fridrik-1997" TYPE="STUDY">Fridrik 1997</LINK>
</P>
</TD>
<TD>
<P>mean haemoglobin nadir [g/dl]</P>
</TD>
<TD>
<P>8.395, N = 38</P>
</TD>
<TD>
<P>9.278, N = 36</P>
</TD>
<TD>
<P>P = 0.00558</P>
</TD>
<TD>
<P>range or standard deviation not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pettengell-1992" TYPE="STUDY">Pettengell 1992</LINK>
</P>
</TD>
<TD>
<P>incidence of anaemia and transfusion requirements</P>
</TD>
<TD>
<P>similar in both groups</P>
</TD>
<TD>
<P>similar in both groups</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>no numerical data specified</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zinzani-1997" TYPE="STUDY">Zinzani 1997</LINK>
</P>
</TD>
<TD>
<P>incidence of anaemia</P>
</TD>
<TD>
<P>similar in both groups</P>
</TD>
<TD>
<P>similar in both groups</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>no numerical data specified</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-06-17 11:00:48 +0200" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2008-06-17 11:00:28 +0200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>G-CSF/GM-CSF versus control</NAME>
<IPD_OUTCOME CHI2="4.587091559474962" CI_END="1.0942838895097016" CI_START="0.865152564267135" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9729966665130629" ESTIMABLE="YES" EVENTS_1="557" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.03913000541003163" LOG_CI_START="-0.06290730065433953" LOG_EFFECT_SIZE="-0.011888647622153943" MODIFIED="2008-06-17 11:00:08 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9170020156499316" P_Q="1.0" P_Z="0.6478711603008637" Q="0.0" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.0" Z="0.4567216063036726">
<NAME>Overall survival</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Peto Odds Ratio</EFFECT_MEASURE>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="214" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.2622503233223164"/>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="215" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.619198160655266"/>
<IPD_DATA CI_END="1.1266382440735543" CI_START="0.7681268417550926" EFFECT_SIZE="0.9302693568105543" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="219" LOG_CI_END="0.05178448940617111" LOG_CI_START="-0.11456705845052545" LOG_EFFECT_SIZE="-0.03139128452217716" MODIFIED="2008-05-14 18:19:56 +0200" MODIFIED_BY="[Empty name]" ORDER="585" O_E="-7.57" SE="0.09771572266446595" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.73" WEIGHT="37.623940221296166"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="216" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6440580543181493"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="217" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.093691622359536"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="218" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.6286822819370599"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="219" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.7975283805144419"/>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="220" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.08593188676534"/>
<IPD_DATA CI_END="2.2940058867495616" CI_START="0.49301155761426335" EFFECT_SIZE="1.0634713984883142" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.36059452802888037" LOG_CI_START="-0.3071428994869416" LOG_EFFECT_SIZE="0.026725814270969355" ORDER="221" O_E="0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.3351056186233654"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="222" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.065670354936054"/>
<IPD_DATA CI_END="1.822324807844783" CI_START="0.5497762542286599" EFFECT_SIZE="1.000935016294698" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.2606257873914151" LOG_CI_START="-0.25981402200468007" LOG_EFFECT_SIZE="4.058826933675385E-4" ORDER="223" O_E="0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.843943095272309"/>
</IPD_OUTCOME>
<IPD_OUTCOME CHI2="0.5482893957195589" CI_END="1.354525648729961" CI_START="0.9140760608234998" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_SIZE="1.1127171560084255" ESTIMABLE="YES" EVENTS_1="216" EVENTS_2="191" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.13178723306533066" LOG_CI_START="-0.03901766485527432" LOG_EFFECT_SIZE="0.04638478410502823" MODIFIED="2008-06-17 11:00:28 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.990248277061327" P_Q="1.0" P_Z="0.2870937911967445" Q="0.0" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="366" TOTAL_2="352" WEIGHT="99.99999999999999" Z="1.0645187273116716">
<NAME>Freedom from treatment failure</NAME>
<GROUP_LABEL_1>G(M)-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G(M)-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Peto Odds Ratio</EFFECT_MEASURE>
<IPD_DATA CI_END="5.271513416178947" CI_START="0.370614542148022" EFFECT_SIZE="1.397748021341585" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.7219353161494817" LOG_CI_START="-0.43107754386565256" LOG_EFFECT_SIZE="0.14542888614191457" ORDER="224" O_E="0.73" SE="0.6772854614785964" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="2.18" WEIGHT="2.194483591705255"/>
<IPD_DATA CI_END="1.3536828148784148" CI_START="0.857566870395718" EFFECT_SIZE="1.0774384135827664" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="143" LOG_CI_END="0.13151691554168068" LOG_CI_START="-0.0667320050326521" LOG_EFFECT_SIZE="0.032392455254514306" ORDER="225" O_E="5.5" SE="0.1164523972933469" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="73.74" WEIGHT="74.22991745520434"/>
<IPD_DATA CI_END="3.3055076582495393" CI_START="0.27704091818933335" EFFECT_SIZE="0.9569539574730467" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.5192381676780946" LOG_CI_START="-0.5574560820855808" LOG_EFFECT_SIZE="-0.019108957203743077" ORDER="226" O_E="-0.11" SE="0.6324555320336759" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="2.5" WEIGHT="2.5166096235152002"/>
<IPD_DATA CI_END="4.409672928005342" CI_START="0.4517567844215341" EFFECT_SIZE="1.4114176073389422" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6444063783952308" LOG_CI_START="-0.34509531654298964" LOG_EFFECT_SIZE="0.14965553092612058" ORDER="227" O_E="1.02" SE="0.5812381937190964" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.96" WEIGHT="2.979665794241997"/>
<IPD_DATA CI_END="2.585570150958807" CI_START="0.5718749480301711" EFFECT_SIZE="1.2159863468427305" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.4125563254231172" LOG_CI_START="-0.242698928056512" LOG_EFFECT_SIZE="0.08492869868330258" ORDER="228" O_E="1.32" SE="0.3849001794597505" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.75" WEIGHT="6.79484598349104"/>
<IPD_DATA CI_END="2.1753357540795917" CI_START="0.674625917206197" EFFECT_SIZE="1.211419777916548" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.33752629802187667" LOG_CI_START="-0.1709369784693359" LOG_EFFECT_SIZE="0.08329465977627037" ORDER="229" O_E="2.15" SE="0.29867384554474946" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="89" VAR="11.21" WEIGHT="11.284477551842159"/>
</IPD_OUTCOME>
<DICH_OUTCOME CHI2="14.978246655068064" CI_END="0.7330058027932487" CI_START="0.6036117230625714" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.665169824660512" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.26555797082252" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.1348925872809562" LOG_CI_START="-0.2192423341516741" LOG_EFFECT_SIZE="-0.17706746071631513" METHOD="MH" MODIFIED="2008-06-17 11:00:28 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.036279318454760845" P_Q="0.0" P_Z="1.892012463866614E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.0" Z="8.228734731589714">
<NAME>Neutropenia</NAME>
<GROUP_LABEL_1>G(M)-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G(M)-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="150" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="151" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="152" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="153" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="154" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="155" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="156" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="157" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.310952770773221" CI_END="0.8910111023231735" CI_START="0.6161614209274159" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7409498409943481" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="109" I2="7.213086927821935" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-0.05011688446183397" LOG_CI_START="-0.2103054971954022" LOG_EFFECT_SIZE="-0.13021119082861807" METHOD="MH" MODIFIED="2008-06-17 11:00:25 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.36555566653802063" P_Q="0.0" P_Z="0.0014407550702280943" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="176" WEIGHT="100.0" Z="3.186359380396625">
<NAME>Febrile Neutropenia, ANC &lt; 1000</NAME>
<GROUP_LABEL_1>G-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.749874535124143" CI_START="0.030012072326879892" EFFECT_SIZE="0.22916666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.24300691116822978" LOG_CI_START="-1.522704015602954" LOG_EFFECT_SIZE="-0.6398485522173621" ORDER="158" O_E="0.0" SE="1.0371873387954444" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="12" TOTAL_2="11" VAR="1.075757575757576" WEIGHT="3.7545315688329604"/>
<DICH_DATA CI_END="2.4810848918153625" CI_START="0.47966220283471966" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.3946416241739553" LOG_CI_START="-0.3190645023951558" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="159" O_E="0.0" SE="0.4192345116490003" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="11" TOTAL_2="10" VAR="0.17575757575757575" WEIGHT="4.711788129537396"/>
<DICH_DATA CI_END="1.1478799304301746" CI_START="0.4538817507736251" EFFECT_SIZE="0.7218045112781954" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.05989646273201818" LOG_CI_START="-0.343057278587053" LOG_EFFECT_SIZE="-0.1415804079275174" ORDER="160" O_E="0.0" SE="0.23669702230401132" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.05602548036758563" WEIGHT="19.400527143682478"/>
<DICH_DATA CI_END="1.0018237358138429" CI_START="0.6683196961138663" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" ORDER="161" O_E="0.0" SE="0.10326993530362182" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.010664679537614234" WEIGHT="56.4589616006656"/>
<DICH_DATA CI_END="0.9927055724696962" CI_START="0.25546312294926343" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.003179540237894515" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" ORDER="162" O_E="0.0" SE="0.34627066144767615" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.11990337097941117" WEIGHT="15.67419155728156"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.940824847285324" CI_END="0.7232973561941227" CI_START="0.4823232575148603" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5906463721986579" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="155" I2="31.991869497219444" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.1406831223388056" LOG_CI_START="-0.3166617959946876" LOG_EFFECT_SIZE="-0.22867245916674658" METHOD="MH" MODIFIED="2008-06-17 11:00:22 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.22983073323793157" P_Q="0.0" P_Z="3.5117386065260417E-7" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="303" TOTAL_2="301" WEIGHT="100.0" Z="5.093682943643993">
<NAME>Febrile Neutropenia, ANC &lt; 500</NAME>
<GROUP_LABEL_1>G-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="163" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997_x002a_" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="26.572782341599137"/>
<DICH_DATA CI_END="0.9407124573010561" CI_START="0.4818570113829101" EFFECT_SIZE="0.6732673267326733" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="52" LOG_CI_END="-0.02654310483093191" LOG_CI_START="-0.3170818173218805" LOG_EFFECT_SIZE="-0.17181246107640621" ORDER="164" O_E="0.0" SE="0.17066387790700488" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.029126159222257066" WEIGHT="32.93392093103218"/>
<DICH_DATA CI_END="0.8648961825730578" CI_START="0.4660954930437218" EFFECT_SIZE="0.6349206349206349" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="63" LOG_CI_END="-0.06303601975085887" LOG_CI_START="-0.33152509650037976" LOG_EFFECT_SIZE="-0.19728055812561934" ORDER="165" O_E="0.0" SE="0.15771181272503298" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.024873015873015873" WEIGHT="40.49329672736869"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.018357383096891" CI_END="0.846545555740295" CI_START="0.6387390577619707" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7353378207505309" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.79395377221509" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-0.07234966593746976" LOG_CI_START="-0.19467652669175162" LOG_EFFECT_SIZE="-0.13351309631461067" METHOD="MH" MODIFIED="2008-06-17 11:00:20 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.28382989113666146" P_Q="0.0" P_Z="1.88252034329257E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="100.0" Z="4.27838756962305">
<NAME>Infection</NAME>
<GROUP_LABEL_1>G(M)-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G(M)-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="166" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951462"/>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="167" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.31978166574582"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="168" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.949904463987919"/>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="169" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.018240590620266"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="170" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737183"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="171" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.8397271305396887"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="172" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633915"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="173" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135291"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="174" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.9058287736211303"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="175" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311166"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="176" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135945"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.46612998853603" CI_END="1.1754225026093295" CI_START="0.5746346635454525" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.821850664239353" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="39" I2="53.6043969836861" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.07019400071010828" LOG_CI_START="-0.24060817971467857" LOG_EFFECT_SIZE="-0.08520708950228513" METHOD="MH" MODIFIED="2008-06-17 11:00:18 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.09100801105785805" P_Q="0.0" P_Z="0.28252846154874134" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="186" TOTAL_2="173" WEIGHT="100.00000000000001" Z="1.0746567248898302">
<NAME>Parenteral antibiotic treatment</NAME>
<GROUP_LABEL_1>G(M)-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G(M)-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1767767813080003" CI_START="0.08626414035202279" EFFECT_SIZE="0.43333333333333335" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.33781389637387343" LOG_CI_START="-1.0641697011995248" LOG_EFFECT_SIZE="-0.36317790241282566" ORDER="177" O_E="0.0" SE="0.8235321051453478" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.6782051282051282" WEIGHT="10.515975455069569"/>
<DICH_DATA CI_END="1.8340933325847841" CI_START="0.7989636815012504" EFFECT_SIZE="1.2105263157894737" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="18" LOG_CI_END="0.2634214320947448" LOG_CI_START="-0.09747296196521697" LOG_EFFECT_SIZE="0.08297423506476391" ORDER="178" O_E="0.0" SE="0.21199115352688372" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.04494024917365878" WEIGHT="45.36080223321901"/>
<DICH_DATA CI_END="1.5024961080018464" CI_START="0.3387432669566242" EFFECT_SIZE="0.7134146341463414" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.17681335569939552" LOG_CI_START="-0.4701293283024679" LOG_EFFECT_SIZE="-0.14665798630153626" ORDER="179" O_E="0.0" SE="0.38001733500062834" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.14441317490097977" WEIGHT="30.18084955604967"/>
<DICH_DATA CI_END="1.5117472041887503" CI_START="0.004788417071278531" EFFECT_SIZE="0.08508158508158509" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.17947917409853764" LOG_CI_START="-2.3198080295550367" LOG_EFFECT_SIZE="-1.0701644277282496" ORDER="180" O_E="0.0" SE="1.4680936750972953" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="2.1552990388606825" WEIGHT="13.942372755661774"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.924072703536467" CI_END="1.4291647267056686" CI_START="0.6030700753335873" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.928378413901623" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="38" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.15508228881634578" LOG_CI_START="-0.21963222092372095" LOG_EFFECT_SIZE="-0.03227496605368757" METHOD="MH" MODIFIED="2008-06-17 11:00:17 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.6557367526900358" P_Q="0.0" P_Z="0.7356406601136303" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="592" TOTAL_2="578" WEIGHT="100.00000000000001" Z="0.3376318206165081">
<NAME>Overall mortality during chemotherapy</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.508915460267357" CI_START="0.041645885675275766" EFFECT_SIZE="0.43333333333333335" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6540720925956411" LOG_CI_START="-1.3804278974212925" LOG_EFFECT_SIZE="-0.36317790241282566" ORDER="181" O_E="0.0" SE="1.1950753650733195" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.428205128205128" WEIGHT="5.433927432356994"/>
<DICH_DATA CI_END="5.612438628376065" CI_START="0.053898139477300114" EFFECT_SIZE="0.55" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.749151605057554" LOG_CI_START="-1.2684262260690662" LOG_EFFECT_SIZE="-0.2596373105057561" ORDER="182" O_E="0.0" SE="1.1851352051751118" STUDY_ID="STD-Avil_x00e9_s-1994_x002a_" TOTAL_1="20" TOTAL_2="22" VAR="1.4045454545454545" WEIGHT="4.830157717650662"/>
<DICH_DATA CI_END="3.3216677574766336" CI_START="0.4237755203434324" EFFECT_SIZE="1.1864406779661016" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.5213561909358118" LOG_CI_START="-0.3728641341915867" LOG_EFFECT_SIZE="0.07424602837211261" ORDER="183" O_E="0.0" SE="0.5252694454418323" STUDY_ID="STD-Bastion-1993" TOTAL_1="59" TOTAL_2="60" VAR="0.27590799031477" WEIGHT="15.087139694544128"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="184" O_E="0.0" SE="0.0" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.227638960769706" CI_START="0.2889613131899766" EFFECT_SIZE="0.5956006768189509" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" LOG_CI_END="0.08907066289663301" LOG_CI_START="-0.5391602977028818" LOG_EFFECT_SIZE="-0.22504481740312438" ORDER="185" O_E="0.0" SE="0.36902597604956405" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.13618017099933344" WEIGHT="46.23168696691185"/>
<DICH_DATA CI_END="6.9419710244292725" CI_START="0.013800833844593588" EFFECT_SIZE="0.30952380952380953" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8414827966075425" LOG_CI_START="-1.86009467278967" LOG_EFFECT_SIZE="-0.5093059380910636" ORDER="186" O_E="0.0" SE="1.5869199785480734" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="2.518315018315018" WEIGHT="3.9446288027480407"/>
<DICH_DATA CI_END="53.77220278059117" CI_START="0.10711854270695871" EFFECT_SIZE="2.4" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7305578277335931" LOG_CI_START="-0.9701353443103812" LOG_EFFECT_SIZE="0.38021124171160603" ORDER="187" O_E="0.0" SE="1.586400537905439" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.516666666666666" WEIGHT="1.4087960009814433"/>
<DICH_DATA CI_END="14.366853508219926" CI_START="0.6566276647834078" EFFECT_SIZE="3.0714285714285716" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1573616634963773" LOG_CI_START="-0.18268082369368" LOG_EFFECT_SIZE="0.4873404199013485" ORDER="188" O_E="0.0" SE="0.7871475902927318" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="42" TOTAL_2="43" VAR="0.6196013289036544" WEIGHT="5.011998949373981"/>
<DICH_DATA CI_END="4.748257706114914" CI_START="0.20543557619237124" EFFECT_SIZE="0.9876543209876543" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6765342817455764" LOG_CI_START="-0.6873243455189888" LOG_EFFECT_SIZE="-0.005395031886706187" ORDER="189" O_E="0.0" SE="0.8011373088642927" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.641820987654321" WEIGHT="7.654749948189854"/>
<DICH_DATA CI_END="4.674962823863242" CI_START="0.4354776364134329" EFFECT_SIZE="1.4268292682926829" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6697781616352216" LOG_CI_START="-0.36103414291033176" LOG_EFFECT_SIZE="0.15437200936244494" ORDER="190" O_E="0.0" SE="0.6055042502932593" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.3666353971232019" WEIGHT="10.39691448724305"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="191" O_E="0.0" SE="0.0" STUDY_ID="STD-Zinzani-1997_x002a_" TOTAL_1="77" TOTAL_2="72" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.666214755493832" CI_END="1.7140593317773687" CI_START="0.5096461326465402" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9346463018527645" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.23402585085295535" LOG_CI_START="-0.29273126700116" LOG_EFFECT_SIZE="-0.02935270807410227" METHOD="MH" MODIFIED="2008-06-17 11:00:14 +0200" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.4644407033566703" P_Q="0.0" P_Z="0.8270926970279892" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="920" TOTAL_2="915" WEIGHT="99.99999999999997" Z="0.2184317922777132">
<NAME>Infection related mortality during chemotherapy</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="61.51069458339692" CI_START="0.1109931096319076" EFFECT_SIZE="2.6129032258064515" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7889506311374421" LOG_CI_START="-0.9547039810486883" LOG_EFFECT_SIZE="0.41712332504437705" ORDER="192" O_E="0.0" SE="1.6116363005074998" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="2.5973715651135003" WEIGHT="2.5332559836213706"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="193" O_E="0.0" SE="0.0" STUDY_ID="STD-Avil_x00e9_s-1994_x002a_" TOTAL_1="20" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.7401107695812104" CI_START="0.09411062429263126" EFFECT_SIZE="0.5078125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.43776811962531825" LOG_CI_START="-1.0263613456353438" LOG_EFFECT_SIZE="-0.2942966130050128" MODIFIED="2008-04-23 15:35:30 +0200" MODIFIED_BY="[Empty name]" ORDER="623" O_E="0.0" SE="0.860036895451853" STUDY_ID="STD-Burton-CHOP-2006" TOTAL_1="192" TOTAL_2="195" VAR="0.7396634615384615" WEIGHT="18.811595321235366"/>
<DICH_DATA CI_END="1.7573865862496374" CI_START="0.024424529152436585" EFFECT_SIZE="0.20717948717948717" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.24486730720237865" LOG_CI_START="-1.612173799706205" LOG_EFFECT_SIZE="-0.683653246251913" MODIFIED="2008-04-23 15:35:35 +0200" MODIFIED_BY="[Empty name]" ORDER="624" O_E="0.0" SE="1.0908351386998358" STUDY_ID="STD-Burton-PMitCEBO-2006" TOTAL_1="195" TOTAL_2="202" VAR="1.18992129982229" WEIGHT="23.280348724106364"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="194" O_E="0.0" SE="0.0" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.266567541693734" CI_START="0.18625966683701572" EFFECT_SIZE="0.649746192893401" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3553686651762351" LOG_CI_START="-0.7298811782036843" LOG_EFFECT_SIZE="-0.1872562565137246" ORDER="195" O_E="0.0" SE="0.6374811300747291" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.4063821912013536" WEIGHT="28.80336631779529"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="196" O_E="0.0" SE="0.0" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="53.77220278059117" CI_START="0.10711854270695871" EFFECT_SIZE="2.4" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7305578277335931" LOG_CI_START="-0.9701353443103812" LOG_EFFECT_SIZE="0.38021124171160603" ORDER="197" O_E="0.0" SE="1.586400537905439" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.516666666666666" WEIGHT="2.6331334596781275"/>
<DICH_DATA CI_END="48.8694119691564" CI_START="0.7721536306057255" EFFECT_SIZE="6.142857142857143" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6890371133255526" LOG_CI_START="-0.11229628219489324" LOG_EFFECT_SIZE="0.7883704155653297" ORDER="198" O_E="0.0" SE="1.058112153272825" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="1.1196013289036546" WEIGHT="4.683879754156858"/>
<DICH_DATA CI_END="6.841725736072132" CI_START="0.14257529392366453" EFFECT_SIZE="0.9876543209876543" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8351656606561424" LOG_CI_START="-0.8459557244295549" LOG_EFFECT_SIZE="-0.005395031886706187" ORDER="199" O_E="0.0" SE="0.9874990232844052" STUDY_ID="STD-Gisselbrecht-1997_x002a_" TOTAL_1="81" TOTAL_2="80" VAR="0.9751543209876543" WEIGHT="9.53815797319431"/>
<DICH_DATA CI_END="6.425630302728287" CI_START="0.1408139774235914" EFFECT_SIZE="0.9512195121951219" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8079157348937109" LOG_CI_START="-0.8513542342801836" LOG_EFFECT_SIZE="-0.021719249693236308" ORDER="200" O_E="0.0" SE="0.9746633934115589" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.9499687304565353" WEIGHT="9.71626246621229"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="201" O_E="0.0" SE="0.0" STUDY_ID="STD-Zinzani-1997_x002a_" TOTAL_1="77" TOTAL_2="72" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.839302371631788" CI_END="1.1018358243565554" CI_START="0.9536373959443804" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0250618743752082" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="637" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.04211688862855376" LOG_CI_START="-0.02061672684266919" LOG_EFFECT_SIZE="0.010750080892942304" METHOD="MH" MODIFIED="2008-06-17 11:00:13 +0200" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.6300562541691859" P_Q="0.0" P_Z="0.5017607673410294" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1185" TOTAL_2="1183" WEIGHT="100.0" Z="0.6717218901794105">
<NAME>Complete response</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours G-/GM-CSF</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="202" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.6860584750976497"/>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="203" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7907056500651"/>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="596" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.782949604567754"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="204" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14463391788987345"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="205" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.82227555865141"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="206" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6518168566236964"/>
<DICH_DATA CI_END="3.0120035209923532" CI_START="0.6640776040572667" EFFECT_SIZE="1.4142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.4788554752134757" LOG_CI_START="-0.17778116604688957" LOG_EFFECT_SIZE="0.15053715458329311" ORDER="207" O_E="0.0" SE="0.38571161348013466" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="0.14877344877344878" WEIGHT="0.8774457685318989"/>
<DICH_DATA CI_END="1.3248988969835218" CI_START="0.8355760327580203" EFFECT_SIZE="1.0521662245800176" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="52" LOG_CI_END="0.12218273853135836" LOG_CI_START="-0.07801402559720746" LOG_EFFECT_SIZE="0.022084356467075444" ORDER="208" O_E="0.0" SE="0.11759657023908447" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="0.013828953331995929" WEIGHT="8.242451529979881"/>
<DICH_DATA CI_END="1.6375574636769459" CI_START="0.9432914030892016" EFFECT_SIZE="1.2428571428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="24" LOG_CI_END="0.21419654879813088" LOG_CI_START="-0.02535412358940746" LOG_EFFECT_SIZE="0.09442121260436169" ORDER="209" O_E="0.0" SE="0.14071325075539257" STUDY_ID="STD-Fridrik-1997" TOTAL_1="35" TOTAL_2="36" VAR="0.019800218938149983" WEIGHT="3.707517331824925"/>
<DICH_DATA CI_END="1.1515258924894898" CI_START="0.7602808241874472" EFFECT_SIZE="0.935672514619883" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.06127370768356176" LOG_CI_START="-0.11902596315601996" LOG_EFFECT_SIZE="-0.02887612773622908" ORDER="210" O_E="0.0" SE="0.10590891914893497" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.011216699155295645" WEIGHT="8.986617376468008"/>
<DICH_DATA CI_END="1.3386453667434657" CI_START="0.783492937268815" EFFECT_SIZE="1.0241187384044528" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.12666553917374582" LOG_CI_START="-0.10596491408882536" LOG_EFFECT_SIZE="0.010350312542460237" ORDER="211" O_E="0.0" SE="0.13664827978574973" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.018672752368404537" WEIGHT="6.801676930566062"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="212" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.418019825653362"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="213" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.087831174080382"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.729810590892833" CI_END="6.120862590350674" CI_START="2.0875475621925985" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.574575748113673" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.7868126299611535" LOG_CI_START="0.31963637913167814" LOG_EFFECT_SIZE="0.5532245045464159" METHOD="MH" MODIFIED="2008-05-07 17:04:15 +0200" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.6774674489315917" P_Q="0.0" P_Z="3.451671081465183E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="606" TOTAL_2="598" WEIGHT="100.00000000000001" Z="4.641931615105889">
<NAME>Adverse events: bone pain</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="18.03566184106943" CI_START="0.1665835427011031" EFFECT_SIZE="1.7333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2561320839236036" LOG_CI_START="-0.7783679060933301" LOG_EFFECT_SIZE="0.23888208891513676" ORDER="230" O_E="0.0" SE="1.1950753650733195" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.428205128205128" WEIGHT="6.640209309199503"/>
<DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" ORDER="231" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="2.9579114195525062"/>
<DICH_DATA CI_END="103.49901743899466" CI_START="0.25291362340873896" EFFECT_SIZE="5.116279069767442" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0149362268668662" LOG_CI_START="-0.5970277763816269" LOG_EFFECT_SIZE="0.7089542252426198" ORDER="232" O_E="0.0" SE="1.5342805849385042" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="2.3540169133192386" WEIGHT="3.0631463633242153"/>
<DICH_DATA CI_END="3.6015819855331057" CI_START="0.47167478457223294" EFFECT_SIZE="1.303370786516854" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5564933053988002" LOG_CI_START="-0.3263573402347888" LOG_EFFECT_SIZE="0.1150679825820057" ORDER="233" O_E="0.0" SE="0.5185908394263474" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.2689364587369236" WEIGHT="37.60773090573901"/>
<DICH_DATA CI_END="12.554563016975525" CI_START="1.5733790489596613" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="4" LOG_CI_END="1.0988016009502575" LOG_CI_START="0.19683336282701747" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="234" O_E="0.0" SE="0.5298206078883775" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.2807098765432099" WEIGHT="24.94409062238422"/>
<DICH_DATA CI_END="242.02294415313497" CI_START="0.8432325842790044" EFFECT_SIZE="14.285714285714286" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3838565397273634" LOG_CI_START="-0.0740526197558771" LOG_EFFECT_SIZE="1.154901959985743" ORDER="235" O_E="0.0" SE="1.4437880071270193" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="2.0845238095238097" WEIGHT="3.174343962446592"/>
<DICH_DATA CI_END="95.8447517250373" CI_START="0.22846947661574074" EFFECT_SIZE="4.67948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.981568336731456" LOG_CI_START="-0.6411718131994673" LOG_EFFECT_SIZE="0.6701982617659943" ORDER="236" O_E="0.0" SE="1.54061054684255" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="2.373480857042501" WEIGHT="3.201372435163734"/>
<DICH_DATA CI_END="22.91964915384711" CI_START="1.1565275278881775" EFFECT_SIZE="5.148514851485149" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.3602079653147936" LOG_CI_START="0.06315597438951993" LOG_EFFECT_SIZE="0.7116819698521566" ORDER="237" O_E="0.0" SE="0.7618947599804093" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.5804836252856055" WEIGHT="12.21366629360403"/>
<DICH_DATA CI_END="42.18688113558866" CI_START="0.5926012856852341" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6251774192981756" LOG_CI_START="-0.22723741062613828" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="238" O_E="0.0" SE="1.0881176406988355" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="1.184" WEIGHT="6.197528688586203"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.1229171621512712" CI_END="3.013450277836978" CI_START="0.5557318232921138" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2940904981115002" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.4790640299704545" LOG_CI_START="-0.25513473316883817" LOG_EFFECT_SIZE="0.11196464840080818" METHOD="MH" NO="12" P_CHI2="0.7131635290433249" P_Q="0.0" P_Z="0.5499830863828985" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="216" TOTAL_2="209" WEIGHT="100.00000000000001" Z="0.5977854756087096">
<NAME>Adverse events: thrombosis and related complications (TIA, MI, cerebral non-hemorhagic infarction)</NAME>
<GROUP_LABEL_1>G(M)-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G(M)-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="61.51069458339692" CI_START="0.1109931096319076" EFFECT_SIZE="2.6129032258064515" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7889506311374421" LOG_CI_START="-0.9547039810486883" LOG_EFFECT_SIZE="0.41712332504437705" ORDER="239" O_E="0.0" SE="1.6116363005074998" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="2.5973715651135003" WEIGHT="5.874974524688465"/>
<DICH_DATA CI_END="67.90969947701805" CI_START="0.13252893282270775" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8319318085736291" LOG_CI_START="-0.8776892991343044" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="240" O_E="0.0" SE="1.5916448515084427" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="14" TOTAL_2="14" VAR="2.5333333333333328" WEIGHT="5.495943910192436"/>
<DICH_DATA CI_END="8.143906058223955" CI_START="0.014285425381653886" EFFECT_SIZE="0.34108527131782945" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9108327553376903" LOG_CI_START="-1.8451068229638132" LOG_EFFECT_SIZE="-0.46713703381306154" ORDER="241" O_E="0.0" SE="1.6188525504152331" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="42" TOTAL_2="43" VAR="2.620683579985905" WEIGHT="16.298316423329293"/>
<DICH_DATA CI_END="2.9141977177146283" CI_START="0.32789853643449723" EFFECT_SIZE="0.9775280898876404" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.46451901373440574" LOG_CI_START="-0.4842605217869943" LOG_EFFECT_SIZE="-0.009870754026294283" ORDER="242" O_E="0.0" SE="0.557317795699716" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.31060312540359036" WEIGHT="66.70077381915365"/>
<DICH_DATA CI_END="96.1564527598966" CI_START="0.23582127159029814" EFFECT_SIZE="4.761904761904762" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9829784337017367" LOG_CI_START="-0.6274170231695751" LOG_EFFECT_SIZE="0.6777807052660807" ORDER="243" O_E="0.0" SE="1.533359213032118" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="2.3511904761904763" WEIGHT="5.629991322636154"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.8995135886510458" CI_END="20.818010863539072" CI_START="2.8390272054686108" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="7.687840997661731" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="1.318439230829736" LOG_CI_START="0.45316955424769045" LOG_EFFECT_SIZE="0.8858043925387132" METHOD="MH" NO="13" P_CHI2="0.3429122891351407" P_Q="0.0" P_Z="5.9963013446437826E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="119" TOTAL_2="113" WEIGHT="100.0" Z="4.012956315726466">
<NAME>Adverse events: skin rash</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="18.007606387404152" CI_START="1.0427692261705772" EFFECT_SIZE="4.333333333333333" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.2554559892311006" LOG_CI_START="0.018188205943248024" LOG_EFFECT_SIZE="0.6368220975871743" ORDER="244" O_E="0.0" SE="0.7267772204775877" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.5282051282051282" WEIGHT="51.44193296960249"/>
<DICH_DATA CI_END="46.246470366866546" CI_START="2.732596958636832" EFFECT_SIZE="11.241573033707866" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="2" LOG_CI_END="1.665078592022323" LOG_CI_START="0.43657558063231194" LOG_EFFECT_SIZE="1.0508270863273175" ORDER="245" O_E="0.0" SE="0.721628750078475" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.5207480529398222" WEIGHT="48.55806703039751"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0014464055808618254" CI_END="14.247894314653056" CI_START="3.008670560350063" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="6.547306329436228" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="1.1537506850393235" LOG_CI_START="0.4783746365088206" LOG_EFFECT_SIZE="0.8160626607740722" METHOD="MH" NO="14" P_CHI2="0.9696624600589542" P_Q="0.0" P_Z="2.1745948765028216E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="170" TOTAL_2="167" WEIGHT="100.0" Z="4.736482520294383">
<NAME>Adverse events: injection site reaction</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="14.58471102825454" CI_START="2.911911322505077" EFFECT_SIZE="6.51685393258427" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="6" LOG_CI_END="1.1638978287215331" LOG_CI_START="0.46417814511451594" LOG_EFFECT_SIZE="0.8140379869180245" ORDER="246" O_E="0.0" SE="0.411018805819057" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.16893645873692364" WEIGHT="92.34441638905982"/>
<DICH_DATA CI_END="131.74613733101495" CI_START="0.3629113258753254" EFFECT_SIZE="6.914634146341464" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1197378909781914" LOG_CI_START="-0.4401994779598117" LOG_EFFECT_SIZE="0.83976920650919" ORDER="247" O_E="0.0" SE="1.503719882408529" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="2.2611734847507203" WEIGHT="7.655583610940185"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9193813625935384" CI_END="1.4538632320698959" CI_START="0.6022897185413605" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9357600530269553" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="29" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.162523553461751" LOG_CI_START="-0.22019455044201214" LOG_EFFECT_SIZE="-0.028835498490130576" METHOD="MH" NO="15" P_CHI2="0.3376375985334742" P_Q="0.0" P_Z="0.767731943556572" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="119" TOTAL_2="113" WEIGHT="100.0" Z="0.2953429061256348">
<NAME>Adverse events: myalgia</NAME>
<GROUP_LABEL_1>GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="23.497834919859493" CI_START="0.28768607929433976" EFFECT_SIZE="2.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3710278484132183" LOG_CI_START="-0.5410811524715822" LOG_EFFECT_SIZE="0.414973347970818" ORDER="248" O_E="0.0" SE="1.1231822922119372" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.2615384615384613" WEIGHT="3.645603181617322"/>
<DICH_DATA CI_END="1.3703865806868212" CI_START="0.5558778247762549" EFFECT_SIZE="0.872792937399679" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="28" LOG_CI_END="0.13684309721212498" LOG_CI_START="-0.2550206506050767" LOG_EFFECT_SIZE="-0.05908877669647586" ORDER="249" O_E="0.0" SE="0.23018270522466" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.05298407778454271" WEIGHT="96.35439681838268"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6473754362840953" CI_END="1.4115941998991772" CI_START="0.6448316675512528" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9540653236684912" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="39" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.1497098652185657" LOG_CI_START="-0.19055364256609483" LOG_EFFECT_SIZE="-0.020421888673764575" METHOD="MH" NO="16" P_CHI2="0.885506256457579" P_Q="0.0" P_Z="0.8140025150701513" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="348" TOTAL_2="348" WEIGHT="100.00000000000001" Z="0.23526570073565464">
<NAME>Adverse events: mucositis</NAME>
<GROUP_LABEL_1>G-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.536873770614359" CI_START="0.4304571898391628" EFFECT_SIZE="0.813362381989833" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.18663819867938375" LOG_CI_START="-0.36607003385286785" LOG_EFFECT_SIZE="-0.08971591758674205" ORDER="250" O_E="0.0" SE="0.3246635517393205" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.10540642182799044" WEIGHT="43.39091587961533"/>
<DICH_DATA CI_END="1.6747707395447746" CI_START="0.5402641322875438" EFFECT_SIZE="0.9512195121951219" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.22395536458768375" LOG_CI_START="-0.2673938639741564" LOG_EFFECT_SIZE="-0.021719249693236308" ORDER="251" O_E="0.0" SE="0.2886209690751326" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.08330206378986868" WEIGHT="39.00101248928932"/>
<DICH_DATA CI_END="4.656997011529837" CI_START="0.3557443389798237" EFFECT_SIZE="1.2871287128712872" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6681059592390406" LOG_CI_START="-0.4488620021906522" LOG_EFFECT_SIZE="0.10962197852419421" ORDER="252" O_E="0.0" SE="0.6561125096243825" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.43048362528560546" WEIGHT="9.998117974648668"/>
<DICH_DATA CI_END="5.835482726753975" CI_START="0.30464965128372123" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7660767878696595" LOG_CI_START="-0.5161993146530597" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="253" O_E="0.0" SE="0.7532153299909218" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.5673333333333332" WEIGHT="7.609953656446697"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="47" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="170" TOTAL_2="167" WEIGHT="0.0" Z="0.0">
<NAME>Adverse events: headache</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.2577741143747265" CI_START="0.3992372937573831" EFFECT_SIZE="1.1404494382022472" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.512920968161088" LOG_CI_START="-0.39876889695245016" LOG_EFFECT_SIZE="0.05707603560431894" ORDER="254" O_E="0.0" SE="0.5355311397053084" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.2867936015940665" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.485788572699798" CI_START="1.381923069291585" EFFECT_SIZE="2.1947873799725652" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="18" LOG_CI_END="0.5423010418404042" LOG_CI_START="0.14048386683549624" LOG_EFFECT_SIZE="0.3413924543379502" ORDER="255" O_E="0.0" SE="0.2360293976249778" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.05570987654320987" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.41995623754172406" CI_END="11.956034808852774" CI_START="2.0660634246407077" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="4.970103240607973" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="1.0775871707759646" LOG_CI_START="0.31514364949177204" LOG_EFFECT_SIZE="0.6963654101338683" METHOD="MH" NO="18" P_CHI2="0.5169588991882128" P_Q="0.0" P_Z="3.433279550887817E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="117" TOTAL_2="111" WEIGHT="100.0" Z="3.5802025614776314">
<NAME>Withdrawals due to adverse events</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours G-/GM-CSF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.41995623754172406" CI_END="11.956034808852774" CI_START="2.0660634246407077" DF="1.0" EFFECT_SIZE="4.970103240607973" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="5" I2="0.0" ID="CMP-001.18.01" LOG_CI_END="1.0775871707759646" LOG_CI_START="0.31514364949177204" LOG_EFFECT_SIZE="0.6963654101338683" NO="1" P_CHI2="0.5169588991882128" P_Z="3.433279550887817E-4" STUDIES="2" TAU2="0.0" TOTAL_1="117" TOTAL_2="111" WEIGHT="100.0" Z="3.5802025614776314">
<NAME>GM-CSF</NAME>
<DICH_DATA CI_END="191.82624828056345" CI_START="0.6683174675797007" EFFECT_SIZE="11.32258064516129" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.2829080329882228" LOG_CI_START="-0.17501718772511998" LOG_EFFECT_SIZE="1.0539454226315514" ORDER="256" O_E="0.0" SE="1.4437974415730856" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="2.0845510522929875" WEIGHT="9.556925724118152"/>
<DICH_DATA CI_END="10.829005067357805" CI_START="1.706538703118017" EFFECT_SIZE="4.2988505747126435" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="5" LOG_CI_END="1.0345885569387623" LOG_CI_START="0.232116142224961" LOG_EFFECT_SIZE="0.6333523495818616" ORDER="257" O_E="0.0" SE="0.4713762687054041" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.22219558669862932" WEIGHT="90.44307427588184"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-06-17 11:00:47 +0200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Sensitivity analysis: Overall survival</NAME>
<IPD_OUTCOME CHI2="4.539781601147617" CI_END="1.0910650634471606" CI_START="0.8626077259042263" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9701346057087674" ESTIMABLE="YES" EVENTS_1="557" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.03785064962916991" LOG_CI_START="-0.06418665643520127" LOG_EFFECT_SIZE="-0.013168003403015672" MODIFIED="2008-05-26 18:34:55 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9197298579866903" P_Q="0.5174746524654824" P_Z="0.6129478275489695" Q="0.41892360180679944" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.0" Z="0.5058701256171912">
<NAME>GM-CSF versus G-CSF</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard Ratio</EFFECT_MEASURE>
<IPD_SUBGROUP CHI2="1.313334716106949" CI_END="2.2707703545612947" CI_START="0.6288289736759071" DF="1.0" EFFECT_SIZE="1.194958656821421" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" I2="23.8579481882388" ID="CMP-002.01.01" LOG_CI_END="0.3561732157742291" LOG_CI_START="-0.20146745612628958" LOG_EFFECT_SIZE="0.07735287982396977" NO="1" P_CHI2="0.25179190409640995" P_Z="0.5866127798532479" STUDIES="2" TAU2="0.0" TOTAL_1="104" TOTAL_2="97" WEIGHT="3.348182210087656" Z="0.5437510791267472">
<NAME>GM-CSF</NAME>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="599" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.2622503233223164"/>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="600" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.08593188676534"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="2.8075232832338686" CI_END="1.0854029963746306" CI_START="0.8546757553439842" DF="8.0" EFFECT_SIZE="0.9631550372495132" ESTIMABLE="YES" EVENTS_1="534" EVENTS_2="560" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.035591016162907864" LOG_CI_START="-0.06819861553268815" LOG_EFFECT_SIZE="-0.016303799684890118" MODIFIED="2008-05-26 18:34:55 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9458496449085357" P_Z="0.5380515556252887" STUDIES="9" TAU2="0.0" TOTAL_1="1011" TOTAL_2="1009" WEIGHT="96.65181778991234" Z="0.6157620885920547">
<NAME>G-CSF</NAME>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="601" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.619198160655266"/>
<IPD_DATA CI_END="1.1266382440735543" CI_START="0.7681268417550926" EFFECT_SIZE="0.9302693568105543" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="219" LOG_CI_END="0.05178448940617111" LOG_CI_START="-0.11456705845052545" LOG_EFFECT_SIZE="-0.03139128452217716" ORDER="606" O_E="-7.57" SE="0.09771572266446595" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.73" WEIGHT="37.623940221296166"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="602" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6440580543181493"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="603" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.093691622359536"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="604" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.6286822819370599"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="605" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.7975283805144419"/>
<IPD_DATA CI_END="2.0283500144278745" CI_START="0.43591867212552227" EFFECT_SIZE="0.940316779013957" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.3071428994869416" LOG_CI_START="-0.3605945280288803" LOG_EFFECT_SIZE="-0.026725814270969362" ORDER="606" O_E="-0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.3351056186233654"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="607" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.065670354936054"/>
<IPD_DATA CI_END="1.818921774646319" CI_START="0.5487495948555267" EFFECT_SIZE="0.9990658571440939" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.25981402200468007" LOG_CI_START="-0.2606257873914151" LOG_EFFECT_SIZE="-4.0588269336753823E-4" ORDER="608" O_E="-0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.843943095272309"/>
</IPD_SUBGROUP>
</IPD_OUTCOME>
<IPD_OUTCOME CHI2="4.5393298242907365" CI_END="1.0912363772888822" CI_START="0.862568192381846" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9701885329251141" ESTIMABLE="YES" EVENTS_1="556" EVENTS_2="576" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.03791883512810913" LOG_CI_START="-0.0642065607132995" LOG_EFFECT_SIZE="-0.0131438627925952" MODIFIED="2008-05-07 17:13:27 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9197556724873701" P_Q="0.954648510112234" P_Z="0.6139050204046026" Q="0.003234235972430888" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.00000000000001" Z="0.5045071792177503">
<NAME>HD versus NHL</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard Ratio</EFFECT_MEASURE>
<IPD_SUBGROUP CHI2="2.3798150928377684" CI_END="2.45913251611112" CI_START="0.4032013192324883" DF="2.0" EFFECT_SIZE="0.9957537218928745" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" I2="15.959857300714258" ID="CMP-002.02.01" LOG_CI_END="0.3907819323439059" LOG_CI_START="-0.3944780555941464" LOG_EFFECT_SIZE="-0.001848061625120192" NO="1" P_CHI2="0.3042494489495824" P_Z="0.9926393703280202" STUDIES="3" TAU2="0.0" TOTAL_1="44" TOTAL_2="35" WEIGHT="1.6913775730531166" Z="0.009225312080288808">
<NAME>Hodgkin's disease</NAME>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="609" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.2627033251763351"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="610" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.6297682452857349"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="611" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.7989060025910466"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="2.1562804954805372" CI_END="1.09184724155752" CI_START="0.8613144033572321" DF="7.0" EFFECT_SIZE="0.9697544820310732" ESTIMABLE="YES" EVENTS_1="546" EVENTS_2="567" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="0.03816188123563792" LOG_CI_START="-0.06483829021995803" LOG_EFFECT_SIZE="-0.013338204492160046" MODIFIED="2008-04-23 15:11:17 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9506863750628721" P_Z="0.6117208594021133" STUDIES="8" TAU2="0.0" TOTAL_1="1071" TOTAL_2="1071" WEIGHT="98.3086224269469" Z="0.5076185806998239">
<NAME>Non-Hodgkin's lymphoma</NAME>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="612" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.661724485389378"/>
<IPD_DATA CI_END="1.127083766688127" CI_START="0.7677540553023234" EFFECT_SIZE="0.9302274627961847" ESTIMABLE="YES" EVENTS_1="199" EVENTS_2="218" LOG_CI_END="0.051956194713807594" LOG_CI_START="-0.1147778809210118" LOG_EFFECT_SIZE="-0.03141084310360212" MODIFIED="2008-04-23 15:11:17 +0200" MODIFIED_BY="[Empty name]" ORDER="613" O_E="-7.54" SE="0.09794042137487835" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.25" WEIGHT="37.516194040593064"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="613" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6486253058874336"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="614" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.1318554771844"/>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="615" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.0912624154311215"/>
<IPD_DATA CI_END="2.0283500144278745" CI_START="0.43591867212552227" EFFECT_SIZE="0.940316779013957" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.3071428994869416" LOG_CI_START="-0.3605945280288803" LOG_EFFECT_SIZE="-0.026725814270969362" ORDER="616" O_E="-0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.339139196775587"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="617" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.0692385202245576"/>
<IPD_DATA CI_END="1.818921774646319" CI_START="0.5487495948555267" EFFECT_SIZE="0.9990658571440939" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.25981402200468007" LOG_CI_START="-0.2606257873914151" LOG_EFFECT_SIZE="-4.0588269336753823E-4" ORDER="618" O_E="-0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.8505829854613505"/>
</IPD_SUBGROUP>
</IPD_OUTCOME>
<IPD_OUTCOME CHI2="4.539781601147616" CI_END="1.0910650634471606" CI_START="0.8626077259042263" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9701346057087674" ESTIMABLE="YES" EVENTS_1="557" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.03785064962916991" LOG_CI_START="-0.06418665643520127" LOG_EFFECT_SIZE="-0.013168003403015672" MODIFIED="2008-05-26 18:35:27 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9197298579866903" P_Q="0.36027531071381" P_Z="0.6129478275489695" Q="0.8369335961435009" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.00000000000001" Z="0.5058701256171912">
<NAME>Age</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard Ratio</EFFECT_MEASURE>
<IPD_SUBGROUP CHI2="2.9223789994652045" CI_END="1.5859077399206143" CI_START="0.8007142197652471" DF="6.0" EFFECT_SIZE="1.1268801527182033" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="64" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.2002779186632795" LOG_CI_START="-0.09652245885295854" LOG_EFFECT_SIZE="0.05187772990516049" NO="1" P_CHI2="0.8185242224498968" P_Z="0.4932403777276777" STUDIES="7" TAU2="0.0" TOTAL_1="228" TOTAL_2="216" WEIGHT="11.819226900416728" Z="0.6851641029887047">
<NAME>Adults, all ages</NAME>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="619" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.26225032332231646"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="620" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6440580543181498"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="621" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.62868228193706"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="622" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.797528380514442"/>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="623" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.0859318867653402"/>
<IPD_DATA CI_END="2.0283500144278745" CI_START="0.43591867212552227" EFFECT_SIZE="0.940316779013957" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.3071428994869416" LOG_CI_START="-0.3605945280288803" LOG_EFFECT_SIZE="-0.026725814270969362" ORDER="624" O_E="-0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.335105618623366"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="625" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.065670354936054"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="0.7804690055389103" CI_END="1.077566161115279" CI_START="0.8390413437253099" DF="3.0" EFFECT_SIZE="0.950853595342147" ESTIMABLE="YES" EVENTS_1="486" EVENTS_2="513" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.03244394474939829" LOG_CI_START="-0.07621663880254934" LOG_EFFECT_SIZE="-0.021886347026575534" MODIFIED="2008-05-26 18:35:27 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8541327012524874" P_Z="0.4297909474053462" STUDIES="4" TAU2="0.0" TOTAL_1="887" TOTAL_2="890" WEIGHT="88.18077309958329" Z="0.7895494488068104">
<NAME>Adults, age older 60</NAME>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="626" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.61919816065527"/>
<IPD_DATA CI_END="1.1266382440735543" CI_START="0.7681268417550926" EFFECT_SIZE="0.9302693568105543" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="219" LOG_CI_END="0.05178448940617111" LOG_CI_START="-0.11456705845052545" LOG_EFFECT_SIZE="-0.03139128452217716" ORDER="607" O_E="-7.57" SE="0.09771572266446595" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.73" WEIGHT="37.62394022129617"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="627" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.09369162235954"/>
<IPD_DATA CI_END="1.818921774646319" CI_START="0.5487495948555267" EFFECT_SIZE="0.9990658571440939" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.25981402200468007" LOG_CI_START="-0.2606257873914151" LOG_EFFECT_SIZE="-4.0588269336753823E-4" ORDER="628" O_E="-0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.8439430952723095"/>
</IPD_SUBGROUP>
</IPD_OUTCOME>
<IPD_OUTCOME CHI2="4.539781601147617" CI_END="1.0910650634471606" CI_START="0.8626077259042263" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9701346057087674" ESTIMABLE="YES" EVENTS_1="557" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.03785064962916991" LOG_CI_START="-0.06418665643520127" LOG_EFFECT_SIZE="-0.013168003403015672" MODIFIED="2008-05-26 18:35:35 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9197298579866903" P_Q="0.7235673728897114" P_Z="0.6129478275489697" Q="0.1251003103875119" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.0" Z="0.5058701256171911">
<NAME>Antibiotic prophylaxis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard Ratio</EFFECT_MEASURE>
<IPD_SUBGROUP CHI2="4.05994316060704" CI_END="1.1556075688790575" CI_START="0.8453209618399044" DF="7.0" EFFECT_SIZE="0.9883619284626044" ESTIMABLE="YES" EVENTS_1="324" EVENTS_2="325" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.06281037767860102" LOG_CI_START="-0.07297836147681941" LOG_EFFECT_SIZE="-0.005083991899109207" NO="1" P_CHI2="0.7728479185692101" P_Z="0.8833183965632058" STUDIES="8" TAU2="0.0" TOTAL_1="610" TOTAL_2="598" WEIGHT="56.46644632849548" Z="0.14676387868278765">
<NAME>No antibiotic prophylaxis given</NAME>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="629" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.2622503233223164"/>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="630" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.619198160655266"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="631" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6440580543181493"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="632" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.093691622359536"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="633" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.6286822819370599"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="634" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.7975283805144419"/>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="635" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.08593188676534"/>
<IPD_DATA CI_END="2.0283500144278745" CI_START="0.43591867212552227" EFFECT_SIZE="0.940316779013957" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.3071428994869416" LOG_CI_START="-0.3605945280288803" LOG_EFFECT_SIZE="-0.026725814270969362" ORDER="636" O_E="-0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.3351056186233654"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="0.3547381301530648" CI_END="1.131542480778556" CI_START="0.7925413520820015" DF="2.0" EFFECT_SIZE="0.9469921898592717" ESTIMABLE="YES" EVENTS_1="233" EVENTS_2="252" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.05367086303789433" LOG_CI_START="-0.10097806852661294" LOG_EFFECT_SIZE="-0.023653602744359303" MODIFIED="2008-05-26 18:35:35 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8374706834670115" P_Z="0.5488033705697886" STUDIES="3" TAU2="0.0" TOTAL_1="505" TOTAL_2="508" WEIGHT="43.53355367150453" Z="0.5995542163086235">
<NAME>Antibiotic prophylaxis given</NAME>
<IPD_DATA CI_END="1.1266382440735543" CI_START="0.7681268417550926" EFFECT_SIZE="0.9302693568105543" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="219" LOG_CI_END="0.05178448940617111" LOG_CI_START="-0.11456705845052545" LOG_EFFECT_SIZE="-0.03139128452217716" ORDER="608" O_E="-7.57" SE="0.09771572266446595" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.73" WEIGHT="37.623940221296166"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="637" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.065670354936054"/>
<IPD_DATA CI_END="1.818921774646319" CI_START="0.5487495948555267" EFFECT_SIZE="0.9990658571440939" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.25981402200468007" LOG_CI_START="-0.2606257873914151" LOG_EFFECT_SIZE="-4.0588269336753823E-4" ORDER="638" O_E="-0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.843943095272309"/>
</IPD_SUBGROUP>
</IPD_OUTCOME>
<IPD_OUTCOME CHI2="4.539781601147616" CI_END="1.0910650634471606" CI_START="0.8626077259042263" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9701346057087674" ESTIMABLE="YES" EVENTS_1="557" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.03785064962916991" LOG_CI_START="-0.06418665643520127" LOG_EFFECT_SIZE="-0.013168003403015672" MODIFIED="2008-05-26 18:35:45 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9197298579866903" P_Q="0.517474652465483" P_Z="0.6129478275489695" Q="0.41892360180679855" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.00000000000001" Z="0.5058701256171912">
<NAME>Blinded versus open label studies</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard Ratio</EFFECT_MEASURE>
<IPD_SUBGROUP CHI2="1.313334716106949" CI_END="2.2707703545612947" CI_START="0.6288289736759071" DF="1.0" EFFECT_SIZE="1.194958656821421" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" I2="23.8579481882388" ID="CMP-002.05.01" LOG_CI_END="0.3561732157742291" LOG_CI_START="-0.20146745612628958" LOG_EFFECT_SIZE="0.07735287982396977" NO="1" P_CHI2="0.25179190409640995" P_Z="0.5866127798532479" STUDIES="2" TAU2="0.0" TOTAL_1="104" TOTAL_2="97" WEIGHT="3.348182210087656" Z="0.5437510791267472">
<NAME>Placebo controlled studies</NAME>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="639" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.2622503233223164"/>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="640" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.08593188676534"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="2.8075232832338686" CI_END="1.0854029963746306" CI_START="0.8546757553439842" DF="8.0" EFFECT_SIZE="0.9631550372495132" ESTIMABLE="YES" EVENTS_1="534" EVENTS_2="560" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="0.035591016162907864" LOG_CI_START="-0.06819861553268815" LOG_EFFECT_SIZE="-0.016303799684890118" MODIFIED="2008-05-26 18:35:45 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9458496449085357" P_Z="0.5380515556252887" STUDIES="9" TAU2="0.0" TOTAL_1="1011" TOTAL_2="1009" WEIGHT="96.65181778991236" Z="0.6157620885920547">
<NAME>Open label studies</NAME>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="641" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.619198160655266"/>
<IPD_DATA CI_END="1.1266382440735543" CI_START="0.7681268417550926" EFFECT_SIZE="0.9302693568105543" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="219" LOG_CI_END="0.05178448940617111" LOG_CI_START="-0.11456705845052545" LOG_EFFECT_SIZE="-0.03139128452217716" ORDER="609" O_E="-7.57" SE="0.09771572266446595" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.73" WEIGHT="37.623940221296166"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="642" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6440580543181493"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="643" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.093691622359536"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="644" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.6286822819370599"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="645" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.7975283805144419"/>
<IPD_DATA CI_END="2.0283500144278745" CI_START="0.43591867212552227" EFFECT_SIZE="0.940316779013957" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.3071428994869416" LOG_CI_START="-0.3605945280288803" LOG_EFFECT_SIZE="-0.026725814270969362" ORDER="646" O_E="-0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.3351056186233654"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="647" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.065670354936054"/>
<IPD_DATA CI_END="1.818921774646319" CI_START="0.5487495948555267" EFFECT_SIZE="0.9990658571440939" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.25981402200468007" LOG_CI_START="-0.2606257873914151" LOG_EFFECT_SIZE="-4.0588269336753823E-4" ORDER="648" O_E="-0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.843943095272309"/>
</IPD_SUBGROUP>
</IPD_OUTCOME>
<IPD_OUTCOME CHI2="4.539781601147617" CI_END="1.0910650634471606" CI_START="0.8626077259042263" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9701346057087674" ESTIMABLE="YES" EVENTS_1="557" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.03785064962916991" LOG_CI_START="-0.06418665643520127" LOG_EFFECT_SIZE="-0.013168003403015672" MODIFIED="2008-05-26 18:42:50 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9197298579866903" P_Q="0.6914060811370006" P_Z="0.6129478275489695" Q="0.15756762802218027" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.0" Z="0.5058701256171912">
<NAME>Concealed allocation versus concealment of allocation unclear</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard Ratio</EFFECT_MEASURE>
<IPD_SUBGROUP CHI2="4.061105556831028" CI_END="1.1505599793312646" CI_START="0.8501960453791148" DF="8.0" EFFECT_SIZE="0.9890407192825365" ESTIMABLE="YES" EVENTS_1="346" EVENTS_2="346" I2="0.0" ID="CMP-002.06.01" LOG_CI_END="0.06090926360754639" LOG_CI_START="-0.07048091945125637" LOG_EFFECT_SIZE="-0.004785827921855013" NO="1" P_CHI2="0.8515686570489828" P_Z="0.8864626682972225" STUDIES="9" TAU2="0.0" TOTAL_1="687" TOTAL_2="670" WEIGHT="60.31038942376778" Z="0.14278160125317704">
<NAME>Allocation concealed</NAME>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="649" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.2622503233223164"/>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="650" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.619198160655266"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="651" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6440580543181493"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="652" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.093691622359536"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="653" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.6286822819370599"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="654" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.7975283805144419"/>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="655" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.08593188676534"/>
<IPD_DATA CI_END="2.0283500144278745" CI_START="0.43591867212552227" EFFECT_SIZE="0.940316779013957" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.3071428994869416" LOG_CI_START="-0.3605945280288803" LOG_EFFECT_SIZE="-0.026725814270969362" ORDER="656" O_E="-0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.3351056186233654"/>
<IPD_DATA CI_END="1.818921774646319" CI_START="0.5487495948555267" EFFECT_SIZE="0.9990658571440939" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.25981402200468007" LOG_CI_START="-0.2606257873914151" LOG_EFFECT_SIZE="-4.0588269336753823E-4" ORDER="657" O_E="-0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.843943095272309"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="0.3211084162944082" CI_END="1.1352126952863413" CI_START="0.7818302445893113" DF="1.0" EFFECT_SIZE="0.9420953344628193" ESTIMABLE="YES" EVENTS_1="211" EVENTS_2="231" I2="0.0" ID="CMP-002.06.02" LOG_CI_END="0.05507723926933909" LOG_CI_START="-0.1068875331821274" LOG_EFFECT_SIZE="-0.025905146956394166" MODIFIED="2008-05-26 18:42:50 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5709424172485542" P_Z="0.5306819122330553" STUDIES="2" TAU2="0.0" TOTAL_1="428" TOTAL_2="436" WEIGHT="39.68961057623222" Z="0.6269654108144339">
<NAME>Method of allocation unclear</NAME>
<IPD_DATA CI_END="1.1266382440735543" CI_START="0.7681268417550926" EFFECT_SIZE="0.9302693568105543" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="219" LOG_CI_END="0.05178448940617111" LOG_CI_START="-0.11456705845052545" LOG_EFFECT_SIZE="-0.03139128452217716" ORDER="613" O_E="-7.57" SE="0.09771572266446595" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.73" WEIGHT="37.623940221296166"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="658" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.065670354936054"/>
</IPD_SUBGROUP>
</IPD_OUTCOME>
<IPD_OUTCOME CHI2="4.539781601147617" CI_END="1.0910650634471606" CI_START="0.8626077259042263" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9701346057087674" ESTIMABLE="YES" EVENTS_1="557" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.03785064962916991" LOG_CI_START="-0.06418665643520127" LOG_EFFECT_SIZE="-0.013168003403015672" MODIFIED="2008-05-26 18:36:08 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.9197298579866903" P_Q="0.6408979764841836" P_Z="0.6129478275489695" Q="0.21756969541307214" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.00000000000001" Z="0.5058701256171912">
<NAME>Size of studies</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard Ratio</EFFECT_MEASURE>
<IPD_SUBGROUP CHI2="2.593911937993483" CI_END="1.5802364739278638" CI_START="0.7135809997768046" DF="5.0" EFFECT_SIZE="1.0618976989094653" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="49" I2="0.0" ID="CMP-002.07.01" LOG_CI_END="0.19872208166163785" LOG_CI_START="-0.1465567222557351" LOG_EFFECT_SIZE="0.026082679702951382" NO="1" P_CHI2="0.7622901014201171" P_Z="0.767142275712732" STUDIES="6" TAU2="0.0" TOTAL_1="141" TOTAL_2="131" WEIGHT="8.733295013651388" Z="0.2961149787249154">
<NAME>Study size &lt;100</NAME>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="659" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.26225032332231646"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="660" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6440580543181498"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="661" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.62868228193706"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="662" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.797528380514442"/>
<IPD_DATA CI_END="2.0283500144278745" CI_START="0.43591867212552227" EFFECT_SIZE="0.940316779013957" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.3071428994869416" LOG_CI_START="-0.3605945280288803" LOG_EFFECT_SIZE="-0.026725814270969362" ORDER="663" O_E="-0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.335105618623366"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="664" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.065670354936054"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="1.7282999677410613" CI_END="1.0876270106848691" CI_START="0.8504959045596542" DF="4.0" EFFECT_SIZE="0.9617808057327514" ESTIMABLE="YES" EVENTS_1="508" EVENTS_2="528" I2="0.0" ID="CMP-002.07.02" LOG_CI_END="0.0364799845404424" LOG_CI_START="-0.07032777332880842" LOG_EFFECT_SIZE="-0.016923894394183008" MODIFIED="2008-05-26 18:36:08 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7855707383435251" P_Z="0.534520598006986" STUDIES="5" TAU2="0.0" TOTAL_1="974" TOTAL_2="975" WEIGHT="91.26670498634863" Z="0.6211201162253301">
<NAME>Study size &gt;100</NAME>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="665" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.61919816065527"/>
<IPD_DATA CI_END="1.1266382440735543" CI_START="0.7681268417550926" EFFECT_SIZE="0.9302693568105543" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="219" LOG_CI_END="0.05178448940617111" LOG_CI_START="-0.11456705845052545" LOG_EFFECT_SIZE="-0.03139128452217716" ORDER="611" O_E="-7.57" SE="0.09771572266446595" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.73" WEIGHT="37.62394022129617"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="666" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.09369162235954"/>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="667" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.0859318867653402"/>
<IPD_DATA CI_END="1.818921774646319" CI_START="0.5487495948555267" EFFECT_SIZE="0.9990658571440939" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.25981402200468007" LOG_CI_START="-0.2606257873914151" LOG_EFFECT_SIZE="-4.0588269336753823E-4" ORDER="668" O_E="-0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.8439430952723095"/>
</IPD_SUBGROUP>
</IPD_OUTCOME>
<IPD_OUTCOME CHI2="4.539781601147617" CI_END="1.0910650634471606" CI_START="0.8626077259042263" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_SIZE="0.9701346057087674" ESTIMABLE="YES" EVENTS_1="557" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.03785064962916991" LOG_CI_START="-0.06418665643520127" LOG_EFFECT_SIZE="-0.013168003403015672" MODIFIED="2008-05-26 18:43:17 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.9197298579866903" P_Q="0.6200969025109373" P_Z="0.6129478275489695" Q="0.9557591800019738" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1106" WEIGHT="100.0" Z="0.5058701256171912">
<NAME>Duration of follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard Ratio</EFFECT_MEASURE>
<IPD_SUBGROUP CHI2="0.40468040219677415" CI_END="1.6973356725127746" CI_START="0.7754596049285389" DF="2.0" EFFECT_SIZE="1.147264245951155" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="48" I2="0.0" ID="CMP-002.08.01" LOG_CI_END="0.22976773878435724" LOG_CI_START="-0.11044082043394303" LOG_EFFECT_SIZE="0.059663459175207156" NO="1" P_CHI2="0.8168170787923392" P_Z="0.49179903979830086" STUDIES="3" TAU2="0.0" TOTAL_1="205" TOTAL_2="196" WEIGHT="8.995545336973704" Z="0.6874502596005911">
<NAME>Follow-up 1-2 years</NAME>
<IPD_DATA CI_END="2.601985317118945" CI_START="0.6830498560964255" EFFECT_SIZE="1.333148790054249" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.4153048415290984" LOG_CI_START="-0.16554759582455086" LOG_EFFECT_SIZE="0.12487862285227383" ORDER="669" O_E="2.47" SE="0.3411955969674702" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="8.59" WEIGHT="3.08593188676534"/>
<IPD_DATA CI_END="2.68531023816752" CI_START="0.523652647451751" EFFECT_SIZE="1.1858203133045553" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.42899446766718385" LOG_CI_START="-0.28095669644451005" LOG_EFFECT_SIZE="0.07401888561133686" ORDER="670" O_E="0.98" SE="0.41702882811414954" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="5.75" WEIGHT="2.065670354936054"/>
<IPD_DATA CI_END="1.818921774646319" CI_START="0.5487495948555267" EFFECT_SIZE="0.9990658571440939" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.25981402200468007" LOG_CI_START="-0.2606257873914151" LOG_EFFECT_SIZE="-4.0588269336753823E-4" ORDER="671" O_E="-0.01" SE="0.30570892025787155" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="10.7" WEIGHT="3.843943095272309"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="0.7535997438755009" CI_END="1.076048280952631" CI_START="0.8360445897099502" DF="3.0" EFFECT_SIZE="0.9484852890567885" ESTIMABLE="YES" EVENTS_1="478" EVENTS_2="504" I2="0.0" ID="CMP-002.08.02" LOG_CI_END="0.03183175802265121" LOG_CI_START="-0.07777055922538262" LOG_EFFECT_SIZE="-0.022969400601365698" MODIFIED="2008-05-26 18:43:17 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8605300843176711" P_Z="0.4113610527379705" STUDIES="4" TAU2="0.0" TOTAL_1="848" TOTAL_2="854" WEIGHT="86.67193562293433" Z="0.8215008415062884">
<NAME>Follow-up 2-5 years</NAME>
<IPD_DATA CI_END="1.1404288212779479" CI_START="0.7102665276237348" EFFECT_SIZE="0.9000046771495784" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="150" LOG_CI_END="0.05706818440365092" LOG_CI_START="-0.14857865162505696" LOG_EFFECT_SIZE="-0.045755233610703" ORDER="672" O_E="-7.22" SE="0.12079796945151891" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="68.53" WEIGHT="24.619198160655266"/>
<IPD_DATA CI_END="1.1266382440735543" CI_START="0.7681268417550926" EFFECT_SIZE="0.9302693568105543" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="219" LOG_CI_END="0.05178448940617111" LOG_CI_START="-0.11456705845052545" LOG_EFFECT_SIZE="-0.03139128452217716" ORDER="615" O_E="-7.57" SE="0.09771572266446595" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="104.73" WEIGHT="37.623940221296166"/>
<IPD_DATA CI_END="1.3356761915174957" CI_START="0.8102493137876688" EFFECT_SIZE="1.0403031854318134" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="123" LOG_CI_END="0.12570118472482178" LOG_CI_START="-0.0913813281061258" LOG_EFFECT_SIZE="0.017159928309348017" ORDER="673" O_E="2.43" SE="0.12751534261266767" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="61.5" WEIGHT="22.093691622359536"/>
<IPD_DATA CI_END="2.0283500144278745" CI_START="0.43591867212552227" EFFECT_SIZE="0.940316779013957" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.3071428994869416" LOG_CI_START="-0.3605945280288803" LOG_EFFECT_SIZE="-0.026725814270969362" ORDER="674" O_E="-0.4" SE="0.3922322702763681" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="6.5" WEIGHT="2.3351056186233654"/>
</IPD_SUBGROUP>
<IPD_SUBGROUP CHI2="2.425742275073368" CI_END="1.8914659399935028" CI_START="0.6117600330053771" DF="3.0" EFFECT_SIZE="1.0756966421249867" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" I2="0.0" ID="CMP-002.08.03" LOG_CI_END="0.2767985252713447" LOG_CI_START="-0.2134188993882831" LOG_EFFECT_SIZE="0.0316898129415308" NO="3" P_CHI2="0.48886090773389335" P_Z="0.7999580424205579" STUDIES="4" TAU2="0.0" TOTAL_1="62" TOTAL_2="56" WEIGHT="4.3325190400919675" Z="0.253401404837199">
<NAME>Follow-up 5-8 years</NAME>
<IPD_DATA CI_END="3.2686442321841205" CI_START="0.03325489271998173" EFFECT_SIZE="0.32969442409763317" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5143676534015686" LOG_CI_START="-1.4781444488581001" LOG_EFFECT_SIZE="-0.48188839772826575" ORDER="675" O_E="-0.81" SE="1.1704114719613057" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="17" TOTAL_2="12" VAR="0.73" WEIGHT="0.2622503233223164"/>
<IPD_DATA CI_END="2.3273607922240385" CI_START="0.5487185101187917" EFFECT_SIZE="1.1300734252330975" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.36686371372342025" LOG_CI_START="-0.26065038934490753" LOG_EFFECT_SIZE="0.05310666218925635" ORDER="676" O_E="0.9" SE="0.3686048903872428" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="7.36" WEIGHT="2.6440580543181493"/>
<IPD_DATA CI_END="2.8015278739871063" CI_START="0.14471021109386523" EFFECT_SIZE="0.6367179045935663" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.44739494786679135" LOG_CI_START="-0.8395008229565845" LOG_EFFECT_SIZE="-0.19605293754489653" ORDER="677" O_E="-0.79" SE="0.7559289460184544" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="1.75" WEIGHT="0.6286822819370599"/>
<IPD_DATA CI_END="7.592442980534618" CI_START="0.5467683901971414" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8803815390384868" LOG_CI_START="-0.2621966008338582" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="678" O_E="1.58" SE="0.6711560552140243" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="2.22" WEIGHT="0.7975283805144419"/>
</IPD_SUBGROUP>
</IPD_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-06-17 11:00:48 +0200" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Sensitivity analysis: Neutropenia</NAME>
<DICH_OUTCOME CHI2="14.978246655068055" CI_END="0.7330058027932489" CI_START="0.6036117230625715" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6651698246605121" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.26555797082249" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.13489258728095607" LOG_CI_START="-0.219242334151674" LOG_EFFECT_SIZE="-0.17706746071631507" METHOD="MH" MODIFIED="2008-05-07 17:04:28 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.03627931845476151" P_Q="0.0" P_Z="1.892012463866641E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.00000000000001" Z="8.228734731589713">
<NAME>G-CSF versus GM-CSF</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1463945673331275" CI_START="0.4443531833377977" DF="0.0" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" MODIFIED="2008-04-23 14:47:04 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.16304735057795589" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="26" WEIGHT="4.790662510378095" Z="1.3948955124411169">
<NAME>GM-CSF</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="258" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.995302046766154" CI_END="0.7317996384062252" CI_START="0.6001732973200401" DF="6.0" EFFECT_SIZE="0.6627266419572079" ESTIMABLE="YES" EVENTS_1="241" EVENTS_2="360" I2="59.98746819978899" ID="CMP-003.01.02" LOG_CI_END="-0.1356078094411302" LOG_CI_START="-0.22172333094471425" LOG_EFFECT_SIZE="-0.17866557019292223" MODIFIED="2008-05-07 17:04:28 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.020293315103889542" P_Z="4.196531712754219E-16" STUDIES="7" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="95.20933748962192" Z="8.132751837097485">
<NAME>G-CSF</NAME>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="259" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="260" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="261" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="262" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="263" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="264" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="265" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.978246655068055" CI_END="0.7330058027932489" CI_START="0.6036117230625715" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6651698246605121" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.26555797082249" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-0.13489258728095607" LOG_CI_START="-0.219242334151674" LOG_EFFECT_SIZE="-0.17706746071631507" METHOD="MH" MODIFIED="2008-05-07 17:04:35 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.03627931845476151" P_Q="0.0" P_Z="1.892012463866641E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.0" Z="8.228734731589713">
<NAME>HD versus NHL</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1463945673331275" CI_START="0.4443531833377977" DF="0.0" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" NO="1" P_CHI2="1.0" P_Z="0.16304735057795589" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="26" WEIGHT="4.790662510378095" Z="1.3948955124411169">
<NAME>Hodgkin's disease</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="266" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.995302046766152" CI_END="0.7317996384062252" CI_START="0.6001732973200401" DF="6.0" EFFECT_SIZE="0.6627266419572079" ESTIMABLE="YES" EVENTS_1="241" EVENTS_2="360" I2="59.987468199788985" ID="CMP-003.02.02" LOG_CI_END="-0.1356078094411302" LOG_CI_START="-0.22172333094471425" LOG_EFFECT_SIZE="-0.17866557019292223" MODIFIED="2008-05-07 17:04:35 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.02029331510388943" P_Z="4.196531712754219E-16" STUDIES="7" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="95.2093374896219" Z="8.132751837097485">
<NAME>Non-Hodgkin's lymphoma</NAME>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="267" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="268" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="269" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="270" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="271" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="272" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="273" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.978246655068064" CI_END="0.7330058027932487" CI_START="0.6036117230625714" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6651698246605119" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.26555797082252" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-0.1348925872809562" LOG_CI_START="-0.2192423341516741" LOG_EFFECT_SIZE="-0.17706746071631518" METHOD="MH" MODIFIED="2008-05-07 17:04:39 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.036279318454760845" P_Q="0.0" P_Z="1.8920124638665457E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.0" Z="8.228734731589718">
<NAME>Age</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.583088820725655" CI_END="0.8380733481545541" CI_START="0.5995121232118582" DF="4.0" EFFECT_SIZE="0.7088265883552956" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="136" I2="47.25104644604143" ID="CMP-003.03.01" LOG_CI_END="-0.0767179702661688" LOG_CI_START="-0.22220203026191604" LOG_EFFECT_SIZE="-0.1494600002640424" NO="1" P_CHI2="0.10810086394806184" P_Z="5.647961979816855E-5" STUDIES="5" TAU2="0.0" TOTAL_1="209" TOTAL_2="200" WEIGHT="36.61787633310913" Z="4.027055852791477">
<NAME>Adults, all age groups</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="274" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="275" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="276" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="277" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="278" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.099315903281451" CI_END="0.7204159146870103" CI_START="0.568467922584244" DF="2.0" EFFECT_SIZE="0.6399479185205251" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="241" I2="71.82827152295677" ID="CMP-003.03.02" LOG_CI_END="-0.1424167017597689" LOG_CI_START="-0.2452940365834558" LOG_EFFECT_SIZE="-0.19385536917161236" MODIFIED="2008-05-07 17:04:39 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.028734510620499143" P_Z="1.50792073194322E-13" STUDIES="3" TAU2="0.0" TOTAL_1="303" TOTAL_2="301" WEIGHT="63.38212366689087" Z="7.386457715632722">
<NAME>Adults, age older 60</NAME>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="279" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="280" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="281" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.97824665506806" CI_END="0.7330058027932487" CI_START="0.6036117230625714" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.665169824660512" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.2655579708225" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="-0.1348925872809562" LOG_CI_START="-0.2192423341516741" LOG_EFFECT_SIZE="-0.17706746071631513" METHOD="MH" MODIFIED="2008-05-07 17:04:44 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.036279318454760845" P_Q="0.0" P_Z="1.892012463866614E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.00000000000001" Z="8.228734731589714">
<NAME>Haematotoxicity</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.61758385570094" CI_END="0.7532150768483978" CI_START="0.6172392520328109" DF="4.0" EFFECT_SIZE="0.6818459581560495" ESTIMABLE="YES" EVENTS_1="216" EVENTS_2="315" I2="47.48991181755838" ID="CMP-003.04.01" LOG_CI_END="-0.12308099544436538" LOG_CI_START="-0.2095464636859963" LOG_EFFECT_SIZE="-0.16631372956518084" MODIFIED="2008-05-07 17:04:44 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.10663485175082132" P_Z="4.704631349426634E-14" STUDIES="5" TAU2="0.0" TOTAL_1="387" TOTAL_2="384" WEIGHT="83.05608322038164" Z="7.53986364062372">
<NAME>Rate of neutropenia in the control group &gt;70%</NAME>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="282" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="283" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="284" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="285" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="286" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.618035766249508" CI_END="0.712477453463817" CI_START="0.3655961877976653" DF="1.0" EFFECT_SIZE="0.5103714734173139" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="57" I2="61.80342480834173" ID="CMP-003.04.02" LOG_CI_END="-0.1472288744649698" LOG_CI_START="-0.43699834145863753" LOG_EFFECT_SIZE="-0.29211360796180363" NO="2" P_CHI2="0.10565520334999978" P_Z="7.761779524899632E-5" STUDIES="2" TAU2="0.0" TOTAL_1="107" TOTAL_2="98" WEIGHT="15.664375759358403" Z="3.9516389144733424">
<NAME>Rate of neutropenia in the control group 50%-70%</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="287" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="288" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.8190432087671518" CI_START="0.5718257273132037" DF="0.0" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" I2="0.0" ID="CMP-003.04.03" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" MODIFIED="2008-05-01 16:44:04 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.420134683334659" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="19" WEIGHT="1.279541020259968" Z="0.8061876198882173">
<NAME>Rate of neutropenia in the control gorup &lt; 50%</NAME>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="289" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.978246655068073" CI_END="0.7330058027932485" CI_START="0.6036117230625712" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6651698246605118" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.26555797082254" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="-0.13489258728095635" LOG_CI_START="-0.21924233415167424" LOG_EFFECT_SIZE="-0.17706746071631527" METHOD="MH" MODIFIED="2008-05-07 17:04:54 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.036279318454760956" P_Q="0.0" P_Z="1.8920124638664912E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.0" Z="8.228734731589721">
<NAME>Use of antibiotic prophylaxis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.298127616030033" CI_END="0.7928229040013499" CI_START="0.6510162979941002" DF="5.0" EFFECT_SIZE="0.7184292810902759" ESTIMABLE="YES" EVENTS_1="224" EVENTS_2="309" I2="20.611326018958884" ID="CMP-003.05.01" LOG_CI_END="-0.10082381193131174" LOG_CI_START="-0.18640813886605737" LOG_EFFECT_SIZE="-0.14361597539868456" MODIFIED="2008-05-07 17:04:54 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2782811118162458" P_Z="4.771713721617203E-11" STUDIES="6" TAU2="0.0" TOTAL_1="394" TOTAL_2="390" WEIGHT="81.57770558760825" Z="6.577889888662214">
<NAME>No antibiotic prophylaxis given</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="290" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="291" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="292" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="293" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="294" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="295" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.02030077698476234" CI_END="0.5999240218528892" CI_START="0.3072402721153875" DF="1.0" EFFECT_SIZE="0.4293260063432442" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="68" I2="0.0" ID="CMP-003.05.02" LOG_CI_END="-0.22190374791537965" LOG_CI_START="-0.5125218589166577" LOG_EFFECT_SIZE="-0.3672128034160187" MODIFIED="2008-05-01 16:44:15 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8867002568453548" P_Z="7.305698990122047E-7" STUDIES="2" TAU2="0.0" TOTAL_1="118" TOTAL_2="111" WEIGHT="18.422294412391754" Z="4.953055863433221">
<NAME>Antibiotic prophylaxis given</NAME>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="296" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="297" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.978246655068073" CI_END="0.7330058027932485" CI_START="0.6036117230625712" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6651698246605118" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.26555797082254" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="-0.13489258728095635" LOG_CI_START="-0.21924233415167424" LOG_EFFECT_SIZE="-0.17706746071631527" METHOD="MH" MODIFIED="2008-05-07 17:05:02 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.036279318454760956" P_Q="0.0" P_Z="1.8920124638664912E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.0" Z="8.228734731589721">
<NAME>Blinded versus openlabel studies</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.005771539118591091" CI_END="0.8718028297198084" CI_START="0.5661414570864733" DF="1.0" EFFECT_SIZE="0.7025409057910315" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="77" I2="0.0" ID="CMP-003.06.01" LOG_CI_END="-0.0595817256719668" LOG_CI_START="-0.2470750416802175" LOG_EFFECT_SIZE="-0.1533283836760921" NO="1" P_CHI2="0.9394424515570987" P_Z="0.001347621077366834" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="106" WEIGHT="20.766495660455227" Z="3.205640779212154">
<NAME>Placebo controlled studies</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="298" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="299" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.100009376946824" CI_END="0.7306287467444592" CI_START="0.5878725538826112" DF="5.0" EFFECT_SIZE="0.6553751500390572" ESTIMABLE="YES" EVENTS_1="198" EVENTS_2="300" I2="66.88743778110829" ID="CMP-003.06.02" LOG_CI_END="-0.1363032443785719" LOG_CI_START="-0.23071681532644112" LOG_EFFECT_SIZE="-0.1835100298525065" MODIFIED="2008-05-07 17:05:02 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.009943469735573363" P_Z="2.5545763380022146E-14" STUDIES="6" TAU2="0.0" TOTAL_1="400" TOTAL_2="395" WEIGHT="79.23350433954478" Z="7.619096401117546">
<NAME>Open label studies</NAME>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="300" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="301" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="302" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="303" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="304" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="305" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.97824665506806" CI_END="0.7330058027932487" CI_START="0.6036117230625714" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.665169824660512" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.2655579708225" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="-0.1348925872809562" LOG_CI_START="-0.2192423341516741" LOG_EFFECT_SIZE="-0.17706746071631513" METHOD="MH" MODIFIED="2008-05-07 17:05:07 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.036279318454760845" P_Q="0.0" P_Z="1.892012463866614E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.0" Z="8.228734731589714">
<NAME>Concealed versus unclear method of allocation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="11.485392386645803" CI_END="0.754166778365754" CI_START="0.6193117140804962" DF="6.0" EFFECT_SIZE="0.6834210416809398" ESTIMABLE="YES" EVENTS_1="242" EVENTS_2="349" I2="47.75972994204126" ID="CMP-003.07.01" LOG_CI_END="-0.12253260251938021" LOG_CI_START="-0.2080907053732692" LOG_EFFECT_SIZE="-0.16531165394632472" MODIFIED="2008-05-07 17:05:07 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.07448437103974104" P_Z="3.621421498093035E-14" STUDIES="7" TAU2="0.0" TOTAL_1="471" TOTAL_2="462" WEIGHT="92.45141883658856" Z="7.573914735179696">
<NAME>Allocation concealed</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="306" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="307" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="308" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="309" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="310" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="311" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="312" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7211855122822195" CI_START="0.2704488560780151" DF="0.0" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" I2="0.0" ID="CMP-003.07.02" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" MODIFIED="2008-05-01 16:44:35 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.0010896612513042374" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="7.548581163411445" Z="3.2662912210913846">
<NAME>Method of allocation unclear</NAME>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="313" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.978246655068062" CI_END="0.7330058027932487" CI_START="0.6036117230625714" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.665169824660512" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.26555797082251" I2_Q="0.0" ID="CMP-003.08" LOG_CI_END="-0.1348925872809562" LOG_CI_START="-0.2192423341516741" LOG_EFFECT_SIZE="-0.17706746071631513" METHOD="MH" MODIFIED="2008-05-07 16:58:31 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.036279318454760845" P_Q="0.0" P_Z="1.892012463866614E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.0" Z="8.228734731589714">
<NAME>Published and reported data versus unpublished or unreported data</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.8792948186159886" CI_END="1.134870576366505" CI_START="0.6740609613055011" DF="2.0" EFFECT_SIZE="0.8746267499127468" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="48" I2="0.0" ID="CMP-003.08.01" LOG_CI_END="0.05494633626501336" LOG_CI_START="-0.17130082459025725" LOG_EFFECT_SIZE="-0.058177244162621926" NO="1" P_CHI2="0.3907656545173851" P_Z="0.31346833538386887" STUDIES="3" TAU2="0.0" TOTAL_1="86" TOTAL_2="81" WEIGHT="13.093462019620553" Z="1.0079711307535353">
<NAME>Unreported and unpublished data</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="314" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="315" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="316" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.127887117023409" CI_END="0.7036171786890946" CI_START="0.5705732127933067" DF="4.0" EFFECT_SIZE="0.63361274783672" ESTIMABLE="YES" EVENTS_1="210" EVENTS_2="329" I2="60.50508903010363" ID="CMP-003.08.02" LOG_CI_END="-0.15266356586209678" LOG_CI_START="-0.2436886214085835" LOG_EFFECT_SIZE="-0.19817609363534014" MODIFIED="2008-05-07 16:58:31 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.03832776860646181" P_Z="1.40994727167053E-17" STUDIES="5" TAU2="0.0" TOTAL_1="426" TOTAL_2="420" WEIGHT="86.90653798037945" Z="8.53430967529019">
<NAME>Published and reported data</NAME>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="317" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="318" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="319" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="320" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="321" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.978246655068073" CI_END="0.7330058027932485" CI_START="0.6036117230625713" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6651698246605118" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="377" I2="53.26555797082254" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="-0.13489258728095635" LOG_CI_START="-0.21924233415167416" LOG_EFFECT_SIZE="-0.17706746071631527" METHOD="MH" MODIFIED="2008-05-07 17:05:23 +0200" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.036279318454760956" P_Q="0.0" P_Z="1.892012463866464E-16" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="512" TOTAL_2="501" WEIGHT="100.0" Z="8.228734731589723">
<NAME>Size of study</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.50036716928005" CI_END="0.9020337811508354" CI_START="0.5687893810933429" DF="3.0" EFFECT_SIZE="0.7162871184839719" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="76" I2="60.00195814029774" ID="CMP-003.09.01" LOG_CI_END="-0.044777197832023906" LOG_CI_START="-0.24504852018197104" LOG_EFFECT_SIZE="-0.14491285900699746" NO="1" P_CHI2="0.05754906222990663" P_Z="0.004562641210306335" STUDIES="4" TAU2="0.0" TOTAL_1="127" TOTAL_2="120" WEIGHT="20.642043183031998" Z="2.8363919628408123">
<NAME>Study size &lt;100 patients</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="322" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.790662510378095"/>
<DICH_DATA CI_END="3.8190432087671518" CI_START="0.5718257273132037" EFFECT_SIZE="1.4777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5819545720216519" LOG_CI_START="-0.24273630896612994" LOG_EFFECT_SIZE="0.16960913152776094" ORDER="323" O_E="0.0" SE="0.4844275057779222" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="19" VAR="0.23467000835421886" WEIGHT="1.279541020259968"/>
<DICH_DATA CI_END="1.199776407354922" CI_START="0.6374017891094954" EFFECT_SIZE="0.8744939271255061" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.0791003176311816" LOG_CI_START="-0.1955867218486512" LOG_EFFECT_SIZE="-0.058243202108734814" ORDER="324" O_E="0.0" SE="0.16135252671322856" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="38" TOTAL_2="36" VAR="0.026034637876743136" WEIGHT="7.023258488982491"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="325" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.548581163411445"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.003730022896976" CI_END="0.7250804323807033" CI_START="0.5860579088744502" DF="3.0" EFFECT_SIZE="0.6518735475280595" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="301" I2="57.16568185535084" ID="CMP-003.09.02" LOG_CI_END="-0.13961381494405942" LOG_CI_START="-0.23205946885893292" LOG_EFFECT_SIZE="-0.18583664190149615" MODIFIED="2008-05-07 17:05:23 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0717790618872034" P_Z="3.2753706816194735E-15" STUDIES="4" TAU2="0.0" TOTAL_1="385" TOTAL_2="381" WEIGHT="79.357956816968" Z="7.879940477682067">
<NAME>Study size &gt; 100 patients</NAME>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="326" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.975833150077131"/>
<DICH_DATA CI_END="0.6626253764539918" CI_START="0.2672024931901498" EFFECT_SIZE="0.42077922077922075" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.17873193603192736" LOG_CI_START="-0.5731594938998121" LOG_EFFECT_SIZE="-0.37594571496586976" ORDER="327" O_E="0.0" SE="0.23168869993949567" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.05367965367965367" WEIGHT="10.873713248980309"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="328" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.10259976813927"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="329" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.40581064977129"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="33.870055911082005" CI_END="0.7148876479004294" CI_START="0.6232363404601644" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6674907950808296" ESTIMABLE="YES" EVENTS_1="515" EVENTS_2="770" I2="55.71309347885628" I2_Q="0.0" ID="CMP-003.10" LOG_CI_END="-0.145762206773618" LOG_CI_START="-0.20534723120009668" LOG_EFFECT_SIZE="-0.17555471898685734" METHOD="MH" MODIFIED="2008-05-07 17:05:35 +0200" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.00355133304021793" P_Q="0.0" P_Z="7.447455862613349E-31" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1036" TOTAL_2="1034" WEIGHT="200.0" Z="11.54924177147392">
<NAME>Worst case-best case</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="19.25911389990456" CI_END="0.7582779118512685" CI_START="0.6244290831232612" DF="7.0" EFFECT_SIZE="0.6881066641516478" ESTIMABLE="YES" EVENTS_1="260" EVENTS_2="377" I2="63.65357182899942" ID="CMP-003.10.01" LOG_CI_END="-0.12017159454861309" LOG_CI_START="-0.20451687763747914" LOG_EFFECT_SIZE="-0.16234423609304613" MODIFIED="2008-05-07 17:05:28 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.007413257424901176" P_Z="4.5259411189331186E-14" STUDIES="8" TAU2="0.0" TOTAL_1="518" TOTAL_2="517" WEIGHT="99.99999999999999" Z="7.544911681778216">
<NAME>Worst case</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="330" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.823653158022582"/>
<DICH_DATA CI_END="4.26383930774742" CI_START="0.6256750278863489" EFFECT_SIZE="1.6333333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6298008289749847" LOG_CI_START="-0.20365117835728228" LOG_EFFECT_SIZE="0.21307482530885122" ORDER="331" O_E="0.0" SE="0.4895738347609476" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="0.23968253968253966" WEIGHT="1.222283153164093"/>
<DICH_DATA CI_END="1.5224968954839477" CI_START="0.7984565379862885" EFFECT_SIZE="1.1025641025641026" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="26" LOG_CI_END="0.18255641573803932" LOG_CI_START="-0.09774871863186466" LOG_EFFECT_SIZE="0.042403848553087355" ORDER="332" O_E="0.0" SE="0.16465262346167459" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="42" TOTAL_2="43" VAR="0.027110486412811996" WEIGHT="6.804522212673516"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="333" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="16.08584989225831"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="334" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.600564074092052"/>
<DICH_DATA CI_END="0.7436775618077197" CI_START="0.3033908935635416" EFFECT_SIZE="0.475" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="40" LOG_CI_END="-0.12861532182043495" LOG_CI_START="-0.5179974589298318" LOG_EFFECT_SIZE="-0.3233063903751334" ORDER="335" O_E="0.0" SE="0.22872499481072436" STUDY_ID="STD-Zinzani-1997" TOTAL_1="79" TOTAL_2="79" VAR="0.052315123251165885" WEIGHT="10.593120660755472"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="336" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="24.268581064994184"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="337" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="28.601425784039776"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.262261202054354" CI_END="0.7136365764913786" CI_START="0.5878576167609311" DF="7.0" EFFECT_SIZE="0.6477010862192928" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="393" I2="50.91942363955786" ID="CMP-003.10.02" LOG_CI_END="-0.1465228988767698" LOG_CI_START="-0.23072785035757923" LOG_EFFECT_SIZE="-0.1886253746171745" MODIFIED="2008-05-07 17:05:35 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.046708694508064474" P_Z="1.6212677191706336E-18" STUDIES="8" TAU2="0.0" TOTAL_1="518" TOTAL_2="517" WEIGHT="100.00000000000003" Z="8.780931152351371">
<NAME>Best case</NAME>
<DICH_DATA CI_END="1.1463945673331275" CI_START="0.4443531833377977" EFFECT_SIZE="0.7137254901960784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.05933411930935507" LOG_CI_START="-0.3522717042071158" LOG_EFFECT_SIZE="-0.14646879244888036" ORDER="338" O_E="0.0" SE="0.24177929821526145" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.058457229045464326" WEIGHT="4.630350111285054"/>
<DICH_DATA CI_END="2.6953786257973107" CI_START="0.50497955948897" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4306197801144669" LOG_CI_START="-0.2967262008532404" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="339" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="0.18253968253968253" WEIGHT="1.6426219399309876"/>
<DICH_DATA CI_END="1.0144848406942204" CI_START="0.5464964840567295" EFFECT_SIZE="0.7445887445887446" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="33" LOG_CI_END="0.006245561815852472" LOG_CI_START="-0.26241262778504326" LOG_EFFECT_SIZE="-0.1280835329845954" ORDER="340" O_E="0.0" SE="0.15781115045105268" STUDY_ID="STD-Fridrik-1997_x002a_" TOTAL_1="42" TOTAL_2="43" VAR="0.02490435920668478" WEIGHT="8.290409555651689"/>
<DICH_DATA CI_END="0.8904938323723772" CI_START="0.5489790404249296" EFFECT_SIZE="0.6991869918699187" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="60" LOG_CI_END="-0.05036908414674435" LOG_CI_START="-0.2604442362449161" LOG_EFFECT_SIZE="-0.1554066601958302" ORDER="341" O_E="0.0" SE="0.12339918423124005" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.015227358668935521" WEIGHT="15.44122564344297"/>
<DICH_DATA CI_END="0.7211855122822195" CI_START="0.2704488560780151" EFFECT_SIZE="0.4416376306620209" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.14195300629667612" LOG_CI_START="-0.5679148511605614" LOG_EFFECT_SIZE="-0.3549339287286188" ORDER="342" O_E="0.0" SE="0.2502120962181844" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.06260609309389797" WEIGHT="7.295979116526802"/>
<DICH_DATA CI_END="0.5975475244828155" CI_START="0.24545780305474463" EFFECT_SIZE="0.3829787234042553" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="47" LOG_CI_END="-0.22362754845537383" LOG_CI_START="-0.6100231572094489" LOG_EFFECT_SIZE="-0.4168253528324114" ORDER="343" O_E="0.0" SE="0.22697069327125446" STUDY_ID="STD-Zinzani-1997" TOTAL_1="79" TOTAL_2="79" VAR="0.05151569560403388" WEIGHT="11.948119110688493"/>
<DICH_DATA CI_END="0.7474588632443182" CI_START="0.514335844691191" EFFECT_SIZE="0.6200361971681039" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="93" LOG_CI_END="-0.12641270395016044" LOG_CI_START="-0.2887532081130334" LOG_EFFECT_SIZE="-0.20758295603159693" ORDER="344" O_E="0.0" SE="0.09535961574372745" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.009093456314791352" WEIGHT="23.296042097913237"/>
<DICH_DATA CI_END="0.8595353299719214" CI_START="0.6383645044713468" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="108" LOG_CI_END="-0.06573626755574401" LOG_CI_START="-0.19493126943426828" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="345" O_E="0.0" SE="0.0758897836290186" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.005759259259259259" WEIGHT="27.45525242456079"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-06-17 11:00:43 +0200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Sensitivity analysis: Febrile Neutropenia</NAME>
<DICH_OUTCOME CHI2="4.310952770773221" CI_END="0.8910111023231735" CI_START="0.6161614209274159" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7409498409943481" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="109" I2="7.213086927821935" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-0.05011688446183397" LOG_CI_START="-0.2103054971954022" LOG_EFFECT_SIZE="-0.13021119082861807" METHOD="MH" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.36555566653802063" P_Q="0.0" P_Z="0.0014407550702280943" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="176" WEIGHT="100.0" Z="3.186359380396625">
<NAME>HD versus NHL</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.2431800836969424" CI_END="1.5225386646668229" CI_START="0.32993157413019014" DF="1.0" EFFECT_SIZE="0.7087549494060712" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" I2="55.42043158871493" ID="CMP-004.01.01" LOG_CI_END="0.18256833029554062" LOG_CI_START="-0.4815761209070462" LOG_EFFECT_SIZE="-0.14950389530575284" NO="1" P_CHI2="0.1342048228245145" P_Z="0.3775577477018027" STUDIES="2" TAU2="0.0" TOTAL_1="23" TOTAL_2="21" WEIGHT="8.466319698370356" Z="0.8824051750101594">
<NAME>Hodgkin's disease</NAME>
<DICH_DATA CI_END="1.749874535124143" CI_START="0.030012072326879892" EFFECT_SIZE="0.22916666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.24300691116822978" LOG_CI_START="-1.522704015602954" LOG_EFFECT_SIZE="-0.6398485522173621" ORDER="346" O_E="0.0" SE="1.0371873387954444" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="12" TOTAL_2="11" VAR="1.075757575757576" WEIGHT="3.7545315688329604"/>
<DICH_DATA CI_END="2.4810848918153625" CI_START="0.47966220283471966" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.3946416241739553" LOG_CI_START="-0.3190645023951558" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="347" O_E="0.0" SE="0.4192345116490003" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="11" TOTAL_2="10" VAR="0.17575757575757575" WEIGHT="4.711788129537396"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.1363321413800955" CI_END="0.89856724361834" CI_START="0.615900915396588" DF="2.0" EFFECT_SIZE="0.7439276765183054" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="100" I2="6.3815985697815405" ID="CMP-004.01.02" LOG_CI_END="-0.04644941723096891" LOG_CI_START="-0.2104891504293244" LOG_EFFECT_SIZE="-0.12846928383014666" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3436383505859849" P_Z="0.0021410964276290592" STUDIES="3" TAU2="0.0" TOTAL_1="161" TOTAL_2="155" WEIGHT="91.53368030162964" Z="3.069929028990468">
<NAME>Non-Hodgkin's lymphoma</NAME>
<DICH_DATA CI_END="1.1478799304301746" CI_START="0.4538817507736251" EFFECT_SIZE="0.7218045112781954" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.05989646273201818" LOG_CI_START="-0.343057278587053" LOG_EFFECT_SIZE="-0.1415804079275174" ORDER="348" O_E="0.0" SE="0.23669702230401132" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.05602548036758563" WEIGHT="19.400527143682478"/>
<DICH_DATA CI_END="1.0018237358138429" CI_START="0.6683196961138663" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" ORDER="349" O_E="0.0" SE="0.10326993530362182" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.010664679537614234" WEIGHT="56.4589616006656"/>
<DICH_DATA CI_END="0.9927055724696962" CI_START="0.25546312294926343" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.003179540237894515" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" ORDER="350" O_E="0.0" SE="0.34627066144767615" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.11990337097941117" WEIGHT="15.67419155728156"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.310952770773218" CI_END="0.8910111023231736" CI_START="0.616161420927416" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7409498409943482" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="109" I2="7.213086927821878" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-0.05011688446183391" LOG_CI_START="-0.21030549719540215" LOG_EFFECT_SIZE="-0.130211190828618" METHOD="MH" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3655556665380211" P_Q="0.0" P_Z="0.0014407550702281015" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="176" WEIGHT="100.0" Z="3.1863593803966235">
<NAME>Use of antibiotic prophylaxis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.3119207746807344" CI_END="0.9464166567546729" CI_START="0.6512300965964971" DF="3.0" EFFECT_SIZE="0.7850700674454985" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="92" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="-0.02391762481188585" LOG_CI_START="-0.18626553673718294" LOG_EFFECT_SIZE="-0.1050915807745344" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5102411851344024" P_Z="0.01116599424545129" STUDIES="4" TAU2="0.0" TOTAL_1="143" TOTAL_2="137" WEIGHT="84.32580844271844" Z="2.5374605802290477">
<NAME>No antibiotic prophylaxis given</NAME>
<DICH_DATA CI_END="1.749874535124143" CI_START="0.030012072326879892" EFFECT_SIZE="0.22916666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.24300691116822978" LOG_CI_START="-1.522704015602954" LOG_EFFECT_SIZE="-0.6398485522173621" ORDER="351" O_E="0.0" SE="1.0371873387954444" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="12" TOTAL_2="11" VAR="1.075757575757576" WEIGHT="3.7545315688329604"/>
<DICH_DATA CI_END="2.4810848918153625" CI_START="0.47966220283471966" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.3946416241739553" LOG_CI_START="-0.3190645023951558" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="352" O_E="0.0" SE="0.4192345116490003" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="11" TOTAL_2="10" VAR="0.17575757575757575" WEIGHT="4.711788129537396"/>
<DICH_DATA CI_END="1.1478799304301746" CI_START="0.4538817507736251" EFFECT_SIZE="0.7218045112781954" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.05989646273201818" LOG_CI_START="-0.343057278587053" LOG_EFFECT_SIZE="-0.1415804079275174" ORDER="353" O_E="0.0" SE="0.23669702230401132" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.05602548036758563" WEIGHT="19.400527143682478"/>
<DICH_DATA CI_END="1.0018237358138429" CI_START="0.6683196961138663" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" ORDER="354" O_E="0.0" SE="0.10326993530362182" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.010664679537614234" WEIGHT="56.4589616006656"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.992705572469696" CI_START="0.25546312294926343" DF="0.0" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" I2="0.0" ID="CMP-004.02.02" LOG_CI_END="-0.0031795402378945637" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" MODIFIED="2008-04-23 15:54:35 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.04757928970158743" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="15.67419155728156" Z="1.981106872949204">
<NAME>Antibiotic prophylaxis given</NAME>
<DICH_DATA CI_END="0.9927055724696962" CI_START="0.25546312294926343" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.003179540237894515" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" ORDER="355" O_E="0.0" SE="0.34627066144767615" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.11990337097941117" WEIGHT="15.67419155728156"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.310952770773219" CI_END="0.8910111023231736" CI_START="0.616161420927416" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7409498409943482" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="109" I2="7.213086927821897" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-0.05011688446183391" LOG_CI_START="-0.21030549719540215" LOG_EFFECT_SIZE="-0.130211190828618" METHOD="MH" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.3655556665380211" P_Q="0.0" P_Z="0.0014407550702281015" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="176" WEIGHT="100.0" Z="3.1863593803966235">
<NAME>Blinded versus open label studies</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.992705572469696" CI_START="0.25546312294926343" DF="0.0" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="-0.0031795402378945637" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" NO="1" P_CHI2="1.0" P_Z="0.04757928970158743" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="15.67419155728156" Z="1.981106872949204">
<NAME>placebo controlled studies</NAME>
<DICH_DATA CI_END="0.9927055724696962" CI_START="0.25546312294926343" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.003179540237894515" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" ORDER="356" O_E="0.0" SE="0.34627066144767615" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.11990337097941117" WEIGHT="15.67419155728156"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.3119207746807344" CI_END="0.9464166567546729" CI_START="0.6512300965964971" DF="3.0" EFFECT_SIZE="0.7850700674454985" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="92" I2="0.0" ID="CMP-004.03.02" LOG_CI_END="-0.02391762481188585" LOG_CI_START="-0.18626553673718294" LOG_EFFECT_SIZE="-0.1050915807745344" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5102411851344024" P_Z="0.01116599424545129" STUDIES="4" TAU2="0.0" TOTAL_1="143" TOTAL_2="137" WEIGHT="84.32580844271844" Z="2.5374605802290477">
<NAME>open label studies</NAME>
<DICH_DATA CI_END="1.749874535124143" CI_START="0.030012072326879892" EFFECT_SIZE="0.22916666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.24300691116822978" LOG_CI_START="-1.522704015602954" LOG_EFFECT_SIZE="-0.6398485522173621" ORDER="357" O_E="0.0" SE="1.0371873387954444" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="12" TOTAL_2="11" VAR="1.075757575757576" WEIGHT="3.7545315688329604"/>
<DICH_DATA CI_END="2.4810848918153625" CI_START="0.47966220283471966" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.3946416241739553" LOG_CI_START="-0.3190645023951558" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="358" O_E="0.0" SE="0.4192345116490003" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="11" TOTAL_2="10" VAR="0.17575757575757575" WEIGHT="4.711788129537396"/>
<DICH_DATA CI_END="1.1478799304301746" CI_START="0.4538817507736251" EFFECT_SIZE="0.7218045112781954" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.05989646273201818" LOG_CI_START="-0.343057278587053" LOG_EFFECT_SIZE="-0.1415804079275174" ORDER="359" O_E="0.0" SE="0.23669702230401132" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.05602548036758563" WEIGHT="19.400527143682478"/>
<DICH_DATA CI_END="1.0018237358138429" CI_START="0.6683196961138663" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" ORDER="360" O_E="0.0" SE="0.10326993530362182" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.010664679537614234" WEIGHT="56.4589616006656"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.310952770773221" CI_END="0.8910111023231735" CI_START="0.6161614209274159" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7409498409943481" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="109" I2="7.213086927821935" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-0.05011688446183397" LOG_CI_START="-0.2103054971954022" LOG_EFFECT_SIZE="-0.13021119082861807" METHOD="MH" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.36555566653802063" P_Q="0.0" P_Z="0.0014407550702280943" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="176" WEIGHT="100.0" Z="3.186359380396625">
<NAME>Concealed versus unclear method of allocation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.3119207746807353" CI_END="0.9464166567546728" CI_START="0.651230096596497" DF="3.0" EFFECT_SIZE="0.7850700674454983" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="92" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="-0.023917624811885897" LOG_CI_START="-0.18626553673718302" LOG_EFFECT_SIZE="-0.10509158077453445" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5102411851344022" P_Z="0.011165994245451262" STUDIES="4" TAU2="0.0" TOTAL_1="143" TOTAL_2="137" WEIGHT="84.32580844271844" Z="2.5374605802290486">
<NAME>allocation concealed</NAME>
<DICH_DATA CI_END="1.749874535124143" CI_START="0.030012072326879892" EFFECT_SIZE="0.22916666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.24300691116822978" LOG_CI_START="-1.522704015602954" LOG_EFFECT_SIZE="-0.6398485522173621" ORDER="361" O_E="0.0" SE="1.0371873387954444" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="12" TOTAL_2="11" VAR="1.075757575757576" WEIGHT="3.7545315688329604"/>
<DICH_DATA CI_END="2.4810848918153625" CI_START="0.47966220283471966" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.3946416241739553" LOG_CI_START="-0.3190645023951558" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="362" O_E="0.0" SE="0.4192345116490003" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="11" TOTAL_2="10" VAR="0.17575757575757575" WEIGHT="4.711788129537396"/>
<DICH_DATA CI_END="1.1478799304301746" CI_START="0.4538817507736251" EFFECT_SIZE="0.7218045112781954" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.05989646273201818" LOG_CI_START="-0.343057278587053" LOG_EFFECT_SIZE="-0.1415804079275174" ORDER="363" O_E="0.0" SE="0.23669702230401132" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.05602548036758563" WEIGHT="19.400527143682478"/>
<DICH_DATA CI_END="1.0018237358138429" CI_START="0.6683196961138663" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" ORDER="364" O_E="0.0" SE="0.10326993530362182" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.010664679537614234" WEIGHT="56.4589616006656"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.992705572469696" CI_START="0.25546312294926343" DF="0.0" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" I2="0.0" ID="CMP-004.04.02" LOG_CI_END="-0.0031795402378945637" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" NO="2" P_CHI2="1.0" P_Z="0.04757928970158743" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="15.67419155728156" Z="1.981106872949204">
<NAME>method of allocation unclear</NAME>
<DICH_DATA CI_END="0.9927055724696962" CI_START="0.25546312294926343" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.003179540237894515" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" ORDER="365" O_E="0.0" SE="0.34627066144767615" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.11990337097941117" WEIGHT="15.67419155728156"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.9533855304535357" CI_END="0.9301006964991904" CI_START="0.6564674304804055" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7813967073893126" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="109" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="-0.03147003040675193" LOG_CI_START="-0.1827868158250983" LOG_EFFECT_SIZE="-0.10712842311592512" METHOD="IV" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.412351371265515" P_Q="0.3806978218649971" P_Z="0.005516624657461359" Q="0.7684474244142536" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="184" TOTAL_2="176" WEIGHT="200.0" Z="2.775208982232633">
<NAME>Size of study</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.184938106039282" CI_END="0.9644325401752627" CI_START="0.4864710486750559" DF="3.0" EFFECT_SIZE="0.6849587645949266" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="47" I2="5.806646781882583" ID="CMP-004.05.01" LOG_CI_END="-0.01572814485187832" LOG_CI_START="-0.3129430007703459" LOG_EFFECT_SIZE="-0.16433557281111213" NO="1" P_CHI2="0.36398086499883997" P_Z="0.03020433409221397" STUDIES="4" TAU2="0.0" TOTAL_1="102" TOTAL_2="96" WEIGHT="100.0" Z="2.167400435575106">
<NAME>Study size &lt;100 patients</NAME>
<DICH_DATA CI_END="1.749874535124143" CI_START="0.030012072326879892" EFFECT_SIZE="0.22916666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.24300691116822978" LOG_CI_START="-1.522704015602954" LOG_EFFECT_SIZE="-0.6398485522173621" ORDER="366" O_E="0.0" SE="1.0371873387954444" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="12" TOTAL_2="11" VAR="1.075757575757576" WEIGHT="2.8333603849986817"/>
<DICH_DATA CI_END="2.4810848918153625" CI_START="0.47966220283471966" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.3946416241739553" LOG_CI_START="-0.3190645023951558" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="367" O_E="0.0" SE="0.4192345116490003" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="11" TOTAL_2="10" VAR="0.17575757575757575" WEIGHT="17.342119597836763"/>
<DICH_DATA CI_END="1.1478799304301746" CI_START="0.4538817507736251" EFFECT_SIZE="0.7218045112781954" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.05989646273201818" LOG_CI_START="-0.343057278587053" LOG_EFFECT_SIZE="-0.1415804079275174" ORDER="368" O_E="0.0" SE="0.23669702230401132" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.05602548036758563" WEIGHT="54.40397617326284"/>
<DICH_DATA CI_END="0.9927055724696962" CI_START="0.25546312294926343" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.003179540237894515" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" ORDER="369" O_E="0.0" SE="0.34627066144767615" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.11990337097941117" WEIGHT="25.42054384390171"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0018237358138429" CI_START="0.6683196961138663" DF="0.0" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" I2="0.0" ID="CMP-004.05.02" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.05209835184452936" STUDIES="1" TAU2="0.0" TOTAL_1="82" TOTAL_2="80" WEIGHT="100.0" Z="1.9423201773517622">
<NAME>Study size &gt;100 patients</NAME>
<DICH_DATA CI_END="1.0018237358138429" CI_START="0.6683196961138663" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" ORDER="370" O_E="0.0" SE="0.10326993530362182" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.010664679537614234" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.524732442107688" CI_END="0.8550620875060393" CI_START="0.6612234532007327" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7519222740428497" ESTIMABLE="YES" EVENTS_1="176" EVENTS_2="230" I2="33.45524550282753" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="-0.06800234926915605" LOG_CI_START="-0.17965175066166006" LOG_EFFECT_SIZE="-0.12382704996540805" METHOD="MH" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.14026424881737132" P_Q="0.0" P_Z="1.3771300207528022E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="384" TOTAL_2="376" WEIGHT="200.0" Z="4.347476210657693">
<NAME>Worst case-best case</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.762999161939834" CI_END="0.9941515943828043" CI_START="0.6914751149122277" DF="4.0" EFFECT_SIZE="0.8291146410274178" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="109" I2="40.85464297392167" ID="CMP-004.06.01" LOG_CI_END="-0.0025473866448415786" LOG_CI_START="-0.16022344483994963" LOG_EFFECT_SIZE="-0.0813854157423956" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.14895548644141965" P_Z="0.04304288110273928" STUDIES="5" TAU2="0.0" TOTAL_1="192" TOTAL_2="188" WEIGHT="100.00000000000001" Z="2.0232936508919335">
<NAME>Worst case</NAME>
<DICH_DATA CI_END="2.07915142858136" CI_START="0.10245417844559572" EFFECT_SIZE="0.46153846153846156" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3178861209824303" LOG_CI_START="-0.9894703248288166" LOG_EFFECT_SIZE="-0.3357921019231931" ORDER="371" O_E="0.0" SE="0.7679476477883045" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.5897435897435898" WEIGHT="3.7782675282807614"/>
<DICH_DATA CI_END="4.021841286566116" CI_START="0.8056011585594769" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.6044249280885258" LOG_CI_START="-0.0938799178819136" LOG_EFFECT_SIZE="0.25527250510330607" ORDER="372" O_E="0.0" SE="0.410187723187772" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="14" TOTAL_2="14" VAR="0.16825396825396827" WEIGHT="4.541186933029761"/>
<DICH_DATA CI_END="1.5150093611147497" CI_START="0.6275443385589471" EFFECT_SIZE="0.9750566893424036" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="21" LOG_CI_END="0.18041531631549879" LOG_CI_START="-0.20235558409200283" LOG_EFFECT_SIZE="-0.010970133888252007" ORDER="373" O_E="0.0" SE="0.2248415216458816" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="0.05055370985603544" WEIGHT="18.848597058504705"/>
<DICH_DATA CI_END="1.0018237358138429" CI_START="0.6683196961138663" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" ORDER="374" O_E="0.0" SE="0.10326993530362182" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.010664679537614234" WEIGHT="57.00591201857606"/>
<DICH_DATA CI_END="0.9927055724696962" CI_START="0.25546312294926343" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.003179540237894515" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" ORDER="375" O_E="0.0" SE="0.34627066144767615" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.11990337097941117" WEIGHT="15.826036461608718"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.97522921086161" CI_END="0.8188651686494863" CI_START="0.5684970087828" DF="4.0" EFFECT_SIZE="0.6822920188406545" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="121" I2="33.056961350889964" ID="CMP-004.06.02" LOG_CI_END="-0.08678760169758132" LOG_CI_START="-0.24527181606427062" LOG_EFFECT_SIZE="-0.16602970888092594" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.20100594141065764" P_Z="4.0159995868551665E-5" STUDIES="5" TAU2="0.0" TOTAL_1="192" TOTAL_2="188" WEIGHT="100.0" Z="4.106557250141892">
<NAME>Best case</NAME>
<DICH_DATA CI_END="1.3621330463878576" CI_START="0.02502166754346663" EFFECT_SIZE="0.18461538461538463" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.13421952937566217" LOG_CI_START="-1.6016837505661239" LOG_EFFECT_SIZE="-0.7337321105952308" ORDER="376" O_E="0.0" SE="1.0196781794976246" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="1.0397435897435898" WEIGHT="4.2601642897695875"/>
<DICH_DATA CI_END="1.3695194772973411" CI_START="0.324525829542437" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.13656821316727574" LOG_CI_START="-0.48875073127863833" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="377" O_E="0.0" SE="0.3673154433462265" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="14" TOTAL_2="14" VAR="0.13492063492063494" WEIGHT="7.373361270755055"/>
<DICH_DATA CI_END="0.9113600582533748" CI_START="0.37555387025765047" EFFECT_SIZE="0.5850340136054422" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="28" LOG_CI_END="-0.04031000895553329" LOG_CI_START="-0.42532775805368345" LOG_EFFECT_SIZE="-0.2328188835046084" ORDER="378" O_E="0.0" SE="0.22616133168884892" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="0.05114894795127353" WEIGHT="22.669471514792015"/>
<DICH_DATA CI_END="1.0018237358138429" CI_START="0.6683196961138663" EFFECT_SIZE="0.8182533438237608" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="62" LOG_CI_END="7.913170429134164E-4" LOG_CI_START="-0.17501573955336905" LOG_EFFECT_SIZE="-0.08711221125522782" ORDER="379" O_E="0.0" SE="0.10326993530362182" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.010664679537614234" WEIGHT="51.42135624213813"/>
<DICH_DATA CI_END="0.9927055724696962" CI_START="0.25546312294926343" EFFECT_SIZE="0.503586800573888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.003179540237894515" LOG_CI_START="-0.5926717830264763" LOG_EFFECT_SIZE="-0.29792566163218537" ORDER="380" O_E="0.0" SE="0.34627066144767615" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.11990337097941117" WEIGHT="14.275646682545204"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-06-17 11:00:41 +0200" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Sensitivity analysis: Infection</NAME>
<DICH_OUTCOME CHI2="12.018357383096891" CI_END="0.8465455557402951" CI_START="0.6387390577619708" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.735337820750531" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.79395377221509" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-0.0723496659374697" LOG_CI_START="-0.1946765266917515" LOG_EFFECT_SIZE="-0.1335130963146106" METHOD="MH" NO="1" P_CHI2="0.28382989113666146" P_Q="0.0" P_Z="1.8825203432925843E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="100.0" Z="4.278387569623048">
<NAME>G-CSF versus GM-CSF</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.09339473288999521" CI_END="1.091962082429803" CI_START="0.5190494968597626" DF="1.0" EFFECT_SIZE="0.7528494998836939" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="42" I2="0.0" ID="CMP-005.01.01" LOG_CI_END="0.03820755807805053" LOG_CI_START="-0.284791225604166" LOG_EFFECT_SIZE="-0.12329183376305773" NO="1" P_CHI2="0.7599050371883411" P_Z="0.13458192447516965" STUDIES="2" TAU2="0.0" TOTAL_1="117" TOTAL_2="111" WEIGHT="15.933537764130438" Z="1.496275317254683">
<NAME>GM-CSF</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="381" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951462"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="382" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135291"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.006964965718087" CI_END="0.8521296801141742" CI_START="0.6288379043244636" DF="8.0" EFFECT_SIZE="0.7320187444701624" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="223" I2="33.372005141671096" ID="CMP-005.01.02" LOG_CI_END="-0.06949430773055187" LOG_CI_START="-0.20146128830640686" LOG_EFFECT_SIZE="-0.13547779801847937" NO="2" P_CHI2="0.15089349514945927" P_Z="5.7166214582546706E-5" STUDIES="9" TAU2="0.0" TOTAL_1="540" TOTAL_2="524" WEIGHT="84.06646223586957" Z="4.024212779019871">
<NAME>G-CSF</NAME>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="383" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.31978166574582"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="384" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.949904463987919"/>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="385" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.018240590620266"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="386" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737183"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="387" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.8397271305396887"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="388" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633915"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="389" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.9058287736211303"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="390" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311166"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="391" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135945"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.018357383096896" CI_END="0.8465455557402948" CI_START="0.6387390577619707" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7353378207505308" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.793953772215126" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-0.07234966593746989" LOG_CI_START="-0.19467652669175162" LOG_EFFECT_SIZE="-0.13351309631461072" METHOD="MH" NO="2" P_CHI2="0.2838298911366611" P_Q="0.0" P_Z="1.8825203432925562E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="99.99999999999999" Z="4.278387569623051">
<NAME>HD versus NHL</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.509278570987199" CI_END="1.3744925667456922" CI_START="0.6085823715435219" DF="2.0" EFFECT_SIZE="0.9145993362883202" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" I2="0.0" ID="CMP-005.02.01" LOG_CI_END="0.1381423955217517" LOG_CI_START="-0.21568063175480615" LOG_EFFECT_SIZE="-0.03876911811652723" NO="1" P_CHI2="0.7751960830302781" P_Z="0.6675487838835019" STUDIES="3" TAU2="0.0" TOTAL_1="55" TOTAL_2="48" WEIGHT="8.32426406680855" Z="0.4295145842013268">
<NAME>Hodgkin's disease</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="392" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951454"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="393" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737174"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="394" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.839727130539688"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.074581131553748" CI_END="0.8351330830714281" CI_START="0.6191207737523294" DF="7.0" EFFECT_SIZE="0.7190606654360611" ESTIMABLE="YES" EVENTS_1="179" EVENTS_2="244" I2="30.518203103492915" ID="CMP-005.02.02" LOG_CI_END="-0.07824431177609102" LOG_CI_START="-0.20822462358418084" LOG_EFFECT_SIZE="-0.14323446768013592" NO="2" P_CHI2="0.184386464459391" P_Z="1.5628044041331986E-5" STUDIES="8" TAU2="0.0" TOTAL_1="602" TOTAL_2="587" WEIGHT="91.67573593319143" Z="4.319644938416901">
<NAME>Non-Hodgkin's lymphoma</NAME>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="395" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.319781665745817"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="396" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.9499044639879175"/>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="397" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.01824059062026"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="398" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633913"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="399" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135288"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="400" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.90582877362113"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="401" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311164"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="402" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135943"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.018357383096895" CI_END="0.846545555740295" CI_START="0.6387390577619707" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7353378207505309" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.793953772215115" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="-0.07234966593746976" LOG_CI_START="-0.19467652669175162" LOG_EFFECT_SIZE="-0.13351309631461067" METHOD="MH" NO="3" P_CHI2="0.2838298911366611" P_Q="0.0" P_Z="1.88252034329257E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="100.0" Z="4.27838756962305">
<NAME>Age</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.110788500772295" CI_END="0.9783596161135767" CI_START="0.6881062965256304" DF="8.0" EFFECT_SIZE="0.8204970518619495" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="148" I2="0.0" ID="CMP-005.03.01" LOG_CI_END="-0.009501482035748882" LOG_CI_START="-0.16234446811811104" LOG_EFFECT_SIZE="-0.08592297507692995" NO="1" P_CHI2="0.7456720440823126" P_Z="0.027549231934049935" STUDIES="9" TAU2="0.0" TOTAL_1="363" TOTAL_2="347" WEIGHT="56.216541577243795" Z="2.2036462504673504">
<NAME>Adults, all ages</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="403" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951462"/>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="404" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.31978166574582"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="405" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.949904463987919"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="406" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737183"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="407" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.8397271305396887"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="408" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633915"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="409" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135291"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="410" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.9058287736211303"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="411" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311166"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.437132654371362" CI_END="0.7908231470230771" CI_START="0.4955231189198796" DF="1.0" EFFECT_SIZE="0.6259961280446626" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="117" I2="70.90598180060944" ID="CMP-005.03.02" LOG_CI_END="-0.10192062757627675" LOG_CI_START="-0.30493607844387877" LOG_EFFECT_SIZE="-0.20342835301007775" NO="2" P_CHI2="0.06374633882420866" P_Z="8.569064745128536E-5" STUDIES="2" TAU2="0.0" TOTAL_1="294" TOTAL_2="288" WEIGHT="43.78345842275621" Z="3.9279004985100943">
<NAME>Adults, age older 60</NAME>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="412" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.018240590620266"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="413" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135945"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.018357383096893" CI_END="0.846545555740295" CI_START="0.6387390577619707" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7353378207505309" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.7939537722151" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="-0.07234966593746976" LOG_CI_START="-0.19467652669175162" LOG_EFFECT_SIZE="-0.13351309631461067" METHOD="MH" NO="4" P_CHI2="0.28382989113666124" P_Q="0.0" P_Z="1.88252034329257E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="100.0" Z="4.27838756962305">
<NAME>Use of antibiotic prophylaxis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.314013373084356" CI_END="0.8691201988393469" CI_START="0.6530421157784789" DF="8.0" EFFECT_SIZE="0.7533738072934707" ESTIMABLE="YES" EVENTS_1="190" EVENTS_2="245" I2="0.0" ID="CMP-005.04.01" LOG_CI_END="-0.060920156712713745" LOG_CI_START="-0.18505880944409228" LOG_EFFECT_SIZE="-0.12298948307840298" NO="1" P_CHI2="0.6121027668414152" P_Z="1.0290397180206536E-4" STUDIES="9" TAU2="0.0" TOTAL_1="539" TOTAL_2="524" WEIGHT="92.32895339424293" Z="3.883640622916747">
<NAME>No antibiotic prophylaxis given</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="414" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951462"/>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="415" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.31978166574582"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="416" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.949904463987919"/>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="417" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.018240590620266"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="418" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737183"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="419" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.8397271305396887"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="420" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633915"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="421" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135291"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="422" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311166"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.8886311574651256" CI_END="1.0368794751579402" CI_START="0.2590362945131178" DF="1.0" EFFECT_SIZE="0.5182561307901907" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="20" I2="79.54437617014813" ID="CMP-005.04.02" LOG_CI_END="0.015728277781653453" LOG_CI_START="-0.5866393810830419" LOG_EFFECT_SIZE="-0.28545555165069425" NO="2" P_CHI2="0.027034242527156693" P_Z="0.06322417818057129" STUDIES="2" TAU2="0.0" TOTAL_1="118" TOTAL_2="111" WEIGHT="7.671046605757075" Z="1.8576116834587422">
<NAME>Antbiobiotic prophylaxis given</NAME>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="423" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.9058287736211303"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="424" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135945"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.018357383096895" CI_END="0.846545555740295" CI_START="0.6387390577619707" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7353378207505309" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.793953772215115" I2_Q="0.0" ID="CMP-005.05" LOG_CI_END="-0.07234966593746976" LOG_CI_START="-0.19467652669175162" LOG_EFFECT_SIZE="-0.13351309631461067" METHOD="MH" NO="5" P_CHI2="0.2838298911366611" P_Q="0.0" P_Z="1.88252034329257E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="100.0" Z="4.27838756962305">
<NAME>Blinded versus open label studies</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.016655312957781" CI_END="0.9888088777277239" CI_START="0.6505556099631465" DF="4.0" EFFECT_SIZE="0.8020443644756403" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="109" I2="0.0" ID="CMP-005.05.01" LOG_CI_END="-0.004887643053343615" LOG_CI_START="-0.18671557370980887" LOG_EFFECT_SIZE="-0.09580160838157625" NO="1" P_CHI2="0.5550421249450515" P_Z="0.038891410304665655" STUDIES="5" TAU2="0.0" TOTAL_1="259" TOTAL_2="250" WEIGHT="41.12056402917534" Z="2.065333982639411">
<NAME>Placebo controlled studies</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="425" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951462"/>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="426" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.31978166574582"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="427" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.949904463987919"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="428" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135291"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="429" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311166"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.053951124584664" CI_END="0.8330737309812275" CI_START="0.5694307790724084" DF="5.0" EFFECT_SIZE="0.6887509155401526" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="156" I2="37.918669698186854" ID="CMP-005.05.02" LOG_CI_END="-0.07931655976818579" LOG_CI_START="-0.24455906191678625" LOG_EFFECT_SIZE="-0.161937810842486" NO="2" P_CHI2="0.15328735899357016" P_Z="1.2226820669613715E-4" STUDIES="6" TAU2="0.0" TOTAL_1="398" TOTAL_2="385" WEIGHT="58.87943597082466" Z="3.84153317529779">
<NAME>Open label studies</NAME>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="430" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.018240590620266"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="431" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737183"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="432" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.8397271305396887"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="433" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633915"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="434" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.9058287736211303"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="435" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135945"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.018357383096893" CI_END="0.846545555740295" CI_START="0.6387390577619707" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7353378207505309" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.7939537722151" I2_Q="0.0" ID="CMP-005.06" LOG_CI_END="-0.07234966593746976" LOG_CI_START="-0.19467652669175162" LOG_EFFECT_SIZE="-0.13351309631461067" METHOD="MH" NO="6" P_CHI2="0.28382989113666124" P_Q="0.0" P_Z="1.88252034329257E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="100.0" Z="4.27838756962305">
<NAME>Concealed versus unclear method of allocation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.956058990612131" CI_END="0.8043931070983069" CI_START="0.5820406026355573" DF="7.0" EFFECT_SIZE="0.6842437057155784" ESTIMABLE="YES" EVENTS_1="157" EVENTS_2="222" I2="0.0" ID="CMP-005.06.01" LOG_CI_END="-0.09453165955962627" LOG_CI_START="-0.23504671829597007" LOG_EFFECT_SIZE="-0.16478918892779817" NO="1" P_CHI2="0.4334693748794849" P_Z="4.284124102186275E-6" STUDIES="8" TAU2="0.0" TOTAL_1="556" TOTAL_2="537" WEIGHT="83.82448509664513" Z="4.597099816128291">
<NAME>Allocation concealed</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="436" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951462"/>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="437" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.018240590620266"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="438" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737183"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="439" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.8397271305396887"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="440" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633915"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="441" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135291"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="442" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311166"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="443" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135945"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6272046391045591" CI_END="1.3188143855061285" CI_START="0.7584341037363143" DF="2.0" EFFECT_SIZE="1.0001168964005651" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="43" I2="0.0" ID="CMP-005.06.02" LOG_CI_END="0.12018367574125267" LOG_CI_START="-0.12008214675188424" LOG_EFFECT_SIZE="5.0764494684232376E-5" NO="2" P_CHI2="0.4432586358131875" P_Z="0.9993391754502544" STUDIES="3" TAU2="0.0" TOTAL_1="101" TOTAL_2="98" WEIGHT="16.17551490335487" Z="8.282208450793085E-4">
<NAME>Method of allocation unclear</NAME>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="444" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.31978166574582"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="445" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.949904463987919"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="446" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.9058287736211303"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.018357383096895" CI_END="0.8465455557402948" CI_START="0.6387390577619707" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7353378207505308" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.793953772215115" I2_Q="0.0" ID="CMP-005.07" LOG_CI_END="-0.07234966593746989" LOG_CI_START="-0.19467652669175162" LOG_EFFECT_SIZE="-0.13351309631461072" METHOD="MH" NO="7" P_CHI2="0.2838298911366611" P_Q="0.0" P_Z="1.8825203432925562E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="99.99999999999999" Z="4.278387569623051">
<NAME>Published and reported data versus unpublished, unreported or abstract publications only</NAME>
<GROUP_LABEL_1>G-/GM-CSF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.093524226834015" CI_END="0.9149132345382696" CI_START="0.6351596139079871" DF="3.0" EFFECT_SIZE="0.7623096069240076" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="146" I2="26.713515451202323" ID="CMP-005.07.01" LOG_CI_END="-0.038620090138973426" LOG_CI_START="-0.19711712395393063" LOG_EFFECT_SIZE="-0.11786860704645202" NO="1" P_CHI2="0.2515407894113444" P_Z="0.0035556203681738905" STUDIES="4" TAU2="0.0" TOTAL_1="307" TOTAL_2="301" WEIGHT="54.67851333534914" Z="2.9151110170132304">
<NAME>Unreported, unpublished or abstract publicated data</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="447" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951454"/>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="448" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.319781665745817"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="449" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.9499044639879175"/>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="450" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.01824059062026"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.871805034975805" CI_END="0.8758645507800993" CI_START="0.5639276990705098" DF="6.0" EFFECT_SIZE="0.702797467851761" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="119" I2="23.778600037209358" ID="CMP-005.07.02" LOG_CI_END="-0.0575630506778889" LOG_CI_START="-0.24877657315763574" LOG_EFFECT_SIZE="-0.15316981191776233" NO="2" P_CHI2="0.2476466831334856" P_Z="0.001689352607613575" STUDIES="7" TAU2="0.0" TOTAL_1="350" TOTAL_2="334" WEIGHT="45.32148666465085" Z="3.1400218037339465">
<NAME>Peer-reviewed data</NAME>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="451" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737174"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="452" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.839727130539688"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="453" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633913"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="454" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135288"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="455" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.90582877362113"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="456" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311164"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="457" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135943"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.018357383096895" CI_END="0.846545555740295" CI_START="0.6387390577619707" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7353378207505309" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="265" I2="16.793953772215115" I2_Q="0.0" ID="CMP-005.08" LOG_CI_END="-0.07234966593746976" LOG_CI_START="-0.19467652669175162" LOG_EFFECT_SIZE="-0.13351309631461067" METHOD="MH" NO="8" P_CHI2="0.2838298911366611" P_Q="0.0" P_Z="1.88252034329257E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="635" WEIGHT="100.0" Z="4.27838756962305">
<NAME>Size of study</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.9770014103642306" CI_END="1.1883608988147998" CI_START="0.637222571093943" DF="4.0" EFFECT_SIZE="0.8702013487292902" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="45" I2="0.0" ID="CMP-005.08.01" LOG_CI_END="0.07494835357563591" LOG_CI_START="-0.19570884943094935" LOG_EFFECT_SIZE="-0.060380247927656706" NO="1" P_CHI2="0.7399892430139015" P_Z="0.3818530715536915" STUDIES="5" TAU2="0.0" TOTAL_1="134" TOTAL_2="123" WEIGHT="17.486564163063598" Z="0.8744870633494801">
<NAME>Study size &lt;100 patients</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="458" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.3905866149951462"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="459" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.0939503212737183"/>
<DICH_DATA CI_END="1.8038026623281531" CI_START="0.636410627197882" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.25618902358853995" LOG_CI_START="-0.19626257683365358" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="460" O_E="0.0" SE="0.2657723097595395" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="12" TOTAL_2="10" VAR="0.07063492063492063" WEIGHT="2.8397271305396887"/>
<DICH_DATA CI_END="1.1723204403027687" CI_START="0.4156620167607935" EFFECT_SIZE="0.6980609418282548" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06904633730826704" LOG_CI_START="-0.3812596595564946" LOG_EFFECT_SIZE="-0.1561066611241138" ORDER="461" O_E="0.0" SE="0.26451197160899514" STUDY_ID="STD-Fridrik-1997" TOTAL_1="38" TOTAL_2="36" VAR="0.06996658312447786" WEIGHT="7.256471322633915"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="462" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.9058287736211303"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.01677625969772" CI_END="0.8276681880065384" CI_START="0.6035093510575003" DF="5.0" EFFECT_SIZE="0.7067570240434566" ESTIMABLE="YES" EVENTS_1="158" EVENTS_2="220" I2="44.5478089286911" ID="CMP-005.08.02" LOG_CI_END="-0.08214373688611604" LOG_CI_START="-0.21931599635170276" LOG_EFFECT_SIZE="-0.1507298666189094" NO="2" P_CHI2="0.10839702498932735" P_Z="1.6521505380837012E-5" STUDIES="6" TAU2="0.0" TOTAL_1="523" TOTAL_2="512" WEIGHT="82.51343583693641" Z="4.3073593905727545">
<NAME>Study size &gt;100 patients</NAME>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="463" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.31978166574582"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="464" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.949904463987919"/>
<DICH_DATA CI_END="0.8674126921137103" CI_START="0.5379699266193116" EFFECT_SIZE="0.683111954459203" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="102" LOG_CI_END="-0.06177422747821743" LOG_CI_START="-0.26924200141230126" LOG_EFFECT_SIZE="-0.16550811444525934" ORDER="465" O_E="0.0" SE="0.12186759739092475" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="217" TOTAL_2="216" VAR="0.014851711293836528" WEIGHT="38.018240590620266"/>
<DICH_DATA CI_END="1.0926486385213905" CI_START="0.49140700611827504" EFFECT_SIZE="0.7327586206896551" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="36" LOG_CI_END="0.03848052893647408" LOG_CI_START="-0.30855865596172566" LOG_EFFECT_SIZE="-0.13503906351262576" ORDER="466" O_E="0.0" SE="0.20385253508087323" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="87" TOTAL_2="85" VAR="0.04155585605889865" WEIGHT="13.542951149135291"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="467" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="10.917340135311166"/>
<DICH_DATA CI_END="0.7161948111072338" CI_START="0.0868140139628589" EFFECT_SIZE="0.24935064935064935" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.144968829813447" LOG_CI_START="-1.0614101631244175" LOG_EFFECT_SIZE="-0.6031894964689323" ORDER="468" O_E="0.0" SE="0.5383221756446271" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.28979076479076477" WEIGHT="5.765217832135945"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="32.52197707464307" CI_END="0.81801331160696" CI_START="0.6739416229316109" CI_STUDY="95" CI_TOTAL="95" DF="21.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7424912247320208" ESTIMABLE="YES" EVENTS_1="424" EVENTS_2="566" I2="35.428279923444734" I2_Q="0.0" ID="CMP-005.09" LOG_CI_END="-0.08723962895653876" LOG_CI_START="-0.17137772058140932" LOG_EFFECT_SIZE="-0.129308674768974" METHOD="MH" NO="9" P_CHI2="0.05179384727549752" P_Q="0.0" P_Z="1.6974844138556824E-9" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1358" TOTAL_2="1342" WEIGHT="200.0" Z="6.024390155311708">
<NAME>Worst case-best case</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.978385470879676" CI_END="0.9561385369626448" CI_START="0.7274486697591511" DF="10.0" EFFECT_SIZE="0.8339914309025824" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="265" I2="8.911924922611412" ID="CMP-005.09.01" LOG_CI_END="-0.019479177306089158" LOG_CI_START="-0.13819764595282713" LOG_EFFECT_SIZE="-0.07883841162945814" NO="1" P_CHI2="0.35920454663771806" P_Z="0.009237399625756955" STUDIES="11" TAU2="0.0" TOTAL_1="679" TOTAL_2="671" WEIGHT="100.0" Z="2.6031408449493605">
<NAME>Worst case</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="469" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.4158114214474145"/>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="470" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="8.407569692720946"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="471" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="6.0126862044913425"/>
<DICH_DATA CI_END="0.9869097450709615" CI_START="0.6240659509056691" EFFECT_SIZE="0.7847909075134478" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="102" LOG_CI_END="-0.00572256263930399" LOG_CI_START="-0.20476951191867412" LOG_EFFECT_SIZE="-0.10524603727898907" ORDER="472" O_E="0.0" SE="0.11692116330499168" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="0.013670558428592532" WEIGHT="38.07814351261935"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="473" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="3.1265968263354984"/>
<DICH_DATA CI_END="2.8375372204075036" CI_START="0.870257396922324" EFFECT_SIZE="1.5714285714285714" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.45294156694534676" LOG_CI_START="-0.060352276657410366" LOG_EFFECT_SIZE="0.1962946451439682" ORDER="474" O_E="0.0" SE="0.30151134457776363" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="14" TOTAL_2="14" VAR="0.09090909090909091" WEIGHT="2.630550214464962"/>
<DICH_DATA CI_END="1.5746321651428112" CI_START="0.5974437470647342" EFFECT_SIZE="0.9699248120300752" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="19" LOG_CI_END="0.19717911856628095" LOG_CI_START="-0.22370297990195467" LOG_EFFECT_SIZE="-0.013261930667836827" ORDER="475" O_E="0.0" SE="0.24722822804022965" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="0.06112179673991179" WEIGHT="7.056064104682488"/>
<DICH_DATA CI_END="1.2680554028877482" CI_START="0.596301759035778" EFFECT_SIZE="0.8695652173913043" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" LOG_CI_END="0.10313822881605458" LOG_CI_START="-0.22453390952327792" LOG_EFFECT_SIZE="-0.0606978403536117" ORDER="476" O_E="0.0" SE="0.19247623606376804" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="92" TOTAL_2="90" VAR="0.03704710144927536" WEIGHT="13.677209278348437"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="477" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.9259385498761332"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="478" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="11.032536878302787"/>
<DICH_DATA CI_END="0.9778750683882771" CI_START="0.16362008314999815" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.009716626373273562" LOG_CI_START="-0.7861633909708016" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="479" O_E="0.0" SE="0.45608867299805944" STUDY_ID="STD-Zinzani-1997" TOTAL_1="79" TOTAL_2="79" VAR="0.20801687763713078" WEIGHT="5.636893316710633"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="17.418215756620224" CI_END="0.7596088793110465" CI_START="0.5766973919862609" DF="10.0" EFFECT_SIZE="0.661864381598139" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="301" I2="42.588838376288614" ID="CMP-005.09.02" LOG_CI_END="-0.11940996729830058" LOG_CI_START="-0.23905201260598613" LOG_EFFECT_SIZE="-0.17923098995214337" NO="2" P_CHI2="0.06560721409819015" P_Z="4.298206772983379E-9" STUDIES="11" TAU2="0.0" TOTAL_1="679" TOTAL_2="671" WEIGHT="100.0" Z="5.872288196281703">
<NAME>Best case</NAME>
<DICH_DATA CI_END="2.36136780417904" CI_START="0.31808306600175934" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.37316363760165305" LOG_CI_START="-0.49745945109934203" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="480" O_E="0.0" SE="0.5114083119567587" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.2615384615384615" WEIGHT="2.1287301599627066"/>
<DICH_DATA CI_END="1.1740920154411603" CI_START="0.5936263797790384" EFFECT_SIZE="0.8348484848484848" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.0697021345882314" LOG_CI_START="-0.22648680796839862" LOG_EFFECT_SIZE="-0.07839233669008364" ORDER="481" O_E="0.0" SE="0.17398285101667602" STUDY_ID="STD-Bastion-ACVBP-1993" TOTAL_1="30" TOTAL_2="29" VAR="0.03027003244789088" WEIGHT="7.4084620256329226"/>
<DICH_DATA CI_END="1.7543344856697909" CI_START="0.7214274189661127" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.24411240056449737" LOG_CI_START="-0.1418073556697347" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="482" O_E="0.0" SE="0.22669117514559073" STUDY_ID="STD-Bastion-VIMMM-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.051388888888888894" WEIGHT="5.298172842573847"/>
<DICH_DATA CI_END="0.7789742272864095" CI_START="0.4883502300323436" EFFECT_SIZE="0.6167756829549826" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="115" LOG_CI_END="-0.10847691091852132" LOG_CI_START="-0.31126860337521434" LOG_EFFECT_SIZE="-0.20987275714686782" ORDER="483" O_E="0.0" SE="0.11912084398412877" STUDY_ID="STD-Bj_x00f6_rkholm-1999" TOTAL_1="226" TOTAL_2="229" VAR="0.014189775471491146" WEIGHT="37.82953631277316"/>
<DICH_DATA CI_END="1.5362495323912475" CI_START="0.42464902358009804" EFFECT_SIZE="0.8076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.18646176370252884" LOG_CI_START="-0.3719698701763262" LOG_EFFECT_SIZE="-0.09275405323689868" ORDER="484" O_E="0.0" SE="0.3280255060216089" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.1076007326007326" WEIGHT="2.7550498781384007"/>
<DICH_DATA CI_END="1.3179273512364287" CI_START="0.5079350443522402" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.11989147108749053" LOG_CI_START="-0.2941918225252908" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="485" O_E="0.0" SE="0.24323457641350904" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="14" TOTAL_2="14" VAR="0.05916305916305917" WEIGHT="3.64249382926952"/>
<DICH_DATA CI_END="0.9010033700098568" CI_START="0.3373038438939708" EFFECT_SIZE="0.5512820512820513" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" LOG_CI_END="-0.04527358463253786" LOG_CI_START="-0.47197870958924976" LOG_EFFECT_SIZE="-0.2586261471108938" ORDER="486" O_E="0.0" SE="0.2506487026240066" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="0.06282477212709771" WEIGHT="8.508242270721531"/>
<DICH_DATA CI_END="0.9508087486725559" CI_START="0.4364917201200386" EFFECT_SIZE="0.644220572640509" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="41" LOG_CI_END="-0.021906830853475757" LOG_CI_START="-0.3600239900804813" LOG_EFFECT_SIZE="-0.19096541046697857" ORDER="487" O_E="0.0" SE="0.19861169303687445" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="92" TOTAL_2="90" VAR="0.03944660461097364" WEIGHT="13.725760963041589"/>
<DICH_DATA CI_END="3.846119533528563" CI_START="0.4610996519703078" EFFECT_SIZE="1.3317073170731708" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.585022777548106" LOG_CI_START="-0.3362052055781025" LOG_EFFECT_SIZE="0.12440878598500177" ORDER="488" O_E="0.0" SE="0.5411338774403965" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="0.29282587331367815" WEIGHT="1.6970709886369355"/>
<DICH_DATA CI_END="1.0865251094407584" CI_START="0.4166549036948034" EFFECT_SIZE="0.6728343145500421" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.036039767256229344" LOG_CI_START="-0.38022350250972536" LOG_EFFECT_SIZE="-0.172091867626748" ORDER="489" O_E="0.0" SE="0.244515105196939" STUDY_ID="STD-Sou_x00ea_tre-1994" TOTAL_1="82" TOTAL_2="80" VAR="0.05978763666947015" WEIGHT="9.721493070710347"/>
<DICH_DATA CI_END="0.5035559097116991" CI_START="0.06564881992666124" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="22" LOG_CI_END="-0.2979523028040017" LOG_CI_START="-1.1827730761844861" LOG_EFFECT_SIZE="-0.7403626894942439" ORDER="490" O_E="0.0" SE="0.5197481022171634" STUDY_ID="STD-Zinzani-1997" TOTAL_1="79" TOTAL_2="79" VAR="0.2701380897583429" WEIGHT="7.28498765853904"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2008-06-17 11:00:36 +0200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Sensitivity analysis: Complete response</NAME>
<DICH_OUTCOME CHI2="9.839302371631785" CI_END="1.1018358243565556" CI_START="0.9536373959443806" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0250618743752085" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="637" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.04211688862855385" LOG_CI_START="-0.02061672684266909" LOG_EFFECT_SIZE="0.010750080892942398" METHOD="MH" MODIFIED="2008-05-26 18:27:08 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6300562541691861" P_Q="0.0" P_Z="0.5017607673410257" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1185" TOTAL_2="1183" WEIGHT="100.00000000000003" Z="0.6717218901794163">
<NAME>GM-CSF versus G-CSF</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>G-/GM-CSF</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.11668885954686037" CI_END="1.307625095350486" CI_START="0.8807029974451712" DF="1.0" EFFECT_SIZE="1.0731399447461178" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="68" I2="0.0" ID="CMP-006.01.01" LOG_CI_END="0.11648324677194002" LOG_CI_START="-0.05517052554655054" LOG_EFFECT_SIZE="0.03065636061269475" NO="1" P_CHI2="0.732653861538485" P_Z="0.4838797058494826" STUDIES="2" TAU2="0.0" TOTAL_1="117" TOTAL_2="111" WEIGHT="10.928510005077534" Z="0.7000762277041035">
<NAME>GM-CSF</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="491" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.68605847509765"/>
<DICH_DATA CI_END="1.3248988969835218" CI_START="0.8355760327580203" EFFECT_SIZE="1.0521662245800176" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="52" LOG_CI_END="0.12218273853135836" LOG_CI_START="-0.07801402559720746" LOG_EFFECT_SIZE="0.022084356467075444" ORDER="492" O_E="0.0" SE="0.11759657023908447" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="0.013828953331995929" WEIGHT="8.242451529979883"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.52374988900125" CI_END="1.1012021676828088" CI_START="0.9432357179954421" DF="10.0" EFFECT_SIZE="1.01916299839252" ESTIMABLE="YES" EVENTS_1="579" EVENTS_2="569" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="0.04186705761754745" LOG_CI_START="-0.025379761947510786" LOG_EFFECT_SIZE="0.008243647835018353" MODIFIED="2008-05-26 18:27:08 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.48322057675896657" P_Z="0.6308464394117017" STUDIES="11" TAU2="0.0" TOTAL_1="1068" TOTAL_2="1072" WEIGHT="89.07148999492249" Z="0.4805358219874223">
<NAME>G-CSF</NAME>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="493" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7907056500651002"/>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="595" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.78294960456776"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="494" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14463391788987348"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="495" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.822275558651413"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="496" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6518168566236965"/>
<DICH_DATA CI_END="3.0120035209923532" CI_START="0.6640776040572667" EFFECT_SIZE="1.4142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.4788554752134757" LOG_CI_START="-0.17778116604688957" LOG_EFFECT_SIZE="0.15053715458329311" ORDER="497" O_E="0.0" SE="0.38571161348013466" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="0.14877344877344878" WEIGHT="0.877445768531899"/>
<DICH_DATA CI_END="1.6375574636769459" CI_START="0.9432914030892016" EFFECT_SIZE="1.2428571428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="24" LOG_CI_END="0.21419654879813088" LOG_CI_START="-0.02535412358940746" LOG_EFFECT_SIZE="0.09442121260436169" ORDER="498" O_E="0.0" SE="0.14071325075539257" STUDY_ID="STD-Fridrik-1997" TOTAL_1="35" TOTAL_2="36" VAR="0.019800218938149983" WEIGHT="3.707517331824926"/>
<DICH_DATA CI_END="1.1515258924894898" CI_START="0.7602808241874472" EFFECT_SIZE="0.935672514619883" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.06127370768356176" LOG_CI_START="-0.11902596315601996" LOG_EFFECT_SIZE="-0.02887612773622908" ORDER="499" O_E="0.0" SE="0.10590891914893497" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.011216699155295645" WEIGHT="8.98661737646801"/>
<DICH_DATA CI_END="1.3386453667434657" CI_START="0.783492937268815" EFFECT_SIZE="1.0241187384044528" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.12666553917374582" LOG_CI_START="-0.10596491408882536" LOG_EFFECT_SIZE="0.010350312542460237" ORDER="500" O_E="0.0" SE="0.13664827978574973" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.018672752368404537" WEIGHT="6.801676930566063"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="501" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.418019825653364"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="502" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.087831174080383"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.839302371631788" CI_END="1.1018358243565554" CI_START="0.9536373959443804" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0250618743752082" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="637" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.04211688862855376" LOG_CI_START="-0.02061672684266919" LOG_EFFECT_SIZE="0.010750080892942304" METHOD="MH" MODIFIED="2008-05-26 18:27:34 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6300562541691859" P_Q="0.0" P_Z="0.5017607673410294" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1185" TOTAL_2="1183" WEIGHT="100.0" Z="0.6717218901794105">
<NAME>HD versus NHL</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>G-/GM-CSF</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.34890504766018804" CI_END="1.7182939632588567" CI_START="0.8852348197238191" DF="2.0" EFFECT_SIZE="1.2333262531860663" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="25" I2="0.0" ID="CMP-006.02.01" LOG_CI_END="0.23509746432646336" LOG_CI_START="-0.05294151191998485" LOG_EFFECT_SIZE="0.09107797620323925" NO="1" P_CHI2="0.839916763032396" P_Z="0.2151671002436426" STUDIES="3" TAU2="0.0" TOTAL_1="57" TOTAL_2="49" WEIGHT="4.215321100253245" Z="1.2394819303232836">
<NAME>Hodgkin's disease</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="503" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000_x002a_" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.6860584750976497"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="504" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6518168566236964"/>
<DICH_DATA CI_END="3.0120035209923532" CI_START="0.6640776040572667" EFFECT_SIZE="1.4142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.4788554752134757" LOG_CI_START="-0.17778116604688957" LOG_EFFECT_SIZE="0.15053715458329311" ORDER="505" O_E="0.0" SE="0.38571161348013466" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="0.14877344877344878" WEIGHT="0.8774457685318989"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.531293294564719" CI_END="1.0939418452876546" CI_START="0.9434191852590452" DF="9.0" EFFECT_SIZE="1.0158965126439088" ESTIMABLE="YES" EVENTS_1="620" EVENTS_2="612" I2="0.0" ID="CMP-006.02.02" LOG_CI_END="0.03899423521315522" LOG_CI_START="-0.025295296240182518" LOG_EFFECT_SIZE="0.006849469486486339" MODIFIED="2008-05-26 18:27:34 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.48161356703344826" P_Z="0.6762154991829541" STUDIES="10" TAU2="0.0" TOTAL_1="1128" TOTAL_2="1134" WEIGHT="95.78467889974675" Z="0.4176329552646725">
<NAME>Non-Hodgkin's lymphoma</NAME>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="506" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7907056500651"/>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="597" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.782949604567754"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="507" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14463391788987345"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="508" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.82227555865141"/>
<DICH_DATA CI_END="1.3248988969835218" CI_START="0.8355760327580203" EFFECT_SIZE="1.0521662245800176" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="52" LOG_CI_END="0.12218273853135836" LOG_CI_START="-0.07801402559720746" LOG_EFFECT_SIZE="0.022084356467075444" ORDER="509" O_E="0.0" SE="0.11759657023908447" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="0.013828953331995929" WEIGHT="8.242451529979881"/>
<DICH_DATA CI_END="1.6375574636769459" CI_START="0.9432914030892016" EFFECT_SIZE="1.2428571428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="24" LOG_CI_END="0.21419654879813088" LOG_CI_START="-0.02535412358940746" LOG_EFFECT_SIZE="0.09442121260436169" ORDER="510" O_E="0.0" SE="0.14071325075539257" STUDY_ID="STD-Fridrik-1997" TOTAL_1="35" TOTAL_2="36" VAR="0.019800218938149983" WEIGHT="3.707517331824925"/>
<DICH_DATA CI_END="1.1515258924894898" CI_START="0.7602808241874472" EFFECT_SIZE="0.935672514619883" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.06127370768356176" LOG_CI_START="-0.11902596315601996" LOG_EFFECT_SIZE="-0.02887612773622908" ORDER="511" O_E="0.0" SE="0.10590891914893497" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.011216699155295645" WEIGHT="8.986617376468008"/>
<DICH_DATA CI_END="1.3386453667434657" CI_START="0.783492937268815" EFFECT_SIZE="1.0241187384044528" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.12666553917374582" LOG_CI_START="-0.10596491408882536" LOG_EFFECT_SIZE="0.010350312542460237" ORDER="512" O_E="0.0" SE="0.13664827978574973" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.018672752368404537" WEIGHT="6.801676930566062"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="513" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.418019825653362"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="514" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.087831174080382"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.839302371631783" CI_END="1.1018358243565556" CI_START="0.9536373959443806" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0250618743752085" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="637" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="0.04211688862855385" LOG_CI_START="-0.02061672684266909" LOG_EFFECT_SIZE="0.010750080892942398" METHOD="MH" MODIFIED="2008-05-26 18:27:43 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6300562541691862" P_Q="0.0" P_Z="0.5017607673410257" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1185" TOTAL_2="1183" WEIGHT="100.0" Z="0.6717218901794163">
<NAME>Age</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>G-/GM-CSF</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.657608527432249" CI_END="1.251554149734421" CI_START="0.9814122530518232" DF="7.0" EFFECT_SIZE="1.1082827156945185" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="171" I2="0.0" ID="CMP-006.03.01" LOG_CI_END="0.09744964453322047" LOG_CI_START="-0.008148524101614634" LOG_EFFECT_SIZE="0.04465056021580292" NO="1" P_CHI2="0.4653782897858353" P_Z="0.09742222563087319" STUDIES="8" TAU2="0.0" TOTAL_1="298" TOTAL_2="293" WEIGHT="27.087246906481035" Z="1.6574812052875207">
<NAME>Adults, all ages</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="515" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.68605847509765"/>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="516" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7907056500651002"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="517" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14463391788987348"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="518" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6518168566236965"/>
<DICH_DATA CI_END="3.0120035209923532" CI_START="0.6640776040572667" EFFECT_SIZE="1.4142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.4788554752134757" LOG_CI_START="-0.17778116604688957" LOG_EFFECT_SIZE="0.15053715458329311" ORDER="519" O_E="0.0" SE="0.38571161348013466" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="0.14877344877344878" WEIGHT="0.877445768531899"/>
<DICH_DATA CI_END="1.3248988969835218" CI_START="0.8355760327580203" EFFECT_SIZE="1.0521662245800176" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="52" LOG_CI_END="0.12218273853135836" LOG_CI_START="-0.07801402559720746" LOG_EFFECT_SIZE="0.022084356467075444" ORDER="520" O_E="0.0" SE="0.11759657023908447" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="0.013828953331995929" WEIGHT="8.242451529979883"/>
<DICH_DATA CI_END="1.6375574636769459" CI_START="0.9432914030892016" EFFECT_SIZE="1.2428571428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="24" LOG_CI_END="0.21419654879813088" LOG_CI_START="-0.02535412358940746" LOG_EFFECT_SIZE="0.09442121260436169" ORDER="521" O_E="0.0" SE="0.14071325075539257" STUDY_ID="STD-Fridrik-1997" TOTAL_1="35" TOTAL_2="36" VAR="0.019800218938149983" WEIGHT="3.707517331824926"/>
<DICH_DATA CI_END="1.1515258924894898" CI_START="0.7602808241874472" EFFECT_SIZE="0.935672514619883" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.06127370768356176" LOG_CI_START="-0.11902596315601996" LOG_EFFECT_SIZE="-0.02887612773622908" ORDER="522" O_E="0.0" SE="0.10590891914893497" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.011216699155295645" WEIGHT="8.98661737646801"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7023995174606275" CI_END="1.086204958916181" CI_START="0.9098877440618852" DF="4.0" EFFECT_SIZE="0.9941451501954213" ESTIMABLE="YES" EVENTS_1="462" EVENTS_2="466" I2="0.0" ID="CMP-006.03.02" LOG_CI_END="0.035911781171594555" LOG_CI_START="-0.04101218475771802" LOG_EFFECT_SIZE="-0.0025502017930617324" MODIFIED="2008-05-26 18:27:43 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7902817279731" P_Z="0.8966025093830109" STUDIES="5" TAU2="0.0" TOTAL_1="887" TOTAL_2="890" WEIGHT="72.91275309351897" Z="0.1299543934670123">
<NAME>Adults, age older 60</NAME>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="598" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.78294960456776"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="523" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.822275558651413"/>
<DICH_DATA CI_END="1.3386453667434657" CI_START="0.783492937268815" EFFECT_SIZE="1.0241187384044528" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.12666553917374582" LOG_CI_START="-0.10596491408882536" LOG_EFFECT_SIZE="0.010350312542460237" ORDER="524" O_E="0.0" SE="0.13664827978574973" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.018672752368404537" WEIGHT="6.801676930566063"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="525" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.418019825653364"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="526" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.087831174080383"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.839302371631788" CI_END="1.1018358243565551" CI_START="0.9536373959443801" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.025061874375208" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="637" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="0.04211688862855367" LOG_CI_START="-0.02061672684266929" LOG_EFFECT_SIZE="0.01075008089294221" METHOD="MH" MODIFIED="2008-05-26 18:28:07 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6300562541691859" P_Q="0.0" P_Z="0.5017607673410331" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1185" TOTAL_2="1183" WEIGHT="100.0" Z="0.6717218901794045">
<NAME>Use of antibiotic prophylaxis</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>G-/GM-CSF</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="9.85005638075535" CI_END="1.114824316496966" CI_START="0.932685327489861" DF="10.0" EFFECT_SIZE="1.0196961717715887" ESTIMABLE="YES" EVENTS_1="409" EVENTS_2="396" I2="0.0" ID="CMP-006.04.01" LOG_CI_END="0.04720643295594001" LOG_CI_START="-0.03026485527350334" LOG_EFFECT_SIZE="0.008470788841218345" NO="1" P_CHI2="0.4537455667759198" P_Z="0.6682078831275312" STUDIES="11" TAU2="0.0" TOTAL_1="721" TOTAL_2="714" WEIGHT="62.415373464866185" Z="0.42860888024118077">
<NAME>No antibiotic prophylaxis given</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="527" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.6860584750976497"/>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="528" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7907056500651"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="529" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14463391788987345"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="530" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.82227555865141"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="531" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6518168566236964"/>
<DICH_DATA CI_END="3.0120035209923532" CI_START="0.6640776040572667" EFFECT_SIZE="1.4142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.4788554752134757" LOG_CI_START="-0.17778116604688957" LOG_EFFECT_SIZE="0.15053715458329311" ORDER="532" O_E="0.0" SE="0.38571161348013466" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="0.14877344877344878" WEIGHT="0.8774457685318989"/>
<DICH_DATA CI_END="1.3248988969835218" CI_START="0.8355760327580203" EFFECT_SIZE="1.0521662245800176" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="52" LOG_CI_END="0.12218273853135836" LOG_CI_START="-0.07801402559720746" LOG_EFFECT_SIZE="0.022084356467075444" ORDER="533" O_E="0.0" SE="0.11759657023908447" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="0.013828953331995929" WEIGHT="8.242451529979881"/>
<DICH_DATA CI_END="1.6375574636769459" CI_START="0.9432914030892016" EFFECT_SIZE="1.2428571428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="24" LOG_CI_END="0.21419654879813088" LOG_CI_START="-0.02535412358940746" LOG_EFFECT_SIZE="0.09442121260436169" ORDER="534" O_E="0.0" SE="0.14071325075539257" STUDY_ID="STD-Fridrik-1997" TOTAL_1="35" TOTAL_2="36" VAR="0.019800218938149983" WEIGHT="3.707517331824925"/>
<DICH_DATA CI_END="1.1515258924894898" CI_START="0.7602808241874472" EFFECT_SIZE="0.935672514619883" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.06127370768356176" LOG_CI_START="-0.11902596315601996" LOG_EFFECT_SIZE="-0.02887612773622908" ORDER="535" O_E="0.0" SE="0.10590891914893497" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.011216699155295645" WEIGHT="8.986617376468008"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="536" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.418019825653362"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="537" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.087831174080382"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.005814061167727048" CI_END="1.1685620071736715" CI_START="0.9148843732271777" DF="1.0" EFFECT_SIZE="1.0339724945617157" ESTIMABLE="YES" EVENTS_1="247" EVENTS_2="241" I2="0.0" ID="CMP-006.04.02" LOG_CI_END="0.06765176222150829" LOG_CI_START="-0.03863379035160405" LOG_EFFECT_SIZE="0.014508985934952097" MODIFIED="2008-05-26 18:28:07 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9392202112563375" P_Z="0.592575634009624" STUDIES="2" TAU2="0.0" TOTAL_1="464" TOTAL_2="469" WEIGHT="37.584626535133815" Z="0.5351073442487462">
<NAME>Antibiotic prophylaxis given</NAME>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="599" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.782949604567754"/>
<DICH_DATA CI_END="1.3386453667434657" CI_START="0.783492937268815" EFFECT_SIZE="1.0241187384044528" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.12666553917374582" LOG_CI_START="-0.10596491408882536" LOG_EFFECT_SIZE="0.010350312542460237" ORDER="538" O_E="0.0" SE="0.13664827978574973" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.018672752368404537" WEIGHT="6.801676930566062"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.839302371631788" CI_END="1.1018358243565554" CI_START="0.9536373959443804" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0250618743752082" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="637" I2="0.0" I2_Q="0.0" ID="CMP-006.05" LOG_CI_END="0.04211688862855376" LOG_CI_START="-0.02061672684266919" LOG_EFFECT_SIZE="0.010750080892942304" METHOD="MH" MODIFIED="2008-05-26 18:31:10 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6300562541691859" P_Q="0.0" P_Z="0.5017607673410294" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1185" TOTAL_2="1183" WEIGHT="100.0" Z="0.6717218901794105">
<NAME>Blinded versus open label studies</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>G-/GM-CSF</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.566114485537666" CI_END="1.201762851284627" CI_START="0.9151169794003117" DF="3.0" EFFECT_SIZE="1.0486913704341683" ESTIMABLE="YES" EVENTS_1="147" EVENTS_2="137" I2="15.874826448604953" ID="CMP-006.05.01" LOG_CI_END="0.07981877503796905" LOG_CI_START="-0.038523386522833464" LOG_EFFECT_SIZE="0.02064769425756782" NO="1" P_CHI2="0.31228814151714857" P_Z="0.49402086965822556" STUDIES="4" TAU2="0.0" TOTAL_1="218" TOTAL_2="213" WEIGHT="21.705833031610638" Z="0.6839276311145484">
<NAME>Placebo controlled studies</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="539" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.6860584750976497"/>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="540" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7907056500651"/>
<DICH_DATA CI_END="1.3248988969835218" CI_START="0.8355760327580203" EFFECT_SIZE="1.0521662245800176" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="52" LOG_CI_END="0.12218273853135836" LOG_CI_START="-0.07801402559720746" LOG_EFFECT_SIZE="0.022084356467075444" ORDER="541" O_E="0.0" SE="0.11759657023908447" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="0.013828953331995929" WEIGHT="8.242451529979881"/>
<DICH_DATA CI_END="1.1515258924894898" CI_START="0.7602808241874472" EFFECT_SIZE="0.935672514619883" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.06127370768356176" LOG_CI_START="-0.11902596315601996" LOG_EFFECT_SIZE="-0.02887612773622908" ORDER="542" O_E="0.0" SE="0.10590891914893497" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.011216699155295645" WEIGHT="8.986617376468008"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.247311493869678" CI_END="1.1080213992008792" CI_START="0.936231546683065" DF="8.0" EFFECT_SIZE="1.0185109662304932" ESTIMABLE="YES" EVENTS_1="509" EVENTS_2="500" I2="0.0" ID="CMP-006.05.02" LOG_CI_END="0.04454814799630556" LOG_CI_START="-0.02861672924195395" LOG_EFFECT_SIZE="0.007965709377175806" MODIFIED="2008-05-26 18:31:10 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6195510864420195" P_Z="0.669542556339171" STUDIES="9" TAU2="0.0" TOTAL_1="967" TOTAL_2="970" WEIGHT="78.29416696838936" Z="0.4267759088759448">
<NAME>Open label studies</NAME>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="600" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.782949604567754"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="543" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14463391788987345"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="544" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.82227555865141"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="545" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6518168566236964"/>
<DICH_DATA CI_END="3.0120035209923532" CI_START="0.6640776040572667" EFFECT_SIZE="1.4142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.4788554752134757" LOG_CI_START="-0.17778116604688957" LOG_EFFECT_SIZE="0.15053715458329311" ORDER="546" O_E="0.0" SE="0.38571161348013466" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="0.14877344877344878" WEIGHT="0.8774457685318989"/>
<DICH_DATA CI_END="1.6375574636769459" CI_START="0.9432914030892016" EFFECT_SIZE="1.2428571428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="24" LOG_CI_END="0.21419654879813088" LOG_CI_START="-0.02535412358940746" LOG_EFFECT_SIZE="0.09442121260436169" ORDER="547" O_E="0.0" SE="0.14071325075539257" STUDY_ID="STD-Fridrik-1997" TOTAL_1="35" TOTAL_2="36" VAR="0.019800218938149983" WEIGHT="3.707517331824925"/>
<DICH_DATA CI_END="1.3386453667434657" CI_START="0.783492937268815" EFFECT_SIZE="1.0241187384044528" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.12666553917374582" LOG_CI_START="-0.10596491408882536" LOG_EFFECT_SIZE="0.010350312542460237" ORDER="548" O_E="0.0" SE="0.13664827978574973" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.018672752368404537" WEIGHT="6.801676930566062"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="549" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.418019825653362"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="550" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.087831174080382"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.839302371631787" CI_END="1.1018358243565556" CI_START="0.9536373959443806" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0250618743752085" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="637" I2="0.0" I2_Q="0.0" ID="CMP-006.06" LOG_CI_END="0.04211688862855385" LOG_CI_START="-0.02061672684266909" LOG_EFFECT_SIZE="0.010750080892942398" METHOD="MH" MODIFIED="2008-05-26 18:31:23 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.6300562541691859" P_Q="0.0" P_Z="0.5017607673410257" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1185" TOTAL_2="1183" WEIGHT="100.00000000000003" Z="0.6717218901794163">
<NAME>Published and reported data versus unpublished or unreported data</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>G-/GM-CSF</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6670140608073163" CI_END="2.8576968689180196" CI_START="0.8768349580195528" DF="2.0" EFFECT_SIZE="1.5829493087557602" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" I2="0.0" ID="CMP-006.06.01" LOG_CI_END="0.456016158976204" LOG_CI_START="-0.057082143882124625" LOG_EFFECT_SIZE="0.1994670075470397" NO="1" P_CHI2="0.7164069300490322" P_Z="0.12754060893786984" STUDIES="3" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="1.6738965430454689" Z="1.523872321223099">
<NAME>Data not published in a peer-review journal</NAME>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="551" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14463391788987348"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="552" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6518168566236965"/>
<DICH_DATA CI_END="3.0120035209923532" CI_START="0.6640776040572667" EFFECT_SIZE="1.4142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.4788554752134757" LOG_CI_START="-0.17778116604688957" LOG_EFFECT_SIZE="0.15053715458329311" ORDER="553" O_E="0.0" SE="0.38571161348013466" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="0.14877344877344878" WEIGHT="0.877445768531899"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.625322064131524" CI_END="1.0921690190550861" CI_START="0.9443328926691316" DF="9.0" EFFECT_SIZE="1.0155644386487237" ESTIMABLE="YES" EVENTS_1="638" EVENTS_2="627" I2="0.0" ID="CMP-006.06.02" LOG_CI_END="0.03828985298669582" LOG_CI_START="-0.024874882858677252" LOG_EFFECT_SIZE="0.006707485064009271" MODIFIED="2008-05-26 18:31:23 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5723001536497985" P_Z="0.6772208564127262" STUDIES="10" TAU2="0.0" TOTAL_1="1140" TOTAL_2="1139" WEIGHT="98.32610345695456" Z="0.41625850172098855">
<NAME>Peer-reviewed data</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="554" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.68605847509765"/>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="555" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7907056500651002"/>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="602" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.78294960456776"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="556" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.822275558651413"/>
<DICH_DATA CI_END="1.3248988969835218" CI_START="0.8355760327580203" EFFECT_SIZE="1.0521662245800176" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="52" LOG_CI_END="0.12218273853135836" LOG_CI_START="-0.07801402559720746" LOG_EFFECT_SIZE="0.022084356467075444" ORDER="557" O_E="0.0" SE="0.11759657023908447" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="0.013828953331995929" WEIGHT="8.242451529979883"/>
<DICH_DATA CI_END="1.6375574636769459" CI_START="0.9432914030892016" EFFECT_SIZE="1.2428571428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="24" LOG_CI_END="0.21419654879813088" LOG_CI_START="-0.02535412358940746" LOG_EFFECT_SIZE="0.09442121260436169" ORDER="558" O_E="0.0" SE="0.14071325075539257" STUDY_ID="STD-Fridrik-1997" TOTAL_1="35" TOTAL_2="36" VAR="0.019800218938149983" WEIGHT="3.707517331824926"/>
<DICH_DATA CI_END="1.1515258924894898" CI_START="0.7602808241874472" EFFECT_SIZE="0.935672514619883" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.06127370768356176" LOG_CI_START="-0.11902596315601996" LOG_EFFECT_SIZE="-0.02887612773622908" ORDER="559" O_E="0.0" SE="0.10590891914893497" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.011216699155295645" WEIGHT="8.98661737646801"/>
<DICH_DATA CI_END="1.3386453667434657" CI_START="0.783492937268815" EFFECT_SIZE="1.0241187384044528" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.12666553917374582" LOG_CI_START="-0.10596491408882536" LOG_EFFECT_SIZE="0.010350312542460237" ORDER="560" O_E="0.0" SE="0.13664827978574973" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.018672752368404537" WEIGHT="6.801676930566063"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="561" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.418019825653364"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="562" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.087831174080383"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.839302371631792" CI_END="1.1018358243565551" CI_START="0.9536373959443801" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.025061874375208" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="637" I2="0.0" I2_Q="0.0" ID="CMP-006.07" LOG_CI_END="0.04211688862855367" LOG_CI_START="-0.02061672684266929" LOG_EFFECT_SIZE="0.01075008089294221" METHOD="MH" MODIFIED="2008-05-26 18:31:37 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.6300562541691854" P_Q="0.0" P_Z="0.5017607673410331" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1185" TOTAL_2="1183" WEIGHT="100.0" Z="0.6717218901794045">
<NAME>Size of studies</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>G-/GM-CSF</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.7601921516766077" CI_END="1.5988335766413884" CI_START="1.0775303943262386" DF="5.0" EFFECT_SIZE="1.3125516272895423" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="62" I2="0.0" ID="CMP-006.07.01" LOG_CI_END="0.2038032601766068" LOG_CI_START="0.03242952932185952" LOG_EFFECT_SIZE="0.11811639474923315" NO="1" P_CHI2="0.8812310225921719" P_Z="0.006897707811117412" STUDIES="6" TAU2="0.0" TOTAL_1="130" TOTAL_2="128" WEIGHT="9.858178000033144" Z="2.701742893004188">
<NAME>Study size n&lt;100</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="563" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.6860584750976497"/>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="564" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7907056500651"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="565" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14463391788987345"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="566" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6518168566236964"/>
<DICH_DATA CI_END="3.0120035209923532" CI_START="0.6640776040572667" EFFECT_SIZE="1.4142857142857144" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.4788554752134757" LOG_CI_START="-0.17778116604688957" LOG_EFFECT_SIZE="0.15053715458329311" ORDER="567" O_E="0.0" SE="0.38571161348013466" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="11" VAR="0.14877344877344878" WEIGHT="0.8774457685318989"/>
<DICH_DATA CI_END="1.6375574636769459" CI_START="0.9432914030892016" EFFECT_SIZE="1.2428571428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="24" LOG_CI_END="0.21419654879813088" LOG_CI_START="-0.02535412358940746" LOG_EFFECT_SIZE="0.09442121260436169" ORDER="568" O_E="0.0" SE="0.14071325075539257" STUDY_ID="STD-Fridrik-1997" TOTAL_1="35" TOTAL_2="36" VAR="0.019800218938149983" WEIGHT="3.707517331824925"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.2631469072075117" CI_END="1.0737006158803837" CI_START="0.9195142049666586" DF="6.0" EFFECT_SIZE="0.9936211391589164" ESTIMABLE="YES" EVENTS_1="572" EVENTS_2="575" I2="0.0" ID="CMP-006.07.02" LOG_CI_END="0.03088320222336278" LOG_CI_START="-0.03644155724593229" LOG_EFFECT_SIZE="-0.0027791775112847627" MODIFIED="2008-05-26 18:31:37 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.893976747045905" P_Z="0.8714513100051046" STUDIES="7" TAU2="0.0" TOTAL_1="1055" TOTAL_2="1055" WEIGHT="90.14182199996685" Z="0.16181529267092484">
<NAME>Study size n&gt;100</NAME>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="603" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.782949604567754"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="569" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.82227555865141"/>
<DICH_DATA CI_END="1.3248988969835218" CI_START="0.8355760327580203" EFFECT_SIZE="1.0521662245800176" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="52" LOG_CI_END="0.12218273853135836" LOG_CI_START="-0.07801402559720746" LOG_EFFECT_SIZE="0.022084356467075444" ORDER="570" O_E="0.0" SE="0.11759657023908447" STUDY_ID="STD-Engelhard-1994" TOTAL_1="87" TOTAL_2="85" VAR="0.013828953331995929" WEIGHT="8.242451529979881"/>
<DICH_DATA CI_END="1.1515258924894898" CI_START="0.7602808241874472" EFFECT_SIZE="0.935672514619883" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.06127370768356176" LOG_CI_START="-0.11902596315601996" LOG_EFFECT_SIZE="-0.02887612773622908" ORDER="571" O_E="0.0" SE="0.10590891914893497" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.011216699155295645" WEIGHT="8.986617376468008"/>
<DICH_DATA CI_END="1.3386453667434657" CI_START="0.783492937268815" EFFECT_SIZE="1.0241187384044528" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.12666553917374582" LOG_CI_START="-0.10596491408882536" LOG_EFFECT_SIZE="0.010350312542460237" ORDER="572" O_E="0.0" SE="0.13664827978574973" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="0.018672752368404537" WEIGHT="6.801676930566062"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="573" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.418019825653362"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="574" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.087831174080382"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="26.380696765023625" CI_END="1.0787814853818904" CI_START="0.9745605246444761" CI_STUDY="95" CI_TOTAL="95" DF="25.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.025347672923932" ESTIMABLE="YES" EVENTS_1="1327" EVENTS_2="1296" I2="5.233738810319057" I2_Q="0.0" ID="CMP-006.08" LOG_CI_END="0.032933484253342166" LOG_CI_START="-0.011191184044694266" LOG_EFFECT_SIZE="0.010871150104323974" METHOD="MH" MODIFIED="2008-05-26 18:33:46 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.38751206961482565" P_Q="0.0" P_Z="0.3341610598988026" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2400" TOTAL_2="2410" WEIGHT="200.0" Z="0.9657664747114713">
<NAME>Worst case - best case</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="16.99368726724797" CI_END="1.1337729394455103" CI_START="0.9813968354269892" DF="12.0" EFFECT_SIZE="1.054837037112643" ESTIMABLE="YES" EVENTS_1="671" EVENTS_2="637" I2="29.385542929652072" ID="CMP-006.08.01" LOG_CI_END="0.054526087167439674" LOG_CI_START="-0.008155346761473828" LOG_EFFECT_SIZE="0.02318537020298295" MODIFIED="2008-05-26 18:33:46 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.14983502677709692" P_Z="0.1470723025791585" STUDIES="13" TAU2="0.0" TOTAL_1="1200" TOTAL_2="1205" WEIGHT="100.0" Z="1.449950574443164">
<NAME>Best case</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="575" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.692967001524625"/>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="576" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7953113343497502"/>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="605" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="30.862123167919044"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="577" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.1450059154667106"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="578" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.865542351365065"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="579" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6534933257033091"/>
<DICH_DATA CI_END="4.021841286566116" CI_START="0.8056011585594769" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.6044249280885258" LOG_CI_START="-0.0938799178819136" LOG_EFFECT_SIZE="0.25527250510330607" ORDER="580" O_E="0.0" SE="0.410187723187772" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98" TOTAL_1="14" TOTAL_2="14" VAR="0.16825396825396827" WEIGHT="0.7854487087780158"/>
<DICH_DATA CI_END="1.4428003343708677" CI_START="0.9127589763872841" EFFECT_SIZE="1.1475752508361203" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="52" LOG_CI_END="0.15920623429465233" LOG_CI_START="-0.03964388735517743" LOG_EFFECT_SIZE="0.05978117346973745" ORDER="581" O_E="0.0" SE="0.11680554578108712" STUDY_ID="STD-Engelhard-1994" TOTAL_1="92" TOTAL_2="90" VAR="0.01364353552521764" WEIGHT="8.25843213800885"/>
<DICH_DATA CI_END="2.0589565339886584" CI_START="1.145443494515232" EFFECT_SIZE="1.5357142857142858" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="24" LOG_CI_END="0.31364717845478296" LOG_CI_START="0.05897367001995169" LOG_EFFECT_SIZE="0.18631042423736732" ORDER="582" O_E="0.0" SE="0.14959647950881821" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="0.022379106681432268" WEIGHT="3.7257990515211286"/>
<DICH_DATA CI_END="1.1565452985499964" CI_START="0.7662408286317153" EFFECT_SIZE="0.9413778348309799" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="57" LOG_CI_END="0.06316264750441686" LOG_CI_START="-0.11563471064445811" LOG_EFFECT_SIZE="-0.02623603157002064" ORDER="583" O_E="0.0" SE="0.1050264532378461" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.011030555879721474" WEIGHT="9.064659913156655"/>
<DICH_DATA CI_END="1.500809253941379" CI_START="0.8702787816303059" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="42" LOG_CI_END="0.1763254988889914" LOG_CI_START="-0.06034160493361792" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="584" O_E="0.0" SE="0.1390194283064587" STUDY_ID="STD-Zinzani-1997" TOTAL_1="79" TOTAL_2="79" VAR="0.01932640144665461" WEIGHT="6.597769153735332"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="585" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.442242916646546"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="586" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="9.111205021824983"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.830469147075099" CI_END="1.0707654412026493" CI_START="0.9280224952008392" DF="12.0" EFFECT_SIZE="0.9968422224804234" ESTIMABLE="YES" EVENTS_1="656" EVENTS_2="659" I2="0.0" ID="CMP-006.08.02" LOG_CI_END="0.029694345950466806" LOG_CI_START="-0.032441496385463016" LOG_EFFECT_SIZE="-0.0013735752174981286" MODIFIED="2008-05-26 18:33:43 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7982343867572217" P_Z="0.9309465845992356" STUDIES="13" TAU2="0.0" TOTAL_1="1200" TOTAL_2="1205" WEIGHT="99.99999999999999" Z="0.08665394577893651">
<NAME>Worst case</NAME>
<DICH_DATA CI_END="1.6695037485172588" CI_START="0.7750244652934506" EFFECT_SIZE="1.1375" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.22258739850780984" LOG_CI_START="-0.11068458784950985" LOG_EFFECT_SIZE="0.05595140532914999" ORDER="587" O_E="0.0" SE="0.19576561450922841" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.03832417582417583" WEIGHT="2.6031160562407423"/>
<DICH_DATA CI_END="2.277117687038865" CI_START="0.9446640036898525" EFFECT_SIZE="1.4666666666666666" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" LOG_CI_END="0.3573854766014323" LOG_CI_START="-0.024722633068382367" LOG_EFFECT_SIZE="0.16633142176652496" ORDER="588" O_E="0.0" SE="0.22445219508569716" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="0.050378787878787856" WEIGHT="1.7354107041604947"/>
<DICH_DATA CI_END="1.1884767575929873" CI_START="0.9033464717063338" EFFECT_SIZE="1.0361497409528262" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="199" LOG_CI_END="0.07499069288135254" LOG_CI_START="-0.044145647371380756" LOG_EFFECT_SIZE="0.015422522754985905" ORDER="604" O_E="0.0" SE="0.06998127599885093" STUDY_ID="STD-Burton-2006" TOTAL_1="387" TOTAL_2="397" VAR="0.0048973789904273495" WEIGHT="29.832407267748255"/>
<DICH_DATA CI_END="30.772099938279613" CI_START="0.3980878791038031" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4881571342223876" LOG_CI_START="-0.4000210455218362" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="589" O_E="0.0" SE="1.1091252094144872" STUDY_ID="STD-Cunningham_x002a_" TOTAL_1="18" TOTAL_2="21" VAR="1.23015873015873" WEIGHT="0.14016778764373228"/>
<DICH_DATA CI_END="1.12894318424886" CI_START="0.7790880304890956" EFFECT_SIZE="0.937841202949909" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="106" LOG_CI_END="0.05267208595677288" LOG_CI_START="-0.10841346787856485" LOG_EFFECT_SIZE="-0.02787069096089599" ORDER="590" O_E="0.0" SE="0.09462245170922894" STUDY_ID="STD-Doorduijn-2003" TOTAL_1="197" TOTAL_2="192" VAR="0.008953408367465363" WEIGHT="16.302822896526745"/>
<DICH_DATA CI_END="3.735526389928358" CI_START="0.5132234558649116" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.572351808864496" LOG_CI_START="-0.2896935032715574" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="591" O_E="0.0" SE="0.5063696835418333" STUDY_ID="STD-Dunlop-MOPP-1998_x002a_" TOTAL_1="13" TOTAL_2="12" VAR="0.2564102564102564" WEIGHT="0.6316894963144201"/>
<DICH_DATA CI_END="2.0468607675415367" CI_START="0.6183249100622165" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.31108830189799547" LOG_CI_START="-0.20878325700323286" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="592" O_E="0.0" SE="0.3053751271043014" STUDY_ID="STD-Dunlop-MOPP_x002f_EVAP-98_x002a_" TOTAL_1="14" TOTAL_2="14" VAR="0.09325396825396826" WEIGHT="1.2147874929123463"/>
<DICH_DATA CI_END="1.2060803986394442" CI_START="0.7658777408253079" EFFECT_SIZE="0.9610983981693364" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="57" LOG_CI_END="0.0813762593146176" LOG_CI_START="-0.11584055245966035" LOG_EFFECT_SIZE="-0.01723214657252137" ORDER="593" O_E="0.0" SE="0.11584613147517377" STUDY_ID="STD-Engelhard-1994" TOTAL_1="92" TOTAL_2="90" VAR="0.013420326177763247" WEIGHT="8.750474742901572"/>
<DICH_DATA CI_END="1.2608195687333894" CI_START="0.727541879649948" EFFECT_SIZE="0.9577572964669739" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="31" LOG_CI_END="0.1006529407284248" LOG_CI_START="-0.13814200223568585" LOG_EFFECT_SIZE="-0.018744530753630504" ORDER="594" O_E="0.0" SE="0.1402693315511502" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="0.019675485373806506" WEIGHT="4.651921516976103"/>
<DICH_DATA CI_END="1.1390633521048668" CI_START="0.749967076472827" EFFECT_SIZE="0.9242618741976893" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="57" LOG_CI_END="0.05654787921907244" LOG_CI_START="-0.12495780170166446" LOG_EFFECT_SIZE="-0.03420496124129599" ORDER="595" O_E="0.0" SE="0.10661733544045175" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="82" TOTAL_2="80" VAR="0.01136725621642181" WEIGHT="8.762217194247388"/>
<DICH_DATA CI_END="1.2105738657516474" CI_START="0.7280013913167815" EFFECT_SIZE="0.9387755102040817" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="49" LOG_CI_END="0.08299129399222742" LOG_CI_START="-0.1378677906861065" LOG_EFFECT_SIZE="-0.027438248346939566" ORDER="596" O_E="0.0" SE="0.12973371961015454" STUDY_ID="STD-Zinzani-1997" TOTAL_1="79" TOTAL_2="79" VAR="0.016830838003886198" WEIGHT="7.440573394088121"/>
<DICH_DATA CI_END="1.3087252933134108" CI_START="0.8369492876155903" EFFECT_SIZE="1.046583346859276" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" LOG_CI_END="0.11684849596374018" LOG_CI_START="-0.07730085595649101" LOG_EFFECT_SIZE="0.019773820003624588" ORDER="597" O_E="0.0" SE="0.11404429037273554" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.013006100166620821" WEIGHT="9.127202126625567"/>
<DICH_DATA CI_END="1.16694230634804" CI_START="0.662574900502584" EFFECT_SIZE="0.8793103448275862" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="58" LOG_CI_END="0.06704938504788746" LOG_CI_START="-0.17876501997788932" LOG_EFFECT_SIZE="-0.05585781746500093" ORDER="598" O_E="0.0" SE="0.1443925983130705" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="0.02084922244759973" WEIGHT="8.807209323614511"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Sensitivity analysis: Bone Pain</NAME>
<DICH_OUTCOME CHI2="5.729810590892832" CI_END="6.120862590350672" CI_START="2.087547562192598" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.574575748113672" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.7868126299611534" LOG_CI_START="0.3196363791316781" LOG_EFFECT_SIZE="0.5532245045464157" METHOD="MH" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6774674489315918" P_Q="0.0" P_Z="3.451671081465183E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="606" TOTAL_2="598" WEIGHT="100.0" Z="4.641931615105889">
<NAME>GM-CSF versus G-CSF</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.04793457834243432" CI_END="3.4720900714880405" CI_START="0.5389074931128591" DF="1.0" EFFECT_SIZE="1.3678944974988634" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" I2="0.0" ID="CMP-007.01.01" LOG_CI_END="0.5405909829338446" LOG_CI_START="-0.2684857778162159" LOG_EFFECT_SIZE="0.13605260255881432" NO="1" P_CHI2="0.8266970461531399" P_Z="0.5097887768782143" STUDIES="2" TAU2="0.0" TOTAL_1="119" TOTAL_2="113" WEIGHT="44.24794021493851" Z="0.6591666302984915">
<NAME>GM-CSF</NAME>
<DICH_DATA CI_END="18.03566184106943" CI_START="0.1665835427011031" EFFECT_SIZE="1.7333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2561320839236036" LOG_CI_START="-0.7783679060933301" LOG_EFFECT_SIZE="0.23888208891513676" ORDER="679" O_E="0.0" SE="1.1950753650733195" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.428205128205128" WEIGHT="6.640209309199502"/>
<DICH_DATA CI_END="3.6015819855331057" CI_START="0.47167478457223294" EFFECT_SIZE="1.303370786516854" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5564933053988002" LOG_CI_START="-0.3263573402347888" LOG_EFFECT_SIZE="0.1150679825820057" ORDER="680" O_E="0.0" SE="0.5185908394263474" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.2689364587369236" WEIGHT="37.607730905739004"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5970640656003194" CI_END="10.681277886639192" CI_START="2.6556217166014253" DF="6.0" EFFECT_SIZE="5.325920907863129" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="7" I2="0.0" ID="CMP-007.01.02" LOG_CI_END="1.028623213920654" LOG_CI_START="0.4241662114742055" LOG_EFFECT_SIZE="0.7263947126974297" MODIFIED="2008-05-13 13:59:49 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9964492420074761" P_Z="2.46868707019475E-6" STUDIES="7" TAU2="0.0" TOTAL_1="487" TOTAL_2="485" WEIGHT="55.75205978506149" Z="4.710698923778008">
<NAME>G-CSF</NAME>
<DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" ORDER="681" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="2.957911419552506"/>
<DICH_DATA CI_END="103.49901743899466" CI_START="0.25291362340873896" EFFECT_SIZE="5.116279069767442" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0149362268668662" LOG_CI_START="-0.5970277763816269" LOG_EFFECT_SIZE="0.7089542252426198" ORDER="682" O_E="0.0" SE="1.5342805849385042" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="2.3540169133192386" WEIGHT="3.063146363324215"/>
<DICH_DATA CI_END="12.554563016975525" CI_START="1.5733790489596613" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="4" LOG_CI_END="1.0988016009502575" LOG_CI_START="0.19683336282701747" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="683" O_E="0.0" SE="0.5298206078883775" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.2807098765432099" WEIGHT="24.944090622384216"/>
<DICH_DATA CI_END="242.02294415313497" CI_START="0.8432325842790044" EFFECT_SIZE="14.285714285714286" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3838565397273634" LOG_CI_START="-0.0740526197558771" LOG_EFFECT_SIZE="1.154901959985743" ORDER="684" O_E="0.0" SE="1.4437880071270193" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="2.0845238095238097" WEIGHT="3.1743439624465917"/>
<DICH_DATA CI_END="95.8447517250373" CI_START="0.22846947661574074" EFFECT_SIZE="4.67948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.981568336731456" LOG_CI_START="-0.6411718131994673" LOG_EFFECT_SIZE="0.6701982617659943" ORDER="685" O_E="0.0" SE="1.54061054684255" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="2.373480857042501" WEIGHT="3.2013724351637336"/>
<DICH_DATA CI_END="22.91964915384711" CI_START="1.1565275278881775" EFFECT_SIZE="5.148514851485149" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.3602079653147936" LOG_CI_START="0.06315597438951993" LOG_EFFECT_SIZE="0.7116819698521566" ORDER="686" O_E="0.0" SE="0.7618947599804093" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.5804836252856055" WEIGHT="12.213666293604028"/>
<DICH_DATA CI_END="42.18688113558866" CI_START="0.5926012856852341" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6251774192981756" LOG_CI_START="-0.22723741062613828" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="687" O_E="0.0" SE="1.0881176406988355" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="1.184" WEIGHT="6.197528688586202"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.729810590892832" CI_END="6.120862590350674" CI_START="2.087547562192598" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.574575748113672" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="0.7868126299611535" LOG_CI_START="0.3196363791316781" LOG_EFFECT_SIZE="0.5532245045464157" METHOD="MH" MODIFIED="2008-05-07 17:05:46 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6774674489315918" P_Q="0.0" P_Z="3.451671081465196E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="606" TOTAL_2="598" WEIGHT="100.0" Z="4.6419316151058885">
<NAME>HD versus NHL</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="18.035661841069437" CI_START="0.16658354270110304" DF="0.0" EFFECT_SIZE="1.7333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-007.02.01" LOG_CI_END="1.2561320839236039" LOG_CI_START="-0.7783679060933302" LOG_EFFECT_SIZE="0.23888208891513676" NO="1" P_CHI2="1.0" P_Z="0.6453290400257194" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="26" WEIGHT="6.640209309199502" Z="0.46026079441904144">
<NAME>HD</NAME>
<DICH_DATA CI_END="18.03566184106943" CI_START="0.1665835427011031" EFFECT_SIZE="1.7333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2561320839236036" LOG_CI_START="-0.7783679060933301" LOG_EFFECT_SIZE="0.23888208891513676" ORDER="688" O_E="0.0" SE="1.1950753650733195" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.428205128205128" WEIGHT="6.640209309199502"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.446266575801094" CI_END="6.44997597889671" CI_START="2.1288423822166727" DF="7.0" EFFECT_SIZE="3.705534000404636" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="13" I2="0.0" ID="CMP-007.02.02" LOG_CI_END="0.8095580972318517" LOG_CI_START="0.3281435078133476" LOG_EFFECT_SIZE="0.5688508025225996" MODIFIED="2008-05-07 17:05:46 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6056728880492899" P_Z="3.6236176206436187E-6" STUDIES="8" TAU2="0.0" TOTAL_1="576" TOTAL_2="572" WEIGHT="93.3597906908005" Z="4.631879091440546">
<NAME>NHL</NAME>
<DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" ORDER="689" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="2.957911419552506"/>
<DICH_DATA CI_END="103.49901743899466" CI_START="0.25291362340873896" EFFECT_SIZE="5.116279069767442" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0149362268668662" LOG_CI_START="-0.5970277763816269" LOG_EFFECT_SIZE="0.7089542252426198" ORDER="690" O_E="0.0" SE="1.5342805849385042" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="2.3540169133192386" WEIGHT="3.063146363324215"/>
<DICH_DATA CI_END="3.6015819855331057" CI_START="0.47167478457223294" EFFECT_SIZE="1.303370786516854" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5564933053988002" LOG_CI_START="-0.3263573402347888" LOG_EFFECT_SIZE="0.1150679825820057" ORDER="691" O_E="0.0" SE="0.5185908394263474" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.2689364587369236" WEIGHT="37.607730905739004"/>
<DICH_DATA CI_END="12.554563016975525" CI_START="1.5733790489596613" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="4" LOG_CI_END="1.0988016009502575" LOG_CI_START="0.19683336282701747" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="692" O_E="0.0" SE="0.5298206078883775" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.2807098765432099" WEIGHT="24.944090622384216"/>
<DICH_DATA CI_END="242.02294415313497" CI_START="0.8432325842790044" EFFECT_SIZE="14.285714285714286" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3838565397273634" LOG_CI_START="-0.0740526197558771" LOG_EFFECT_SIZE="1.154901959985743" ORDER="693" O_E="0.0" SE="1.4437880071270193" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="2.0845238095238097" WEIGHT="3.1743439624465917"/>
<DICH_DATA CI_END="95.8447517250373" CI_START="0.22846947661574074" EFFECT_SIZE="4.67948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.981568336731456" LOG_CI_START="-0.6411718131994673" LOG_EFFECT_SIZE="0.6701982617659943" ORDER="694" O_E="0.0" SE="1.54061054684255" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="2.373480857042501" WEIGHT="3.2013724351637336"/>
<DICH_DATA CI_END="22.91964915384711" CI_START="1.1565275278881775" EFFECT_SIZE="5.148514851485149" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.3602079653147936" LOG_CI_START="0.06315597438951993" LOG_EFFECT_SIZE="0.7116819698521566" ORDER="695" O_E="0.0" SE="0.7618947599804093" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.5804836252856055" WEIGHT="12.213666293604028"/>
<DICH_DATA CI_END="42.18688113558866" CI_START="0.5926012856852341" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6251774192981756" LOG_CI_START="-0.22723741062613828" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="696" O_E="0.0" SE="1.0881176406988355" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="1.184" WEIGHT="6.197528688586202"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.729810590892831" CI_END="6.120862590350672" CI_START="2.087547562192597" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.5745757481136713" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="0.7868126299611534" LOG_CI_START="0.31963637913167786" LOG_EFFECT_SIZE="0.5532245045464157" METHOD="MH" MODIFIED="2008-05-07 17:05:50 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6774674489315919" P_Q="0.0" P_Z="3.4516710814652277E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="606" TOTAL_2="598" WEIGHT="100.0" Z="4.641931615105887">
<NAME>Age</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.914627771657175" CI_END="5.853180764213297" CI_START="1.7184684626762132" DF="5.0" EFFECT_SIZE="3.1715148666912487" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="11" I2="0.0" ID="CMP-007.03.01" LOG_CI_END="0.7673919366698121" LOG_CI_START="0.23514156637643133" LOG_EFFECT_SIZE="0.5012667515231217" NO="1" P_CHI2="0.42638796446582117" P_Z="2.2272578434389382E-4" STUDIES="6" TAU2="0.0" TOTAL_1="303" TOTAL_2="297" WEIGHT="78.38743258264603" Z="3.691739205709389">
<NAME>Adult patients, all ages</NAME>
<DICH_DATA CI_END="18.03566184106943" CI_START="0.1665835427011031" EFFECT_SIZE="1.7333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2561320839236036" LOG_CI_START="-0.7783679060933301" LOG_EFFECT_SIZE="0.23888208891513676" ORDER="697" O_E="0.0" SE="1.1950753650733195" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.428205128205128" WEIGHT="6.640209309199502"/>
<DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" ORDER="698" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="2.957911419552506"/>
<DICH_DATA CI_END="103.49901743899466" CI_START="0.25291362340873896" EFFECT_SIZE="5.116279069767442" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0149362268668662" LOG_CI_START="-0.5970277763816269" LOG_EFFECT_SIZE="0.7089542252426198" ORDER="699" O_E="0.0" SE="1.5342805849385042" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="2.3540169133192386" WEIGHT="3.063146363324215"/>
<DICH_DATA CI_END="3.6015819855331057" CI_START="0.47167478457223294" EFFECT_SIZE="1.303370786516854" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5564933053988002" LOG_CI_START="-0.3263573402347888" LOG_EFFECT_SIZE="0.1150679825820057" ORDER="700" O_E="0.0" SE="0.5185908394263474" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.2689364587369236" WEIGHT="37.607730905739004"/>
<DICH_DATA CI_END="12.554563016975525" CI_START="1.5733790489596613" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="4" LOG_CI_END="1.0988016009502575" LOG_CI_START="0.19683336282701747" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="701" O_E="0.0" SE="0.5298206078883775" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.2807098765432099" WEIGHT="24.944090622384216"/>
<DICH_DATA CI_END="242.02294415313497" CI_START="0.8432325842790044" EFFECT_SIZE="14.285714285714286" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3838565397273634" LOG_CI_START="-0.0740526197558771" LOG_EFFECT_SIZE="1.154901959985743" ORDER="702" O_E="0.0" SE="1.4437880071270193" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="2.0845238095238097" WEIGHT="3.1743439624465917"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0031557534803285394" CI_END="15.648064976584926" CI_START="1.6210216920440663" DF="2.0" EFFECT_SIZE="5.036452398817961" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="3" I2="0.0" ID="CMP-007.03.02" LOG_CI_END="1.1944606407994631" LOG_CI_START="0.2097888264907149" LOG_EFFECT_SIZE="0.702124733645089" MODIFIED="2008-05-07 17:05:50 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9984233681068232" P_Z="0.0051880046364535925" STUDIES="3" TAU2="0.0" TOTAL_1="303" TOTAL_2="301" WEIGHT="21.612567417353965" Z="2.7951225384982097">
<NAME>Adults patients, age older 60</NAME>
<DICH_DATA CI_END="95.8447517250373" CI_START="0.22846947661574074" EFFECT_SIZE="4.67948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.981568336731456" LOG_CI_START="-0.6411718131994673" LOG_EFFECT_SIZE="0.6701982617659943" ORDER="703" O_E="0.0" SE="1.54061054684255" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="2.373480857042501" WEIGHT="3.2013724351637336"/>
<DICH_DATA CI_END="22.91964915384711" CI_START="1.1565275278881775" EFFECT_SIZE="5.148514851485149" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.3602079653147936" LOG_CI_START="0.06315597438951993" LOG_EFFECT_SIZE="0.7116819698521566" ORDER="704" O_E="0.0" SE="0.7618947599804093" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.5804836252856055" WEIGHT="12.213666293604028"/>
<DICH_DATA CI_END="42.18688113558866" CI_START="0.5926012856852341" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6251774192981756" LOG_CI_START="-0.22723741062613828" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="705" O_E="0.0" SE="1.0881176406988355" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="1.184" WEIGHT="6.197528688586202"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.729810590892833" CI_END="6.120862590350674" CI_START="2.087547562192598" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.574575748113672" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-007.04" LOG_CI_END="0.7868126299611535" LOG_CI_START="0.3196363791316781" LOG_EFFECT_SIZE="0.5532245045464157" METHOD="MH" MODIFIED="2008-05-07 17:05:54 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6774674489315917" P_Q="0.0" P_Z="3.451671081465196E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="606" TOTAL_2="598" WEIGHT="100.0" Z="4.6419316151058885">
<NAME>Blinding</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.1525920112742147" CI_END="4.983851355781956" CI_START="1.3563427877491832" DF="3.0" EFFECT_SIZE="2.599963623135686" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="11" I2="4.840208017038655" ID="CMP-007.04.01" LOG_CI_END="0.6975650809371603" LOG_CI_START="0.1323694624029686" LOG_EFFECT_SIZE="0.4149672716700644" NO="1" P_CHI2="0.3686918886604731" P_Z="0.004001853326517823" STUDIES="4" TAU2="0.0" TOTAL_1="220" TOTAL_2="215" WEIGHT="72.14994225687522" Z="2.8780156128792513">
<NAME>Placebo controlled studies</NAME>
<DICH_DATA CI_END="18.03566184106943" CI_START="0.1665835427011031" EFFECT_SIZE="1.7333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2561320839236036" LOG_CI_START="-0.7783679060933301" LOG_EFFECT_SIZE="0.23888208891513676" ORDER="706" O_E="0.0" SE="1.1950753650733195" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.428205128205128" WEIGHT="6.640209309199502"/>
<DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" ORDER="707" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="2.957911419552506"/>
<DICH_DATA CI_END="3.6015819855331057" CI_START="0.47167478457223294" EFFECT_SIZE="1.303370786516854" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5564933053988002" LOG_CI_START="-0.3263573402347888" LOG_EFFECT_SIZE="0.1150679825820057" ORDER="708" O_E="0.0" SE="0.5185908394263474" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.2689364587369236" WEIGHT="37.607730905739004"/>
<DICH_DATA CI_END="12.554563016975525" CI_START="1.5733790489596613" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="4" LOG_CI_END="1.0988016009502575" LOG_CI_START="0.19683336282701747" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="709" O_E="0.0" SE="0.5298206078883775" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.2807098765432099" WEIGHT="24.944090622384216"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.4730375649212909" CI_END="16.368494928762324" CI_START="2.2728679922589254" DF="4.0" EFFECT_SIZE="6.099461304495376" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="3" I2="0.0" ID="CMP-007.04.02" LOG_CI_END="1.214008748185092" LOG_CI_START="0.35657421271645806" LOG_EFFECT_SIZE="0.7852914804507751" MODIFIED="2008-05-07 17:05:54 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9760721435488746" P_Z="3.305358726519187E-4" STUDIES="5" TAU2="0.0" TOTAL_1="386" TOTAL_2="383" WEIGHT="27.850057743124772" Z="3.590112026939608">
<NAME>Open label studies</NAME>
<DICH_DATA CI_END="103.49901743899466" CI_START="0.25291362340873896" EFFECT_SIZE="5.116279069767442" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0149362268668662" LOG_CI_START="-0.5970277763816269" LOG_EFFECT_SIZE="0.7089542252426198" ORDER="710" O_E="0.0" SE="1.5342805849385042" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="2.3540169133192386" WEIGHT="3.063146363324215"/>
<DICH_DATA CI_END="242.02294415313497" CI_START="0.8432325842790044" EFFECT_SIZE="14.285714285714286" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3838565397273634" LOG_CI_START="-0.0740526197558771" LOG_EFFECT_SIZE="1.154901959985743" ORDER="711" O_E="0.0" SE="1.4437880071270193" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="2.0845238095238097" WEIGHT="3.1743439624465917"/>
<DICH_DATA CI_END="95.8447517250373" CI_START="0.22846947661574074" EFFECT_SIZE="4.67948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.981568336731456" LOG_CI_START="-0.6411718131994673" LOG_EFFECT_SIZE="0.6701982617659943" ORDER="712" O_E="0.0" SE="1.54061054684255" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="2.373480857042501" WEIGHT="3.2013724351637336"/>
<DICH_DATA CI_END="22.91964915384711" CI_START="1.1565275278881775" EFFECT_SIZE="5.148514851485149" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.3602079653147936" LOG_CI_START="0.06315597438951993" LOG_EFFECT_SIZE="0.7116819698521566" ORDER="713" O_E="0.0" SE="0.7618947599804093" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.5804836252856055" WEIGHT="12.213666293604028"/>
<DICH_DATA CI_END="42.18688113558866" CI_START="0.5926012856852341" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6251774192981756" LOG_CI_START="-0.22723741062613828" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="714" O_E="0.0" SE="1.0881176406988355" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="1.184" WEIGHT="6.197528688586202"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.729810590892831" CI_END="6.120862590350674" CI_START="2.087547562192598" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.5745757481136717" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-007.05" LOG_CI_END="0.7868126299611535" LOG_CI_START="0.3196363791316781" LOG_EFFECT_SIZE="0.5532245045464157" METHOD="MH" MODIFIED="2008-05-07 17:06:22 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6774674489315919" P_Q="0.0" P_Z="3.451671081465196E-6" Q="0.0" RANDOM="NO" SCALE="30.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="606" TOTAL_2="598" WEIGHT="100.0" Z="4.6419316151058885">
<NAME>Concealment of allocation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.497123179067181" CI_END="5.594824980579281" CI_START="1.8571518699399105" DF="7.0" EFFECT_SIZE="3.2234204929964285" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="14" I2="0.0" ID="CMP-007.05.01" LOG_CI_END="0.7477865053134273" LOG_CI_START="0.26884741993794165" LOG_EFFECT_SIZE="0.5083169626256845" MODIFIED="2008-05-07 17:05:59 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7210637105822901" P_Z="3.177264003879275E-5" STUDIES="8" TAU2="0.0" TOTAL_1="565" TOTAL_2="559" WEIGHT="96.82565603755341" Z="4.160374335270858">
<NAME>Allocation concealed</NAME>
<DICH_DATA CI_END="18.03566184106943" CI_START="0.1665835427011031" EFFECT_SIZE="1.7333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2561320839236036" LOG_CI_START="-0.7783679060933301" LOG_EFFECT_SIZE="0.23888208891513676" ORDER="715" O_E="0.0" SE="1.1950753650733195" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.428205128205128" WEIGHT="6.640209309199502"/>
<DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" ORDER="716" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="2.957911419552506"/>
<DICH_DATA CI_END="103.49901743899466" CI_START="0.25291362340873896" EFFECT_SIZE="5.116279069767442" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0149362268668662" LOG_CI_START="-0.5970277763816269" LOG_EFFECT_SIZE="0.7089542252426198" ORDER="717" O_E="0.0" SE="1.5342805849385042" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="2.3540169133192386" WEIGHT="3.063146363324215"/>
<DICH_DATA CI_END="3.6015819855331057" CI_START="0.47167478457223294" EFFECT_SIZE="1.303370786516854" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5564933053988002" LOG_CI_START="-0.3263573402347888" LOG_EFFECT_SIZE="0.1150679825820057" ORDER="718" O_E="0.0" SE="0.5185908394263474" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.2689364587369236" WEIGHT="37.607730905739004"/>
<DICH_DATA CI_END="12.554563016975525" CI_START="1.5733790489596613" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="4" LOG_CI_END="1.0988016009502575" LOG_CI_START="0.19683336282701747" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="719" O_E="0.0" SE="0.5298206078883775" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.2807098765432099" WEIGHT="24.944090622384216"/>
<DICH_DATA CI_END="95.8447517250373" CI_START="0.22846947661574074" EFFECT_SIZE="4.67948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.981568336731456" LOG_CI_START="-0.6411718131994673" LOG_EFFECT_SIZE="0.6701982617659943" ORDER="720" O_E="0.0" SE="1.54061054684255" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="2.373480857042501" WEIGHT="3.2013724351637336"/>
<DICH_DATA CI_END="22.91964915384711" CI_START="1.1565275278881775" EFFECT_SIZE="5.148514851485149" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.3602079653147936" LOG_CI_START="0.06315597438951993" LOG_EFFECT_SIZE="0.7116819698521566" ORDER="721" O_E="0.0" SE="0.7618947599804093" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.5804836252856055" WEIGHT="12.213666293604028"/>
<DICH_DATA CI_END="42.18688113558866" CI_START="0.5926012856852341" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6251774192981756" LOG_CI_START="-0.22723741062613828" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="722" O_E="0.0" SE="1.0881176406988355" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="1.184" WEIGHT="6.197528688586202"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="242.02294415313477" CI_START="0.8432325842790047" DF="0.0" EFFECT_SIZE="14.285714285714286" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" I2="0.0" ID="CMP-007.05.02" LOG_CI_END="2.383856539727363" LOG_CI_START="-0.07405261975587692" LOG_EFFECT_SIZE="1.154901959985743" NO="2" P_CHI2="1.0" P_Z="0.06549515883716872" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="3.1743439624465917" Z="1.8418632263225512">
<NAME>Unclear</NAME>
<DICH_DATA CI_END="242.02294415313497" CI_START="0.8432325842790044" EFFECT_SIZE="14.285714285714286" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3838565397273634" LOG_CI_START="-0.0740526197558771" LOG_EFFECT_SIZE="1.154901959985743" ORDER="723" O_E="0.0" SE="1.4437880071270193" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="2.0845238095238097" WEIGHT="3.1743439624465917"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.729810590892833" CI_END="6.120862590350672" CI_START="2.087547562192598" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.574575748113672" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-007.06" LOG_CI_END="0.7868126299611534" LOG_CI_START="0.3196363791316781" LOG_EFFECT_SIZE="0.5532245045464157" METHOD="MH" MODIFIED="2008-05-07 17:06:44 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.6774674489315917" P_Q="0.0" P_Z="3.451671081465183E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="606" TOTAL_2="598" WEIGHT="100.0" Z="4.641931615105889">
<NAME>Study size</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3878058904874648" CI_END="20.877885738337703" CI_START="1.503695770603742" DF="3.0" EFFECT_SIZE="5.603033864245922" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="1" I2="0.0" ID="CMP-007.06.01" LOG_CI_END="1.3196865164248406" LOG_CI_START="0.17715997820178064" LOG_EFFECT_SIZE="0.7484232473133106" NO="1" P_CHI2="0.7083957736427137" P_Z="0.010234991413581125" STUDIES="4" TAU2="0.0" TOTAL_1="133" TOTAL_2="130" WEIGHT="15.835611054522815" Z="2.5677873744762287">
<NAME>Less than 100 participants</NAME>
<DICH_DATA CI_END="18.03566184106943" CI_START="0.1665835427011031" EFFECT_SIZE="1.7333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2561320839236036" LOG_CI_START="-0.7783679060933301" LOG_EFFECT_SIZE="0.23888208891513676" ORDER="724" O_E="0.0" SE="1.1950753650733195" STUDY_ID="STD-Aglietta-2000" TOTAL_1="30" TOTAL_2="26" VAR="1.428205128205128" WEIGHT="6.640209309199502"/>
<DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" ORDER="725" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Avil_x00e9_s-1994" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="2.957911419552506"/>
<DICH_DATA CI_END="103.49901743899466" CI_START="0.25291362340873896" EFFECT_SIZE="5.116279069767442" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0149362268668662" LOG_CI_START="-0.5970277763816269" LOG_EFFECT_SIZE="0.7089542252426198" ORDER="726" O_E="0.0" SE="1.5342805849385042" STUDY_ID="STD-Fridrik-1997" TOTAL_1="42" TOTAL_2="43" VAR="2.3540169133192386" WEIGHT="3.063146363324215"/>
<DICH_DATA CI_END="242.02294415313497" CI_START="0.8432325842790044" EFFECT_SIZE="14.285714285714286" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3838565397273634" LOG_CI_START="-0.0740526197558771" LOG_EFFECT_SIZE="1.154901959985743" ORDER="727" O_E="0.0" SE="1.4437880071270193" STUDY_ID="STD-Pettengell-1992" TOTAL_1="41" TOTAL_2="39" VAR="2.0845238095238097" WEIGHT="3.1743439624465917"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.9993597129977623" CI_END="5.767897292043125" CI_START="1.7674958039693849" DF="4.0" EFFECT_SIZE="3.192919394756561" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="13" I2="0.0" ID="CMP-007.06.02" LOG_CI_END="0.7610175183729438" LOG_CI_START="0.24735839145614769" LOG_EFFECT_SIZE="0.5041879549145458" MODIFIED="2008-05-07 17:06:44 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.40609271704478367" P_Z="1.192563306267422E-4" STUDIES="5" TAU2="0.0" TOTAL_1="473" TOTAL_2="468" WEIGHT="84.16438894547719" Z="3.8476498568338835">
<NAME>More than 100 participants</NAME>
<DICH_DATA CI_END="3.6015819855331057" CI_START="0.47167478457223294" EFFECT_SIZE="1.303370786516854" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5564933053988002" LOG_CI_START="-0.3263573402347888" LOG_EFFECT_SIZE="0.1150679825820057" ORDER="728" O_E="0.0" SE="0.5185908394263474" STUDY_ID="STD-Gerhartz-1993" TOTAL_1="89" TOTAL_2="87" VAR="0.2689364587369236" WEIGHT="37.607730905739004"/>
<DICH_DATA CI_END="12.554563016975525" CI_START="1.5733790489596613" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="4" LOG_CI_END="1.0988016009502575" LOG_CI_START="0.19683336282701747" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="729" O_E="0.0" SE="0.5298206078883775" STUDY_ID="STD-Gisselbrecht-1997" TOTAL_1="81" TOTAL_2="80" VAR="0.2807098765432099" WEIGHT="24.944090622384216"/>
<DICH_DATA CI_END="95.8447517250373" CI_START="0.22846947661574074" EFFECT_SIZE="4.67948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.981568336731456" LOG_CI_START="-0.6411718131994673" LOG_EFFECT_SIZE="0.6701982617659943" ORDER="730" O_E="0.0" SE="1.54061054684255" STUDY_ID="STD-Zinzani-1997" TOTAL_1="77" TOTAL_2="72" VAR="2.373480857042501" WEIGHT="3.2013724351637336"/>
<DICH_DATA CI_END="22.91964915384711" CI_START="1.1565275278881775" EFFECT_SIZE="5.148514851485149" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.3602079653147936" LOG_CI_START="0.06315597438951993" LOG_EFFECT_SIZE="0.7116819698521566" ORDER="731" O_E="0.0" SE="0.7618947599804093" STUDY_ID="STD-_x00d6_sby-CHOP-2003" TOTAL_1="101" TOTAL_2="104" VAR="0.5804836252856055" WEIGHT="12.213666293604028"/>
<DICH_DATA CI_END="42.18688113558866" CI_START="0.5926012856852341" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6251774192981756" LOG_CI_START="-0.22723741062613828" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="732" O_E="0.0" SE="1.0881176406988355" STUDY_ID="STD-_x00d6_sby-CNOP-2003" TOTAL_1="125" TOTAL_2="125" VAR="1.184" WEIGHT="6.197528688586202"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-07-17 17:05:22 +0200" MODIFIED_BY="[Empty name]" NO="1" REF_ID="CMP-001.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.1 Overall survival.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA2YAAAEwCAMAAADrQ5IPAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2008-06-17 11:07:17 +0200" MODIFIED_BY="[Empty name]" NO="2" REF_ID="CMP-002.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Sensitivity analysis: Overall survival, outcome: 6.1 GM-CSF versus G-CSF.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1wAAAHwCAMAAACFep5KAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2008-06-17 11:07:17 +0200" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-002.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Sensitivity analysis: Overall survival, outcome: 6.2 HD versus NHL.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1wAAAHwCAMAAACFep5KAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2008-06-17 11:07:17 +0200" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-002.03" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Sensitivity analysis: Overall survival, outcome: 6.3 Age.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1wAAAHwCAMAAACFep5KAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2008-06-17 11:07:18 +0200" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-002.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Sensitivity analysis: Overall survival, outcome: 6.4 Antibiotic prophylaxis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1wAAAHwCAMAAACFep5KAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2008-06-17 11:07:18 +0200" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-002.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Sensitivity analysis: Overall survival, outcome: 6.5 Blinded versus open label studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1wAAAHwCAMAAACFep5KAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2008-06-17 11:07:20 +0200" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-002.06" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Sensitivity analysis: Overall survival, outcome: 6.6 Concealed allocation versus concealment of allocation unclear.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1wAAAHwCAMAAACFep5KAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2008-06-17 11:07:20 +0200" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-002.07" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Sensitivity analysis: Overall survival, outcome: 6.7 Size of studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1wAAAHwCAMAAACFep5KAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAynklEQVR42u19Pc8sR3pd3ZdDPZRAWZC5XO3VykvITixgBQd2ICWC
4LiCBSxAkQHn/gd27MBw4NCBfgMNBRU5MQTHGxhYQcACXnktUKKX9y7AlUXwASnQM9Nf9f3RXVXd
M30OL9+Z6a6ur65T9VR1nX5ekQAAoAVeUAUAAHIBAMgFAIAQl8fIprz/Vd5TKnadKklBJS6XQj1r
O7gXLVW+4bx9L66VdICKOWIBHoRc4eLLNCdz7420qSgF4L8bWl3JUK+HAlweqlLkyLOhem4f8tbx
yNunmjqvkYpyPJnf7ynhudxI8gRYyjsXWwZ6N+MGHKaKDlSAR5tzqXsl3f5IdfuYODGMO3I6ORxR
xbXlu3xJ8gzcUmNx1fJjqgLpCzrV8VGq6EgFuDxsMzBqQjm9jtoa+9kgzVq99eVWY5sb59DHH627
OV4BHnK1UMrI8oLETGmlTaC0Wp2m/ipgPhxwfed4BXjIkUvFakaBJ5u6fxX4YVayHOYpKMDTjVyJ
4WnF2HW3EDDmxVulRAGenly3tYvBYpb21Gs+6ZuXZUfqXm4efmrjcOpipJTLj+GEMsOZN+AoVXSk
ArzCxl0AwMgFACAXAAAgFwCAXAAAcgEAAHIBQEvoOzTG5X5rJ3ls8X+6Ih1yAyJaLv+md+sC6c9g
abR5sZrhVSAp6dljkl17ctj7r8uXlmunb1KlalDO99rN6SLHUMt2IiuUCjyntZQcU1j9OVNol3r2
3X+QvF+suKVUZSIoVwVVHype825wveyyUrS5sWp1s1SN8hJEZeVmTQXJnKKOzceXU+2eKjllNrpR
Olx+NTVRf9Wsu/sPkfeLpwnN+hal6TulIXcS+jaGJeQcdNzfr0tppqMrG9ESs63XCupwFrlOLExp
tDmxTgKx5G3QKknqtaVJ09xUpv5PeupXTKXxpOy7C8qb06k5xVXeQmsmIiAElu5YP2vnSm//w+Xd
mHONu0EMQ09ayc36mOUKo0OWy0UeIZTcus3fFVwFdTjDiSGMSmh18qMtiTXDwjPqc/6pS9P8GRkP
LSfnWs8Qss13QYoymyBee65iamgiVbf0PVLeLyblXf7eO4vADmLnCmX1HvmWWLp/l1LpNWDMYFLR
hti3LdoCZlmjz1Sj7sZIKxdF9aWkiA7iSsq0UeSOxr7bP0U0xSjCN36Ssc4Xrbr7D5n3i2sSFtn6
pVdsn1JIt0mlbU3pr7qN0UqRO0FVeTEE+s/0hD8v/RyjXBWVR+lLBnaz1gLelx9KpvNPkffL2r54
9RXVVzcGzX96wlY92qz5Y7TLkyJnYVa5t16Nf8v603hPuKZznmJUwSWHimvGD5f3F2vG5XSJsaVH
7QrTDg52v3ILqeZlZmllYttCW7NoB6W517jMXoiWvlsTuAsy2ZrUbONk5XRszVpmnTYyzwcndfj8
bWw4UtjrC6u0cw+Z9xfTwJwmAmoitVS2Dao1Cu0KbexWZmbcAOW91jKxdAVXQR3Okrah69kYbTJW
b4zSPzW2YjB/eiVmwVTMW2UbFGb6811QwZyqwp7EvvHTirUR+Tp13OPmPU/PVUQJGXw7o4QGvxmk
EtmPZZdH2DLygMJ7NGeC3XAS/lh5v2SVqIgU6jwv+TsQVtS6VMEFmdADvp259WB5hxIZAAAA2IZ/
1Tm9C0Yu4DTo3NghOQEAkAsAHgu2nkvbEGJphbLVXtEF4eh2bwB40pFreWSttAfeUjs7bB9OQQVV
GMLYyn0e1yHA6Ucu74hkNv5MtZcyvCNpJAWVAMy5fJTLV3tN3pGM3VuqdJspADwTudyXMhjKIunR
7InRwlvo5Zl4TcfBLeCs5IouRSiVsuvUQr9pD5i+3REATjvn8rxDSLgzrji7pO1KQmjswrgFnHXk
skYbywrMUHtJ36u+pD7wAcBpzcLICzkK1V6zdyQVHMYwmgHPjRq74kER4CEgO7fTSwVqgVsA0IRc
YBYApOdcAACAXAAAcgEAyAUAAMgFPCNeg1wA0AS/+cXTFclcimcyvi8/jR/3A8PbPvwfvV96k0qQ
x8yVvaGEE8GHVL2hloPTt4I6mS+echzNiJMU3y+pfgs86czZpMhZ37VDwdgo1eu/e3lucjGZN4Wi
DWsknP3B4/3tyK2s85QR0lPERKzeUMvB6RuvSXfMcTQjTlL3fw245UlnyhVFz3quHfsAvVJef/Hq
mycfuaZmQ1pd3CtvvMlzFxS5edR75GLizPNFGaOsVKlKFqNtmqrktxooJ7lAH01BY+OLl29Kdep/
Kn5QmvcVuidVl1wDiYxeh6YuMaeBtug4t7QqEmu4VbUtk1jPrX6X7WnIf/6dL79RrRv+nnsLbwP2
aJBwuo0E7yCJZ3nRaF4jjYUirjGkZJrZ92B0t7eaGuZj5PE0jLOc7uE+/Q5vaLqPMOdKTWhYAEWr
IFxlcSHT0qbZiuSmtvkYeTwN42xOdj79znPPuXwzb6epPIzpsdlYWjNw0a453jjD63YTvAX79OnI
9WKVe7gvHBy8HpdbOxiF1QbDisFqZYfzM8OPNBtsNnLN84Sl6yPWDI3lDA/2z3jW/HgaAy+nON5Q
Y0UwramS5eKceZsnqeF75RvhpGPkKnR2mcGPK/TiqZpICgElMsP5CbB9hGdaeWEbHECJzOJMvQuw
29TwlGYhmgtQYjGuOnWGdoaNuwAAcgEAyAUAAMgFAO1g6bki00yvsCIzaCtMCSUSjCiv1ofPUGq5
sq6cxJfJvk8blUyjkZ7LFPeJmJ5r2ulDkTzer6EzkSu6Ey67JvoJutj6jAbL3+aXFT5DqeXKunJA
dg4OoefShRJ29ZhZdCUpAbUXPf1a/MXum0gXP4694NQZjt9mwRdrHetwju974juNXJl76Eq32mnh
06vMTfbxsSOaI5HV5VGHuo4L2casGy3A0XM1bR6R+/Hx9f93xN9n9G4tzEK3y9H6GrH0jEMJTJEX
D9Rq1XNGaiHRwGlltFnjL4lm3NLbS77kpJFZTrklzjFlu7QKD247NL7umK9LRj49FUuLTU3auenI
EY3p4m1+Sd0GF76RY00vnCEg0Sae47ZC7mKX+9OgWT5tvZDFuGi/+dblsdLa23Rmyg5WU+dfSOxV
5iOt0Pm313MZmUv1x/6L6BS7V182c+U6M925nph3IXhJ8yiposJm5wY/Xrs96T7wF8twmmdXJaPV
vmPXjdx07AazroL4yO2Wo4fZn0c+QnvZySycpiUJK8Y8vdbkOfqcKxE+Q5q0SdYVUE4FstFcz+VQ
uUDP5eSRTqLqWutZEoIvIN0UoOdaZRGAW8BGkpxSz5U2mNCegKzmAD0XAAAgFwCAXAAAgFwA0AjG
rnj/NNO3GKS9OJU1lQRZkRjKn2ZOvJJPTUr1XLGSZ8Va5mIrlKxepZQufGf/XNp+A13P5dPYQc8l
ihr9LGWat+xNF5Owtnm0duKV3DRYqucyr1sRa5mLrWCyOS77dvPPZeRTK59HYwc911xTjp5r6XHY
ffI/a8C8NyRYfTU3blKyXRQ7lcxqbZmxMq2KWKzpETr76Mq852tytZV4XtnWx1Xb1QpyWe3CcpA4
k4Ju3SOvz11HJ160jT4bY2XakN0ye7alnstNx189mRq75i3bK9s61A4NKqKLZsiQvx+6nxq3l9Xs
ZUvFhPUtpqZdcebo1UvPtUbPMnfJvUbXQzjvqpcJCjJy2Nk7fnCD6XaR/6q6nMlbXNm0uZnKwjXX
c1H2Yk/59PjJ51zt7LJHq1TOHjAiTGDaUPZD++fi1IuvmLYW5NHxErihnLJtdAeviV6szhR1q8FV
mn6mTCyr3XCH8nVGvHrMs2eVUFx80ybHitGFXq7FkydraqblyYyxjb2f8M+1Pu2j++eKF9hakIGe
q5mZAjw1oOfKNgsBoI/dCj2XiM3WAQB6LoxcAAByAQDIBQAAyAUAe6CdnmvaJ0A+pYJH3rN+aTZT
z7VCcZKzkuyN1HgNZqGeiwPVkx16Vz2Xxz+X6XFsrg7ouWItK6nncuQpRkBRSeKVqecqXftNRRvb
eMJmnRbtqQuonwpC76rn8mx20wNrUUDPtVrPpe8wyGpam/aaJtQttaNcYvVGrjuz2pDukfZkFips
mPJH+fpDbAhxPVfac1dp7bTUcxV3juvtQsooed38xlo+FZisTdoXdUmEI+YjO74le1VHwj9XGPU9
dzXVc5mTuPveMo+73M0Sr1YCixqTglXvirfdD2cVb9m310jPlVfHfv9c1tlDbs+4HDhGj56LxDLK
LRVKenuoIfGiim2jmqFqZK2HjonJmPP2SK5wQNcahKAzeDrpqdh03XN3tZj4UXYerxq4tk8yC9nE
ZWs0+933/dBKz2V6nF6WFDlz7tmA2oVuvLgSobtzq89IFajOuHjvzP65auu5Uu9HqiPvaaQO2h7t
OgHTon6avsWWAXrpuTx+wGK58Am8oOeqPG0Bnh/Qc2WbhQDQwfYV0HOdcx4KiEqtAnouAABALgAA
uQAAALkAoBECei62P5zXpxobNGcxV+dJap5QK0cW5YmWk3spU7GyubOysGy2RCoj2BH8c3kefcM/
l/CoHXy/fE63hgpj0bnC8oRaObIoESzhhlj1c7ym3+C06OR4ei53Fwb8c+l1wePuddJ+TX1RaOPa
nWJ9R67MPXS0LlrKjnVPlwfUPheViiGaVliyJdzUWh9XbikryLX0Mmzc28VXYuiajk639KxU3qha
+t7pvDfK84r2Qq51WWQt79G1xUSkPQls46bW2tU/17SDcM6x8SaEiNOtuYTH7D555Ya21FSuqbpD
E6Ym3jdAVjEb++das7fC3VLfu6Xs4bDrkkt/WyxiON3alzp5bxCorqmiWT4VX8pYOZRQ8UhKXfRc
mggvfDOYcrJ6wjlXXnWYc+1dq6qVUKviOz0aasnceBubZBQtEs8vL4J/rpeVw/+BlDkpoRY34RbX
zOIGI8x4iVunrixSpPFw3D/XKfVcvuFfP0DG2UdR5qzMKscXEjJiDXmtKsl16gUcHp0V/HMdBa+w
0x1oZj1DzwUANQzFTpc944IGAEQXOApPQc8FAADIBQAgFwCAXAAAbEHEP1d6D40WwiPy6vDW/dy3
ZmruxPKj3aDnKnOx5V4sSL8fmXquOdtthHX2u0oXWVfAPxf0XGv9c3kahK1xav+C9NxtIpwXzFuY
WFsLFbLMxZYD/a37KfWLFjMvHV4LboWrx+Ofyygw9FxOb8jj/jDTNRfPnkrMjakcbiMNx60SdUP2
jrtiPVerEUJkeHCg8vJtqetkOj63h9SxWUTrYNBz5fnhokbkmjoWYzP5/Is993yf8T3XORwTi6LN
5fvCY+jl5IkC/Kxa1+nqSRrT1KNN+DHs0Pi62x32vis+mut4B2laag++GzpHz5U0NzUPZNntwxEg
ZOm5ptvTXM8VGyXIO8PVpua7++e67JOSd4M1Z9frkURe2RTZ0kmOW2QjZV3hgWyrKL6Tf65AwbOM
6VP756JkdVGWoXaQgWutmCrropZTs6wMdNdzZZqHMbHoWf1zJQevyCuXrNW7g3BrrZgqS8+VYRNu
NbZ4OwH7rRxwDrfOrOeaZgh348KcLiyGn1cpZzpnEg8t29mg5wq5q8q1t8xZVqaeS2/K1GrOFciV
U2AjW9Bz7T+HAZ5u2efkeq7CpZOiNW3g9OyqbDI/yZwrPH8BtwCrTaxb9Ojekr78s3/4S6/fPbZZ
CAAPiO/9m//85vrxwS/9lz8GuQCgHn7rj/7j/P03/tO/fq87ueTtj1p+KXsWKH0n5XDRcLG8fZ+D
DaeuYXvPJK1smh91YpVTXdWKdX1u5ox4bkHlmpxTk0uiysmCXSv6xXNwKbpV3I/+5ZefmUdev/ff
vt91znWtAqXG+rEY53xdjtyuGmvt+sWor+WU59Je7c75qBPrXDYpxM7c0upfGd1j/ZqcU5NLS1Ge
LJi1ov0YWtjwp5tx9sHvfTFy64Px0Ad/85e//8ufN0/ZXi1UQz8jp+5HLqOT1AeqJbjZOWnj2/2Q
mrvT3bglGnBLqMqxVh5fVMuaFFYj8A/r7sV7jPHvfvi33/z1lU1v7/+/XT7fiO/++q/87KteI9e1
9FZzHMyLqa8Zvuqjm1mHUhbcni4wW5qqGuutspQQO9uEfWsy+26b4VXuVdXxwz957y/fXPkkvP9/
+pP3PvyoE7mUTS/lrbVQ/Yz2wg5VmNciKnNrLK/av5ByHhEme6P6LVCBux0aOwPcmuxB2WsM+xf/
7k30/Dff/NdeI5dSGUOMdNrs/T6OtvZ1XLsOFIfqzeVzjy3SbucHvAV6+/LkuB2++ez9j749zrXc
/1//9ps3/7ybWTgVv4Bb4zrGoZufPNrUqPGM69xZMPHVp5//6evBCvxA6J/f+uX3f/7XjVfkX7wz
roIlPilNY3EZKAYzcfdm7SxiVmPs0XqQ1mN1oszOaePA9cdOdfbHP//yH31rnGeJ8fP1P/7ss6+a
p/xiGni3nmd+SqLGX5OVPH/VrenbAWWa/toi7Xzs2WyzjhOHVRmRTVMzE82tC+/FPfBrP/vst/9o
+fnhf3j/55/0eIy8bYdGbiXJkyyqnQ/ROxsfQjs3inf/wVef3Vbif/O9//VepyS3vRRUVQ8IPB69
1nKr8+zr7c8+fOefffT+2096cQt7C4ET9QPwzwUAzwGQCwBALgAAuQAAALkAAOQCgIeDpuca38bj
vi6XS16u2hfcxg8Y93EvBpyGXPR4ryTkiQl1M94oWgBmoWDm8TWp92/WYbGcuIbxhgQAwPtSUMM9
l88/oDCddlEXL5J+640fKFoAI5cwDEXnEOskSrtD6WgePky0wHlHrlDr4kiz2+XV+tzG2xOfy4kU
sA+5Ru/HnpHJ56FtB7NwSJQeI1oAZmHMMrp7D6LEqNYNo+MtfoxoAYxcunsuwzLSLT/LCrS9eHXm
WJu0Cc+5gJrkIusvTf80U5B8QfZqhiSapN0oWgBmIQAAIBcAgFwAAHIBAAByAQDIBQBnhL4UPzwe
ztdxORh38BqHpmdmY4DbYzN/kOHb+PiWrGivx8i+aL5qeBbnZHaOZjp9P6BlMJYbFlCcABXJtRnk
o5u50dfd+qAHIc81AZ4bXQAJ/yU8P7Bifbe/Hok/N/d/4BbQwCy0FV26ZIt5EHVpii492BJ+avA0
XTYqwSjESG9jNuITawdVNh+E8xI7CAR0HblcRdfy9fZPWIquZZSgSQtl7/KdLEbWtwNTyJAzLc1p
Q6N+0WLzkW0t+izE6SIa4qIleCQ34B1Qj1ycZ/DpSgy3AZLXniLzk0Ljyjjv8yZnEVafPYmcLUvu
lJDChbgr17AFCqhFrrlhc5pvLPJoWT5lyxFSUWqylzcljIf1rM8AwNYFDUo3SMpvt54WahhinEkV
zkhqlYHnvQpif6AJuUR0RZ69J3jRo5DQv/qaNvkuZPKmx56LQnRZN9BgeAK6kctQdGnW2rAeMHwz
Fh+0XyZDMkRRPD9/WlJYplQBG3GJN7hgbkRjHQgPZXPEQ35AO2A9VvnnSphZdSYqubGsWZXHVOqU
6O2fq/ghMifNqM4tt/BZL3gFHJZcVCFE3YkQlUcLggEdgI27AAByAQDIBQAAyAUA7RD2zzUd1fa8
ZsPZOMTOQyMmI9mYxstylpWr3xo+sDoIHIBcsec/G5tobJdeXItlbsmfjmTpt0bNI9gFHMgsZE2j
NYq3LGmXCHjrcv10TZFYirBB+pVBXVrN5gp9AgBUGrmsIUAX7lrSLhHx1mW2aEMZpuu/dFVVzD5M
jKEJ/RbBMAQORa7EuGGoqgztVr5nEK+cK3Ctb7aXp98CgMORaxwO8h0RsPer+5vXzOco9gINAHgs
clF6gSPU1tl+5UuB70lewZuofgv2IHBEszBXhEvsCB45OjLZr2/TdWCrhjUAeCBymbKq5QUXIQWX
MEVfhvzKuEhThN3jHd8643lqtUivrMyU6Lfy6AkArfDq4Zre2reqAadHbz3X421/Kny1BbgF7IUH
3FtIDUMDwKnJBQAgFwCAXAAAgFwAAHIBAMgFAADIBQAgFwAAIBcAgFwAAHIBAAByAQDIBQAgFwAA
IBcAgFwAAHIBAAByAUBz6G9/ktf/1fRF+6rms7ev5ls+pHBe+uE5ZJ0cI13iBoDnHrmu7V6NFLrC
Pnb7dvsqk1Eq5aGU/mWMdIkbAJ585PKNSBZP7mSQSt6/qGkYmv6MQ9H1u5wDz8OeMkgGAJhz6Xwb
uaI0AkqLkMvQZ/0eroYVCJyWXPN0SRoUmmghnZFHDQOUXAYo5Z94DTQDt4Czksu3FDEfUypl16mF
fpMZKLVhD8wCTjvn0rjl+zZNoqLskuZi4hILqAWceeTyjTYay6Q1oM0fSrvSMQrHyxS4BZwOmiOG
kQbzMuCyYLGs9I0Lg3IONnxoj8L8q4Umg/GcC9gDvR0x1PBygukUAHIl5lxrqQVuAUATcoFZAOAF
Nu4CAMgFACAXAAAgFwCAXAAAcgEAMEBfiufbH7p+3v/n8fHy8MnGw2Z2Hz2PwQYP3+ZHA8QyZxSo
LDdzIe7VEAifjnWqyMKacMJGMzIfZbIup3CNbKhxPVdGNm8Jaj/Gohs5WH5oN467OYP/2mnq/ck1
VQrdv1Jp3YuJltZHC26ZqUaoUpQb1uohGD4jVgpUSJrZVthIRuaj7Fy+dIx1ezMmfzb1H1OO2Fev
5o0jPtPIZVTkOIZpFWr1VzT0WMuvfjBTC6ZNxof1NRxtomVSTlRLu8sJHMigGUcsZF75ut0d654s
P/o2k5nK74y/Pu5cSZd4R2V3Vlp/NQ7sS4fVD2TcK8qva8qLdnt51g0ddgZzMqK11/lypp25ZWab
AjeuWzv5evy1695Ct6mSv7qmUxTsLVhELbaud3qynyiz1SVtODYmO5yfhWTIm1HO+oDHFO4VrCjn
y6//2s5nnt6eazjnWl+Vw521PlozZ5XJVSGcXuKiwSaesDl/0SY1qTog4yY2G70q3FWmE5IrdM+5
dM5AK5rpuh60ZIhpMRzaZXQSbJOFJUpPHTQ2umg7cbgvwS47keuldmvvaBMSJdY01zVsLuFWUeBN
temPOVkHR7QJ+2f6ACPXMuciw7xZlnYpbvaMp82P/SZcg5E2fmTnJpH7/FiZrMAl6S6zL38SZpT6
XG2ceFU3BiO5Ws5GhrGzGIMLXtF5TWKg9dQ3y2jvh96rhS/gFrCPofj8a46X0gkrAGS3F1q/MPIM
wMZdAAC5AADkAgBA1HlvIQAcG1+Pn52fJvv0XPoh/5Mej6Cp6zOtzKSN85yeRLO+mTJPz+WN1dRz
DXKnaNpWgmxqo2J6Lp907AB6LqvAtp5rfPj37B17xt5CX0twBE3ttFu5OUgF07VP0WhNKdaaWPWD
ZB/wN1zhUWiN36N6Lp907AB6LrPA7C3p8+u5XgL3mu97AO7bAJiHA8xac/GhW0dEK4PlKbXyQqVG
d/J22ZFxK3gqpedy9+7uew8iRY8q1Bp1xMzM3h+dRy63lrQuKrXT+vijfGZ/ThViZfJamlkJ6got
Kkn/QHquAOV3yBfpc67O6cf0XBRsAv53aPS8p3lpcekWR+tVIfFuhPPu7fZq4cAmx331XFvS4PNt
3CWxvikcsrJow3QwrFvSGnFk3r+2VjxZ9fdb9tHeeq4tadApNtmtWpzcv2KYmlzDBcTwm2ABhUlJ
frlIqOI1IvbXc2GDqgg+ROZn4BZvipbjsbJokgWP2IlrxVzTJtyUfve8Xwb8YM+Ra5xz6RbPsGJq
3WxdybSHdsubA68BU5Q1UyIVuiw/VqaiajHDciIjTugH0nPtLfTrBezQANqZEdBzAUANQ/HwxuFj
LGgAQNYCB/RcAACAXAAAcgEAAHIBQCPoS/EJ1ZGxudnZhNdX4eXzBpYIlqHnyow2Hcp6pWBZXTh7
ff3eJtz0p3xRwxf8Cp/sjFy1V+ARl35t9/2F9+27PVfwVu0tJI+vm64Kr0znV0awtJ4rM9p0KP0g
2wdyGvGiKhOhLsFNn5eOrwW3nMLxkj1H7RXwz2Vce0I9173Io+plVnKJUcw1K71mvVfw5rfsljKd
X5Xu8MuLlilZStpaF5RWgjm5bPtItvSV4IGtGXs0cZ7g+dVx5Ar0iqOuyxdsn22GK8WSTDWiLW1l
5XeRLdMgz6Yk0ZJnhduDacO1zbL+dW9+X7JzRxyrQa8gvn1JtGlGlk1TNVqONGXH80jBnMujJclT
O4+3qbmeK9ZWEj0Bn+mds5emXUangS2e0GqHUtFo82JdPFjk1wVtsylb67nio2Nqdkn72TsHmHN1
Mcn7zgSoVGKUFZIoZ+AaXkPSsvBM+9yMLSVrWCuxgeQHl8tlV3KFfRhGLCym7abYBqOwrk2YFy2L
HG6N4qxNdcGF3Opk/63xscUbrn10s3B6oOJKduKOWHdSeGU63irNSF60k4TJt9wweeVaJWAKC7W8
adhJNdJzxbPjqL18PU+hvO0JsFbPBRk3kG4K0HOBW8BGC6LnZY9qFhZY3GhSQLotQM8FAADIBQAg
FwAAIBcANILjnysijQroOoydCo7zpsbvLM8RS+XruYRVlKhPrcVRDgXOzZEVpG15wgr753KT6qvn
8vvn8t4T/9kT+ufa0NCFqzJqutyaKRzL13MZRUkxdkqVIueExisuK9WSg2j5dtNzBfxz+e5J4Ozz
67ku3hvGk49CNjtO1n0qkq4m5R2qikq7hMy3YBOXBA5nbEXaxZeQne1mHRln13p853FX/6MmPl6+
viPE34v8ItQj1+KYi62+kYIyL0rckiOg0D9X3ladlMSCeL15XLRZqLeeK5zpo0hOnJS0HRpf92C5
s7fQEOpZ3DD9AgZkXhVe1F/MF665t1ArbVxyIigcaoN3HdZHh/QmYqu5dtBzjZFzaIT2bCLUJubH
2Nxz6Z4I5Y2uHG0Z2gbfY9TjWv9cWbFmvfFmZXbNTdPhfLovHmjbhmmabPq9hsXq/Fw7ey7lrYxj
GgrTIm9NsCLZxS6OL1lsf1MPFSd+tKWCk25FfcmaEnJ47OKITdhat9NU0rTFAZet59qUA96eywb1
wuDWujmXbeL5rHq/xdLVW5cpaao958rTc3lDeURWxekyZVWmxzNWHz1XwD+XeXaaMfLi67a7M7cd
8YrQ5wCtbL6T67ku8fEf3AJaWX2n1nOBWECWHbuyCUHPBQAAyAUAIBcAgFwAAKyHR8/F8Y2o+qch
3ikSLVVBnp5rzFd+9rwupgKxpvxzZcXlrWNNLxXLuEcrtbeea2oMFL/2+fVc9nOuzLvCsy8vy0dU
z/oqcARWkr3FxRSlQyb8c+XHFajb1G3xaaUa6bkoUOveFmC+DtR/befnXF/39XwnnOTmYvPS18/y
Le2ZOyW2/XRBvp6riPrZCjWmfGkzF3QZXFCv1K0j4+wOz+GWfW1bT2KhE+/EHq1RB3IZfbLPS1c0
K0fdz7FqWKXMWKvEFQ9bWq976rk8pnrfVkGRkatz+3zx3xVyMxvVo/Aj0aZy69y5S+FJbM/3b3T/
y7ttf6BBvk9eFf+Yx30q7XL5wY4LGgE/p5GxNOqe4ZTovyWVrOldJ/9cq0z1ln6yD4hLsk+Oybcs
9Vb3asvrBrmJfy72lpralbL6/Gh/Q/3J8ZJTYo4f551v0amNwuON3BnZOsnoddHrxXqiMuhwIkbf
zvKcTD3Xymg3BA65qyqyr1jkPLDyJHU4PZdzLYtzCLpeYe870Gygh38uANjDNIV/LgBIGbCrTnW3
C1+Lv9lzQQMAnha/9b//3/d6p/kOhi7gBPjon/74i3d/2tkS1Rc05O2PWn4pexYofSflcNFwsbx9
n4MNp65he88kzeSnYkmhqsdq1tkOxdNvxpQjVXvqPic1f5Nz2kK5p61ake5ZNcfQBe++9+b693d+
sptZeK0CNbUai3HO1+XI7aqxMq9fjPpaTnku7dH47smre76q5cGOVcxf9ineUq7pgGqX1PxNLi1F
eU6btWJlcKrBjnX15a/cuCX+4of7LmiooZ+RU1cvl9FJ6gPVEtzsnLTx7X5o+K6k2BNt7uRSTzsX
zr4X7decZXy4llYfuzte3zyafPBW/OGPvr/bgoY060EO5sXUNQ1f9dFNmhfLnCawXyNs0+Dixe4B
pd+/XlxPFNs4vXv/8yefvr3+vf7/5g/2MguVTS/lvZOhWh3thUO0t14D11zsQ3Cr5y3wF1tN/NZP
784t8e+XJYa9yCWUyhhi7JY6sm00sa/j2nWEUIfglNkP1Bq4zFiVOkjx9Cw1vAXhvtWckG6IowF+
9vpmFV7///AXO865VDG3lsWh42HMmZzXtaowzIx1/+I9XqL9M/63v/F/xdvrnOtX+5LrxTvjKlji
k9LsjJb2O9go+xFPGtNuZy2zSqyHKd71l+cWVE9RRpYylroYvxmVY53t2zN99Xcf3uZc8hOxF7nU
3VJXy1MSNf6aTOn5q25N3w4ozdrWWKkf26GbH3PWNFbVcxEhUTzfLahoDCoRuNvW6aGh+GpFO9u7
yr76798S4tt/1TnVbbvicxuWPMg0DOi6WBTnUN9G8d3Pf//Hv/tQu+JV9YDA49FrLbe64pP3//yn
vasGei7gPP0A9FwA8BwAuQAA5AIAkAsAAJALAEAuAHg4GO8tvGN2pZT2X5N5vj4WJ1AZ/rl2jxYA
uR7pPd6WR6paGW8ULQCzcO7Abz4y7m9FZd1bxnhYLCdY+EM2H7ioZbQgFFB95NLbGBPZnbf+w/DZ
Rf27+UYWGwxBoDG5LCvJOmT4BG3u4COcMbZfVF4zWt7xDfjAOchlvnGYQydE75ZInpH2uNECIFdg
EsLetkfRseTRAU4BrRY0gmPXfVIyz7tEZCRrPuVqGS24BbQauSYTj03XXLrlZ1mB95A9zULDCVS1
tE3vUZhzAVXJRdZfmv5ppiD5guzjsT3ugHdttHEP6wBQyywEAADkAgCQCwBALgAAQC4AALkA4CzQ
l+KXfXX67wKMO3iNQ9MzszHAKJmyL5vC6noq4zwHrxojdVfO52iMeLUMenMzi7mw+wmoSK7NIB/d
hLHRl9z9Faxfzv5NfeyjznKKhP8SJidefd+xJzeLmMvYoQwAtcxCW9GlS7aYB1GXpujSgy3hpwZP
02WjEizGGyZn/6we32pYiS7MBIGAviOXq+havt7+CUvRtYwSNNpozi7fyWJkfTsw2SE9AxQtGxr1
mKd0rEvYP4IaoxXT8ioDJzfRzADAanJxnsFHHLMEyWtPWXuK4u3WnGDNyVHkAg9TA+E8ufIV4vaP
sQUKqEUumhogp/nGIo+W6+Zuhe/EyeKAsQ05Z/rIhNELqL6gQelmW9C6PS10lSFmmIX+0NF4KSdi
7SJG8wDqk0tEV+T9uicmbVKjf/WRgAq4yJ6LQuvkVMbxkoEPAGqQy1B0zROTWT11/2Y8jNJ+zU+0
7BMi19CbZFWUZcsFF8yNaKwDEZ7x8oI1wpwL2IJV/rlS5luVJpkbS2lqeDfGadHbP1fxQ2ROmlGd
W27hs17wCjgsuahCiEoJrUqPKmYRAGLAxl0AALkAAOQCAADkAoB2CPvnmo5OOyJKFgGcjUPsPDRi
MpL1q6qEz1lWUr9l+NnC6iBwAHLFnv9sbKKxXXpxLZbrLCut3zL8bEGVBRzJLGRNozWKtyxplwh4
63L9dE2RWIqwQfqVSV0qXDuHny3gaCOXNQToHb8l7RIRb10mVQxlmK7/0lVVMfvQMUhz9FvW1iyw
DDgKuSyTLXbM8daV2Y4pf6SZLUqDsyL6NHhiOPYGAkcj1zgc5DsiYO9X9zevmM9R9kH3LJYzgKOR
i9ILHKG2zvYrXwp8T3I0jD8rjNkV8GhmYa4Il5jsts9RWnhMvCyvIkz545qpegGA45DLcnvFpp5L
uL9M0ZchvzIu0hRh93jHeZHnqdUivTJ9Zoks/ZZZAHAM2AmvHq7prdFvAYDor+d6vO1Pha+2ALeA
vfCAewupYWgAODW5AADkAgCQCwAAkAsAQC4AALkAAAC5AADkAgAA5AIAkAsAQC4AAEAuAAC5AADk
AgAA5AIAkAsAtuO7r7sneUGtA2fAu5+/+h5GLgBogH/79s0v/kfnNLUX1Mj73/kdHsvbPOR48HpE
DiHuQZW8fZ+DDaeuYXu/BsSHMcv6hzRKtznWsSaE3Brp6oxo90IZd0C/K7XSc9LQi2+ftmtFmme1
fHbDt//q+ud3frLbyKXU8L9ONauG5S3A0Ervoc37PVW6PAC3PB9DnivFOhVXzqXuXbwxB0u9T99U
Cy6baSitKpUnC2atSDOaKY6uY8gXt79/8cPd51xyHJWk3iWZg5o7vt0PDd+VPCK3tt9N6el1pNhh
4ErXbwfjIVafZq3s39eKd//J/xTig7fiD3/0/X3nXEPHogbjQuuBzEYl5aa73xjK9xHPc3GsolKs
6zNyYBi1sn92f+3KLfFWiDd/cJwFjSuzAi1nHP13alyruCW2GnBebokdzEKVHtia3xX/wHVvMMqq
lQN0Bd/M5uFxyOVU4ci20eC+jmvXEe743eg8ozwFmt6VcHdrT7xXx9ECn1wT/OD6+eEv9p5zxbon
dQgTGtjTKJBbZ7D9G9F737tahdc516/2JVfZcy4pzZ5HGmtGQh6YePK5OwW9eK2WM65pyMgKjlPD
xoHlh9xhFej/fHSbc8lPxM7kGu3mYbVUqx81nlOaaa2tXujHjmiBGXmuFl3lWDflwHdXatfd2ABi
p8O1op3tXmWffmd81tUTBV5OcluRFGeZ3gDxmx3nUN928tHPf+/Hv3tcLyeqekDgKei1lltd8dP3
//ynvavmFbyAAKfpB+CfCwCeAyAXAIBcAAByAQAAcgEAyAUADwdtbyEPH9PaPM+L9JxYrufuy/k8
5HP4YD3XFaId46sXLQBy0R40WQnSPmjpGKpEO8ZXMVoAZuHcgTPf2hWP36zDYjlxDeMN2XzgosKx
tShaXwIAsGnk0lsWE10/WB/M9B/T93sYJ2QXs1AbX6qlbMUHbgG1yeUYX8YhJq3NUSJ0Q6vwlova
jCYQCuhFLnPOwaETd871JBe1YTN4BfQjF5NOI4q1wz07/doJwyoEmi1oBMeu+6RknneJyEjWfMrV
IlGsDQKtR67JxLstVdx/uJafZQXeQ/Y0C4fUaifatxDAychF1l+a/tkzHTtI50ZJbeZejaIFYBYC
AAByAQDIBQAgFwAAlYEX1ABHQPyhYu4jx0S43olg5AKADmYha3/Nb7ndj3vNuFt+fuzLvu3zvARm
T8r3DfjsvUaLbYjbEzmzlRc28+nN1BxW4OEysBJVHY6Td4w0NvqSp606O6w4PRSzHf24kdcJuQSZ
t/FPm/71ZNl71f0ftkEBNcnFgxSXaVRh3FvYrPOgcc/hcEITf9x+8Rx+aunD9/H48FlgzA7X2eeY
uEIPsMhp8MR490nXhrPZ4bokkiCXq+havg4ss07MwwNNrd7e5TsGuluO80BBFlHmfVesZ4UXfs4X
UZyYHBhI9UwxLW80cDNVPs8FKls9j7qgESAX5xVdHzXI12o9yZP5SaFUfJdyTv1P+adYSPZXD4XL
IqbBGAA2mYU0Lx+k+cbrRspYR0Bbh4r4hcY25IIYp0EXAGrMuSjdXmnToG6YhR6jLjD9yhq/giEp
Ma57r9owuwNArhQjAit1DiVIm83oX31tmXy2IJPXOOS8gSnJdU6NjBieDjrlyr4zdKxELgEDalF0
zTOSWUR1/2Zon7RfFlGyJVK39QUj8BBD3JZbrggumNO0kDl/G9dCo9pp0t5VQ5hz9QB7TQvWn89Q
ztUcbv9R6z63pXrjZ/JFsWr706ZFmUqJbE2U8TaaY3FLs2AEuUfj94sp4+0M0U4yuz34AvH8iNU4
W7z96baboQe3iu0KbspFoCvN1httTOtu+Zb4QzEX79CgCiEqJbQlPGGS9ZjTrxLzskm75PBK2WZy
AcChhjQPh1aaJdXjx654AONeo/hBLuCpBq4jxQ9yAU/FLT5Q/K/Ivoy8aZY963F2DLHztEjbke5L
1XlsoT/U9rvOch+JYLn9kcizTGec51ycdJe2XB15XsWUIA1l59Mbc/w5FwcvK37oZG6yIK/OKpiu
+9iC9SeMnCXc0p4+AMAOCPrn0t106S64WNcA2966XD9dUyT6ySlezuhR1r63HWMWsDuC/rkMxa4l
7RIRb11mozaUYbr+S5dTxezDcailwCAX2MvL+ouCQTLgMOQy+//oMcdbV2Y7Jt/oVKDxSgi3IBIB
jkqucTjId0vA4cWUDF8oUR6setgOYgFHJReVTltMo42D7TxHH124cgIyPQPk7Y/KD65yD/rOFSaW
zkAw5YvYZFiRK5Li6MjkLj4yxajHdTQ4wLGhnjKxFx9h7vvex4+ZLGRsh9d/ad/J2jJvXLREPMQ7
vtHQ87rBMSTbqYrI7vfQNZh9PdAIJuUwssjx+/xjOTL80A+MV93/ux+dD05HhtFqVWKh+KxAGSMX
WWahsDxxCf+bZsj46nHqZTrxIn31IzapIjc9sfYa4AG4pRYbS/8+/JyPqPGb8TEfFEoPfP+qfIZb
ZmLjDzc+I1D2yHVwQLj1rEPWaK8p6WmxyrbofN/uX1XSBCxOTIl4siULGkdnV8PQwK5zrqiRdeWB
1aJl5CpZO7EVgJ4LOJZZGCWFOcqoyFWqdmJ1FjQAYD9+TXMqdwyKDFBSFA5eZYnJlYXByAUcxziU
d3NMt8u0Q5qlNhDCCmKwxDLrPINQbmK3g4H4UrYjnN8BQCNoI9cGPVfZkty0h3f1GwHZkHgN+q6Y
IIyEq7VZNCnecuSLxqwH7rHcMDbrn5VcsRtfu0XQlt21GU6/Al65EoUynKvkefsaNxHD2xeQt6CR
r+davDbMSi22Qo/+JjX3jmKMhdmrBWPBRoxspjb7KprD3K9MvdPe2oevl2R9DxJ6sSsIBAQWNIr1
XEJz08W63WefF4tgW5gaL/erLQETlgAs4fQraZdGnX7li8YmM9BUpsPbFyC26bnIc5D8r+o2RWDx
lMifesSdQ9Tpl1/NnOH0a61oDN6+gDC5cvRcBWqv5OKE52tRXhohSzRWNBLB2xfIlaXnqrXuRVnj
pJtawulXYuBKXpQdJORMDN6+gLV6Lku/Zb0ozWlkhoArHJf3nVB2XnKcfiW5VeL0K6GU5qavJgee
ilyLIy5jNdrrkWtynzU8sdKcaXnPC9fflusATJug2HnJd/pF2vvuBndci1euDAeu+d6+zEWglA0N
b1+nQvUdGn6Hq0dpT5U8tnvDYyoFZJmF6xcnnqOFUfGeEwBoPnIBADAAkhMAALkAAOQCAADkAgCQ
CwBALgAAQC4AALkAAOQCAADkAgCQCwBALgAAQC4AALkA4HHx/wHVGYfaWjezEgAAAABJRU5ErkJg
gg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2008-06-17 11:07:12 +0200" MODIFIED_BY="[Empty name]" NO="9" REF_ID="CMP-002.08" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Sensitivity analysis: Overall survival, outcome: 6.8 Duration of follow-up.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1wAAAJQCAMAAACtjpU5AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-10" MODIFIED="2008-06-17 11:07:12 +0200" MODIFIED_BY="[Empty name]" NO="10" REF_ID="CMP-001.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.10 Freedom from treatment failure.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA10AAADgCAMAAADPGfxbAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-11" MODIFIED="2008-06-17 11:25:05 +0200" MODIFIED_BY="[Empty name]" NO="11" REF_ID="CMP-001.03" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.1 Neutropenia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqsAAAEACAMAAACj9s9zAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAYn0lEQVR42u1dy870ylX1/51GGwnBgCCEogTEYzBkimrGgIeDV4iU
QT0DT8A8SphwOygCBmfrfBC+btt1v9pVdrm9VnL+r7tdrptX7dpVXt7+RhMAXAIf6AIAXAUAcBW4
JR6jVUh8/Seff6V4fXj+K6Rz9Pnn6+/ypzpv+0fppJEHtXJugfTKXY8ZFTymUqPX8zEcVb9aLBYa
enxajr665JmqrmvWvANX43jMLZCJY6kBdst6Psaj6txiOa3G9WlY3aNb+kWdLVZT8fr/Uog8hRTC
KtcxS2Jp+jw4T+XsEPUc1F8Vue9iV7/PPfo03wt9X79IeYaV1eW6FJBSV/C06g1Uz8eQPF364uWy
Btr9GsSridw+huXZo1Gqi+17gnI6l5oD1nNAu1pAIammcimna0JK0+mzZw8pD1zmXaeeg+9ZCWPW
F8EuvC5WeySlvzB5HhuCqiPV82PM6xca38ts88XZbd7qevZow1Fd6zEm/XHrOZpdlXOfqF6Rll+g
jgqxYTQbZ+uTVcfbPx83MMPlvlYrQm9QnFC94er5bVDtitXeUWZD4FSM6q/KcVbswCD4Bk0gALsK
AOAqAK4CALgKALth6gFWOahwVDTxVbgtIN2ztSQS630hs+lFuBKdcpWrEEH97Os7rey1FFclMU6d
XgqHYHUcwZ1SncnJ0eLt3ta7QBUfTrFCSFHRPkvBuA8yTWMvtdl0cXCu+WJEZctltqPnfpYrFfxD
PTFEFR+Bq6WEiNIYX8KSfk7mjR+dUiWdlaH6joehF5VZ8utzlcI0qorU2sm4cLJ5rut4FoEGTmtR
7vMGaRuwnGwIQEVoAHgm35L07sToVbT81eVemTWrC6cmS0WlcYY1Owp9UkAUKoruJfsK05gqcv59
TiIzwsm2uWotp/4kVBt3XJ0lRxFUQwoxhk7wlCp+2HbeL0cmxDTeGVnNfuICfrVRuCVJp3/S05QQ
R+WabJ3MT6L29Vy+eXfSQz0+z3tdKDF8FR/+/F/VvNozCl0+t5GyQHoWHOZ9ct3qmVp+kz/Cxbqw
8dILcxX7Wv7WrCum96jiIzSx1bK1jy/vlZMeFAXLzEa5ylmutZiY0pEqjOV2NIWI5CgPeYhx8Cp+
ON6qZy9S+w3GGcKyMSLRD1nqy0Bt9unM+uTqd0PBtTIfZPA6XLnGQqzZLZ+E7Y4IW9LYdq4dtoof
tmu26DvXzTHpWB3HXzHOkHqKkHY9/QRxfzVYzFKfiMdsVlkclWuoR+y+8uYbWTos3C5bf5NOC9rL
bkevYpnOqqooIWMnvLUONd7s5Ckt0nRu1ShVfBQxteoSyJOjL5yE+maDqj3sKgAAwGXxt0cX+IBd
BTbiaOpAEwhcBeAqAK4CALgK3BP2/iqT9Vl/tb68fphd6/Cftk73ml0yW7sGpblyZolQlquq4Jqa
cn2gMlQV0HmQVdzyu3NhrE/PPIgnuhdXmewupuTlWfjr/uHlajWjqvO3oD7FuVI637Jc2Uvt9mMk
X6MCbPS5WRz7bWfvE81k7YzP0wOgPoKdv/T1q9de3ff8w8aIp9RORlO7ykVXgTbnylSUaz+rpUZ4
fc05O91sRUAD8Uvv19TTbAdxdeak1ZO02ouSrslZlTpQFWdrcy22wlQ1mCo64JWU0nmbRZDfMx1G
kiz49fDbvw+72xaaRXhBRdeDTnGdOjlsTCFvPdzumTRP15GnA/1H6mRbC2bgM/3VhDeW9xn7UpGy
V6zfBaOiiq2zTjm7Cxudzuk+Nx4f7ghNdQWTvZI41m72KDKXZUGRgYpVuZ8FefPx3T0iPlzPiX37
yZFF75Egoszm0inWPFuxFo1OF8G34eoj6Hdpu0BsTGr6CM8evXbRjD9noE8N7FbmWK2SzZ8pW9vI
SIgdZQp+ObHXD0ZEv4opZzy/PL9neyxO3QcwJhVQddhF5H09gcedF5YDgjYdusdFg3YFAFcBAFwF
wFUAuM7aKrVVl97va7GWza5z8/c6a/cauUGu7IhICvSr5mG2FLK2fnWunt1266g694b61aQkpfz6
t++5jNJ0OcbVOg7Kj5BMruz0XoF+1WwJOyXYajby2q6PWupausGm1cMd7GRqpxcTsVqK5ZMSuLKh
mp+P8Utlxf0kT9Fj3DrLwlx1mhodIFdWz7hNtdmG7JnRQviF8/276X8bmYgiH8DJxpb8T9psKGtg
iFp5ZmqJWWlO1c0XjLfvaKbSZNpPpbQ17tqehmjR7n2rz97D5lFQTV/eO8sC7EcEyPjlrK6tvjde
6jMU2sGt+tVYvYPVW7PWJ41xR/xxgQIG8pRq/VUqZVLZpE3V+lVDoRpIT4lStjjnF8fHburxU7J2
DA1PmwapW12ZJ96b310I++HMRGqk19jSy65BuWGqTb1QL03l21LVeS6A1QO8qUnPPlw8Qw7or5al
b65f9Rf37KwFyM7RSO4d5ekuAtat8VchcD3c1YF+dePMCaqO5ZffVL/aaPUMTG37FvpV0AMAVwEA
XAXAVQC4yNrK0Emy+8cVXNqhSdczu2hWiu5618ZfLYysmk9ldlp9/FWn/wL61UT81VvrVymyrCTv
4jihSecu6yJcVXe9m8ZfLYysWpCKAl1SHn/V6r8lP+9oJP7qWfrV0wKxBmNazn29qFNJ9fwSM49j
/d9FuEoNUwXT74+/2qTVsUz8pzF4Y5t3Tm4K3y1ffzEdXJFHtNsMlar5MyW6uo9w1b1GjS8C7U0V
aHN9N0TOUPZimk5gaHjEfC5fz71vxaYKdbJUqqHnrbwhR9PhDwTYV7VGD1AUWZXrI1RW6Vcp+ygX
d7foLczbmf5qehZQV+Q44UpZ/NVqSWdZVFeqtkE1+tVEwpGk1IOtrfJXzbvK1H+Aq32Hxu8h6JdR
vb9SFIZ1DLN6Hj5KPeqsA9CXqq3jrzZ8cqW/sxhp+93s7SPjd1k/kOdo9Q/+WSbPrK1OWWTVilw3
xl8NZZ3WrxqebHl02PfAN/hCQwH61Y0+AHACWQ897T3XVsAxvunGPQvoVwEAXAUAcBUAVwFgpLUV
2y+z9xablDpk/ElpXDescdsoTTekT6dyg7Nu0K8q4W8q/qr94PBJ8Vc/p7HeyW6+UXQX4hrXrZk1
UJrWp0+ncoOzbtGvLp2Sjr/qxm5E/FU3/qplUth8BTgt6j/TjqwWIadx7bCXs3XnZueINBpJ+/LJ
HTrzXqpq43fmFzqdq2Y9bJNiDHXvR/MT5TWuezjR9iLs7HBK5FQTfK2lZ9MeZPoAJ2/iPmKeVHAC
ivxI0XY0lLiU3GEvp0mRaK/oVrub05b4qwmmLD5ZKOKl7fXebW2l3qTgyjY4OT/EL/V+jSvrWMR5
z7KxA1CUazAoOjd5noeSdWUlcDnCWX2Mx9XIkKZN17uJxpXbTamHOXnl5GnH6PdHJv4qZ6ZzThnY
Jg7AIt7kC1G19cKGy1Y/9/IBDP/M9gHsA14SCpOlpca1TGlaHIu0rGolqQJq0wr9aqh1Xo5W8tjR
GwD61cFMKfSrRT4AMM68f9Bpl94HAM4F9KuwqwC4CgDgKgCAq8D111aOwjR/n9BIERCstpJcuDLR
dLLCEjvFX52oMv6qF+o2EH/Vvi5h7est469uFEOp/g6Ks3ZR1cw6m6yC/63jr+o7AeX6Vf/eFCWj
s0a1r00lAZ9j7g89osOel45Y75PwKlZl8ixN8AZ4m4G+ZE01ifNoKoftJjONxFyxS6YWpsDGd5FB
T+NxdR2pVug99Y0DVq5jI6iG0qd0phsTvYq2y+jKDLIEVXv07+eY+7Vu/NWJcm3K9Kr9p2GTW3tk
XHIvnWsUoqZGj5tNK60S7Z1sB/RXvStTIV3tGpSVtt8rL3Ic44UWtodsr7+GZYiwunkIUXYSTge3
p07jPW3P60qrSV0rGqnRr07r022JCKsZF+AuTP8ocbmDXzjnADT2ANJsosr47zXxV7lJFVP13hVh
9TZG+RGeyvVEZrt0epYP9a2jt2z5TFtjleYo8VfTRzmwEeudy9NdBKwb9Ktwro7YVKjt9xvoVyuX
fKdtDIGs7R2Qt1hbbVxlAC12O7b1PfSrAACuAgC4CoCrADDO2mqNDlTyBtCmAVZLVsaZF5fOZddU
oSCqqxcdNV2xDfFXvXpU6FePjb86GFeX/f+S9WbTAKsZTplFpaqVCr0VybYs147xV/16lOtXe8Vf
/RxVvPII9uKsVtXGSgtY125qHmA1fl3rwgNxBzXWvooVgHI/c5kAY6slsBBWr9JwXDX65musTr6A
NVnxHvdOql6xXvEMSxnTsu+g3tsRZfWIiVd0lOaG3fs56m7tI9wnAR119wCr6T4996Y3F7+FYKt+
dYOc2n5c6F5rK7/JnHYAu+pV4y7ecdyrHU7q4YRK/eoum0g9KTGwvxqiaiKiZJMAqy3JV1yFMr1r
nUKUNriybPRyfKsBt7af+CgZ5Jz+/YK6iTq9Kxe+5317PTo+UPWWPgB7AQJeWwCJGf7ACKB9yijL
NakQbRJ/1SqhVL+K+KvAqYB+tcwHAEYg66GnXXcfADjfkd50CPpVAABXAWAvV/lGb6ABrs1VwgNV
wEXWVjzF3lVlHjZuppg6vICqskUoVhXVdEre2tF7m6W5JuvlaFND2foHWUtJSvWrbj08/ap3qyAU
fzWzn7sPn6Mswj09QNVLT9UvNoVD78LevgFIyarZKtJW8VcdbSqneoO9k8r1q3497Er5kd+8+KvL
q5tv4Lx591jnF13y0u88dwfbh/0TMpsnO8a8cdXzUXRqxwPlCy0/d+tgpJzGMp5xY0WPl/0L/uch
fACnC0JqocMdWjW7B4umLpUjtz84NZjYO6nmZceZh2hS0YALo9Pv7IbPc657IVfVxPL64M9oHHMq
p4Rzt8MF6KLS5J31ilGyTr+qmsUUb3tRB91tbaW7e6KsB1ll0DYzjbrYcyXIKakX1z0CUKNfbXAz
6j47N4/aobrz0o6CugCYkbmCIgc3PIq1pdMO6uhhbsN/OObUWk3bD2Grw/4JuR7c4ZP3ceerlLcR
seuyGqcWm9Jh2vF5HTS8XV3nfuMvJV2DgLNgRzbdr7Esy6G2gAa5hsSl6nOpfjUUqjagiDXHhqt9
hX71cpP6mwD61TIfAFQdgawjuUpXWFvddKE59poP+lXQAwBXAaAjV6FfBa7ir0K/CsTwWbzAOYar
g+pXy5WmBe+JCUSO3ZZrIAuujb+qO47j8VftS4H4q6pHSvSrlri4s361UmlKBdRvk2sgi1U6Wa5f
VQOd9dTmqVutHan+8Vcv4a8W61eJ3RMymycdJZZkFtBKrFCSK7VtQQxj6Fe0dPVEFev4+tWqq5T1
NahLrmu3bXgTbSb48jJjcXqqoAO6+fP0679JvzoFFa199KvFt7vXybrqBdbZzJO5ckhSsDH+aqz0
eHOs1+bebx+g+BK6ZO2nX61ydalL5hXPTk3TJv6kQ6wngggy3ei+4tvoV/uUWiWz5tyMHs8jHQ6W
RxBlnC9j3apf1WuszvrVOrfvyFzdhu5QsqZPbSORfTO7WqNfVWQdQr9ql3pIrvbBjfrV9NG0fhXx
V4eZ1O8J6FfLfABQdQSyHnraG6ytdi2ugR2AfnWXXQUAcBUAwFUAXAUAcBUAwFUAXAUAcBUAwFUA
XAUAcBUAwFUAXAUAcBUAVwEAXAXeA//4U3AVuAR++Jtf/QW4ClwBf/mv029/OL0WxrOB4vWveuBL
P/ollh+/fhFzildSKZ6fVbL50FfaQ58ZE2udxVov2S5XlZ1wczVL04WuXWB2SzhzqT5Ko9+FVejy
3W6UUSWzjqJNuyP4p7/6j2n6+b+57Tjx2UAp5/9M5jp9LJ4J5gv5Sm1fvbXbxaEteNVkLtOoQ4tc
VXYiyOXlsC50/SQz40B31FKI7nXpH7YaZV0AqX/oS5u//t3XP//8s7Pt6iMy7oVpRlVHOobWGFyv
n+bPUhxpVmVoTmiUa2zY5htYZHNMgyyT9jdezSNs25//5/c/+X6a/uv3fhyNq88eEEKKZSITmo12
P8qdV6qdEyDbDxC7fV7mrUrLGOGimb3v9P/E/3w/fVF1+veffj/w2upJ2tgUObsETy6LUxvgTLuN
pkPLl5B+v2TtZVm3KB9D5msRs/7N3J4ofuf8HcgHsLtD2PZEGNfqaXWlkGdyVaZn70a5Vp99dre0
xR/9y9MF+Mm3/x55z8q/8sYyYESISV6QC9tqfVxbf/2z5+T//T/8ODJX/f4RtmcgrAXsdLw7IESP
y7elHeY5Jf56pgzvsPWD/nJIl//2T77++fnfTcNx9UVFOe+emF0hl2NSJbHWXOZvxxk3qyazmyia
5epmnksV6pZUlYP5e4etVN4pmTq2wY9/ME1/9pvT559v5YGQSvvkmhPx8M6AkOd1+g9/+n9//Jsz
d3tqfQDZPCEQ2kLYRtWu+P2//8PzzWqNXQWAq9hVALjQPgAAgKsAAK4C4CoAgKsAEIKhXVle5WG+
b939FEanF7WwfmU5OW983Z0rzy3lacK7O67IVRrr9UDqRadkj6EmuZI9FoCr+gCvN8S/XotnvSt+
+XnSB77SBFM2AVlGu9Uocl/Dh7d3XdKu2qaHllc1M7l2zvj8SuOl7OUKNM0fVH0HroaMkP6Jzdex
UyZ1Cz7pN4+34RXDQX1Hrtq+HMcOTD1fYEutBwLBlr4jV833s9t0oQClmlOgJ6fgArzH2ipqWV9O
o/JZp4SdbUcnblsAVv1vZVfX+fy5anp98ad5Z8p/pWztA/C8nFpyblVAP2cFOJar5PxL6/9dz9FN
0uH6Ux+HlTq5wcDpPgAAgKsAAK4C4CoAnAk8G/iGSO8aF+8pZxIeXgrsKnAVPDwKl+tWQ2PAPUft
1S4JQjJUJudvWK0y30UjJ3dDkBVWo+ps1Ce7nsFKadXsXBXCPa6huLobFLTgltaF/FtH7P4lxSaP
+eQXyPoQTeFT9CBkpd420wUqNZFdFUuyAwzEVZ5F80yrjJ7Ux6eNYWVxnjZJ28DnN1bpV+IQm6bJ
kzkxldz3nE8P2LY9FNJ6xyk8KK5KT95xtDzhMaVkuOorWPXHmbTOAa3hX5nnCl3WaZdNRQyZKZOc
XYYKa0NKYf/BbD7F8loNq6aqWylfLnsps/pOa6sIV7ms8Sap/IIoOF3W3THlyb9zr0ql9Gkb7GGg
UtpfmMUI64wBDOIDKGET5+nL2+x4wfBaFDMbHjWgBuPYyYlMRxgu64D+KuUvP+2adAKTNJd6idZU
TdkkoYPh01JnlXnVwCn7AImtKw4eYC0YNExkxDgGnQQu4F+Z9aT0sUgJ5DXmooaU9s8+BQkPLyXI
VUvBqrw5JSR9fbK8SeObfZWr5aLsKlbnjCwlbbjKFDuwZmPXJe1iuKrZ+fTrMJdDcR5CW8250zm1
Ri2rQMHSJJy1m8eme6y7Fohty9pcKL/z7r7ROGOEBbaa86dTnGTUondDqVjtlFtHq++x8hcOpGr5
vMddhsA7sHbHBJ2gKjXxAIJUpUp/dXst2rKAmifUqW/A171NjM7lrfouUABNjbgKvLPBrViJHl8A
dFbAYXPkzgLAVZjVqxQAroKqaW9ynAK+kXtaWHFUt7no3Y9kb3vS0DiFSnV3AtkTueSFqsE/771Z
ZfcFOyJJ9Wsu7qw+PbFPypShIJXXNJh1en+Vo6dR7aiyzgiJsClRrrcTaO/4MVWc4+TAQZUrcAFE
46+aYVjNEKu8GMJgNFY/DuuaiXlwzZcLRmiJLovrRhFwUUTjrxoi1vkOpqFYnRLRWG06WEpYU+9q
ykdTzkCWbJU3cdUNY3D2Hbia2VGwNaVONFaqYoxNP/OhEpOBq/NCNq0R6A9cVQau3GJxfD4uiCbI
2ce0ZiYHYxQjltq9uap9xPJ7DybJoha05GmF2geq8ICpg9crr2XdCXNyIefXAa9/raNiztXLvbq4
QAVk/FuBD1Aqgif/eSdOks3fVmBKMrlgHwJUtSDrmfLix/rhyU5FGPXjmkLuLK7tPgDNSqrlj+Ie
WQIr85vxmRwRlnWSzpj0hgK/lFscrMKyhcBmPlE9lT7HboDTnNtsBwghZqsnls/qi/5lNWNSpExe
9OiG4qb5w5pCLAmcRCV2lfx9IivS6hR+yI+sj4GgrXaQVjIXYikVD3nFpQypW9NIqNWbWGFlDJ3P
81fnl0kqWj7/ZxpW03TK/cXNXwxrLaRUn1IOwHRFnVWL7aa3NquzhzlfdCmkiM3avk+aciwWf9VP
W12cDPkPJZ7EBTWBNEQWw/urIkc9kygiseTSuab81YriWu4DAO/iAyQJLWTpEm2ZoLsWt21tBbzR
7pUzJ4vJtYKvyV0nctI7R/cXl7PAsKt33LkSev2+TMHGT8akvH60aKY+66Npp7K0uOePnk8wl5Z1
FBArGHD5ObWYsDsAPgBgzvcDUxV2FbgMYFcBcBUAwFUAXAUAcBUAwFUAXAUAcBUAtuH/Ab9yaOn5
DicOAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-12" MODIFIED="2008-06-17 11:25:05 +0200" MODIFIED_BY="[Empty name]" NO="12" REF_ID="CMP-003.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.5 Use of antibiotic prophylaxis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAGwCAMAAABW/rc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-13" MODIFIED="2008-06-17 11:25:01 +0200" MODIFIED_BY="[Empty name]" NO="13" REF_ID="CMP-003.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.1 G-CSF versus GM-CSF.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAGwCAMAAABW/rc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-14" MODIFIED="2008-06-17 11:25:01 +0200" MODIFIED_BY="[Empty name]" NO="14" REF_ID="CMP-003.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.2 HD versus NHL.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAGwCAMAAABW/rc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-15" MODIFIED="2008-06-17 11:25:00 +0200" MODIFIED_BY="[Empty name]" NO="15" REF_ID="CMP-003.03" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.3 Age.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAGwCAMAAABW/rc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-16" MODIFIED="2008-06-17 11:24:59 +0200" MODIFIED_BY="[Empty name]" NO="16" REF_ID="CMP-003.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.4 Haematotoxicity.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAIQCAMAAAB+CrxLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-17" MODIFIED="2008-06-17 11:08:58 +0200" MODIFIED_BY="[Empty name]" NO="17" REF_ID="CMP-003.06" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.6 Blinded versus openlabel studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAGwCAMAAABW/rc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-18" MODIFIED="2008-06-17 11:09:12 +0200" MODIFIED_BY="[Empty name]" NO="18" REF_ID="CMP-003.07" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.7 Concealed versus unclear method of allocation.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAGwCAMAAABW/rc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-19" MODIFIED="2008-06-17 11:09:21 +0200" MODIFIED_BY="[Empty name]" NO="19" REF_ID="CMP-003.08" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.8 Published and reported data versus unpublished or unreported data.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAGwCAMAAABW/rc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-20" MODIFIED="2008-06-17 11:09:30 +0200" MODIFIED_BY="[Empty name]" NO="20" REF_ID="CMP-003.09" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.9 Size of study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAGwCAMAAABW/rc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAoMElEQVR42u1dve8tuVn2vfe38i6wbKSbXSVsRLptoGIrkBA0dO5C
xV+CFIkCif8D0VBFonCfCgqkdCuKFJCgXSX7cYF876tcCOec+fDrb3vGM+M553mSvb85M57XHs/j
1689z3ieSQEAZ8BzVAEAqgIAqAo8Hp46Kou6/auDh3TqPF2Tg86croTe8VpNbnzLrgeldypU38Xs
iarxS1X56iyr+EsWLrHVYVd7LYtOHEu1rwcsZk9Uta55vPLbH3Vtsur6d2TzlGTYWepWb6dqETjd
ynLni+X5Ok3VuvhDKdtDMbuMVfWNR9d/Lu1Z35ioxx7m1suMB4c9urpmQqebLI+gwZivSwF+8YcV
r5tiPomuYV219tqrXmv98M5jutl+GKjFoczsr5j9zgAolRjkKCXOjjn+0+ZylH1MHduYOivm845v
pY6Ps24HT0/WaRCt/UHJGOegmGegasZ1LvCrtzrvzx+r+V530eN3W8xeqaqHqtEDtZzK0azeamqO
G/VPt3fv56/C+ephFGkKuH/xOivmM8hVgHMAD1YBUBUAQFUAVAUAUBUAQFXgEcA1AOO8mCNUSs2S
TWfkU+aQ0KqGhVPOCSpcilqzhVaH5zaa7fYFnZb5KbUwT9HZqUIMqrFAcRyJ3ZR2mM/kh9ZOZvZf
wicnVzUo4kovz1IsroNOs9hPzi9dNTJbajWfjaq8dJ2t6aGi9UQF/9CG6KGET4F7NQsPNWtdylJ6
Cv60x6Sckw5CUPOcg8lDdZb75lyjR42qII1YMpWm1mzG6tSeVeAKxZSV+3aBzgjEWaXbHjvYwynu
ztsQtfMSWrHq+IDM6tKVU5CxnJqdYfWMypwU0ICqoqegvqA0qoIcDgxpdEYpWW62xKoRb5otNV/k
irszSXVFiDlKdSEMPKKEz20n72ejE/IZ7wyd63UTt+9yicrNSTvVk+mklGpvVtcIXHT8Iu0u1L6f
4y/v8XmoyodubwtK9F7CJ7/zr7q62jMKoz33GnWJ1izYylebDfuOhVGpFTX5LVxNgxovveIj2NvQ
t2ZQcRclfAp1arVk3SaM9/JR+cC+vdmQVT0ItEYPU9pSFRtpR1OoiEW9x/uKfZfwuROpes4iNdHA
zlCWg1GJasgyXwdKs1JYtpFZrx4K7hXXhHs1PofF0ysQ85ayYxFlaxib9rS9lvC5HZWNcs5pUkw7
LseJVdgZ2vQP2i6mnyAeqwazGcsTPtNkkIhVq81mrYaqxK4sr7vRpa3CrbNpn3auoLnMtvMSlulV
q3JSOnZCJ29gbNV96uorLAnzlT76ojop4VMRUatugD52jYXDUH/dYGp7rwoAAHBWfGvn/J7gVYGF
2Jk6EAECJwGoCpwErl5VO1tMfylEmZo1OWHDFvKLy5pCjxyUxs2CVzUs8tRC/AGUHuU0OcT0H2qy
ZoQ5OvZcy7OhcKvgVQ3FYvziSYrUrFrNie0nFyrqapW3mKqoEK0Cjxarhld6YUcL1azjY2T7ibFO
STuUt5hqjWgVeDiqBpjAxf55NatRf9qkn/andayRx+1VolXgsWYAgpzROhcyWitwasG4XahPdpdD
VlH7wGPPANikCDI4M6By1Z+uwqqKqYtEq8BDzADMYaWrPQy4uJCaVYVeNVaZeYHkAH8TdSlweqpa
ykvPeVWqWYfEKvhGU2CZU+0vplohWgUeAS2UVav5AwKeEXuHYk8NiAqiAaegagOegupAVawKAKAq
AICqAKgKAKAqAICqwN3CnqwiaW2bn9aP247hLbDwn7bvh03m0mbtIpSapeuWXGt1LuGUWhaWlhXA
2JBWduN+585YW1cbkoR8JKqStCtYJm/OSF/3D433qhlTnb8lBSo2K9OGy6ySl9qtyIhdVgBilc6z
I//iyduSA1c3xusGk/DtvOrcsMfmKsf2T9c/xJp74kbItl6Vyu6BXGyWZJHV7XzW3MLrS0753mYZ
QvKhf3L32l+COIKqAyWtepSTsyipmJxLqYOso2yt2WIfLKsaU0UN3JLKtG2ehfSrpn1D0gV7j9QA
XCptZFmEFrLobshjoqaNgjWSoVA9fOEDZ65hI4kdY0e5jWct6YCPi1UTgVhBvLgpEWX+hm13v2RR
yaZOp5zchVedtvQo6+M8uc0zVREk7THEvk5zkyxzNgvyDJSsKvQssE3713d/eO4GTeR7T4qMdveE
lOm4YiN/X9Lty+0intF2Ogt6EKo+BUMu4xQksQ7NHKEhljfRGftzCLYpgn2ZOVLPyYZtmS1tpCHE
jpIM/jiy2vdE5C0AdDcdBuX5udpd0cFbAPRAofq5uCr2j4A6DwBAlwMhFx16hLsGuQoAqgIAqAqA
qgBwjmFVaoYuPc3XYhCbHeAWTNbUzjHmpjtKrJKjGynQq/LDZClibb3qUDz74q2j87kPp1dNqlDK
7377essIS6eDVC3dkGKtVXKqr0Cvyi+FnBxsAZv0Lt4ctdS08u5nq57cli65VHr0D5ObGLdmQSsx
ifxwjG66KtpO4xQ/SM1tllk1aWqEf1RZPPZwarEPWdGfhfAd5/cL8b9t/ENRAOCYsQX+wviM2RUw
ESsNRC3xKe2Zuvh+0fKZzFSaTAXIUtayR7VHIZqz+7Tq9caN5qmglL6Yd5AC2C8ESLbnsIqtfh5e
GjAUesGletVYuYPFm0ybk7p4Dv7Uv/2egqTaWFWWEqn0tZlavSpTpAbSy0QuSwLzU+P5aubRVaK2
DwmP6wTlZoUlErTW3mPw9bnTC83NvMaTnnfwSQ1TLaqGeikqPShTnbcAaH5RN9Xh2YeLe8ceY9Wy
9M31qv6wnpyBgLQtsuTeURKPIVhdumo1BK37BzrQqy7qNcHUzoLyh9SrNho2A8tCmIX1Dr0qAICq
AACqAqAqAPQwrGKySHL/uPpKe+XR6cxNZCplD7pr11ctXDk1n4rXWv36qk4FBvSqifVVH1ivKiPj
SendGmfl0aHCNhGqzg+6266vWrhyakEqGaiT8vVVrQoc7XlHI+urHqRXfX3QSmvBRSuHmh7VqHKu
93FRPIrV/iZCVdk0WSj9+vVVm1x2zIj/8gUtvOZ1XduMF+PP7+xcjKdopTFVKt8tExW9jVDVvUOt
b4Jcmypw0fX1EDlj9heLG2Vzh/F6/Hno0yriqlNhqVJD71Z5DU6K/eX/9k2t0QAUrZxK9UtQVulV
Zfa1LdrcnzfwbgfGqukuYL4f+2lVCtdXrZZwyhKrlS2wVq+aSNiRcrqvYVX+nnn3WG7fuucZh7aZ
NLMW7P+paWliF/9QHH5eGkxne/9tmdp8fdWGr6lsHylGLv6xvO1TJuSydkgvxtp+bc9CNWZtecpW
Tq2wunB91ZDptF6VRbHlq7/eA54hDOoL0KsuCgCAI7i662n3OKwCdopLF85WQK8KAKAqAICqAKgK
AD0Mq5w1TPPPBlmKgIi11evppQunUtVCZBvpVYWs1Kt62uCAXjWyvuqsEn5Qveqy6bmQiLXRkkql
C6cS+7eM/631quYBQLle1X/uJ5NqVn7uuLu9XvW16HFq6Cna5mmsBr586ry0KrkfX6Wtpk9G07Iq
dR6yYaqyr/YuQeRJlZ2zbOAJbLyI7JfdUXVqpt7yqfPSqq6b2fAaZBWlj/m8u/S69XLWjo0r08Zo
s482yohX7S+c8D6ynl1fXRascz7/afq9U9meYdnn5ySKlpub62h8/E/Niluz9OWmXW1/sap3X6i0
29hYxJoe5C1dPicXAktDvmIHtXB9VWBBA5LZHjj9HpDcprHnYq667JqtGLxOrzqNi5KK1Ez//3jr
q0bdZvAH5Xr/xt1/hkyy8m2ZGr3q9uurrlKkPuL6qiwanTsxO5ozXXyoZm15Z9N1P1uLMnvRq6aP
UmAC1jsX66s+eiM+CNCrNhrsYWnVI7naOvq4j1g1HlqBqZtC5l5frT+vDb58+dU3zkRV4FHxvXfp
k7feB1WBzvHlW3/9xSvx+b+/+2Ufwyp1/UebX9qNnlXooBpOGk5W1+052XDoknbTCFxN2Q9lYZfQ
yOr0J5DGPazGUujUoGNOPxWX72C/TJ2y/O2j/Mo3rOPf/+mn49Z73/2jo4ZVz62bo6e77fDX2zR7
rmeNdXrZsOrLHAqc2pCpJit9K0Nrq+w6XDY7h5UuII1VY9qup6Flm9yuCayLMkft3DelzdfeGpn6
Unz2B18/yqu6MwB68CfDtatbk548p+JO1CS33Sxrbbddw7ZW2zJVaBEoSEOrQeiouyx3Odfi6pRj
b3hRC/HRn/5QvHwlrv+9uvz3g6+//cPjY1VlM0oN3djU0IdN7nmVfbLK3vstoHuymq6Eo80twvt/
/GMhLkyd//vRf/3L0VTVLll18BbGam+gsNq7gh2/3sj/6EIn7R6urYQ55g9nM7qFQ53q/3l7vvjW
4V51DJzKKtfh7hhOXXyu0odU7Da3s5KpYmElxOykW9M+HuFHH3/tEqMK8997H/yog8mq/KDEr9Rm
I5kWnGpM2EVMbV7qqMvdp+Lf+e9v3vr+l0P//9Y/HxOqWjMAyoksixqtUnYLN+OJoS9UezL1SJ/K
r7RkUGXSB7O5HFYqOpCYju5D1h9/9O4Yp4r33vz8D8XhVNW3+EqbOUE9/hqYyDZ5RHfdocWUxBpD
8X2b16naJEJWQ5WoCGmdw6FKiPTcOlr4iLngUS0ShWuIDz8bn1N945e/OazjXLcSYGklHTouOBGS
9aT0kVX8/s8+F1995+Pi8mwdq242pQOmFpN1KVM3xie/+quvffnxkVWD9VWBpa0K66sCAKgKgKoA
AKoCAKgKgKoA0BxMrzp/5Hv86S4AGsW2r/XOi5Y2XgdgE7PALlSVnb7iz1cabWqU2psF9g0AiGhc
s+O25ewW5sAlTTBlU6e64Wfb7W4EOI1X5bdwXl6VLR4q7fW85kVXZbsVqiNd9ZafbidQ9bxUdbpe
Z5e1dnh+ycAmXTVt9yHR0sUlgb6pGl8PkDwGb0VV6fv0DcwDJ6cqSU5KmbrDpxuewJfew7Aq6ldv
caPzZZCwl20aqgJA2Kua5VWthcV5H+/09+4qrE176PIlTpdbB05HVen8K6f/s05fhpJseL83mlLC
TNW9BQAAAKoCAKgKgKoAAKoCAKgK3AP4ZJX75bnqBzqBB+pkfbo99M1e9mHqiDR1eGgmQ3aNUX/a
iX2cdxb9WQUMfkGYpx2zxYOt7qi6GqEvOFp3WgrpPX/iH7uPSlNDv9nnSWUyifnw9qgD43lT8Cz+
rW4wtecAwFWsckkq0SBaZYpVnsykn+gjp9NGpWuY0DEvbtlLNIqqxkTGuixpcUCvXtVXrNqORjiK
VePB5PQhXFfbMsUGxEUw7tdsA085h+wkGd+b9LeU5BoNj2gl/0S3Xxo31ABzO6QqlXXt/LPM/n2U
wS5T2n9lLJfQqRTKy2LUHHPmPu3omA+Uxko0iCCgvu6PqnK67ZRnL4kykq8KdZOJYxLvdfZ9LkN9
3fOwqoAEspwFoeiUnVXMAyrIalGwmTqLJGSInc8AJOasKBwmGoUg60Ajcz2ykNKWx5b5AHKZ94PP
PC1VLcXqHNDNwtHbljUEYr/s0Xy5HtS8P2V98N6SzIpAhtG5JGPGtxt35K48djgdXO4Ai9ZXzXTZ
bSK7Uiu1ueHV/0bYe33V6kcAlO0wd+ZB5RQ9WHp3seryuK4RF2TzhCY16HpCQK4CgKoAAKoCoCoA
nGBYRcFRyqJVyLxnkeTNTnKNioipRvkWLdOnjnMWGPjfE1VT840r73TqMXqR1pTr9ur0qWMO4Opd
BgDENKijONWRrorIaqv+OquTEUfxOkhbow2h6frU4OjdeVXHPXHRvCNdFYnVVm1uWMpXrm/lqtFU
JCDsXr9On8rDAbjVO6RqxrtZoml3tdVCOgTFy+GdQRFBmT61ILABzk1VSpAk5rcCm/5vqu+hmbde
GCCApXdMVVnrjaTNrChRZAHhZZi/FC4MgY2PHgCUKt8ledSipNd0X+DmOteEp401m4IyovO/X6o6
kk2y9arC/2WLWi15qXUSU7wOAyVpZhTct/ynd/a9MKRan2rJX4Hz4tnp7uBCzoGqrbG3XvV8D1aX
vesEpp4eJ9QAyN1OAkBVAABVAVAVAEBVAABVAVAVAEBVAABVAVAVAEBVAABVAVAVAEBVAFQFAFAV
AEBVAFQFAFAVAOrB31hVl/90cuu6ab/9pYT3Mlhgl398tGvMO2l0wMze750BvXrVCzf0QMjY1nVT
ZU1qHWCnsz3aNeb99J4ZhbsFrzpSLEQ796e6OjclBqc3+sfpn9FHXrbVnHh2yTpNuNtJk5tlmcwG
h51RNww8Vqyqkn23GmmiLXqJkFvWWju/h7NFgmg3Hqqb654ymQ2oaWfMDQMPRtUgDUb66omsrtcd
O3JD1mDAOpuOtoUxF6XSzl2FAgzgUWcAOGFmzmmdixe1IfN4FjOjyvptJ5lLXC3CXAYeawbAZoRP
nWzXO3ThAW+oSgNMzxlnswAecQZATX/GqFQpPhxSoeH4PO6xPad3WkGnrRIRcmE0Ddwz+PJqhndq
dKyaxZfzvOo8Jjd/rEnY0AyA5zndeVU+A2BZZpMNSmAGoCPs3bm1WAmwhaeDtwRVF8WqdSQDy4BT
ULUNT8F2oHxYBQCgKgCAqgCoCgCgKgCAqsDdwp6sovD3y+fDMnWI/Zm+pDaaGz4cdd2z6IEDGSOJ
RDyvEqNF6dOprKvkqbPfyZrPmWqF7ZC2xanupHeuVTra+Mscr0WLmc1mVJ2+O736oombG/9IEfvI
aokxytz9yJezV6ZPp7Ku0kpNme9km3PGWmE52NnZf2L53T4F/khe1f6euuVPmFsZfQZJy4lM7oDG
D/2lXO8SyKbJFiQOXQ01sZRpKuLQj27Nl/iC/5BHU5UXw/YnrJ17O/mWpNSnz0muZETjm7CywmXC
UsWl0vIAZAdIHgAc+/Gvp1gQFex8Ijtl9DLIaZubUct8i7WQJUUfPC760LxrafjObJvY0URkgcJK
O+J9rGHVEJ+zapCmWSc6h/iNvp1PYoVjZB+2LohVG/f+RVZlaEfpp7+LTMtk6dbV7/Lu9/gAINie
5aK7bdf00u/41p3ZxcdUK4KWdoS+dzx3OpQ5JPUcZ7Avp5R7bdL7Synnqa6zMLX1oIbKRj6PFACw
0MwOAOwDXhIZpop/8grGZozIafK2MLOyspWkmnKWJtnYK+dLK4OX51m0kseO3j2e4ZPOnTlSueTQ
Ef3J3m8B4MFqp53+TqedeAYAOBhy4fDp/ntHeFUAVAUAUBUAVQHgDMOq6ZFqUj+xhSA1M7Z1VKHx
AbCsKkOBDNZTk6ZLtkCv6pXD06t6NXuMXrUvqo7PrksGmk0FqRlG8ayS5UrpFSJ2M2Z9NWmqZEv0
qn45pG/RuqrN9arHi6jzVOVXT8ZFTU9HmLPYQJAav6uVz1QblyEuNW+pTpS53ZROIVd6Ao4Xwb2y
N6qymrk0VEuryrVCTQWpi27iaqYWEi3jchectqgcFNNYSvanUf2+Fn3O0j6Fa0T617K5IDVdowc/
6KbiN7aW6lVjbEwrH10n8iCxqn/BlI79mghSy29ky/uxSQcw1kONXnVVOVb3/jUdba8BAGdqQoLX
RJDalHvFZSiTwVLVpckFYSyxao5PMkBUZM+rRiuE0vvPqJQYZbBNfTCtKMeC7v/R8MRr2pmVHMSf
ie59R8HkRnmUmU2qYJvoVa0czFHyJ2ChVwU6AfSqJQEA0AVXdz3trDMAQAdB9KJD0KsCAKgKAGuo
Sg/zpi5wcqpKgQkB4BTDKhKxd/r5YfYEhevuAiLKFuuDmSVGkyIZNqdZajZZMEeLGjLrHySjHinV
q7rlCK6valkLrc2amcddhdedjL+D66uKOCfsw/Mem8Gh1QKXz/vJdNFs1WiNYjBVMEeLSqnqIO+k
cr2qX47Q+qoUPNdyEve/vqr3YHVYDYjGWqehMsg+7J+QmTRZ0eDZPZeZ46K+Pch8ruXnLm2MMqeq
jBtureJxrN/gb/cQADgVEJIH7R7Mzj17SStoVTrpVgilGhN5J9Wsr5p5Yya1injRuzxra+H1Mfe9
jKpzp3Lb8HszigWUIhHXrej/txFl0sqCxRhZp1edrytsq4T1UjyeXpVVdnotM4+vBdW5sDblNt58
FuGUFIzqBP9V66uufwT1KJM2T7XtdOWN7QZVhYyIW+f+l2oChna1tk9N9/LsPbi+Klld5NT/8+VX
RWRPfFpnXTe9RQRcbj0ibh3H4bLFbHRqduOYGurbq04dP/srk3FBIFIYJZbR9VkX9NQlFmpzqFpf
NUYRigToFXrV0LqwAQUsbxrJtVnvGCV6VUjR95zwgF61IAAAU7vgaleBUvfDqoccYXY/3INeFQBA
VQDYiKrQqwIniVWhVwVieF08uNmFqp3qVdMW3KVeczkFloZdZjVggmrXVzU1R/H1Ve17gfVVRble
1ZISb6xXzVogvyQ56otqvaosK9kklizXq84NnX3A3FOz2l9l3Hp91TPEqsV61ala9tCrllBZVCyb
RbKVVdn2CmLoQrJipKrHqVb716vW3aRspCE3sTrVG1U1CB5pxBZXHjssSncUcvtafn30/V+kVxVB
Bes2etXyJ9xTT10TaeStJ61SSEawcH3VWO6U+7rrQ66vWn4DXa5up1etC3PlJtYr3pMSYhF90uun
J5YJJPkwjxPvR6+6TbZVqmrKdedxG+nlXqkDJcbhstWlelUzvNpYr1oZ8u1p1b3SFcrV9KltJLF3
5VVr9KozV/vQq9rZtjKbtGofXKhXTR9N61WxvmovPfpjAnrVkgAATO2Cq7uedvph1apRNbAGfepV
v/78k8NrBiJAII9vvvWzLw8vxAssWw3kHdoPfvn3P3d3fvD94wIAdf1Hm1/ajZ5V6KAaThpOVtft
Odlw6JJ2wwicZa/dS2hl1Vyvl2i4QJOnGn7r1KCDpVd2qZVtTvn2eZH4UdXksiP4m28L8Ys3ft1P
AHCpZa3HGnDvh7tp9lzPGuv0smHVlzkUOLUZU295OKVobTVcfD3kxS5z5k+B8aGlu6XWlrnxjrAd
1oWy3LccjX/v2y+F+OIrvQ2r9OQYxmpQxnMq7kRNctvNMt972zVs682oql0WbGA10dCiGRb1I8pU
eJVxnmD7GaOP/kS8evlKfPzBDzuiqlM3SqvL/0fiTpvXqjVktOs9UW3bhQB2vq06QttOaVNTtW1S
sY4/W4qiorbHn30uxKvL35/2EwDc6kzFfcvUQUXuxtAx3bpLpXa8Aj01pVt5AyHMequ60qmWV8JY
3Fip01cz5t7qkmN45vztYbJqjH3ynU6Au2OsdYmf1B6dUiT+03oLq9loYWKlWlYJsVJPdSp2bfoe
fvKeuMSq4uV/dBWr6mqmmhHsA2Jya4KPqtqHOpEaVju5hF//9Nb/y3c6mgFQzjiiiIFK2Q3f3Kkh
INiYxrb9VrlV2TE1MM+BlNDV5BHM7bJz3O/WcMHJbfGbf7jmc/jjKi5XUWYKYP7/PFPIN8cjwy0x
I4PpLik+LzjGfFuOqpx5Vd3casyDqXmGcx7HK68SYsateuXZhA5rntl8VBdMIzTBVz4Vf/e3+42U
81Rd3AM2S/foUMsnUTat4jf+/F8/ffNoqq7TAOjmCUHWpUzdNFz9t9958/CqeQbdFLCwVZ3KqwIA
qAoAoCoAqgIAqAqAqqgC4BxgGgDno7aUXIOKY6tXWvkSp3wF15VW7VVR8T7uCana21dlrSVOnUVG
1/GfrYqKBeVPHQDQsKwq8WU1zW5hDpAIp2zoU5s7b7lLhwBs6lVtvyPdNZ2t1Zn5Aqxy3bLUZZza
iFVg6p0MqwI38rpyqAwn2Oy2N/bXBFd6L141RhJKsGe7Jb6GhXXbelJw9e6oao87ZMqDbjcmK17l
H3jgAMBzn8TWq6YN++gNLWPIf0de1Swxb3W+0v9ivfG+mwYATS0/2KKkd0tV6fwrp/+znliGkojt
huey8aDNsQe+3ksAAACgKgCAqgCoCgCgKgCAqsA9gE9WkSPgpAWfgaTwh3Snb95J62OsU4r5A422
lJSXg/yzjI4mLGY1Sbjklfh3oPzSjF+LnSxSd9JIULUJZIi8trzFl4gaJaojJRVeKwranb4yGk9i
SV6tr8OGBKuSFepWGjC15wDAVaxySSrRIFplilWezKSf6COn00ala5jQUU/N7SUaRanbN558sB5t
E2DoGbyqr1g1mzT0jvaB2YPJ6UO4rrZlig2Ii2AKlChDdpKM7036W0oSeSqiiR380ngvsoCyPVKV
yrp2Lsrz76MMdpnOc8ya2z9n55BSugFmvbcNlMaKPgYRBOHpa3dUnT/TTHn2kigj+VaQUYl3y3Bb
hgeLQDfDqgISyPLYMRSd8i63lAdUkFUqSTSjwFnkzC8A/c4AJMYXFA4TjUKQdaCRuZ4aL0WBk2Ks
W+b9CgwDfVLVUqzOAd0s9LxtWZOf7BdZrrJcFup9336wEHlfxdiNziUZM3Yh0m8sugUeTgd/O8Ci
9VUzrqeNZyq1UpsbYVK/DfZeX7X6EQBlu9mdeVA5RQ+W3l2sWjhEbhYvLjcj682CricE5CoAqAoA
oCoAqgLACYZVFBylTPOkdbP20pORuLOTJK1sKzSspfrU8B9MVt0BVVO3cOW9TT1GD2lNUxrWYn1q
8I8vsAZOHAAQ06CO4lRHuioiq63666xORhzF6yBtTTWECjJRXaMBTu9VHfdkRKuDF2IKVZFYbdVm
g6V85fpWrhoNRQLF/r1yQZ/5KTEoewdU9W9sdJ+tTZXFrAkuHR08N7zElHlkBso9NFWJk6SyB6ZU
50z1fXLYWweFMsDjUVXmh1kxJ+l9CaJiXetFGla8UfrQw6pxrFREFH+1VRJ5x0ohpypvWHANYOqj
elUnPCQZ6mojq6268lLrJKZ4vdkd3+2Lf5LK07CKGn1q8A8mAk6LZ6e7Z01YBqqux9561fM9WG3x
rhOYej+xatdc7cIEAKoCAKgKgKoAAKoCAKgKgKoAAKoCoCoAgKoAAKoCoCoAgKoAAKoCoCoAgKoA
AKoCzfD++6AqcAZ89JOfv3F0GV484T4AWfzj57/4vZ87+z74/r5lYExVt3/nd7vMW15q3HnZo4YU
t6RaXbfnZMOhS9p9Xw9TU6HVVDDdzupsTrlWeW4m06kOeL2Ejet5U7OKV1am42/7oliReBlVm+uO
4K0fC/GzN37dTQCg9fAfJ65Tw+qaYLiNt9T2vZsqXe17CbeiDJmyQrSwOptTQSqPh02m05bONANT
U2Mmptq1f9i6KOsOaLNjU/fw7OrQXv3uwZ79KdLoFXeiczU6bpb53tuuYVurXZ2qDnUJjazGmm3+
Cou6Fu6OddL7xou5Qxf2xm999vKVEPS9Dzuj6vX6ldJq7MSUIaNdi3rlfWoYAej2DcS+QM94q9wy
LrioW9+277/gnU/Eq6tb/YuOZwCunI11j0M8cKWyOvYKnD63UV9oBRLar5istyyrlznA0PlSxHx/
s5gnht84f3ukqleFI3fH0OoSLKldeqD0vU6WuI3V6jD38HppiU/efXn596V4u2Oq+vdd677vgDol
Q5aVerdrffO7t/7/G//Zs1f1akfZYYGyRq7igFhAqS3u3pIL4eeUBOuZPLzD1g7zY486//Arl3++
+j+iN6remKiHWRNeEXo8puck1nCL79vRs1lFGUJE1cyqazyXKlQvqSIH7XuHrVTeKZkytsGv/lKI
3z54WrVmJcDSGlF3FKb1FAkofVyt/+Qbzz5788h5nroAQDdPCAQnD5YxdVO88/bbbx5dNc+wKB6w
sFVhfVUAAFUBUBUAQFUAAFUBUBUAmoOJAMcvl0yzV+YrJLnvkWz0vRIyH1uX/LOqTcyOH8uKfzML
6JiqnX0Ccv6sqrSbUBuz0m4LwDkDACIav9J323J2C3PgkiaYsgnsr603a0TeFwHxDavzeVXb70j3
e9H8x7R9SyP9L0tvEwe0tQ+mnp+qIQ9kdpEMfux8k5Bv6v+vf9u1BUJwen9UDX10OnBAuB/b3SAO
kC0twpPeHVVJclLKlAfdIgDYlFHo/+9hWBX1q7eAcY5XRcLLtiMTNc4A4/078qpTZ34dMLHvRPM+
3unvbylbBwA0jKRGy80y2C5UAfakqnT+ldP/3ajRTbLB3ZcbBatyqxgYODYAAABQFQBAVQBUBYCj
gNcA7xHp2eLSueRMur0zgVcFToInj8HlOtVQE3DPmedoxwQh2SlJ529YoDI8O5OOdSbBCotPjZl5
yy5nsFBGJTsUReLBVk9UXQ0Z9N+WvEX6z4vI/StnMnnEl36GZA5JET7FtEGaxdo8XaBQQtpFsVQ6
QD9UpUEhT3LSzMt58+phaPY3V49kPOD1F83pJ95I4o7J0zWRLHnWOZwe8GxrGGQEjiLcJk7LTlpx
tDjdLplkqOorVs3mwFnngFHsT8RztS1Tn0tcBCN5yiRlx5ZCxo3KcPDAL1/GbE1u1TDVLZQvjz2X
U72fYVWEqlR26ZxTfkYy2FfWPSYl4T+sn3OV6dMWeMNAoUywMAgQpv4C6CMAmKVMlGcvLfPiBa1r
FMkseLFANmjGjiXJg2CEq/3FqjJ/9+WqDifQQ1NphGj10zKbJHQwfFrqrLKIGjhiBiAxZ0XBA2QU
gsxBRlxjMEKgAvqV+U6ZPhbJQXoXc1Y3Ktd3Pvl0e2cSpKqlWJ0juVk4etuyIkn2y77J1epQchWq
gyFLORsusowdmMzYZUnHF65Kdjj9RMSl0IIOoTnmzNmUGp6W5Z8flYQtuyYWPVhdNTRsm9fiTOmu
J/XZ1bEWFphjzp4dT5TkemnthhLRPEFuHa1+sEoX7MjU8j6PNmkBd0Ha5d1zms7ru/8gU2VlrLq8
EG1JIJsnNKkfga4rrzHakbda7Ma3JEUjqgJ37W7LB6G724eyCtith1xnH1SFUz2JfVAVTE2Hkt3Y
fybd08Iao7pJRe8hJHnTkkzVFMrVnQAkT9eSF6YG/9z5LJVdGeTIIue9mXVlzdmJ+VGSGQrK4nIG
LafnVSl6mqxtU9YZIc21TOTrTQDaM30kK85xLFBQ1Qr0j+j6qnyZVb6EKo1uMLjaqr/O6mSEH5zs
UkH7LFFiUV0jAs6J6PqqTLQ6PLZkClWRWG3VZoOlfOX6Vi4XTUUCWa5VPrmdnxKDsndA1cxcgq0h
dVZblVWEsdnH3yDhBJwiF2mzGiv5gaqTeyv3VxTvjAvWC6TsK1kDkYNLEGO1tIemqokPC32Wo1eK
+s+SdxNqX57Cq6Qebl+xLv9Wb/Czvqr0a++VmeULEM35qXC2KUYU/90mSnLNn1AgmSRywQwEmOpA
32Vmz0P0u2mnxj8z9aQlqeK/2LZ0ZFfWScawNFMJdNNqUbAI4+QBcTtRBZU5x74A53IeaCJAKTV4
PTVuzz/MnuEH3zGedfvfbe+8c9ozeNJFmcXsOYkKvKr0J4islVRF+H0+aW0GFmW1F2GVfAyW0u1I
L7uUG3VLGllJ9WF88LUnnXpTvj38nPfoccv6M+8Umie+bepQF12Y2fjDt2clKvaqnaPFS0537lQH
9zTcda0C91+7fXdo67aps519dWZapLNdNlnVJ1e7MHGCWDXZnV5Y5fBDJc5SrTNrNAMA3E8AkKSY
7QF14izdOrM2wyrgrqatnNBSiazzVKLSsdZlphZeDLzq/YYB6tbx8h6Y7WJ98kAvJ4nFOacDDzjI
0syuOyP2clEClgIGTgIEAACoCgCgKgCqAgCoCgCgKgCqAgCoCgCgKgCqAsBx+H+Na8nOAq3U5wAA
AABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-21" MODIFIED="2008-06-17 11:09:38 +0200" MODIFIED_BY="[Empty name]" NO="21" REF_ID="CMP-003.10" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Sensitivity analysis: Neutropenia, outcome: 2.10 Worst case-best case.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqoAAAIQCAMAAAB+CrxLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAtdElEQVR42u19Ta/1unWe3vPuYBkt3KS4tuGiaZxJZp0VHXRSZNKZ
Ru0f6m/p3EAH/BuZuTBgoGhukyAFei/auGlzF3wM9JytD36TixIpUVvP4+v37L1FkRT1cHGRerT4
hQYAuALe0AQAqAoAoCpwPzw6qsv4/FcFD6nUeaqkBJU5fRzUgdeqSzM/2e0wqoMq1Xc1e6Jq/FLH
fHPKGv6jCJfY42lX+1kXlTiW6l83rGZPVLWueb7y55/xs8uOn39nNi9Jph+lZvV5qhoCp1tFHnyx
ZrlOV7Uu/lTK9lDNLn1V9eTR5z8f/Vk9majmEeY5yswHp19UccuETtdFnkGDuVyXAubFn1a9bqr5
GLqGddXK669qb+6nDx7LzfbdQDWcysz+qtnvCsA4JiY54zhcHav/p/TljPax8dzO1Fk13zq+lSo+
z3oevDxZl0m08icls5+Dal6BqhnTucGuPtu8P3s8rve6ixG/22r2SlU1NY2aqOU0jjLaraTlzEz9
0+2fj7NX4XLVNIvUFTy+ep1V8wvkKsA1gAerAKgKAKAqAKoCAKgKAKAqcAeYGoB5XcwRKqVWyZYz
8ilzSGhVw8Ip54QxXIvSbIW5Ts9tlPGzL+i0sl9SD/opunHqMEyqsUB1HIndknZazzQP7V3M7L+G
D6fUcVLESS/PUizug0qz2E9uXvpYKVtprvlixsJLV9mWnhpaLVTwDzVEDzV8BO7VKjxURu8aLaXn
YD7t0SnXpJMQVD/nMOShKst9fa7Wo0ZVkFosmUpTmm0m16U/j4ErHJai3LcLVEYgbjS6bbGDI9xo
mvM6RO28hpavOj8gs4b00anIXE9lnGGNjKM+KaABHUVPQX1BaVQFOR2Y0qiMUlKerSRXLd7Un8b1
InfcnUWqO4SYM45dCAPPqOGbbeT9YlRCPuOdoXKjbuL2fVzi6JaknObJDFLjWD9bVSJwUfGLtIdQ
+37O37zH56Emn4a9FpTovYYPf/AvurrSM4TennuNSqI1C/by3dmGbcdGr9TymvwePi6TGi/9aM5g
n1PfkknFS9TwERrUSsnaxo33yhnzjn39bEO5qkmgNVsYaU8djZl2NMUYyVEd8b5i3zV8czxVz1ik
FhqMM0bLwIyJZsgyXwVqs1NY1ihbrx0E98rUhHstvrrFyysQ66fR9kVGW8NYdaTttYZvtlc2yzmX
RTHlmBzHVzHOUHp8UHY1/QRxXzVYzFyf8Jm6gISvWpxtNtdQk9iN5Q03Stor3DZbflPOFVSX2XZe
Q5letaikUcVO6OQNjFbDpyq+QombP6qzL6qTGj5ERC26AercGAunofy6wdT6VhUAAOCq+A8Hl/eA
VQU24mDqQAQIXASgKnARuHpVS3Xp/bD+HF+PUmhToLVVNWVGY/CHPEa0KNDeqqoE49YHPmNIqrn+
u4pXzOio7h8A2O2rmmGJHLjPVy2ruwpTnSCbs9ZTyxsVzC5Qw1fV7xWkmRoZ+5UX+1S7DwrWFOhk
BUAFxTOrSs5Q3wDAIVSdxEYBVaAK6BWXRGtkTgXrCtRYATCFiIP3e2b497irTzNlYbCrwH6qBl6c
SesMlR0edtRx4b3oqH5YUwAoA5RVwEYc/bQHD1aBm60AAACoCgCgKgCqAgCoCoCqAACqAsBu2HEA
mKzP+qv15fnD9BZY+E/dxwpLduls7SpIs+XPT7Q317WGS2oS1taogM6DrOLm3507Y336zIN4oDtR
lcluYErenJm+7h+e71U1pjp/JRUSZ0vpjGW5spfabchIvkYF2Gh0szj2L569TzRxtTHeRfFNjrKq
a8eeuyvN/Z8//7DR3RM3gupaVZbdA9qcLZMo13Y2a+3h5TXn/GizDSFV0X92f7V3gjiDqhMlrXak
xVhIGiZnUspAZZQtzVZsg6moMxW0wDMppfM2iyC/aep3JCX49WgNwMNutJllEVqQ6G7QOV5TI2eN
KeSqhy984syn28jDgb4jtbGskgH4PF814YgJ/MWmRKT8DWt3v0hUs2XQkZNbeNXpnO6ijXu43TPV
EEz2HOJYo9mkyFyegjIDNStyPQV58/Ht3R/eXKeJfevJkdnukSBK+xWN7L1k2Kd2Hs+cd7oIvglV
H0GXSxsFYmNA00d48uW1d2b8OQVtqmBfZo7Ua7LpM2VrG+kIsaNMwS9nNvuRiLwFgOGmQ6c8v1Z7
KM5cATAGFDC14wnkTd2Ax31nlH2CNh26w12DXAUAVQEAVAVAVQC4xrQqtUKXXuarMYnNTnAFizWl
a4yZ5Q5jpVQwZ5frVQPnrAJWU68a1sty4Ojt9KpJFYr87tdvt4ywdDnIxdINka5UUPJQolcNnbPU
2/wS1sty6Fx6+dWqh9tZyZRKz/ZhMRPzp1XQykaXn47xU1fF7TRO8YNcPU9t24glJZcI/9guJb1E
Rdle1tiiBi//l4Hfvg6/r2Mksg6Ak4Mt8B+0zRjY+ramGmQ2pT5TN98rkcNQXrKsC6wjfqp+lO+V
zQf/YPahp1XvDWvyENTQF/NOUgD7hQAyfjnNbSp+Hk51n1dysV51sQPh9OmjRWraE6Y+3eXdk5NU
6qtSKxskpo/u6aH0gaN+sps8XnzbzTz+lKgdQ8KTuF+eumllmU+TYnZD1eeoziQhLHdrV+uOCNuY
Wrse1lFDvHov/dsj5OlZitWgQ2i+lsZDPwslpb5qJj3L12mZdOqsXlWfE9LZar2qfdTVqxaoaV8B
W6NWQ9B6vMcBveqm0QpM7cwpv6Ve9ZxpM5BtXOhVAQBUBQBQFQBVAaD7aZWhCWX3j6lBM4WhrGOy
NAqdJA6cykXxVaXZ5nMNqEsL9KquzlagVzW1rgPdU69KkfmkGwR4cJWUU3M2EaqKA6eykbpetvlc
Q+pSuV7V19lm9ars3Jjz9Krvw5FB14JBK6eWntWotLb7LOPh2B1rIvChNqmLtJ5Ut5KBGKkbz91U
+O5BbsYvh6+D+9D3YKrqHm1HmtVhlqPjJJ33EGtr/NWMXFSSa1BTKqQ27em7ZzxR1QWO6v3QjvII
eF0hVWro3arAeNRM/k8lD+Pl2UrFeulQwIOOSls3vmrmqi1H4Wzv8SxfNWX4l0Z8tuNRWpWcU7n1
ZgknPylCN46vKij4fisAmXsa3NLiADmaeBsKLtreRTb72nZpfOwk5x7aoTeZCx07xL3ch0XFWZep
c66dSkFuJrB+pPwk2zZYc6bDQqqWiTLFAtOibJOpPHVpkV41VIJUr7r8PNxDsPoFMqnOTCX0qlsc
AODEYf2Y015xWgUcA+hVYVUBUBUAQFUAAFWBa0+reEiuoyeeFjpbLCY0rRsmtxJhqVjWWpQ+ncoL
6br8IFEsGqFBKKVXXdqOvHMPja96rOAvS1XzIfYuxDWtWzOTaADEe2uL06dTeVJT1h2aRXFbV6pF
9KqBCHcxNeud46ta9sS0HHM0VbJE74s5yGlaG6zhbF6y2dkjjask94fiQUM0Vp2A9YosbSqdTVW7
2d3wqvbLK9af9RPlNa17GFH5JuxscHJzok2XytsdkANApgNw7trtI+ZEBQefyI8UvYyKqpY0tfRD
dC6La5q+URKOuDlV1KsO2iMLVJZsj/de06rJPzeagTgRhp/zN3q/plUkGd2wCQBJC8/mGox3Wkev
Ssm68qppOcBRfXRH1Uh/pk13u4qmtVAy2oUirsBpqUfoV0cmvipnxnJOmdcqo3+hZPS1tJuiFuR7
MDUcX9VzAOwDXpLIfKKmpjWXSal2U1Y3SaqAmDSrV/XOKdCrxo6+PKBX7c2QQq8qcACAjgb9g067
8AoAcDKgV4VVBUBVAABVAQBUBa48rXIUpflng0aKgEC1lsjCU4Wm0wmLrKFXdVtNHl+VnfhBxp9A
fFX7xoS1rjeMr7pR/rS2dlCOtYupZtb5dAX836tXNRrNSS3Xq/pPpALxVS0VRkTrWlMGcL6MOktV
q9/y3AzLwxFeLAaTZ2aCz7zr9PI5aypKnQdVTGXSuK5po1ARbslUwRLY+Br5nbqj6tJNTS2qVqZy
wMY1vAYqovQpjcmecrVgNJk7V6aPJZjaoH3P16ZmqZq62XbQ1Vwn5WpNOXg0qMkwyr+yVaAInfpy
Tb1qwes3rYfa/nxV774USFWbBl2lFvFVsy4wlShCyXL5S0iGLWs3diDKjsCUvVdH3wBuuSN6qU6k
RK86LK+yMZUua/CtNlt/k3jbwS+cG/0rD/8ZMlFhdHdpJOCSZYUtY8VU71j1zxj+r2RViY1BzPbm
9BAfallHXlnz7bXaokxZfNUCRWhRfNVQwNTQUQ4swHrnIr7q3TvxSYBetdJk77QFIXB1p4f0otOq
jfMLoMpCx7bGh14VAEBVAABVAVAVAHqYVi0hgEgwP60aQFUyJWbBvppUpJEVhG3N5OrWbLteVbdd
SK9ql+/pVecl2DvpVedlf8lEs2oA1QyjzKKS9eKi0FWSsK3pXN2a7dCrGm1HsQiq3rnrSc8lxLpN
36Fk9RFsw0mdOjeiJVhdmrB6ANX4XT03BlA818oi3VBBdNA1+xcSkaxSP1Q1moDJ7tKmVoiOIwsN
bZgq7AIZk+vd8q161W1tlzYcexq5Q8nqI3xjArLp5gFUy7v+nmQtCm+gV2U8dQlS1evZnPY/m+pT
g0VVSlYai7W5XjWRJVPNS9k52nbkq4aYmggZWSWAah1HgKnQXxDVtzTXYge7cC4YrB3fQ0L0Jume
nP79iqN/kb61vV51T8HFUt3rOwDsBQJ4Tv4To9+BAT6FZZRWRZZeGF+1vl41HV/1ZkB81c4AvarE
AQC64Oqhp111BQA4H9CrwqoCoCoAHE9Vvs3OMsDFqUp4jAdcY1rF6T1t2YxryXYk1YjEcn+o1fkl
Wc6IZIw1TWm2yYo5WlSmaBaWnq9Yr+rWw9OreqFEQ/FVM+u4u/Deyfzb0wDko42GfrEZHNrdevu6
H6WrZqtGa8VXdbSonGoO9vKU61X9etiV8oO7BfSqNAxHbLPaEVUn0pnhU9lsOH3YPyGzaLKjw+di
l9qP20v1cNFHyYJ8qNZVUk5VGa8NN31uNZX61fjcnV41JFGtwLrN7bV2myxhqsUdKmBu6GABfTjz
xkwq2K809vyuVng/naRD2gVZhvVPq+k2PMccyiHh1+2wObFuU8NmcCWTrzMr06uu1xW8OpHRvIki
IBy0Mrf3rsdXQXNubE1qY81XEY6kYqIXI3VmJXrVCo+g7rJo8yjtp3zU+z6NURbhMjJUUOTghldI
trTaMS3dy7P3N8eYWtNo+23r9bB/Qq79dsxOG01si6S2EUXoPA9fD+6pamp145wW6tuqLgO/8ZeS
fkHAU7ADl+5XtApz2ChUlcVXjVHEeZt/i141FIs2oIA1u4arV6V7hFcV6VURUPXIBQ/oVQUOAJja
BVe7cpS6n1bdcobZ/XQPelUAAFUBoBFVoVcFLuKrQq8KxPAuntwcQtVO9arpHNxQr7mSAqFht+Xq
ZbFBr2rFSB2GSHxVK7uw1vVe8VXFelU/1mc7vWo2B/ZrkqP+UKxXJUnNtuhVrRip88jm5WgtRUW0
rq+vV/UCAU0PS3m+VTy1EtuHid0TMosmDTu8HVWqlkJBkmutK83UqAvJykKI56eTOkX/etWym5T1
NKhJrmu68khzmeDK84DFomJbtvL72fd/k151CCpY2+hV5U+4l5G6aEvqbO7JXNmWEdSPr5rUElp7
4d5tBUB8A12uttOrlrm51CR3aVz/DfFVM04ApY4uJd9k1eZ19KpHbwWQOlgSX1USI7WHCKqny1a3
6lX19KqxXrXQ5Tsy14rsScdIvUsE1YK+UqJXXbnah17VLrZWtslc7YMt46taXSMWffXlAb1qZ4Be
VeIAgKldcPXQ0y4/rdo1qwZ2ea0bb0Tru/TPv/x1R9MqAIjhh7//u19dwFcFgH/2l8Mv/se5vqrp
AIyf/yj9Tbk1GkMHx+mk6eTx8/OabDr0kbbhVa2VHpdaqNq5Pr842Zql6UKXCzYbIZy5Wj+aGYzz
6ZHD1slrrca1zIZG9SfD8H//4He9OAAfra+W++LcNO+j/uXzrPnOfnyw2ksfCpxaD89ypxKMEivm
qqbPXqvMpelCl08q0w10szgZzD07fthubqUTNbZwf/z9MHz3R31Nq9RiSGaTMmrLOZpGVCe3zaxh
e58/TZ/V2M6oqgZ9wcvV4UK+NNE4khkD5sMqWc1a40gSf/HnH/9889d/9t+7mVaNo9vco9Idffqo
rC5unTzmRtQ2ZB3Hof7tyuSq6haz8XBBon34d999/PP98O97cQCUS1YVvEexhpkoPB7Tdl65StdO
1c7VM6q5IuSNkPFXDM8ibvur+TxZ/NduFqu0dyYYGx3uzt7ch839sL7qUKKG3cCKuW5wc4saId79
I21+OH78Ub9vhm/+Y0e+qipmqp79vzBaUyXThJHiDyTwt//wMf5/86N/1c0KwOh4liIGjqNtF/R8
YnIIGtO4Tf5bcjXPkUyqdPoxNDUa3SmdVafxYOvwv37y8c/Jj6vMRwCjXgJY/7Ommesio1qab1nW
07PZ0XDy1nXVhsvFxjpj5XVVM1cVNGnWuqo5HR+Ta1ZeeqPBAtmNg9XkxlHjh9Y29uffnv4IYN/T
Kmn7nO5svYKnkaZG4yb+4Wdf/t/vzqXqPg2Aqp4QZN3K1Lb40T/5x787uWmgAQC29qpLWVUAAFUB
AFQFQFUAAFUBUBVNAFwDhgZgfufRDEjpfgqj0Sut1SK0hrJdNq00rxi4ClU721W2WoTWYLZuHGPg
kg4AT2FV2QyrqX8e9AEewimrgIIfK2bL1HJMABpaVdvukGvKzC9WAFaqafSCI3bLwGlg6ktMqwJ3
8TNyKIUTUBs2VY8dzmDnq1jVwZtp+V/YZ3Cr2QnVzxBcfTmqmgEsbc5QgFDVCdCUURj/X8oB8Mwn
G/GqeUhY2X6Zivn+C1lVHWJ+imofGOPJ3eCqgQMQDNRaYfhnLKS+AlXJ+ZeW/4xBn0JJGtx9Gvxi
K+ZbO1vgbAcAAEBVAABVAVAVAEBVAABVgVeAuVjF5r70w4Y1+MBujWxuwD7vkkf+aUNsm3snmSNd
MeWm8w58Xp0j+U6J2RRaBerG1t6R3JtQ8rZU3Q0KkdeWt5D/vIidlAmFqvvdkJsum42GTgnlO1OP
ba0hR07mtSeCqX05AK5i1ZSkMk+iVUOxaibT6Rfe0HLarHTNbXQZFKpa2SZPLxoEjL4yRDRXoGbP
VtVXrFpyfB4cxaq2PrRshOtqWxbfgE0RDKWpwNa+7av+wCqAKcRYlpBsqbB+Rcer21IHvb0vjGof
VGXZ0G7qR/07R8FBUvKYlG0WOZ7vWmpyg+cc/QX+C8W870kSwbCzHVB13aaZ8+zlQUZyMU94cCTU
tJVr1b1vJn94APqYVlH+7pOcJEwRosdeIsjsexsgUT57uZMbOJn11Awiwu5WABJrVmG/jbVC0Bgy
I6s7lGIOp90DgU3bZfaC3gssaZ9UtRSrqwu3Ckefn6xVT+Obra6Xq0P1Nve2UHXKyHcPfA85l29Q
+Zp+f9Gt/pQLWHsKNsVXZdpzuGpZewtlWMytOHOPVdm93e4ENsW2tXmw9AV81e1uYN27T9UTeieB
rpcA5CoAqAoAoCoAqgLABaZVHJyeLOukRZMP7+kje+uRTFaxdu6G8nRdcTDivBUJU135K5anrk/V
1C3ceW9TD85DIlMz7Kmn1CsUpjryV09SDVzYAWBDgzqLUx3p6hCJturHWV0ycRSvk7Q11REKYkpx
WacBLm9VHfOkRauTFTIUqkMi2qrNBkv5aupbTZ1oyBMw/QNLMcqxV0pkWJ8Sg7IvQFX/xkZ/s7Wp
JGYNhSwdxZJyyC0dEMkPVF3Mm9xecXwwFsQLTLItKPIPC2WA+1GV8tOsmJFk91W6grjWSR0qxyqD
+fydp1UzM0Qk9aOt8pA3rBwyqvRE+OTPA0KVN3Afq+roOplCQ20k2qqrK7VOMhSv00SJ9IoCRVwD
b4AvFqZGZarAtfDlcves2u5VwD4crVe93oPVGm83gamv46t2zdUusgBAVQAAVQFQFQBAVQAAVQFQ
FQBAVQBUBQBQFQBAVQBUBQBQFQBAVQBUBQBQFQBAVQBUBQBQFQDCMN9YHT/+r9bPyvxh/TQ+v3ov
gB39Shhwa6v6wU41U3H6o38wDyn90SI5ABxlVVWcegGbOdvZ559xMavmj+4fAKjnq47jwqkstWY7
O/1Rq3cw/aiMY5ZFBoAqvuoH38bJOgatqPI92qeXqlwDrN0IBWsKHL0CsDJ19VXHZXwfI4nXYyNs
KlDZqkqY6viv04AfTrwcg2kFKq8AjEPQBo5jiKnzAe+IPt04BrsK7IYZXm2cLaEarHXV8TnFn+3o
+smd5bsrALPHihWAl8XRa+lfEL4JuAZV8WAVeLEVAAAAVQEAVAVAVQAAVQEAVAVAVQBoDlsD4Ozk
q796u6TzuhN64E/dxwoc3rzSTWVVQZptfM+sklyNfeam1CSsrVEBnQdZxQV28Gbn4HPHWX75vTge
dpOzcKNJe6Nq6w/P96oaU52/kgqJs6V0xrJc2UvNmZ2xdYZLBdhodGtXcP/i/Y0Xp83FW1PlXapt
OsSqrh3b2En92XjzHqdrd0/cCKprVVl2D2hztkyiXDftyS027yxnmllzzo82++yDia/Or7/cesH1
qDpR0mpHWoyFpGFyJqUMVEbZ0mzFNpgknYkHKslVJ6V03ubFk9809QlDQatq/3q0BuBhN9rMsggt
KObXOqlO8ZoaOWtMIVc9mnba4pV4ONB3PGjz7nOHf9dXzQ0FfFo98/eCGt4vktVM704vJbfsqtM5
3UUb93C7Z6ohmOw5xLFGs41TRnu7SKhmRa6nIG/GtrDWuirriSRHDetZTCVK+xWN7L3gMnM1q3DV
6SL4JlQNOCCTr6W/6AFNH+HJl5+P2n9OQZsq2JeZI/WabHZYs7WNdITYUabglzOb/UhE3gLAcNOh
U55fqz0UZ64AGAMKmNrxBPKmbsDjvjPKPkGbDt3hrkGuAoCqAACqAqAqAFxjWpVaoUsv89WYxGYn
uILFmsI1RqFeNX1F7OhGBHpVV3Oq62HrVefVGOuqPK3rLH67mV41qUKR335uIvXhLOkK9KqibJfs
BCUPJXpVT3Nq1MMWsJF3VZ7WdRG/3cmqzk9WDan0bB8WMzF/WgWtbEjkp2P81FVxO41T/CA3yJYE
mdsHSVgmBz7J6kbiNqkzlEXx1Kt+HYbfC01CXQfAydUW+A/aZgxsfVtTDTKbUp+p29tCUlVxyVK9
qq85jZzBYlVXC6Rzfz6tej9uRfchqGqgYUk/0iLj2PLLaW5T/efhJWyor1cN+zMdPfZ+XKqonpwk
pjNvZHW9Kh4cGnjbzTz+lKgdQ8ITst1WbPlZhca7O+t6MFWfozqThLDcrV29RAfZNWDdVfX2CHl6
lmI16BCar6Xx0M9CSRu9qpDUcr1qmnRar2qrcJeVY7bfzrm5XrV3c/O6gF615rQKgtYOfY5b6lUx
Lz3VhdnY7tCrAgCoCgCgKgCqAkAP0ypDvMnuH2NeaglDWcdkoWZB6SThcLTwk0qyzabP52qpSzfH
V9XPXsJ61YH8NQJTTXszvSpF5pNuEODBjTw63aAmQtX1qT7nuVegAZDGY83nqg/uia+qLy+gV3Xl
W04uE93br1a9nxtiLRi0cmrpWY1Ka7vPQfE41vpNhKrUJjWVpG8XWzUzWoTCq3k3gFuy1Mz6q/31
l3Q6VbWNsCPNajMQHSep3SOT3A1pc8O25loaXzVWUMBNoUo9pLz7OdrUU59Wsak6HSxVaujdKq/f
0XC8/H9zatbvMokTB28mm0F5aWihV6UunmQ/Oiq+INTeLFI5TKtSX6xHS7xoyVN3kviqS7INetWY
cOUAu3nNaZXgzkZasWWfX1cccvMfrr+9y8bApuXxVRFBNYs3qU+dHf3bMjUXxXQ5Lh/+JfWfc+Wi
PDcN9OHLO66VL21VvbHdmjMdFlKVi17tF6cuqn8ylacurRhfNaRXNVZc+Fa+wReMOn0BetVNDgBw
BlcPPe0Vp1XAMYBeFVYVAFUBAFQFAFAVuPa0iofkOnriaaGjAUpoWjdMbiXCUqn+tCx9OtV6lbZQ
Yote1fghp1cN6GPvG19190XHNa1bM8sJS6X607L06VTsTb51gMRCvapRQk6vGtLHHhBf9X04e7ko
Hl/Vsieueuh5L0zR+2IOcprWBms4m5dsdvbIdQP0vf26TK96LNYb+XWw5N+nOwC6GrY9Mfq596P5
ifKa1q2MaHATdjY4+QMybdiClrc7IAeATKt6rovxiDlRQ0SCFvqRopdRUW+RphaJX8HK+92hXNN3
08rpML0q2R7vvaZVk39uNANxIl4+52/0fk2rRDI6bAisStLCc7n6r+dVj69Kydodoxl+dEfVSH+m
TXe7iqaVhxoi5aMcu+TrJ43qexPFUSa+KmfGck6Z1yqjf5lk9ASmslvV+nmzsAI3cgAM18x2AOwD
XhIKU6WmpjWXySLprKtXlaQKiEnL9apWCWm9auzoywN61c4AvarEAQC64Oqhp114BQA4GdCrwqoC
oCoAgKoAAKoCV55WOYrS/LNBI0VAoFpLZGFlnU8nj1mxW6/qttqG+KqDF8vW1at6Ut+w1vWG8VU3
yp/W1g7KsXYx1cw6n66A/3v1qkajOanlelX/iRT5ilRLhRHRutaUAbx3uTL0iPZ5nptheTjCi8Vg
8sxM8Jl3nV4+Z01FqfOoGliVqeIFh8uPUH+/ED7UXl8jXZ66o+rSTU0tqlamcsDGNbwGKqL0KY25
axv0VaDNhUWUFVPUvu9dLtO68VUHyl1Spk3tP1X3O6X6DKP8K1slitDq8VULXr9pPdT256t696VA
qto06Gper7qRCMlTqUgRWh5f9fxXUq45rQoOCiVSVUcKfOQN4FbRrbNeSHD858J6x6qfXNZgGm5E
9DeJtx38wrnRv/LwnyFTqVZUZvNkhQ9FyUL1jlX/jOH/SlaV2BjEbG9OD/GhlnXklTXfXqstypwr
V0GvqvlSP74qBxZgvXN5uIdgdYNeFX7VwcsJsoZ/eb1q4WTvtAUhcLWB9/EC06qN8wugykLHtsaH
XhUAQFUAAFUBUBUAephWLSGASDA/rRpAVTIlZsG+mlSkkeV8nTO5uk9Ft+hVXUVsSK+K+KouVedl
f8lEs2oA1QyjzKKS9eKi0FVsnLYtV/dZ1ha9qq+IDehVj4uven4UVRlVzavnJdCaI1hNx2RqsAwt
f5y+Q7Gy6bBMvpcBSY4mqkj7rYCJr8FfqUeqGjfoo6MOvmA1WfcWD0xoaMPUhWGbmZoM08fVY1eF
i9nHIgpa1V4diUe4hQOy6eYBVNOtWhLkvwEKFCuFelVOqwyW8T9E/jqRMa/oq/rXzWlfrqk+Nebd
5Rgtq0pZLFZZrkuysviqlH/Hiwp/rz7I9uwAmExNhIysEkC15jpByR7XEvqX5UrlDnYjB/wV8SZp
Fk7/3pFSQlyVIn1rQ70qS5jK4KltVdkLBPB05xOj34EBPoVltKlKQ71qqAk9vSriq34C8VU7A/Sq
EgcAuJQPc8TCx2WmVcDxgF4VVhUAVQHgeKoy1kWAa1CV8PIUcI1pFQ+xPajMw0bED3Nfy6AAc3+o
1flRJWdEMsaapjTbZMUclWzwEbybRRO9qhdKNBRfNbOOuwvvncy/PQ1APtpo6BebwaHdrbev+1G6
araetVZ8VUcly5Is6utVQ9v9evFV5+2Y+U5WdSKdGT6VzYbTh/0TMosmOzq8kXtEbsfRb8JukM01
eS7tvkrKqSrjtakUbjkxoE0a1vUVkW4cAKcBQvKgM/YwXbtNlmzV4g6VMzfWwfLXR7mLp3QxzR6s
kuEAnD+JSe1cPczPnL3RjGMO5ZDw63bYnFi3qWEzeL/JZyPaZ3F81fW6glcnMpp0DwFWOGhlbu9d
j6+C5tzYmtTGmq8iHEnFmITXVh5ftcIjqLss2jxK++nuG9sJyiJcRlX4213dCq12TEv38uz9zTGm
1jTaftt6PeyfkGu/HbPTRhPbIqltRNzqikn3VDW1unFOC/VtVZeB3/hLSb8g4CnYEsv9kkphDqUl
yLKl9IZVjph0h17VipEayNGgsxdfFXrVq43oLwLoVSUOAJjaBVe7cpS6n1bdcobZ/XQPelUAAFUB
oBFVoVcFLkJV6FWBi0yrOtWrpnNwQ73mSgqEht2WqxdWdpXWyvWq+mxOxFe1sjspvuq7eB5+BFWl
elUm95d2etVsDuzXJEf9oVivSvGamXLWpQXketX1bNYjWyC+KofObRBf9SoOAK8SXeb5VvHUSmwf
JnZPyCyaNOzwdlSpWgoFSa7uY6RGAV67kKwshHh+OqlT9K9XLbtJLIyuWzNXN8B6GWszwZXnASuz
sz21b+X3s+//Jr3qEFSwttGrFgRWTUQi3Z57Mlf2hN3rlux16JPUElp74d5tWiW+gcSF6nva6atu
s7GVci+MWbmBPpzctT6xxzrTbR4nvo5etU2xgu1mQhtayCc568Q/OaHtQIlxumx1q15VT68a61UL
Xb4jc82/xyN3RJLhXouCwd7DqpboVVeu9qFXtYutlW0yV0tjulWvmj6a1qsivmovI/o9Ab2qxAEA
U7vg6qGnXX5atWtWDexBl3rVP/79357fMhABAln88Nu//xNQFbgA/vR/fvfbH7qaVo2f/yj9Tbne
8xg6OE4nTSePn5/XZNOhj7QNPfC10uNSC1U71+cXJ1uzNF3ocsFmI4QzV+tHZZU2KCc76wfzZF2r
cSmzEf7gX/x6GP7oHzqaVn1csVrui3PTvI/6l8+z5jb9+GC1lz4UOLUenuVOJRglVsxVTZ+9VplL
04Uun1SmG+hmsdpuIaZxDdMdMX6wmlsFLEwD/NNffzMM//sveptWqaWTzt111JZzNI2oTm6bWaO3
PX+aPquxnVFVDfqCl+tocyFfmsjkjLrBU7VIV3NsTZFf/Gb4/pvvhz//1b/syFcdR7e5R6U7+vRR
WV3cOnnMjahtyDq2MCuZXFXdYmJtl27TynWJ4f98/P/7Yfju3/YzrVIuWVWwXWKtN1F4lDZwxfFf
j7nP2qnaufr2LWvtpI0w9/uY25J2Z6ZaHeYxfuloBUB7Z4Kx0eHu7Dd92NwP66sOJWrYDayY6wY3
t6gRYqUplbEOx+C/fTN8+KrDT3/bla+qipk6HOIunYxxUGcWH2nho2r1hz/9HP+HH59N1begp1ow
bR9Hu+Pr+cTkEDSmcZv8t+RqniOZVOn0wdI+fpx/d1u43WVH8Fefhf2nvxn6oap6+ldKrwmq+dvi
Aq4fTZft8wfleInj4HmOqpnFMb3TWr6qLB/dLHPiUCOkMvcyiB6ufoUl+NGvhuFn/+b0sW3fztXS
Vjt5BH0NTyNtqls28Q8//9e/+bawPm2nVZu8qMoJQdatTG1pVv/Rf/n2/Kb5At0UsLFXXcqqAgCo
CgCgKgCqAgCoCoCqaALgGjA0APM7j2ZASvdTGI1eabVjmwoCp5ZmuzPwK3AaVTvbVdaNbUpVs90f
+BXowAHgKawqm2E19c+DPsBDOGUV2OEfuc326WDpJa2qbXfItTnmFysAK7W1ThipgRhVkzbHjrZK
bS2UGdu0Xl9gMwz/AWF0gQOoakeX4diBoWWIL6reD0jH6x12BH4FeqKqGcDSZgsFGFX9ljflEPj5
CtOqqF19OoxMGYtbl6lcuQAO/QGuaVV1iPl1lHTHeHI3uGrgAAQDtVawprUCvwKnUpWcf2n5z/Ua
3SQN7jc1claplQ8MnOsAAACoCgCgKgCqAgCoCgCgKvAKMBer3M3teMM2kBzeSHfVR4Vkp+zsoRsR
qEzPzsjJ3ZBgmd+8Ggy2AJbN7aAClVp+Wp5DQCzYFVV3I7SDo3WLaSD/CRG7f+NSUvc76dOWzUZD
p+g+uApgrU1iA5WyJS2ftQFTu3QAXMWqKUllnkSrhmLVTKbTL7yh5bRZ6Zrb6JJCH61sk6cLTL/b
SaKVAj17t6q+YtXSzfPgKFYNg7VshOtqWxbfgE0RDJkp/S102doWctUfWAW4zoPJwdiGxvMjVb1v
qV+pJdGOLgG0pCrLhnaTU/4NpOBYWfaYlAP7lK+lJjd4tukfu5bwFvEUSzRpIaBs7Yiqq5SJ8+zl
QUbyDePyIKKzyFeulIjCc0bg/GkV5W9swTtKTBGiu4N2eDRPnRtJyZu4njrLd0+AXlYAEmtWHDzA
WiFojJyRRR5KDcth/nGBWaSyjuOfBft5EapaitXVk1sVns9P1qqn8c2eOxfrQZ/zJ1OoOmVkKWfD
VabYgSUbW6KafnHRrff8igv4ciI2xVfN2JyqJkmaWWmhiACwF0fHVy1+BJCPcnIOAQqX6MHS1/FV
t0+g65KAqifUqUHXKwFyFQBUBQBQFQBVAeAC0yoOTk+WddKiOYj3EJK9ZUkmq9iwzFUrUtnTtYiE
qYFIqliluj5VU7dw571NPT9Pi0xNNZZ+uCASpoYjqU40B1dfwwFgQ4M6i1Md6eoQibbqx1ldMnEU
r5O0VdYRsrTisk4DXN6qOuZJi1YnK8QUlNQPQ0DU6uRFlqp1DcpKIcZRhlwccxVkWJ8Sg7IvQFX/
xkZ/86KtUhFhbPY52lRPIks2q6HTB1UX8ya3VxwfjAXxAjn7SlbgHa0oqYE7UZXy06yYkWT3jbqC
uNZhByBXBczn7zytmudKIpL60VZ5yBtWDnGRnthwDWDqXa2qE3qUKTTURqKturpS6yRD8frMd36p
L7BKamlV7XyKhanBSKowxNfDl8vdsyosA1X342i96vUerNZ4yQlMfR1ftWuudpEFAKoCAKgKgKoA
AKoCAKgKgKoAAKoCoCoAgKoAAKoCoCoAgKoAAKoCoCoAgKoAAKoCoCoAgKoAEMYXvLvxgtgZBEyW
7uhCYFUBOAAAAKoC8FWB1/BVX+dSND8fuK+viNeZVsEBAOCrAgCoCmBaBQD9A9Oql10DIH/i4m3t
lT07sVF5ckIkjXsfzH/eGcU5Aqq+JlONfb5Cv6b3mTOPkmBuns4hDYrl7GUBX/UGpBURpNBypom4
J/9YzrCqL46dc5HoQF5pjhPIn+CrAgVm0eDNxhDf1fOHAwC0s8lV8wdVYVQvkj+oCqamXclu8scj
gBelonYDvXXVz/2Y06OvPjuxPsqUoSCJ6xnM2T0EqgIXARwAAFQFAFAVAFUBoFfgadXrYfz8R75X
b3Bb39Rev9axwsLyFYiWDKq+INRLFgYH4IWt6zhOVm+cP69f9C/TF/OH+azn/56/rj8uv0yWdFNh
sfycRLCqN2Oq0qOp+Xn6uv6i5k/Wn/XHQZmJnx9VaIgWFjZ/8fOzEsGq3sucziOzGgP3X7ljd+jT
86PKDvbFhakhXSys6v181eRw+sEqhx9j4qyxdmFYAQCcMTlJMdsCqsRZqnZhmFYBnjF0XMtxyBrP
cSg0rGWFjRsvBlb1dd2A8TnwmiOw8ZMxJk/0cpJYnHMG8ICBlBb2+WMkv5yXAGUVcBHAAQBAVQAA
VQFQFQBAVQAAVQFQFQBAVQAAVQFQFQDOw/8HhlYC/gvBunAAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-22" MODIFIED="2008-06-17 11:09:38 +0200" MODIFIED_BY="[Empty name]" NO="22" REF_ID="CMP-001.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.2 Febrile Neutropenia, ANC &lt; 1000.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArwAAADQCAMAAADSzUJ5AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-23" MODIFIED="2008-06-17 11:09:37 +0200" MODIFIED_BY="[Empty name]" NO="23" REF_ID="CMP-001.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.3 Febrile Neutropenia, ANC &lt; 500.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqkAAACwCAMAAAAbvgePAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-24" MODIFIED="2008-06-17 11:17:10 +0200" MODIFIED_BY="[Empty name]" NO="24" REF_ID="CMP-004.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Sensitivity analysis: Febrile Neutropenia, outcome: 3.1 HD versus NHL.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAGACAMAAACUQSQsAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-25" MODIFIED="2008-06-17 11:17:10 +0200" MODIFIED_BY="[Empty name]" NO="25" REF_ID="CMP-004.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Sensitivity analysis: Febrile Neutropenia, outcome: 3.2 Use of antibiotic prophylaxis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAGACAMAAACUQSQsAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-26" MODIFIED="2008-06-17 11:17:10 +0200" MODIFIED_BY="[Empty name]" NO="26" REF_ID="CMP-004.03" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Sensitivity analysis: Febrile Neutropenia, outcome: 3.3 Blinded versus open label studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAGACAMAAACUQSQsAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-27" MODIFIED="2008-06-17 11:17:10 +0200" MODIFIED_BY="[Empty name]" NO="27" REF_ID="CMP-004.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Sensitivity analysis: Febrile Neutropenia, outcome: 3.4 Concealed versus unclear method of allocation.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAGACAMAAACUQSQsAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-28" MODIFIED="2008-06-17 11:17:10 +0200" MODIFIED_BY="[Empty name]" NO="28" REF_ID="CMP-004.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Sensitivity analysis: Febrile Neutropenia, outcome: 3.5 Size of study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArcAAAFwCAMAAACVRqPUAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-29" MODIFIED="2008-06-17 11:17:10 +0200" MODIFIED_BY="[Empty name]" NO="29" REF_ID="CMP-004.06" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Sensitivity analysis: Febrile Neutropenia, outcome: 3.6 Worst case-best case.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAGwCAMAAACQOyOBAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-30" MODIFIED="2008-06-17 11:17:11 +0200" MODIFIED_BY="[Empty name]" NO="30" REF_ID="CMP-001.06" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.4 Infection.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsEAAAEwCAMAAABhSVxnAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-31" MODIFIED="2008-06-17 11:17:11 +0200" MODIFIED_BY="[Empty name]" NO="31" REF_ID="CMP-005.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.1 G-CSF versus GM-CSF.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAHgCAMAAACctSt2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-32" MODIFIED="2008-06-17 11:17:11 +0200" MODIFIED_BY="[Empty name]" NO="32" REF_ID="CMP-005.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.2 HD versus NHL.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAHgCAMAAACctSt2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-33" MODIFIED="2008-06-17 11:17:11 +0200" MODIFIED_BY="[Empty name]" NO="33" REF_ID="CMP-005.03" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.3 Age.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAHgCAMAAACctSt2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAskUlEQVR42u19O68uyXVd3XMPsTm2LAaXM+Z4RhpIAQHBipw58D+o
wIAyBY78HyzAsf+CE4aGlA2goHICDpw5EyBIhg3J5nDIGV56RFni3eCl5PN1V3e9X93Vr+9ba+ae
06e7Xl29ateu6tVVr0gAwHXxhCoAQGAAAIEBoB3Ppy+hHH6q6CWVi6daclCF6FKoHe/V5GYfufUg
1U6FOncxz0/gdAXIciXXPY6XLHy6y8Pu9lYWlbmWa3UPWMzzE9ipCV0fwy95a97y9ltzfAoynqw1
wUNUJSLRnSx3vlk7X68BOzd/KJHPUMwL+cBqYNftx0vbVwM/le6jhn5KXxzPqOb6ikU3WR5BDp2v
Twz75g8r3mmK+SwuCKcuVNC21drUD+9oJgqE7qUSh/L1fMW82iyElJkhlZTi6pj9SmVuR7rX5LFN
7GTFfLrcA1bpUd1w8fIUngbyKhwCaU8JxbwugQtmdoENHp7E+Wy3nBlwCp/htMW8FoHVWGFqJJxX
ZcqqzZb6tBMNo7un97Nt8XzVOGY1Bdy/eCcr5iuIeYArA6+SARAYAEBgAACBARAYAEBgANgHthZC
z9h5Mq7c/N0UoxxyGTJa4LjYzIsg42VrTbYy1fGdlLJOh4JZJ/kptDBqAiuqEKPSLlIcT6w4hR3n
X+1Lax/J+Uv47OUqRxVh7e052s8toPLcDoPbFSI7JVubajkb2Xjrqlj/Y/WriSDhpY0fztElfI48
q1nCqaw2Jx3NrLDfWZmQc9BRUmve1lhCW7XADEyJ+nrfpMrUiFFzYVqTLaQ6tX0ZuW8xZeV/6aEK
snzrUbjWPdpHStv096HvyUvo+MD65Z/jFEivILqcyorh9KLSRIqoaeWKN+ahYDepMh0vjGFUQYla
n2xNqkYca47kfOsrntkkhRYxPkl5ConlESV8cjuEMBuVERcFMVSph25+fC83Lv38lVdphW5Oyv7J
qhb5j0rfutsJu09Z/xXICGIPYuw4tyDK2Uv4HLoPTXfXGmOVD+zfuapR7UUtwupk43ZmobfreGOh
NZDTECoIL+1R9DD8bhnC3EUJn2MdYCuF90JM9VRqPxVO94JkY6mqUdSmrVFtq5bWaD8ZQiZSVHt8
fXruEj55HnBgQnKTHVYM6ZgdmamGRcSdZ6Gkl79a1R42STaonYqbtpX4wXOY3e3pc5T5SLrejHTV
oF376rOW8Mn167QwdpquU54h8rwdK4YyfYlyixkGaPWBo5nrUsbTM9lmfODmZIupxirKrcKgw1K1
9eHX5HROeXfQXcZ88hLW6YGbcpIqFeEkX8PsOzZXzfddM6iQ6uibOkkJn6vo2/QA1LFrbpwM7bUB
/va3wAAAAI+AP9g5v2dYYKArdiYU5JTApQECA5dGTA/sLrVi6z+jMleZWvxUSUxGADsS2CHoJNUs
viuRqETgFASWMTGZdCyqtITBZlFeXx7rz3wanaj0lvhF/QM9fWDzftVe8iriGbhG21PQ+lpZ/beO
aFSjCsYb6Etgw6n5KK40iHq8xn7LcM2yMGJZygsALQRewSflKdOyG6RM331IGGCgrwUujNVkesSm
lK2lzG/wM67iqxTGf0BXAstZ0iltcadNPGdgJ52o8Q+S4hMWYxZwIIC+LoStYU3yK1AKBwrahA9s
Ioar8QLAQvRVo+U0dAuEscD1sLfQ83m3wkMmDJydwGrFVQDYdBYCAEBgAACBAQAEBkBgAACBAWAV
3Gk0JufY/On8MZwYv96L/9rvuz4ufEToFqxXsjWp2hd5DE2lqjFxxiO+HZLQkf2rbv7xqyzokQjM
5FZw5vHQTGr/F4v9qo0LnHDL1yvZmlTtizybgAJ/5zj6iKbIAxf9q07+iavEj2WBpwonqy7Ghsxj
rUykzjwI2tMC54uyph1R1SXaIOdkn+ilnbA11LEQDXLBPxXi39bHUVsSeCSq07JpbNJ1lqxkaDr7
EHRcspWhZjPYXi9rarJD1aj20EdqIW6d1lhjiZ6HquqWdvS7mIpuJW2SLJVDee7YrV+rLQ4VnXAK
szDuhKCae9i+K9/fB44PLPIBDgWVAyx5itQxFFs9fi2pSl0dVVx9kCWXnr0nwrmnxFYAfuQ1qWpu
3jKI8/CK++YTN8CPhSevBsY65qQRvhZ/+QT8JertU3GWv/xYBH6OOmDGVBBbnZ+5wuOEhL7q/trT
gyjkuLBghfDuzWfDeBPrlPWBdYIcTzq46mRh/jjsYRyDxBcZjEUrr+KzVIw298QJvshg8TAjgPvy
uvfzoU7uQoAupwMtuvQIzxJiHgAEBgAQGABAYODR8OwPWSky/o0PgfXZeXpSzO+ayEtrmqqMaIdX
Dst764HrwrfpgefQzXpgcyLQAwvy82dffixEYd75/mYhUmr0BH8nRYsTZzpHDsVFQkK8nL92mlmW
t2RWF75ND2xCN+uBrRzc7Ci8efaqRreZnebR3h+m5nkuWRjW9T4ZWo5o0mgUXCYtNVe2iRb7W/Vk
WnOhqmi0JM0loFznk6qQNerNdhOi8Xr++/M+D3gVgT1Nv9Pc4w7F7nOR1+wYezEq9qI5PNr4JRx5
Flj/feibOO1b5TT9dvVEe0Seu68wNjvdfx8WcukyLSJZnQ4snbktRWCtTVigB46HJ2sIcEJP9Hgf
mINnUGYOaQ/P9oH9hzKkODlmPfTWVPTyNlR1ZzN3PVZrUNCmB871d7Sfi3uVQZxdfXZDT3Uh3NRb
1TmYB7sSLQaYmtPuy7cGsfD94iltXrlYPZMNmEZyNX09V/X8ffyH9lxa+Mt9ytgetWsV3pUFnnzg
ubM3k2FJf8K/kNSybaEd7q0HZusjbCqFyqYa0fa264GdHFJXH/yzjFfQnl18/uLB9cB4lXwRBu8a
7eKDOOB0gB4YFhgAgQEABAYAEBgAwkFcix541v+SUQCGB3bQrmrgrfTAdclW6oEFuaGpYakdrxyO
HtjSXEf0wLYiG3rgqrHsLJ8ID8Q2auCt9MB1ydalSkFornxZGSuHnZ1uPAk9MNmm6BCxxK7i4KV6
YKolxRZq4M30wFaytC7VJc0z0PTm2xAlK2S9fWg2JTM+t8XBXZ95PYFb9cCDEI2jB1uVe6PasOwZ
rX+u1Mhqqr49plyF1HlXGz0KqSxx8N4WuEUPvLip9lQDl0UO26wPzDXrurrr7TXpgWszyi+yepQy
4vmwzFr0wNS2EPsWauCavnKb9YHLqZJ/58sWnV5eTY+icVmuB15WoQ+oHaJGx73ewc5+Lf4gWKoH
dvS/82F4EPUfdtOY8GGpco8ycB2Pd7z1k1vgJXrgNm+18+K1x6wPXJPqEj1wwMuEHnh+WsESxKm4
dwzogS8B6IEbXQjgbAw+kw919kEccN6BYON0A/TAAAACAwAIDAAgMHDPg7iEAiq+GOL8k10F3+YL
A4tyicOCNubJ61PlsBba1we2RL7kZMdhTbrKC30GeuDcIzTSX39RtA0XBg4G2VxkeHOeRZlxOZR1
cQ7dvD6wdW9uxXGYPwdTD1pC9EgEHu7e5hq7FoHDN0m5VaV4j+rLv0+lso1ekmU5VepRC/moCT3w
Zq8uMmV5LcSv9eHnhYJuTmCPHCk1sKX4ravhI/h7CjEy1Ra2PqNIzVPgiHQ3H5nCWwrgE+zUmSly
ST1SsTDwMe/ouacWoo6RXpbL1gdekv8BQuADX4c9d2+ghYWB+RChNXX1gRdluWh94OW9zqOIKp93
Yc9m/fmxj6kx93564GkagioC3TmeEg+FS368HriZ9YFLzv+B42Hen79b3i0RZSaM2A30UBZ4cl+D
xesnnyyiZy27a9tIgZueeF898FxbmWCRxXvb1wfOp5jQAz+KEFijSQ/MEA+fz1mBHhi4AoNP5Txd
dRAHA3wUoAeGBQZAYAAAgQEABAaAcBDXVw88r+7n6oGcXFZLhLluv8rGDIpisyY98JL1gdnTVrt6
YLNSMCXjTmuLQg+cruqiHjiQXjoBxXqJcDHmMj1wSWbcpAdesj6wjmOVgyJqYaeMftxpbdFHssCz
weyhB/YWnjrmHchyPXB+2WyuagMLS1tVDlpQpv7VGzn3uXg9a4PXV8kCAnu1t0YPfDxoOfN3TzWa
biIGB4pfOkv1SvV+18Jsqgd2zd/wnp48wfBqiTB34c425l83dWvBuT4+aVaVebgW4vmiuUX0wGap
SnbcOauu10mEA9XRCTHd3aL1gXNVnbLO9FCilT2bCwX2knq1ms4GuNfi22v91KJOFfKqrfTAzikz
jHMf4WrjyTsSsq+/28MePIjit8EC99YDl6YAVkuEK2PyJjueZDM3Yt0l6wPn9cDu1YQeGOsDn8OQ
AaWahx4YuAKDd412r4M4GOCjAD0wLDAAAgMACAwAIDAAhIM4a9qW/V/sTzw6Ut4t1oAsja+rllBq
FhxX6YcrUrXrsloPzFaUqV6nE/XrA9uy6wfUA8dGrxQ8Gk/KW1yntz9/vd9pOjYJjqv0wzWpUqSm
6tcH1rGtHBrWB2arAFsrRd6Loze6eo7VI2vVGFl/zS07USf7zphXygpok2SpLoO4qr+1h6m8OXt9
4G1WCo7WzOvgwudizV13IbDRALNTDcY4HM5fa/V+3iLZ6mdKTQxsqKSadbsLnWfnR0IpC+xeOHR9
4EnxMJeZhb/TQ9gkz/2yhxfqAriCudWLpfbWAx9lNurs3yl84OITdRf9PYyeFf3sgo/uindFs8K3
znb11QNDkrKkCcXWaxaHL6e8kSR2Ezlwi79TJwRmAs2fFvaj5/AfSpLYbSQw3DOxFXcNS5y1wBFR
MDlXL6A6XVjKQviGVJv0wMEKwE4OtesDPxheoRVfAdADL3IhgBPNpuwZ7R4HccChvtDCASf0wAAA
AgMACAwAIDBw34M4FtHVJ9NnItpgscvUcKUOuVWuXHcLnN4VWoSSYh1sNz3wA68P3LysVkwbvMva
XJU65Fa5ct0tOEsi5+vETAXspgfeeX3goxXBz77pmBaQpGlBara/vBjW4pufSvTl/i5NnjJdRJIc
LcnWraATPcuLChhLvWl/8p2mfP1sfEXw50IcvLwqOcsBzx8TuAsEZ7XBe6Irf+3HVLViVSQUZYLt
ogfezXQYC2yfO1QP7D8U001SoZ4cbc8+jlcNG9qlGjVKXzK66ZyjYQn2tAyiXQ9cCF9SLT/cIG70
+2O3zhny+NpgOo2mpN0fr1H6Wp51MSW37TfrgSnzYUdetbyXUvv5ZAROGFp21vb1K5V27sassf42
HsRWRe6rB27esOAe8eR1je5At65D4tivc/i+K0coywNzj448EVXrgeE/BBbYWgbY/7De6pDYH764
+thdJMKVK/4uFAJ30ANHVvPtrQcOTgisDwycFNAD17gQwIkZvGu0C89CAKcE9MCwwAAIDAAgMACA
wAAQDuJCGRUX36m6y/TuLQyuEPo2vbGz06Xs5fL9hfrc8nvtqKZXiBo9sKM/ntXKD7g+8LKJw4OE
wWWhL1s/+4z6K1XDEX1uSQ+c0PTqAuX1wOYPR61Mdz+P9py0MKxfuRsl8LRmMgXG5zhhcFUTaRXL
8nqVwRJ9rolTLS6hZJmOetf+uTl8LX7d0Ww0EHgS80eUwHrRYN/4HNdPFftkXlK89c4PbdQwHKZz
hZ/Tv8vLw3oT934PXjzXun7uosGlJspbmoHtUXJ+WFCLazK5ow16YB2wtIS2vXWJmFWWFWrlw3r3
zX3g4LlwfVdyjkWD1/ejdasOV97mFKxND0yTH5tZ6J1iMSrVyvftA1PxaVL2ydOmflgLQ3nLQlBj
sG7frTGWVp3xVOOtR//gkv9wgkourR+8bKjSJnxmsbgAXH9X3CPbe7HAkxc1dHiurtQ4CTFiuFJU
FleVpB60PnAQp0EPHOiPoQfu7VgC27hKD64HbhwpLpqUAg4bjkIPvGzcAuw3XoQeGABAYAAAgQFg
CwIzqgm4xCAuPsegF6lMvdIMpKu7DBwqJcetyuTW9YEpOWEQ0efWrw8crGuM9YFrCJzYvjT1Mium
Ad5zYZ4KyXGrMrlpfeBUs7bDiBY9cBDHqs9Trg989NrAQuT0wEZIqdXBNDwAy9Ie6FrQNqG77JHM
PW8xt0jmJtm2OJKvI6cPXx+YgqY9q4Nds0PbPr+rotP+2ywyn0Idsj4wxS2wf/rIN3FF8Tdl2+bO
zG1bH7iaO1xW+jbLDNr1wJW6S16xevA9DuLiPjBna8XVAJ9MJ7Hws7yC0rct1UV64PX6hj1E2c8n
I3CiYihfta4GeDcSt+XSaIC73sEKPTAnh89c/AD3AdcHTndCGSPs+g8LBbgn429Xy9XfDE6VXPjq
6TEQ84GNotTW/jq608Ah3Fl+qrXGpVxblcl1yW6/PnAs6UAPrAuL9YGB8wN64GUuBHAaBp/Ff7mW
DwycBFT5PqMhXlf84KN3B9XMa6xwDazFu//8X37xg/f/MBx//y9hgYGL8fePvhTix7/xrcMHcfL2
Q5m/lO+Vy9hFOUYaI8vb8RxsvPQSdm/PfiqUkHPZVMdUh9sfbjiW7FSNcro6VYNdNZnE7RrVuQll
30PkphKRZZ/7zuOz//v18Puj7/zvYwdxL09FTc/FexzBoTlzi6Wf2cuBU1/mUiTqxvwdc5bDL6sc
XVKdbzf1rIYrcsp0iqbqEp+O7FIrpy7Dm0pF3oNMv/39r8Wb28FX37w6wAL7LrCazMtov5Q0Vlba
BtcEd02y1QaHU+Ox2pnAyrFLqm+qDumiTHRtohWmxTypoqU+BT79Hz8X4u2bt0K8+frNb/74WAJ7
D0Qq+fK/pvN0eGO4VBGTnLcxe/cs0nYhunWluvMutMfOmabSPwU+/p/ihbv639u3n/1k7wI8uU1e
yoINUG4Qp98cPYpbIvLwitVdqvurV6o5AxzNVE5uaU3VDFWsMhlU3I1JY2N888b582/EgQQWSlV4
q369aEZrf/DF+3uxtSfq4bYwgKpE8midVVeN5WqrAkWTp2W3NlvAL3/zuy8/3+h/v/PLg31g1cxf
MwPxOJDT9IuqDa+WZaMKPrKsP70ZfvzJh38+ehBvxN/t7wI7sxDSm2+oqggpXXNg7NPoUhxCbjfX
XmXQ6QSzLYW8ZyLWjANM7PgIUabqfcps9zHeF+8/HA9evfnHAx51bB54mHzQ/5s5T+tQXxkfiRmy
jL9VOAGqjhjDWXOlm8wDJy2kNxOr5gljmZ1NsyrL6guV7UEr92FYhXCuKrsQO1T8Z7+4Dd0++vtf
HTFaX6dGq60feedu8datcfH0zj4V/+5ffCm+9+W3D5luWvcqWXUPCKSs8zL+7oJv//zTTzR/D3Uh
AGDrOZqTWWAAOBggMAACAwAIDAAgMAACA8CFYGkh5oU89Z/uYrQZ7Pvptr38LtsF7pFsdOVd4BoE
pktsAecsv9tvQWJnDSIm7IZ3ZReCmfW6L8ORd1qYCy9hoiE3t7+WfexDNND1Diyw/TDHBYEdS+Ss
EE7WSuDUsgb6WtA2zDM3iQ1BLk/gNFtup5x18svb2m9uizdpJfCB74PA6T3r+T4fOZOAD3xHBGay
qUo5a0sHTUZ0zpPB3DsYxCVt8DC95OyUk7LIF3UgdlveGNjQApsFgZ1l6m0vgfwtyvZ2IXjTqVr4
wFclMHk/afrfchsoFmTH5+3sAUB9k/WTBy7vQgAACAwAIDAAgMAACAwAIDAA9EG4U2e9DjhAZCdV
Z5M5rZUJgwhycvQSGV8IUixdk6iIbZFr7XtM05bFtpAtXppRpInXyZcj8GpQjNLCEf9Q5K0d2VQW
0dd6Qbsgh+2UDUIWiR0GR0oza+yEo1oCruVC+IpgW/LLPIqCLUWwHcyEn0hFUzStJKYUN6P210lv
MbyGxCZ1kPQOLXCoCDaHt/+Fpwg2/KBJUOsrfybvgm2JELldPUXs+Jgdsfn2gnK2meM9gf0ZErHR
O0RKk7b6wOkJzHXOgS36Dh8yRfte792vx28ubXjsR/LFGKLmHXCYEaVv4vY/453ytQg8b9XOZU5n
NrBf6zi3uwTUPSOKj0mBawziKqhB9eSIsICXcLci0jJnIOGb4OuiK89CZGbTOO5+Gq0lCfswRh9q
cDW5wYRSWzta0wkA5yWwowieHcVpDDQeOU6o9Zc7lVChrNVBOG42HUlyzAdOTnYF6VonMlyeEr4N
9eADnx+L1gcuGM19v3RvzQ0fvG2KvdcHbn6RwcUud2d2NL5vAHcfxAde7i92Ygh1D2hCg8R3A4h5
ABAYAEBgAACBgQcexHF0TDTN6zYNfIKXsBxMqjI52cZVucLS59brf504mHV4GALn5kdX0iCnKshr
eV0p3HSmIQ5UvY/nQrCl8dXiX08aLBKrBYfrBE+JeIriUTqcbB6NMp10ywAeyAJ7psw2YJ40WGRW
C3bp6CiLbf2wrcrN+RKFvqAiDkzwoxG4YMTIJYcraqzkCsU4SQmiJsRsFW8koGV4TAJrs1a/wh1H
D8O/uZd/Xd1OYH0fkcBUHtSl+MT+Z5INa7g77kDlt9GLdMXA/bsQtR8jEIeEy1rYcF1qjq00Wftt
/zL9L3DXBDbCX2e6KqkAFq5o2JHvOpEsRfGQrv5SMzKry/Mcrj5q0v+6NwAe3zVeXe7xLtH/Arth
bz3w9V4lN36qBv7eNy6ohaANQwMgMACAwAAAAgMgMACAwAAAAgMACAyAwAAAAgMACAwAIDAAAgMA
CAwAIDAAAgMACAwAIDAAgMDAvcP+KlnefqjpSAn36HY4Hylhjho/45NTFipy6XbSyhIAmiywUhO5
1Ehnc5QhZC/IIa+KLAEgYoGNTTT2TzmXpVRTsMH0ansplWs19R+3CEJFrbm0Df10GpYXWGmBpZTz
UYpLAy1toz1y0LKaUk2WVCasuX9JKT9/AFhAYMNCm48BlVWc18Z+TzzM2NPoJfgOwAoXQuXGXHko
aYfzjLTcw38GQOA8f+Xk7iYMqpyv+ZRvtcMAsMiF0B3/yy/ryB7QKeXYTelEVSaFwMBGXNvMJQBY
RGA1D92UNYiT3shKz/ua6d9xNkLacxhSOgGDVINLdv4qM4IEAA99V6e0PQwz5QY8EE6/W3114RXm
dYGLEbh68AYA/X1gAACBAQAEBgAQGACBAeDseEYVAAvx/gwcsjOfNmwbN+V2tzD09tiObF9MOgkK
fm2AuaipHKYLei86USxJrPz5VBOhgiTmE8VN6yJx9IlbZOeq8J+KH3e85/vfLdppPXpfw2F/+sY7
55kFzrb0W+1ypZ9uMofpAtuhW8tfSDUeKkjCnGAq8DcSx+yEbmdHdqHjcXWbYfFIBLYrQ9tiq1I8
m0CjVTB/7YwsGebeg2tC++Wn2lQjIalnG11w5wvCLev/hHjt/kmnIbBtawIjMtcLj/Qd/9q/8HVb
OdeGpkXUau2gGxiVTXreBJgP4e9UtPfiSObGCMxBaYynRbG7oGTr5KCTOyXDm2N725RHHQ17p2lT
XUN/Xkv5MWlK+OJZ14z4oXZ3jPnAcUpWNc3R63J/3S1Su47H3WhKUz6VdMIXp2wb48fa4Py5pjLr
64Nivw6xr06A5gdaY4AXlLlvc+ZseR6ExE+9q/Qc/sMODkS+Cja9N20eiA52PzXOY4GND+w6Umb6
p+Bg6cvury078fSE7aK8aZpDTU3x2ufjmbv3bjuy43G59kwcimQXuMZ6FJ24evd4RQ/b+VwJi12F
3Z/l3l9kPIG/12DwrtGuPYgDfy8z4VF8XPf/LKFGA0BgAACBgR3wAQgMXJm/39z1IE5rD7OzEJ5K
2Jat1qhuNxieU2kQTi0lm+8rpwbTyXEp0KTlXaMH1nPIvh44UC1b0mGrdO688wffvPl/90xgSw5c
GtbG5LMVqtsN+FscvLNoKBnXDu25KDogq0ks1APbrzGyamE7rlM65+X1i/19W27G76/1mc5ztA4n
se9kv2jS/85VyO3m8BgY8WdVYK4LfAux4QsEWpdIonTfVLXj161miM5EYKsKXpqv09BtJdUWUpeF
j4o78tdYzfX0jCXRrilaRI9UNvTR39dZ4CvNHj/Hb53Ch0q5PvfO3vjUKhLzHoSjUmjTAxsPouzj
15fuqw+Xm7RLEDi4Y857j4frfjf84q5bElMP1qQHrinHgmr/+re+uudBXJwf5ivGZA3TpnQq9LE1
kyadS8bLbrhFD1yTNLWX7u7468wDJyuN8+eP8x82ksTyepJxjybCa0r5IJqsZ7tCvPnSUf6a6al2
0/3u3S6qbiirOV6nB9ZJ5/XA5oTw/iiW7o7wCtqzKwB64BoXAjgxg3eNdlEfGDivU1N+49caby3e
vfnut0Bg4Kr47x/yFx98AgIDl8S7D/7oZ2/F1//rw3dnGsQN+8HZG8b6XrmMXZz3phfjzkRmB7l5
N3q1t2dvF0rZ5e2ZanoXJulenqrBrppk4vrQLbxQXnLOCeGGta7Kjbba+e1f/FQfffTDf3WaQZwU
KrLbtowemjNmD/phJ0/lPscpPbk3f4ec5wLIDVKVyb3JpXvz05GqSXzkgJ++cnMbn5O7Ibt5CMqc
2IhM3/tA8/eN+OpffnysBfbfxOndCfXWsYNJnaystA2uCe6aZKsNDqfGY7UzgdXxqUYDV5knXcMq
zfRiO9u0cv/s3/y1ePNW3P69ffn3Vx//s78+iw/sbVwsxy5vau3joXIavhNZFp7KYdi3W5sb8GIm
6apMJSAP3WD6k3/9EyFe+Dv/+/Ln/+0cBA6261ZRw5KqvZHY8vAK3tQOWZs5F/d0nnt1HbC+anTM
lIuSOr+PAf6H4MzP/uAkFlh7T23EmLb2VpN3JtUZ9ujU/stQtn4GWBMx6wMHuU3+aKeqUTVJpO3M
anz5o++9+L7C/Pvo+1+exgdWzfw1MxCngi7mZPc6sbjOuPVtM+vufAt8R3x2c3pv/u/Ng/jgh79/
5JN+inrADVMHUroN3jy60aWQBz5FXbZgemRT/urc9I3b91/DahM+WnMvJ6VMDlu8yJs1op/82Yfa
/xUfffvrQ/kbnQceJh/0/9OkhLAP9ZXxkegJoqnGpDVlNM8D722RrNlQ1c8xdOdY6+aBrdpzqiY1
+SAj6ceTMye8yGbueDuH+N2nXwy/P/3mV4cOmNeq0WrrR2Lr+q1qOU+Y7Sr+k7/9Wnz3Oz86eMZn
7atk1T0gkLb9S/i7Gb745R9+792Pjq8a6IGBvm0NemAAAIEBEBgAQGAAAIEBAAQG7hLOuhAD7AU7
/aM4jlmRx97IuUeK1ho+x6x0DKwk8JX22J1pxj1bxLzGt3iED9Lv14VgZr2yy3DknRbmwkuYaMh9
jDD1T6y+1wHOZ4HtZ3db2zu5Brhw1wym6Obs+/C31/7Z/u7k4O9dDOIiT/G2xi3FA+CZA6ewwKFn
GP7BIa+PIDAMJQhc4gdHLSxFjPWubOJ5S54tskXDuA8XIjC1bO3CxSJjkfeajNhmfWDg0hZ4cgfY
XRrY9hI8j2HczglMAo4mMHk/afrfH6n7QXZnL/UeOlJYA8AduBAAAAIDAAgMACAwAAIDAAgMAP0J
zNZP96gSHMbRKrVZrcihbM0+E906cRC+cZiXsBMNC2vOTYVgt4Cx0sxJ6cpgAWXlqdF1a+dw+tRT
qQ3vzTgdJLn1Z7iLs3OJIkFMurNublLZ2QXm8BYMaYdYeK98PRfCVwTbkl9mbRKNItgOZsJPpCK2
bRn7fCh97mGnlyZ0WxNjk3qx0QHXs8ChItgcDhuheopg88xpEuj6yp9pn3a2JUKBWdVcJ8e+zgIM
KxIlqMzZNsHjDq1GPxErDXsvFsHl6xCY65wDW0QePl2Kdrrk/qaAVxmryUVbzSGx4+3SKxkVEh7F
IIxXyxch8LxFesVAjkUd9av6dba/z1xg8qhjqNAlJljhqw3iqPzQqZ4bMT8z7kLMPXqUMVyR1SKm
2rHCsSAmIS45C5H5vpHj7qfRWpKwD2NkjPqYNE8pOFG4wYIus5Swr3dGYEcRPDuK46HWCLsCYOsv
1w+o0AnrIGEzIeOFZqNTKV1TckGtkwxjdDD8tFi0PnDh+ffxGGtTac0Ns2SbYu/1gZtfZHCxy92Z
HY0vGsDdB/GBl/uLnRhC3QOa0CDx3QBiHgAEBgAQGABAYOCBB3EcHRPNS+C0DHyCt68czKYyOdn6
udrCMXJOTO/GgvKk4rC1kjDmIO6YwLnnu/LB5+QEDVre+VpLnFk3N2QGBj+AC+F+wODpgWepb2y1
4HCd4CkRT1E8SoeTzSO29FqmeVS2IeC+LbBnyuwPGDxpsMisFuxSxVEW2/phW5Wb8yWKRKxd02p+
IQ4i3zuBC4bPkao72l+qfkNAMU6mNMIcOuHmdSD4CAInuuSG9fo43Z1XrGHJ8WbiiXkovrA2VhUE
gZO9bbV9cz/w4aStpYpmUHSHw+uwwhjERchUNTSKrBbMomyEOWaAaUA8NW51dIDHtcCufHYmWFIB
LFzRsCPfdSJZiuIhXf2lZmRWN6XlFQv0v265Ya3vDK8u90DXURAE3hh764Gv9yp51Tdq4O+D+MCn
ZvBBcQEQGABAYAAAgQEQGABAYAAAgQEQGABAYAAAgQEABAZAYAAAgQEABAYAEBgAgQEABAbuDB9/
AAID18Wnf/X6ExAYuCo++z3x9hevDiyA9VWyHH7O3+SZr/OkPvlyRo4hhqBK3o7nYOOll7B7f9YX
hXTLad9Yl1TnxL3r7mXl1IxdW9G0x/CmuHI+oazkdCnMcxFhZvYT2hLf+vlL+j/7vf/zqzNYYKXG
fzadvRqWtwBj3Qyh3WenL0Wi7s9fu5xKKdUxVa8SPA5Ol02o6UgV2oaVqvLqUTnVq49kLLJbuK1N
ybt/8rPbrz//p986gwV2WrO0De5cjZ5Jtuz0cGo8VscTeDZDKizx6lRVKklZ0QJqc6qw1EsT6DmA
+/XLjzdvxU//8I+/fRoC3+5dSiV1hycNRYO+dO1z2tyFEJ37UDfVIPG+TVemktOOTD63zb2HF/zg
391+vn359yf/9ZSDuBuTE1fU6FHcCH4CjyFVQDH3tmqDVOdO3e+h0qazrrYKxfXzDR6ZKgTqhf9o
Dv/xnLMQfk1qRmsf7cXLkkoocVoodaLEW2ur0I0lLmsfWO3yVL76+OZB3P79hx+dyAfOWQJ1iiFa
e8+vLlhcmWexPIGv9rf//Kfi7YsP/PTvj3KBG+eBpXQdC1OBo0txMnJvUx6dal3idqgaupnwwTxP
9LJTCvPHTk/iV3/34c0Hlr/8fXEeAmsvSunRnOPhqXFMNzta1uDOPne4vTP30NP4uqmmEg8ux2or
47yWLscCBlc733mawT/87svPvzhuGrhldcraGrlYh31xDyhv1rd/Fp/8zdvf/aLedT/ShVDdAwLV
FF7K383xxW/8py+OrJpXWK8R6NrWsD4wAIDAAAgMACAwAIDAAAACA3cJSwuhd/+Z5tXMhj6lrX12
3fpn2r1OF7RX3m6yLLAfzPUIfIlNW82O9+G2tv2SBXsv7UIws95BczjyTgtz4SVMNOSGoG1sP12s
HQMRC+xaI7INkmWknOMhTBByP/TPkR0HBbj2IC7yEIltotK2bNrV5R53bqZhI1AiYnDjqhZYBOO6
8A8OeX0XNot2bYrAxgR2h0mUs7b7uRBbGmDgvlyIwNTe7OzsB4uMRb42f+E+XNoCT+7A4A8aX9D2
EjyPYfQcdzFhPA6weufnJksYxF2UwOT9pOl/y22gWJDdnjclfvdNFuy9GxcCAEBgAACBAQAEBu4N
+KjzcZCfgaydnyyE2zsTWGDg0ngOeF2vA441DD/OPKesA8SUtjrf+YIn+bWDsR/Zj6uzCCfC4slb
xc2UbUqRIVU7NYFXg6K23hH/RDS87IX0tbm5nsWPO/wiEY8ZSZ7YE1JG09ckHmKBv1cg8Gidhiem
ZQ7z4c0MaY3EeMGylre/eA4/0Yi0FdPECW1o3GR6yt+RXkyxuB1amckknv5d8JZXXK0Ot0smBQKH
imBzODLZu2C+ZJgeua/8mbwLtiVCFCdUwjkxTSEd1+UZi2IGtyQNf5NlY7oHIt/PIC5BYK67ddvs
UYwSkexr3tUy5U7MuVJN6822DY7rHUrvkUdpCONF82ldiGlAZDGZ62w8X8bQJLzz6oQjA1XgdD4w
lclAqzqnWOeeN8BNjkE+ZFX/RHEvGV9qXGUWIjObFh/YMFlupX0Y4wu1OhCWka+3f7TID7tb+0pd
bpvOlclzwtkziuDZNZy1ssOR40Jaf1nTWaJFWcvzxKyOw/ZMraNMTpbXaTzRIMNg0Jb+tnkSY+mu
y3COLfsRTpEXY2fWzchWZi0bON1x+kksepW8aiDaN6+1efMjvZqw58vdGRZnirwidjpQtgXUVnYs
EM/z+87V5lfJ/IId+dvcTfKmfL8nKi/v4PMkX+9AMNWn3PwmjjqE6D6lsDg89S/wHbjDLa7IJs8+
kj6JTgQGHtA0R3i6sO/qnj7UaMDe9rtr+iAwsOOYoH/6IDDQzC8+UfqvyI8WVzC2zX4G71s5mD+1
JGDRXoOT4uA2xa+7lPCDvwU2c9/hPLBWaWWeszVznteZZIlJ1eWMppyfB+ZktObZWHepG8pLeznC
RjPj6IqDZ11bneLXWkqYBOTod4fk+sD2MsH2EsA8ichjqwWH6wRPidgXp3S5otXWSx4O9u6AY5Bc
H9j5ZMGTBovMasEuVRxlsa0ftnW4EV8iLZpJfLNUO7LFFxX3T+CC/XM1uuSuFlzJjqgMrUG9yxbT
8QxB4GiX3LDCHae784o1LJnKp4Jv60wTwkpmIHCit622b+QSLWlr63W47Doo+bxhhWsw7FxfvxN3
dNPu3E7ezrXGzMoFSOb8XDeNkKRPSDPOmtNwUoMjC01SNX9rB3qAUHeZ2VOMlDy6nWx9Q2n+Dv+y
jsmTqjmRTMJkpjN40LdxyibzOHVh0kmO7nQQ9m/ALTestZRytJBSH89/mDPjH/YJHWv4bzg7n5zO
jFZ3UWap9LxAFRaYPBdCeCsBi/jXmeQcRhYVdhcRJnvERxmzSol1gHNKKD+f7ksJX52/yvTH9vH4
53xG6SPn13xSKDvwcKhinXxlZvqPMD0nULUFPjlWfZX2yAZ4NGUjF5SMsEL5vX/saDhURXehOTMl
8tkum0Y7J4MPinsnPnC2Q37hmscamYkle2fWaRYCuHcXIks811qqTCzVO7M+gzjg3jk8+bihLc0Y
WikajXBbZnLhzcACP5ojIYeu2+7DrVNWrz6SzgviMNFzASLGtDaz28lEeiU/AwtcA5cGXAgABAYA
EBgAQGAABAYAEBgAQGAAAIEBEBgAQGAA2AL/H+NpNjNzL4g4AAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-34" MODIFIED="2008-06-17 11:17:12 +0200" MODIFIED_BY="[Empty name]" NO="34" REF_ID="CMP-005.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.4 Use of antibiotic prophylaxis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAHgCAMAAACctSt2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-35" MODIFIED="2008-06-17 11:17:12 +0200" MODIFIED_BY="[Empty name]" NO="35" REF_ID="CMP-005.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.5 Blinded versus open label studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAHgCAMAAACctSt2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-36" MODIFIED="2008-06-17 11:17:12 +0200" MODIFIED_BY="[Empty name]" NO="36" REF_ID="CMP-005.06" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.6 Concealed versus unclear method of allocation.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAHgCAMAAACctSt2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-37" MODIFIED="2008-06-17 11:17:12 +0200" MODIFIED_BY="[Empty name]" NO="37" REF_ID="CMP-005.07" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.7 Published and reported data versus unpublished, unreported or abstract publications only.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAHgCAMAAACctSt2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-38" MODIFIED="2008-06-17 11:17:13 +0200" MODIFIED_BY="[Empty name]" NO="38" REF_ID="CMP-005.08" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.8 Size of study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAHgCAMAAACctSt2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-39" MODIFIED="2008-06-17 11:17:13 +0200" MODIFIED_BY="[Empty name]" NO="39" REF_ID="CMP-005.09" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Sensitivity analysis: Infection, outcome: 4.9 Worst case-best case.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAJwCAMAAACwOyeoAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-40" MODIFIED="2008-06-17 11:17:13 +0200" MODIFIED_BY="[Empty name]" NO="40" REF_ID="CMP-001.07" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.5 Parenteral antibiotic treatment.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqsAAADACAMAAAAUadpzAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-41" MODIFIED="2008-06-17 11:17:13 +0200" MODIFIED_BY="[Empty name]" NO="41" REF_ID="CMP-001.08" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.6 Overall mortality during chemotherapy.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs8AAAEwCAMAAAB/gGzUAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-42" MODIFIED="2008-06-17 11:17:13 +0200" MODIFIED_BY="[Empty name]" NO="42" REF_ID="CMP-001.09" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.7 Infection related mortality during chemotherapy.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs8AAAFACAMAAAB0omEVAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-43" MODIFIED="2008-06-17 11:42:43 +0200" MODIFIED_BY="[Empty name]" NO="43" REF_ID="CMP-001.10" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.8 Complete response.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs8AAAFQCAMAAAB3dGOOAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-44" MODIFIED="2008-06-17 11:42:43 +0200" MODIFIED_BY="[Empty name]" NO="44" REF_ID="CMP-006.07" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Sensitivity analysis: Complete response, outcome: 5.7 Size of studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAIACAMAAABdMOEtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-45" MODIFIED="2008-06-17 11:42:39 +0200" MODIFIED_BY="[Empty name]" NO="45" REF_ID="CMP-006.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Sensitivity analysis: Complete response, outcome: 5.1 GM-CSF versus G-CSF.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAIACAMAAABdMOEtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-46" MODIFIED="2008-06-17 11:42:38 +0200" MODIFIED_BY="[Empty name]" NO="46" REF_ID="CMP-006.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Sensitivity analysis: Complete response, outcome: 5.2 HD versus NHL.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAIACAMAAABdMOEtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-47" MODIFIED="2008-06-17 11:42:38 +0200" MODIFIED_BY="[Empty name]" NO="47" REF_ID="CMP-006.03" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Sensitivity analysis: Complete response, outcome: 5.3 Age.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAIACAMAAABdMOEtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-48" MODIFIED="2008-06-17 11:42:37 +0200" MODIFIED_BY="[Empty name]" NO="48" REF_ID="CMP-006.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Sensitivity analysis: Complete response, outcome: 5.4 Use of antibiotic prophylaxis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAIACAMAAABdMOEtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-49" MODIFIED="2008-06-17 11:42:37 +0200" MODIFIED_BY="[Empty name]" NO="49" REF_ID="CMP-006.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Sensitivity analysis: Complete response, outcome: 5.5 Blinded versus open label studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAIACAMAAABdMOEtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-50" MODIFIED="2008-06-17 11:42:36 +0200" MODIFIED_BY="[Empty name]" NO="50" REF_ID="CMP-006.06" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Sensitivity analysis: Complete response, outcome: 5.6 Published and reported data versus unpublished or unreported data.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAIACAMAAABdMOEtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-51" MODIFIED="2008-06-17 11:17:19 +0200" MODIFIED_BY="[Empty name]" NO="51" REF_ID="CMP-006.08" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Sensitivity analysis: Complete response, outcome: 5.8 Worst case - best case.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAKwCAMAAABH+vJYAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-52" MODIFIED="2008-06-17 11:17:19 +0200" MODIFIED_BY="[Empty name]" NO="52" REF_ID="CMP-001.11" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.11 Adverse events: bone pain.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArsAAAEQCAMAAACHjkwAAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-53" MODIFIED="2008-06-17 11:17:19 +0200" MODIFIED_BY="[Empty name]" NO="53" REF_ID="CMP-007.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 Sensitivity analysis: Bone Pain, outcome: 7.1 GM-CSF versus G-CSF.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArEAAAHACAMAAACCksDmAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-54" MODIFIED="2008-06-17 11:17:19 +0200" MODIFIED_BY="[Empty name]" NO="54" REF_ID="CMP-007.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 Sensitivity analysis: Bone Pain, outcome: 7.2 HD versus NHL.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArEAAAHACAMAAACCksDmAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-55" MODIFIED="2008-06-17 11:17:19 +0200" MODIFIED_BY="[Empty name]" NO="55" REF_ID="CMP-007.03" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 Sensitivity analysis: Bone Pain, outcome: 7.3 Age.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArEAAAHACAMAAACCksDmAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-56" MODIFIED="2008-06-17 11:17:20 +0200" MODIFIED_BY="[Empty name]" NO="56" REF_ID="CMP-007.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 Sensitivity analysis: Bone Pain, outcome: 7.4 Blinding.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArEAAAHACAMAAACCksDmAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-57" MODIFIED="2008-06-17 11:17:20 +0200" MODIFIED_BY="[Empty name]" NO="57" REF_ID="CMP-007.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 Sensitivity analysis: Bone Pain, outcome: 7.5 Concealment of allocation.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArMAAAHACAMAAACGZxDbAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-58" MODIFIED="2008-06-17 11:17:20 +0200" MODIFIED_BY="[Empty name]" NO="58" REF_ID="CMP-007.06" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 Sensitivity analysis: Bone Pain, outcome: 7.6 Study size.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArEAAAHACAMAAACCksDmAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-59" MODIFIED="2008-06-17 11:17:20 +0200" MODIFIED_BY="[Empty name]" NO="59" REF_ID="CMP-001.12" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.12 Adverse events: thrombosis and related complications (TIA, MI, cerebral non-hemorhagic infarction).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsEAAADQCAMAAADRekxRAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-60" MODIFIED="2008-06-17 11:17:21 +0200" MODIFIED_BY="[Empty name]" NO="60" REF_ID="CMP-001.13" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.13 Adverse events: skin rash.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArQAAACgCAMAAADKOA9MAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-61" MODIFIED="2008-06-17 11:17:21 +0200" MODIFIED_BY="[Empty name]" NO="61" REF_ID="CMP-001.14" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.14 Adverse events: injection site reaction.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArQAAACgCAMAAADKOA9MAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-62" MODIFIED="2008-06-17 11:17:21 +0200" MODIFIED_BY="[Empty name]" NO="62" REF_ID="CMP-001.15" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.15 Adverse events: myalgia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqYAAACgCAMAAADpY16ZAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-63" MODIFIED="2008-06-17 11:17:01 +0200" MODIFIED_BY="[Empty name]" NO="63" REF_ID="CMP-001.16" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.16 Adverse events: mucositis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArMAAADACAMAAAAgEBtvAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-64" MODIFIED="2008-06-17 11:17:00 +0200" MODIFIED_BY="[Empty name]" NO="64" REF_ID="CMP-001.17" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.17 Adverse events: headache.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAoIAAABwCAMAAAC96+EcAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-65" MODIFIED="2008-06-17 11:16:20 +0200" MODIFIED_BY="[Empty name]" NO="65" REF_ID="CMP-001.18" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 G-CSF/GM-CSF versus control, outcome: 1.18 Withdrawals due to adverse events.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArsAAADQCAMAAAAwEVkAAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-06-09 12:04:35 +0200" MODIFIED_BY="Nicole Skoetz">
<APPENDIX ID="APP-01" MODIFIED="2008-06-09 12:04:35 +0200" MODIFIED_BY="Nicole Skoetz" NO="1">
<TITLE MODIFIED="2008-06-09 12:04:32 +0200" MODIFIED_BY="Nicole Skoetz">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-06-09 12:04:35 +0200" MODIFIED_BY="Nicole Skoetz">
<P>#1 the highly sensitive strategy for identifying reports of randomised controlled trials (<LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>)<BR/>#2 G?CSF*<BR/>#3 GM?CSF*<BR/>#4 CSF*<BR/>#5 RHUG?CSF*<BR/>#6 RHUGM?CSF*<BR/>#7 RHG?CSF*<BR/>#8 RHGM?CSF*<BR/>#9 R?METHUG?CSF*<BR/>#10 (H?EMATO* near GROWTH* near FACTOR*)<BR/>#11 ((COLON* near STIMULAT*) near FACTOR*)<BR/>#12 (GRANULO?YT* near FA?TOR*)<BR/>#13 (MA?ROPHAG* near FA?TOR*)<BR/>#14 FILGRASTIM*<BR/>#15 LENOGRASTIM*<BR/>#16 REGRARMOSTIM*<BR/>#17 ECOGRARMOSTIM*<BR/>#18 MOLGRARMOSTIM*<BR/>#19 SARGRARMOSTIM*<BR/>#20 NEUPOGEN*<BR/>#21 LEUKINE<BR/>#22 LEUCOMAX<BR/>#23 GRANOCYTE<BR/>#24 COLONY-STIMULATING-FACTORS*:ME<BR/>#25 (#2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24)<BR/>#26 LYMPHOMA*:ME<BR/>#27 HEMATOLOGIC-NEOPLASMS*:ME<BR/>#28 LYMPHOM*<BR/>#29 HODGKIN*<BR/>#30 NON-HODGKIN*<BR/>#31 NONHODGKIN*<BR/>#32 IMMUNO?YTOM*<BR/>#33 ((HAIR* next CELL*) near Leu*)<BR/>#34 BURKIT*<BR/>#35 SEZARY*<BR/>#36 (MYCOS* next FUNGO*)<BR/>#37 (HEMATO* near MALIGN*)<BR/>#38 (HAEMATO* near MALIGN*)<BR/>#39 (HEMATO* near NEOPLAS*)<BR/>#40 (HAEMATO* near NEOPLAS*)<BR/>#41 (#26 or #27 or #28 or #29 or #30 or #31or #32 or #33 or #34 or #35 or #36 or #37or #38 or #39 or #40)<BR/>#42 ( #1 and #25 and #41)</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>